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9by Richard Hartnoll
Why this monograph?
‘How many addicts are there?’ is a question commonly asked. Unfortunately, the
answer tends to be either that ‘no one knows’ or that ‘experts consider that the num-
ber could be more than 100,000’, with no indication of what counts as an addict or
of whether there is any sound scientific basis for the figure. The problem is com-
pounded when the question is phrased in terms of comparative figures for the preva-
lence of ‘addiction’ in different countries. 
This scientific monograph directly addresses the question of how to obtain preva-
lence estimates that, scientifically, are more valid and comparable. It does not aim
to offer a definitive answer to the question of how to estimate prevalence, but rather
to reflect the state-of-the-art in European countries and to provide guidance for
future studies.
The monograph is the result, although by no means the final outcome, of a
process that began in 1993 when epidemiology experts of the Pompidou Group
of the Council of Europe began to discuss how to improve prevalence estimates
in Europe. These discussions, and a review of approaches used in different coun-
tries, led to a proposal to hold a Scientific Seminar. The proposal finally came to
fruition in June 1996 in a joint seminar on ‘Addiction Prevalence Estimation:
Methods and Research Strategies’ organised in Strasbourg by the Pompidou
Group and the EMCDDA. Over 80 scientists from 30 countries attended the
meeting and many of the papers they presented at the event form the basis of this
book. 
Following the Seminar, the papers were sent to other experts for ‘peer review’ and
then passed on to Professor Gerry Stimson who, together with an editorial group,
organised and edited the material into its present format, in some cases asking the
authors to revise their contributions. 
A separate follow-up to the Seminar was the initiation, by the EMCDDA, of two pilot
projects to develop and improve prevalence estimation at local and national levels
respectively. The first project focuses on comparative three-sample capture-recap-
ture estimation methods in different cities while the second looks at whether the def-
initions, methods and assumptions used in national prevalence estimates in certain
countries can be applied in others so as to provide more comparable results. The
reports from these two projects will be submitted to the Centre at the end of 1997
and the work further developed in the coming years. 
General Introduction
10
General Introduction
Prevalence of what, and why?
One of the traditional methods used to measure the prevalence of drug use in a
population is a survey based on random sampling of the population concerned.
However, there are some types of drug use which often cannot be assessed reliably
by this method, notably rarer and/or more stigmatised or problematic patterns of
drug use, such as drug injecting or heroin addiction. Thus, alternative strategies are
needed to complement the information obtained from population surveys.  
The title of the Strasbourg Scientific Seminar used ‘addiction’ as a short-hand term
to indicate that the emphasis was on methods for investigating the prevalence of
heavier patterns of drug use (e.g. frequent or high-dose consumption or drug-inject-
ing) that have a higher risk of problematic consequences, such as dependence or
HIV infection, and that may require interventions such as treatment or secondary
prevention.
This, however, raises a problem. What is to be counted? Or in other words, what is
the case definition?  In some studies, the definition refers to heroin dependence, in
others, to daily or almost daily use of any illegal drug (including cannabis) and/or
any drug injection. How can researchers be sure of the criteria actually used (e.g. by
treatment staff or police officers) to record cases in the original databases on which
they rely? If this is not clear, then what population does the estimate describe? The
theme of case definition, and of the uncertainty that this implies for any estimate,
runs through many chapters of this monograph. It is one of the central issues that
must be addressed and discussed honestly whenever presenting or comparing the
results of prevalence studies.
The answer to the question of what is being measured is closely linked to the purpose
of the estimate. If the purpose is to assess possible treatment needs, then the defini-
tion should relate to potential clients, either now or in the future. If it is to assess the
possible demand, and thus the illicit market, for a drug such as heroin, then all hero-
in users should be included, regardless of whether they are likely to seek treatment.
More overtly, political demands for prevalence data may push the definition in other
directions. There is no simple answer to this, apart from stressing the vital point that
it is essential to specify, as clearly and as consistently as possible, what criteria have
been used and what these might imply about the resulting estimate.
A further point regarding the uses of prevalence data is that a prevalence figure is
only a starting point for obtaining relevant information about a largely hidden
phenomenon. In itself, a number or a rate does little more than establish the approxi-
mate dimensions of ‘addiction’ or ‘problem drug use’. Putting a figure to a problem
may reduce some of the anxiety and wild estimates that are aroused by an unknown
and apparently threatening phenomenon. It may also indicate, in a general fashion,
whether there is a problem and whether there are sufficient treatment or other ser-
vices to cope with it. In some cases, it may also be used to justify a decision to
increase spending on such services. However, it is the information that lies behind
the bald prevalence figure that is important: not simply how many addicts there are,
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but what kind of addicts, with what problems and needs, and living in what sections
of the community, under what circumstances. 
It is thus important that prevalence estimates lead on to other more discriminating
studies that provide information that is relevant to action, policy development and
service provision. Good prevalence estimates may help to establish a consensus
about the dimensions of the phenomenon and reduce the energy wasted on argu-
ments about the problem based on uninformed and unscientific points of view.
However, this is only the beginning.
Overview of the state-of-the-art of prevalence estimation in Europe 
A variety of methods are available for estimating the prevalence of heavier or more
problematic patterns of illegal drug use, for example drug dependence. These
include: population-based surveys (although, as mentioned earlier, these are often
unreliable for rarer, stigmatised and hidden patterns of drug use); case-finding stud-
ies; capture-recapture estimates; multiplier techniques (e.g. based on the number of
addict deaths and the mortality rate amongst addicts); nomination techniques,
including snowball sampling; synthetic estimates, based on social or demographic
variables assumed to correlate with drug prevalence; and a variety of more sophis-
ticated statistical modelling approaches.
Some of these methods have been applied in different European countries, although
only in a few countries has a body of expertise and experience in prevalence esti-
mation begun to develop. In most cases, the more scientific and rigorous methodo-
logies have been applied at local (e.g. city) rather than national level. Reliable
national estimates are rather rare. At all levels, more attention needs to be paid to
the question of case definition.
Table 1 (overleaf) summarises the different methods that have been tested in
European countries. In many instances, they are based on data produced by various
registers or case-reporting systems (e.g. treatment notifications or police registers) or
by active case-finding methods. An increasingly popular method uses such sources
to apply statistical estimation techniques, in particular capture-recapture, whilst 
others use them to make extrapolations, for example by taking account of the time-
lag between starting to use drugs and first entering treatment, or by applying multi-
pliers obtained by nomination techniques. Various other multiplier methods are
used, especially the addict-death multiplier, although it is all-too-frequently applied
without paying sufficient attention to important sources of error. A few countries
derive estimates from population surveys, whilst in others, a less scientific approach
involves combining estimates obtained from a range of key persons. Several snow-
ball studies have been conducted, but these do not usually generate prevalence esti-
mates per se, unless they are combined with nomination techniques (which is
unusual). More sophisticated statistical models have not often been applied. 
In a few cases, attempts have been made to compare and cross-validate the estimates
produced by different methods. These indicate that, when careful attention is paid to
12
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the likely directions of bias in each estimate, it is possible to arrive at a reasonable
‘best estimate’ of the probable range within which prevalence lies. They also show,
however, that it is rare to achieve identical estimates, underlining one of the impor-
tant conclusions of this monograph, that there is no one ideal method that can be
considered as a ‘gold standard’, and that it is always wise to compare different meth-
ods in the knowledge that the answer will be an approximate range rather than a pre-
cise figure. Thus, apart from improvements in specific methods, it is also important to
develop research strategies for obtaining estimates based on more than one method
or set of assumptions. At European level, it is also essential to develop common 
instruments and methodologies so that the results can be better compared.
Table 1:  “Addict” Prevalence estimates - methods tried
POTENTIAL BASIS                                ESTIMATION METHODS TRIED
FOR ESTIMATES                                        (NATIONAL OR LOCAL)
Registers1 Case          Capture       Death     Nomination     Survey       Other2
(T)              (P)           FInding      Recapture   Multiplier
Austria ? 
Bulgaria ? ? (k)
Croatia ? ? (k)
Czech Rep.  ?
Denmark   (k)
France  (e)
Germany      (e)
Hungary  ?
Ireland  
Italy   
Luxembourg    (e)
Malta 
Netherlands    
Norway 
Poland    
Russia 
Slovenia ? ? (k)
Slovakia ?
Spain      
Sweden   (k)
Switzerland  ?  (k)
United Kingdom        (e
1 Registers: (T) = treatment; (P) = police.
2 Other: (k) = key persons; (e) = extrapolation.
Finally, prevalence estimates are only as good as the data on which they are based.
The science of estimation cannot improve unless the data collection and databases
on which they rely also improve. This means that it is as important, if not more so,
to invest time and energy in achieving good data quality in the reporting systems,
registers, surveys and other studies as it is to develop ever more sophisticated meth-
ods for analysing these data.
Structure of the monograph
The outline of the monograph follows the broad structure of the Strasbourg Seminar.
It begins with chapters on the relationship between scientific prevalence estimates
and policy since, as noted earlier, prevalence estimation takes place within a polit-
ical context. It then deals with case-finding methods, not because they provide a
prevalence estimate in themselves, but because they are a basis for many of the 
more reliable estimation methods and because discussing them raises key issues of
case definition, double-counting and data quality. 
The following three sections deal with the methods most commonly used in Europe.
The first of these is capture-recapture, which directly uses data collected through
techniques such as case-finding. Whilst this is a promising and interesting approach,
the elegance and deceptive simplicity of the basic model hides difficult methodo-
logical issues of sampling bias, interdependence between samples and interpretation
of the results.  
The subsequent two sections deal with other single-method approaches to prevalence
estimation: multiplier methods and nomination techniques. The former, especially the
addict-death multiplier, also appears deceptively simple but is based on assumptions
about the quality of mortality data and the relationship between mortality and preva-
lence that are often unjustified. At national level, however, some sort of multiplier
approach may at times be the only way forward, especially in larger countries.
Nomination methods, which may be linked to snowball sampling techniques, are an
alternative approach to obtaining multiplier estimates. Under certain circumstances
they may also be used in estimates based on analysis methods similar to those found
in capture-recapture.  
The final section of the monograph is concerned with combining and comparing dif-
ferent estimation methods. This makes it clear that there is no standard combination
of methods that can easily be applied in all circumstances. Rather, it is the local or
national conditions that provide the context, and the limitations, within which
researchers have to work. It is for this reason that information exchange, dialogue
and collaboration between researchers is essential to understand better, not only
which methods are most appropriate under what conditions, but also to improve
mutual understanding between researchers of how far, and in what way, estimates
can be compared and how far they cannot. We hope that this monograph con-
tributes to this understanding.
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Introduction
by Gerry V. Stimson
n this first section of the monograph, the authors examine the relationship
between epidemiological work on the estimation of drug problems, and the
development of drugs policy and strategy. A recurrent theme is that there is a 
complex relationship between science and policy.
Gerry Stimson and Ali Judd examine different models of the interaction between sci-
ence and policy. They warn against undue optimism that epidemiological data will
be used by policy makers and influence policy, and suggest that both epidemiolo-
gists and policy makers need to find ways to bring evidence into the policy-making
process. They identify several key questions to which policy makers might expect
answers. These concern: the extent of drug use; who is using drugs; the nature of the
health, social and criminal problems connected with drug use; the scale of costs to
the individual and society; whether the problem is getting worse or better; whether
(and what) can be done; and the impact of interventions.
Peter Cohen also explores the relationship between prevalence estimation and pol-
icy interests. He argues that epidemiological data are not neutral. Epidemiologists
may – quite rightly – argue about technical issues. However, the kinds of data that
are collected, and the manner in which they are analysed and interpreted, depend
on the policy framework. Estimation issues, he suggests, are not merely technical but
are also strategic. He illustrates this argument by examining the data requirements –
i.e. what to estimate – under three different policy models – repression, harm reduc-
tion and cultural integration. He ends the chapter with a discussion on whether there
can be general indicators that are useful across different models of drug policy.
Philip Lazarov presents a case study of the utilisation of data on drug use for the
development of drug policy and interventions. Drawing on experience in Bulgaria,
he highlights the responsibilities that drug policy makers have in educating govern-
ments and the public. He makes a strong plea for the usefulness of good data in sen-
sitising society, and in helping to implement and develop policies, programmes and
projects. In many contexts, good prevalence data and estimations will often be hard
to obtain. Following the experience of the Pompidou Group Multi-City Study, he
argues for the strategic use of both qualitative and quantitative data.
I
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Estimating the Scale and Nature 
of Drug Problems: the Relationship between
Science, Policy and Drugs Strategy
by Gerry V. Stimson and Ali Judd
The European Monitoring Centre for Drugs and Drug Addiction and the Pompidou
Group of the Council of Europe have a key role to play in initiating scientific debate
and development in the drugs field, and in making the science of epidemiology
understandable and relevant to the needs of policy makers.
The task of estimating the scale and nature of drug problems, and of encouraging
policy makers to use that information, is ambitious and will span many years to
come. The task is ambitious for two reasons. Firstly, the science of estimating drug
problems is still in a relatively undeveloped state. Considerable international work
has already been undertaken in this field and there are many landmark methodo-
logical achievements in both the direct and indirect estimation of the scale and
nature of drug problems (Brodsky, 1985; Cormack, 1992; Hartnoll et al, 1985;
Woodward et al, 1985). This monograph has many examples from across Europe of
the development, application and comparison of different methods of indirect esti-
mation.
However, despite growing concern about drug problems, there is still much to know
about the actual extent, nature and consequences of illicit drug use in Europe.
Epidemiological expertise and methodological sophistication have to develop con-
sonant with the demands for information and understanding. There is a need for
more reliable and valid information about the extent, patterns and distribution of
illicit drug use, changes in patterns of drug use over time, and the natural history of
consumption and the development of associated health and social problems. It
remains unclear to what extent the use and misuse of drugs is associated with
increased morbidity and mortality. Existing indicators inadequately reflect the range
of health and social problems that are linked to drug misuse. This monograph aims,
therefore, to give a European overview of the current ‘state-of-the-art’ in the field of
epidemiological estimation of drug problems.
The second difficulty regards the state of drug policy-making in Europe. There is no
lack of interest in drug problems in Europe. A concern that drugs and drug addiction
are problems is one thing about which governments of Member States in the
European Union agree. There is an instinctive feeling that something is wrong, and
Chapter 1
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that something needs to be done about it. However, instinctive reactions are not
always a good basis for policy-making: whilst politicians may have passionate
debates about ‘drugs and drug addiction’, it remains unclear how far policy makers
are currently using scientific evidence in setting policy agendas and developing
strategic responses. 
Many researchers believe that they can contribute scientific evidence to policy-mak-
ing and strategic development. Therefore, the issue to be considered is whether sci-
ence can influence the policy-making process and influence the development of evi-
dence-based policy-making.
The relationship between science and policy
There is a growing interest in the relationship between science and policy. However,
at present, it is little more than an act of faith that science can lead to sensible policy-
making. Recent events concerning Bovine Spongiform Encephalitis (BSE) in Europe
serve as a good example to show that this relationship is not straightforward.
In an analysis of drug and alcohol research and policy, Virginia Berridge and Betsy
Thom have pointed out that the potential ‘for social science research to guide and
inform policy-making has, at various times, been greeted with enthusiastic optimism
and cynical pessimism’ (Berridge and Thom, 1996). There are some instances which
demonstrate the contribution of social science to policy debate and decision, but
there are also many instances where social science research has been ignored.
Social policy analysts have described several models of the relationship between
social science research and the policy-making process. 
A rational model of policy-making is based on the belief that ‘policy-making is a
rational process which calls on the scientifically derived facts of research to provide
the empirical evidence needed in decision-making’ (Berridge and Thom, 1996). In
this model, scientists are seen as being relatively autonomous and producing objec-
tive evidence which can be used and referred to by equally autonomous and objec-
tive policy makers. Due to the objective nature of the evidence, ideological differ-
ences between scientists and policy makers should not be of concern. However,
technical issues, such as a lengthy timescale for research, may hinder the imple-
mentation of research results into policy. Although it is possible to sympathise with
such a concept of the relationship between science and policy, the model can be
criticised for its over-simplification of this association in reality.
An alternative model promotes the concept that science offers enlightenment to the
policy-making process, rather than directly influencing it. The enlightenment model
suggests that the work of scientists, including their theories, ideas and findings, influ-
ences the policy process in a rather diffuse way. In this model, as Berridge and Thom
point out, policy and science are not separate spheres, but are ‘linked through net-
works of influence and policy communities where information and ideas are con-
stantly reviewed and exchanged’ (Berridge and Thom, 1996). Research permeates
21
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through many channels of influence, including the mass media, professional jour-
nals, and conversations with colleagues, thereby shaping the way that policy mak-
ers and the general public think about social issues (Weiss, 1986). Rather than
enabling policy makers to refer to the findings of specific studies, in this model, pol-
icy makers ‘have a sense that social science research has given them a backdrop of
ideas and orientations’ (Weiss, 1986). Research sensitises policy makers and others
to emerging issues. It may indeed change the debate and help define the policy
agenda, turning what were once non-problems into policy problems and vice versa.
Another, more cynical, model describing the relationship between science and pol-
icy subscribes to the view that science legitimises decisions that have already been
taken. This legitimation or political model (Weiss, 1986) suggests that research may
often follow key policy decisions and be used to justify changes that are already
under way and to deflect criticism of decisions that have already been made.
Decision makers may not always be receptive to new evidence elicited from scien-
tific research, and ‘for reasons of interest, ideology or intellect, they have taken a
stand that research is not likely to shake’ (Weiss, 1986). Research evidence is then
utilised to strengthen this predetermined stance of policy makers. Less cynically, this
relationship is understandable given the temporal link between the political imper-
atives for funding scientific research and the timescale of this research. The political
decisions need to be made now; the evidence for the decisions may take much
longer to produce.
Other models of the relationship between science and policy are discussed else-
where (see Weiss, 1986), and there may be some truth in all the various models.
However, the reason for highlighting them here is that they serve as a reminder that
social scientists work within political contexts. They also reveal that the relationship
between science and policy-making is not straightforward, that it brings both bene-
fits and dangers and holds out the prospects of triumphs and disappointments. The
optimal relationship between science and policy therefore needs to be developed.
Prevalence estimation and the policy decision-making process
Estimating the scale and nature of drug phenomena could have an important role in
drug policy-making but, as indicated, this role is in need of development. Social sci-
entists are not in the business of counting things for the sake of counting things. As
Peter Reuter has pointed out, ‘for conscientious policy makers dealing with drug
problems at the national and local levels, prevalence estimation ought to be a funda-
mental element of sensible decision-making’ (Reuter, 1993). In practice, prevalence
estimation has not been important in policy-making, either in setting the policy
agenda, or in the formulation and implementation of policy and its evaluation.
Policy-making decisions are all too often determined without consideration of 
prevalence data.
Thus far, much of the interest in prevalence estimation has been in providing gross
measures to show that a city or a nation has a large drug problem (Reuter, 1993).
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These measures are relatively simplistic and have had limited relevance to policy
makers. It may be important for them to know what percentage of the population has
had some experience of illicit drug use, and what proportion has had recent experi-
ence of it. It may be considered important to know what percentage of the popula-
tion has been exposed to particular risks, such as injecting, and what proportion has
problems linked with their drug use – for example, dependency or criminal justice
problems. However, it is doubtful that the knowledge that 15 versus 30 per cent of
young people are regularly using cannabis, or that 0.5 or 1.5 per cent of the popu-
lation has injected drugs, is going to make that much difference to the policy deci-
sion-making process.
As Reuter (1993) points out, what may be more important is the use of prevalence
estimates in order to improve decisions about the investment of resources in differ-
ent kinds of interventions, and in the assessment of the impact of these investment
decisions. For example, estimating the size of the population of problem drug takers
that may benefit from substance misuse treatment should be crucial in making a
decision about what resources to allocate to drug treatment. Similarly, investment in
a harm reduction programme, such as syringe exchange, needs to be based on evid-
ence about the size and location of the population at risk. Furthermore, estimating
the scale of drug-related crime, or the size of drug markets, can also lead to informed
decisions about investment in different kinds of interventions.
Prevalence estimates can hopefully be used to help in making decisions about 
where public money should be spent. Of course, this requires some consensus about
what the problems of drug use are and how they are to be addressed (see Chapter 2
by Peter Cohen). If drug use itself is seen as a harm, measures of the scale of drug
use, and estimations about how different interventions might influence the scale of
drug use, are needed. If it is specific harms to health that are of concern, such as
overdose or risk of infectious disease, then estimates of the specific target popula-
tions at risk of these problems are needed. If the concern is about the size of drug
markets, or the scale of drug-related crime, again the target population and measures
will differ, as will the interventions.
Key questions to which policy-makers 
might expect epidemiologists to provide answers 
It is helpful to anticipate the kind of questions that sophisticated policy makers might
ask. They might reasonably expect epidemiologists to provide answers to eight key
questions concerning the prevalence of drug use. These questions are phrased here
in lay, rather than scientific, terms.
The first question that might be asked is ‘What is the extent of the phenomenon?’
There are a number of ways in which the extent of the phenomenon might be
described, for example in terms of: the number of people involved; the number of
drug use events, exposures or risks; the amount of drugs consumed; or expenditure
on drug use. Note that many epidemiologists tackle the estimation problem in terms
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of the number of people who are affected. The questions asked by policy makers 
may not require people as the units of analysis.
The second question that policy makers might want to ask is ‘Who uses drugs?’ Do
drug use and drug problems affect different sectors of the population? Where are
these people located, both geographically and socially? What are the correlates and
characteristics of different kinds of drug use?
The third question is ‘What is the nature of the problem?’ Predominant concerns
have been about harms to the health of the individual, such as drug dependence, 
risk of infectious disease for those who inject drugs, acute accidents linked to con-
sumption, such as overdose and drug interactions, and drug-related behavioural
incidents, such as risks related to driving motor vehicles. There are also concerns
about criminal activities and drug use, including the cost of drug-related crime,
threats to public order and public safety through to drug-related intoxication and
affronts to public sensibility. There are also concerns about the ability, or otherwise,
of the individual to perform social roles in the family, as an income earner and in
terms of social relationships.
The fourth question pertains to the costs incurred from drug use, including the health
care costs of helping and treating people, the costs to victims of crime, criminal jus-
tice costs, and the cost of morbidity and mortality on lost productivity.
The fifth question that policy makers will want to ask is ‘Is the problem getting 
worse, or is it getting better?’ Many estimates are point prevalence figures, but poli-
cy makers are more interested in trends over time. Situations may be deteriorating
because more people are involved or because they have worse outcomes. This may
strengthen the arguments for interventions. On the other hand, drug use trends may
reverse and this might give policy makers an opportunity to congratulate themselves
and divert resources elsewhere.
Drug use patterns and practices change rapidly. The growth of injection of illicit
drugs in Europe is a good example. The first diffusion of drug injecting occurred 
in Europe in the early 1960s. Whilst each country within Europe has its own spe-
cific history of drug injecting, it is significant that trends in the diffusion of drug
use often transcend national boundaries. Increases in the use and injection of
heroin were seen across Western European cities in different stages and waves in
the early 1970s and again in the 1980s (Stimson, 1996). The spread of unwanted
consequences may also be fast. Here again injecting provides a good example,
with the rapid spread of HIV infection associated with injecting in many European
cities in the mid-1980s.
The epidemiological task must, therefore, move beyond point prevalence estimation
and towards an understanding of the dynamics of changes in drug use over time (see
Chapter 18 by Ludwig Kraus). This involves serial estimation of incidence and preva-
lence. Prospective developments in social epidemiology are the application of the
diffusion of innovation theories (Rhodes et al, 1996), the use of social geographic
techniques to describe and predict the spread of new substance consumption pat-
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terns and practices, and socio-demographic mapping of the links between drug use
and social condition (Giggs et al, 1989; Pearson and Gilman, 1994; Squires et al,
1995).
The sixth question is about the causes of new patterns of drug use. This is not a ques-
tion which many politicians like to ask in public, particularly those in governments
that have been in power over the period in which drug problems have developed. 
It is notable also that social scientists have been unable to give clear answers to such
questions. It is necessary to examine causal issues at the level both of the individual
and the community. Regarding the latter, a social epidemiology would attempt to
explain and predict, as well as to describe, the epidemiology of drug use (Rhodes et
al, 1996). The sub-regional diffusion of injecting may provide important case mate-
rial. However, because epidemiologists have mostly been concerned with trends
within their own cities and countries, there has been no attempt to develop a model
for the diffusion of drug use practices across Europe as a whole. Cross-regional stud-
ies of past and current epidemic dynamics are required. 
The seventh question on which policy makers might seek advice is ‘Can anything be
done about drug use? and, if so, what?’ It is here that the relevance of epidemiology
to the development of interventions is apparent. Epidemiology should be able to
describe the characteristics of the target population in order to indicate the scale and
nature of interventions required, but it requires other expertise to advise on the
appropriate kinds of interventions.
The eighth question on which policy makers may require advice is about the impact
of their policies. Epidemiology should contribute to the assessment of the impact of
interventions. For example, if treatment is effective for certain drug problems, one
indicator of whether an intervention is successful is the ability of services to attract
problem drug users into treatment – therefore, it is necessary to develop measures to
determine the ratio of those problem drug users in and out of contact with helping
services.
Why estimate?
The above questions may seem relatively straightforward, so what are the difficul-
ties? Why is it necessary to be concerned with the methodological issues of esti-
mating drug problems? Difficulties in describing the extent, nature and impact of
substance use and misuse present considerable scientific challenges, as described in
other chapters of this book. Drug use is usually illicit and hidden and subject to
rapidly- changing fashions. Routine surveillance sources remain only partially vali-
dated, are of variable coverage, and measure only a part of the phenomenon.
Research studies are usually conducted on selected populations of unknown repre-
sentativeness, and with little opportunity for methodological development or col-
lection of time-trend data. Some household surveys have included questions on illic-
it drug use, but doubts remain about their ability to elicit reliable and valid data
about illicit and socially-disapproved behaviour. Properly conducted population sur-
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veys require large samples in order to identify behaviours that may only be quite rare
in the population (but see Chapter 7 by Paul Griffiths and colleagues).
Therefore, the reasons for estimating are connected with the nature of the pheno-
menon – serious drug problems are sufficiently rare to be difficult to measure
through other means, and estimation may be cheaper than more direct methods. 
This monograph describes a number of methods that are used for indirect estimation
including capture-recapture (Part III), the use of multipliers (Part IV), and nomination
(Part V). These are under-pinned by case-finding methods (Part II). 
Conclusions
Two emerging problems which were identified at the beginning of this paper were
the need to develop epidemiological expertise and the need to educate policy mak-
ers in the uses of information for making decisions about policies and strategies. This
is a critical time for scientific advances. The European Monitoring Centre, the
Pompidou Group and the scientific community have a major opportunity to show
policy makers that scientists can make an important contribution to policy-making.
However, scientists must be cautious – one of their first tasks is to convince policy
makers of the worth of the product that they are selling.
Inevitably there will be tensions between the desire for scientific rigour versus the
adequacy of information for decision-making. Scientists want precision, whilst
policy makers want only sufficient information to be confident that they have made
the correct assessment and taken the right decisions. There will be a tension 
between the time required to conduct good scientific work, and policy makers’
needs for quick information relevant to immediate action. There will also be ten-
sions about the cost of providing information and about whether investment in pro-
viding such information leads to an improvement in policy-making. 
Finally, epidemiologists need to be modest in what they think they can achieve and
the contribution that this will make to policy-making. Prevalence estimates are but
one kind of information that will be assessed along with a wide range of other infor-
mation. The astute policy maker needs to be able to understand the relevance of
prevalence estimates alongside a range of other information which provides a pic-
ture of the unfolding state of drug problems within our countries.
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The Relationship between 
Drug Use Prevalence Estimation 
and Policy Interests
by Peter D. A. Cohen
My comments will focus on the local level of drug use prevalence estimation. It is 
at the local level – often the city or local municipality – that most decisions are
taken, and where the relevance of good data and understanding for drug policy 
practice is highest. Furthermore, national estimation of drug use, or related behav-
iours and events, is difficult without reliable local data. If local data collection is
good, and covers the most important areas of a country, national data have a chance
of being of relatively sound quality.
In this chapter, I would like to discuss some problems related to the selection of appro-
priate methods for the estimation of drug use or heavy drug use. I do not propose to
cover everything, but will look at the kind of problems that have to be solved before
one begins this task or while analysing, interpreting and digesting the data. I will also
discuss questions about how clarity regarding a general model of drug policy can
improve the relevance and interpretations of local drug use data and estimations.
Data of reasonable quality are often available only in part or not at all, but once the
importance of collecting reliable data is recognised on the political level, this prob-
lem may be solved. Then, by means of good sampling, sound survey instruments 
and by means of good police registration techniques, prevalence and patterns of dif-
ferent kinds of drug use can be studied on a regular basis. Moreover, once treatment
institutions are in place, reliable treatment registration can also supply interesting
data sets. The inherent problems and potential for error in using particular methods
are not always fully grasped by those who use them. This means that the match
between type and quality of data and technique of analysis is sometimes poor.
I will not discuss here ways of making available reliable sets of local data or the sta-
tistical techniques to digest them. Solutions to ‘technical’ problems will only come
if the perceived political importance ascribed to data and good estimation rises to a
sufficiently high level. Therefore, most important for the selection of the most appro-
priate objects and methods of drug use research in general, and prevalence estima-
tion in particular, are problems of drug policy and the way drug policy is made. As
long as it is made without a heavy input from systematic and scientific data analy-
sis, the political basis for drug policy is not much more than emotion or orthodoxy
(Ehrenberg, 1996; Cohen and Sas, 1996; Boekhout van Solinge, 1996).
Chapter 2
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Every estimate has to be tailor-made to its proper use or functions. This implies that
estimation problems should not only be seen as technical, but also as strategic. What
exactly is there to estimate? To what broad or narrow policy aspect is the estimate of
relevance related? What precision of the estimate is required? Do we need the esti-
mate to be comparable to estimates made in other areas? What are the political
implications of the estimates? In other words, the sophistication of drug policy itself
has a strong influence on the quality of the estimation process.
Drug policy models and what to estimate
Let us take the example of general prevalence estimation of frequent and/or heavy
heroin use. In what policy model can such an estimate perform a role? Let us
assume, for the sake of brevity, that we have three distinct policy models. One is a
predominantly punitive and repressive model, the second a harm reduction model
and the third what we might define as a cultural integration model.
In the repressive model, the dominant aim is to suppress all drug use. Estimators will
probably work with a definition of ‘drug addiction’ that includes all types of heroin
use since, in this model, all types of heroin use are considered harmful and abusive.
Estimation needs will encompass all forms of heroin use, intravenous or not, regular
or not, and problem-related or not. The size of the heroin problem is more or less
the size of heroin use prevalence. The function of this estimate repeated over time 
is to assess the success of suppression. If estimates are reliable and go down, sup-
pression is deemed successful. If estimates go up, suppression is not considered suc-
cessful enough and has to be increased or changed in scope and implementation. 
Prevalence estimates in the punitive model are used to evaluate the short-term success
of suppression techniques and not their intrinsic merits in relation to another model of
drug policy. It is also possible that, in a particular version of the punitive model, the
size of the heroin-using population is not so important, but the number of heroin-over-
dose deaths is. The number of emergency room visits of heroin consumers may also 
be deemed important. The latter data probably say more about the conditions sur-
rounding drug use than about the seriousness of the problem (in terms of the number
of users) but the public or politicians often do not perceive this. In a repressive model,
these types of data represent deterrence, and giving them a high profile is part of the
policy. In such a case we will sometimes find that extremely high prevalence estimates
may play a role, either in the press or in the speeches of politicians. Such estimates 
may simply be anecdotal (if not worse) but this fact is easily clouded behind the emo-
tional appeal which is the real function of such estimates.
In a harm reduction model, the aim is still to reduce drug use in general, however,
the emphasis is not placed on punitive action but on the prevention of potential
harmful effects of drug use behaviour and drug distribution. It allows for the fact that
drug use exists and will continue. In spite of the goal being to reduce its prevalence,
reducing individual and social risks of the existing types of drug use is seen as a
major concern.
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As far as this model is concerned, the need for data could be very different from
demands made in the repressive model of drug policy. Policy makers who work with-
in a harm reduction model are mainly interested in the number of heroin users who
are clients and potential clients for harm reduction intervention, be it medical or non-
medical. Such clients could belong to quite different sub-groups. One sub-group may
consist of drug injecting prostitutes working on the street under marginalised condi-
tions, another might be prostitutes working in a completely different site of the sex mar-
ket, such as clubs or expensive brothels. Other sub-groups might consist of homeless
users, inmates, ethnic groups or students and employees. Providing assistance to each
of these sub-groups – where needed – is deemed important. However, the attention
given to these different groups will probably have different policy priorities, different
budget consequences and different kinds of political usefulness.
Estimates in this model serve for the assessment of the treatment and assistance
needs of particular groups based on knowledge about drug use and risk patterns in
these groups. The estimates may also be needed to find out if some groups remain
without adequate assistance. For instance, one may have data that generate esti-
mates of high injecting drug use in certain ethnic groups, but these groups are rarely
seen in institutions which give assistance. In that case, the treatment system will have
to be able to relocate or devise new options. Similarly, in the Dutch city of
Rotterdam, a general increase in the use of base cocaine by heavy drug users has
been reported (Grund, 1993; Visser, 1996; van Swol, 1996). The adequacy of the pre-
sent methadone-based treatment system – designed for heroin users – has to be
investigated in the light of these developments.
Another function of estimations in a harm-reducing policy model is related to evalu-
ating the level of harm reduction that is characteristic of the context of particular
kinds drug use. For instance, if drug overdose deaths are reliably estimated (by
excluding double counting, by including corrections for false cause of death regis-
tration and by maintaining unambiguous definitions) and these estimates rise, some-
thing may be wrong with the style of police activity in a city. Crude suppression may
result in high variability of drug purity, unavailability of quiet drug use locations and
so on. This, in its turn, could result in rising numbers of drug overdose deaths. Since
drug policy in a harm reduction model aims at reducing risks, changes in the style
and intensity of police suppression may be more important for risk reduction than
the development of accessible assistance institutions.
If one investigates the prevalence of injecting drug use in a particular city and finds
that it is much higher than elsewhere, one might start to investigate the possible rea-
sons for this. In Amsterdam, among the population of heavy heroin users, only a
minority inject and a large majority (about 70 per cent) are smokers of heroin (Korf,
1995; Grapendaal et al, 1995). In Amsterdam, those who inject have a higher mor-
tality than the non-injectors (van Haastrecht et al, 1996). Although this difference
might not apply in other settings, it is very interesting from the point of view of local
mortality prevention. Would it be possible to decrease heroin-related mortality in
cities by having heavy users change their route of ingestion? Could we find out under
what conditions (heavy) current heroin users abandon injection as the route 
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of ingestion, or new users start by smoking heroin rather than injecting it? Might
cheap heroin base, of stable and relatively high purity, provide such a condition? Is
such a condition attainable if law enforcement against individual heroin use and
sales is given a low priority, as is the case in Amsterdam? In this example, the avail-
ability of the estimate of low prevalence of injecting drug use among heavy heroin
users in Amsterdam is the starting point for broader drug policy questions.
In the third policy model, that of cultural integration, the main aim is no longer to
suppress drug use per se. The overall aim is to bring drug use under the normal regu-
latory mechanisms societies have for controlling accepted behaviour and attributing
meanings to behaviour. Drug use in this model is as ‘normal’ as are its problems. In
the Netherlands, this approach is called ‘normalisation of drug use’ (Engelsman,
1989) and it implies explicitly that possible problems are no longer treated as
extreme or principally different from other social problems, such as traffic, broken
marriage or stress in the office. In this policy model, the basic aims are exactly oppo-
site to those of the suppression model: in the latter, drug use is maximally ostracised
and marginalised. In this model, it is integrated into the normal social process.
In the cultural integration model of drug control, the need for data is different. One may
want to know how many heavy drug users are treated in the normal care system (e.g. 
by general practitioners and hospitals) and how many are still referred to special insti-
tutions. Taking care of heavy drug users in special institutions pertains more to repres-
sive and harm reduction models where heavy drug use is so deviant and its problems 
so special that those concerned need these special institutions.  But, as we can see in
the field of alcohol use (which is culturally integrated in the Netherlands), much of the
treatment takes place in the normal system. In the Netherlands, it is mostly general prac-
titioners who prescribe vitamins, monitor health status and refer to other health care
when needed. Only very few of the heavy alcohol users are referred to specialised insti-
tutions. In repressive and harm reduction systems, heavy drug users are still seen as so
deviant that most do not have a chance to be treated in regular psychiatric institutions,
although a certain percentage of them would need such treatment. (In spite of ‘normal-
isation’ attempts in Amsterdam, the Municipal Health Service has had to set up a small
psychiatric care unit within the Municipal Health Care system for heavy drug users). 
Other data that could be needed in a cultural integration model would focus on
what social processes hinder cultural integration. A good example is the shift from a
repressive policy model around homosexuality in the Netherlands towards a cultur-
al integration model. With the latter, it is relevant to enquire into the prevalence of
teachers that are denied employment because of their homosexuality, or what career
problems homosexual officers in the military might have, and how to redress them.
This short overview illustrates that ‘estimates of the prevalence of heroin addiction’
or related estimates can only have meaning and function within the local models of
policy. If such functions are not well ascribed, estimation will probably never reach
an acceptable level of accuracy, nor will it have very much impact on drug policy.
Fuller accounts of types of estimates and their possible uses are given by Reuter
(1993) and by Anglin, Caulkins and Hser (1993).
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On a higher level of abstraction, one could say that, in all countries, there is some
sort of local construction of the drug problem. This construction appears in the kind
of problems that are considered relevant, the causal attributions that are made to
‘explain’ these problems, the policy interventions that are produced to ‘do some-
thing about it’, and the type of expertise (e.g. medical, social or legal) that is con-
sidered mostly relevant in the situation. It is usually a change in the latter factor (the
dominance of particular expertise) that shows the introduction of a change in the
type of paradigm that governs the problem construction. 
In the Netherlands, this was very clear in the late 1960s when drug policy commis-
sions, which included not only medical but also many criminological and social sci-
entific experts, were created. This made a broader view of drug use possible, with
dramatic consequences for the way the ‘drug problem’ was viewed and responded
to (Cohen, 1997). Latterly, in the USA, a military general has been made the direc-
tor of drug policy (a ‘Drug Czar’) after this function had previously been in the hands
of a police officer. This might point to a new way in which the problem is perceived
and a new direction for policy development.
What precision is needed for estimates?
Functional considerations for precision
Creating estimates for the size of small – albeit well-defined – groups is an intricate
procedure. For some groups, it may entail case-finding and nomination techniques
or costly survey and/or fieldwork methods to provide data which, combined with
other registries, might yield reasonable estimates. The highest possible precision of
the estimates is always important from a scientific point of view, precision being
defined here as a narrow band of confidence intervals. However, since policy mak-
ers will have to provide the funds for estimation-making, the elevated costs for high-
er levels of precision will, unfortunately, not always be considered legitimate.
The required precision will often be dictated by drug policy aims, budgets, simple
technical skills, and by the quality of the raw data which are available, but most of
all by the political agendas of those who will fund and use estimations. Estimating
the prevalence of rare or hidden behaviours or events is a matter of combining
results of different methods for estimating. If estimates vary considerably among
methods, something is wrong and precision probably low. Fieldwork and databases
must be improved. But if really independent estimates are not too far apart for each
method, or if variations are clearly understood as artefacts of data collection, one
could be relatively satisfied with the results. For instance, if one knows that a data-
base of drug-related arrests is biased towards certain ethnic groups because of
unequal arrest probability between ethnic groups, the error resulting from this will
be reflected in estimates using capture-recapture in which arrest databases are used.
This can be dealt with to a certain degree simply by allowing a certain correction for
such an error. But, if such errors are not well quantifiable, one might have to decide
to set up the estimates from different assumptions on arrest probability, to set up cap-
ture-recapture using other data or to move to different methods altogether.
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Political considerations for precision
An important aspect to be discussed when speaking about the desired level of esti-
mate precision is the political use that is made of estimates. Since political differ-
ences about the right kind of drug policy occur quite frequently, an estimate might
be of use to a particular type of drug political rhetoric and not to another. 
Imagine a situation in which the size of the group of ‘addicts’ is an important polit-
ical issue. If someone responsible for drug policy can say that this group has dimin-
ished during his/her administration, this can be used as support for the particular
policy. In the recent exchange of opinions on drug policy between France and the
Netherlands, the Dutch Prime Minister used French estimates of addiction preva-
lence to show that addiction was less prevalent in the Netherlands than in France.
The quality of the Dutch addiction estimates, even if marginally better than the
French, is not high enough to play a role in a serious comparison of addiction preva-
lence between the two countries. This leaves untouched the question of the rele-
vance of such a comparison for an evaluation of drug policy; addiction prevalence
is probably determined more by broad economic and cultural conditions, immigra-
tion and quality of social security than by drug policy. So, estimates can become
weapons in a political struggle. This gives the researchers behind these estimates a
particular responsibility. It requires the provision of estimates of the highest possible
quality and precision, with a clear minimum standard. It is hard to give a standard
‘bottom line’ but this topic cannot be ignored.
Sometimes strong pressure is applied by politicians to drug policy functionaries to sup-
ply estimates of drug use or addiction – ‘Just give me some figure that looks like some-
thing’. But if decent estimates cannot be produced, this should be made very clear, for
instance by stating how uncertain the estimate is, and why. One could supply differ-
ent estimates and not just one, by making use of different assumptions and data sets. 
If, under conditions of high uncertainty, more than one estimate is systematically pro-
vided, this prevents the development of quasi-knowledge. The absence of ‘clear fig-
ures’, due to insufficient data, should be used to legitimate the funding of the research
and registration improvements needed to be able to make good and firm estimations.
Specialists in the area of epidemiology should not be forced, or let themselves be
forced, to supply unwarranted estimates; they are not magicians. They should stick to
the adage that if the data do not exist, estimates cannot be provided.
Another problem attached to the results of estimations is the realistic threat that these
results may pose to particular groups of professionals within the field of drug policy
and treatment. One does not need much imagination to see that particular groups of
professionals may have an interest in these estimates to be high or on the rise. Such
groups could be specialised forces in the police, customs, treatment personnel, etc.
By providing their own estimates, they can influence the political debate in what-
ever way they wish. If a scientifically sound, independent and regular estimate of the
most important drug use phenomena is in place, such interest-related estimates pose
less of a danger to serious discussion about drug policy.
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Standardised estimates for purposes of comparison
Up to this point, this chapter has focused on the thesis that well-described local pol-
icy needs should be the basis for all local prevalence estimation work. I will con-
clude with some remarks about estimates that can be used as general indicators. 
It is possible to create particular prevalence estimates which are relevant across differ-
ent models of drug policy. If it were possible for the same phenomenon to be estimat-
ed reliably in different places (which does not necessarily mean in the same methodo-
logical way), thinking about the impact of drug policy in relation to the drug use phe-
nomenon can be improved. In spite of the fact that an estimate of all heroin use is seen
as not very important in a drug policy model that focuses on harm reduction for heavy
users, an overall estimate of all heroin use in the general population is very useful as 
a general descriptive indicator, which can be seen as a baseline. This means, for
instance, that if one were to find relatively high prevalence of heroin use among home-
less adults, one would want to know if heroin use prevalence among the household
population is relatively high as well. The meaning of estimates or measurements relat-
ing to sub-groups in a city can only be established if one knows the extent of the same
phenomenon in the city population as a whole, if one knows the relative extent of the
same phenomenon in more cities and if one knows the sub-group data in these differ-
ent cities. In order to make such measurements and comparisons thereof, one needs
to standardise the definitions of a phenomenon and the methods of looking for it. Some
of the epidemiological work of the Experts in Epidemiology of the Council of Europe’s
Pompidou Group is an example of this drive for comparability between cities.
To be able to evaluate the total level of heroin, or other drug, use in a population, one
would need estimates valid for the general household population (from 12 years and
above) and for the most important population sub-groups that cannot be measured via
household surveys (e.g. prison inmates, the homeless in some cities, etc.). The type of
drug use experience to be measured could be recency and frequency: lifetime experi-
ence with a drug, and experience in the last year, the last 30 days and the last 24 hours.
Within each of the time spans one could measure the frequency of drug use. In this way,
it becomes possible to define many different patterns of drug use including long-term fre-
quent drug use. The advantage of this simple way of measuring recency and frequency
is that an overview is created of all drug use. One will often see that long-term frequent
drug use is rare. This is true in different drug control systems and slowly we start to see
that drug policy may have less impact on drug use level than politicians assume. Total
heroin use would be near the sum of household and sub-group use, and this summation
should be done in different cities according to standardised methods. This could yield
massive information on the effects (or the lack of effect) of drug policy, the effects of eco-
nomic or cultural factors on levels of use, and the prevalence of particular patterns of use
or the prevalence of particular problems (such as overdose, first treatment, crime). 
Conclusions
Estimation of drug use and the interpretation of such data are, as in all other drug
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use data collection, very much a function of the drug political situation in a city or
country. Technical matters, such as statistical techniques, are only a small part of the
problems with which epidemiologists and other researchers of drug use have to
struggle. This chapter has attempted to give some insight into these problems and to
show that these other problems have a much larger impact on data collection and
interpretation than normally acknowledged.
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Policy Makers 
and the Use of Prevalence Data
by Philip Lazarov
Experience in the development of drug policy and practical interventions in Bulgaria
indicates that the policy maker in the field of drugs and drug-related problems has
rather unusual roles and functions. In this context, we use the term ‘drug policy
maker’ to refer to those who use their expertise to sensitise society towards the
nature and extent of drug use and drug problems and to help facilitate changes in
attitudes to drugs. 
The ‘drug policy maker’ has a crucial advocacy role in persuading and motivating
policy planners and politicians in government about the need to adopt and imple-
ment policy, programmes and projects. ‘Drug policy makers’ are professionals who
have specialised education and training in the drugs field and who often create and
run programmes and projects at a national, community or local level. Sometimes
they act as temporary policy planners. Their work involves relationships with peo-
ple working in many different parts of the ‘drug system’, including politicians and
policy planners working at the strategic level, and those engaged in concrete prac-
tical works in the areas of prevention, treatment, harm reduction, rehabilitation and
law enforcement. 
Due to being involved with a wide variety of people, the policy maker needs to
develop a large number of activities according to the different target levels of the
drug system. The policy maker also has another very significant obligation which is
to be a vehicle for the transmission of information and ideas and to provide links
between people working in the respective services. Additionally, he or she should
also be a professional and experienced person with social and institutional support.
Taking into account this definition, it is possible to conclude that the policy maker
is one of the most important elements in the very complicated structure which we
refer to as the ‘drug system’. 
The role of the policy maker will vary according to the different audiences and rela-
tionships within the drug system. For example, in Bulgaria, at the level of society and
policy planners, there is a need to: increase information about drug use, drug prob-
lems and the overall drug situation; sensitise members of the wider society and peo-
ple working in various institutions dealing with drug problems; encourage a more
humanising view towards drug users and people with drug problems; and help find
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the best balance between drug demand reduction and drug supply reduction in
national and local policy.
At the level of practical implementation of policy, there is a need to: increase the
knowledge of professional workers; provide them with ideas for the development of
different approaches and programmes; and help them in their efforts to recognise the
local drug situation, including patterns of use and associated problems.
In general, there is a primary need to describe the current drug situation at both a
national and local level. This requires addressing the following questions:
• Are there any drug problems in the community?
• If there are, what kind of problems are they and are they of a major social
significance nationally or locally?
• If they are significant, and depending on the kind of problems, what measures
should be taken in order to establish and develop appropriate and effective poli-
cies and interventions?
The role of the policy maker is, therefore, to describe the concrete drug situation
using data from scientific studies using mainly, but not exclusively, the methods and
techniques of both epidemiology (which includes direct and indirect estimation) and
in-depth research. On the basis of this information, it is possible to see the overall
framework of drug issues, and the policy maker can provide expert evaluation and
help people working in different sectors to develop proposals for appropriate inter-
ventions. 
Epidemiology
The methods of population surveys can be used to assess the prevalence of experi-
ence with psychoactive substances and of problematic drug use. The prevalence of
problematic or addictive use is very difficult to estimate by population surveys
because it affects a relatively small group, and population surveys are rarely eco-
nomical for assessing the size of relatively rare groups. Other chapters in this mono-
graph focus on this crucial issue of estimating the size and nature of problem drug
use. However, estimation of the prevalence of drug experience in the general popu-
lation, or in major sectors of the general population, is still important for the needs
and aims of policy makers, particularly for the development of preventive pro-
grammes.
Such surveys, like those which target specific populations such as school children,
can provide useful information on the socio-demographic characteristics of drug
users and risk factors such as lifestyle, tobacco smoking, use of alcohol, availability
of drugs, peer pressure and so on. One example is the surveys which have been con-
ducted in schools in Bulgaria by the National Centre for Addictions in Sofia. The first
was carried out on students aged between 14 and 18 in four cities in 1993 (n = 998).
The second was a representative sample of 1,111 students from ten schools in Sofia,
again aged 14 to 18. Both aimed to examine the use of drugs, alcohol and tobacco
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among students, and to assess the level of information and attitudes of students,
teachers and parents. Figure 1, for example, shows data which indicate that most
often the onset of use of alcohol and tobacco was in the 13-16 age range. There is 
a correlation between the first use of alcohol, tobacco and drugs. The implication 
for policy planners is that the early onset of smoking and drinking appears to be a
marker for the development of drug use. 
More than 50 per cent of students in the ten schools surveyed in Sofia in 1995 knew
people – most often their peers – who were using drugs, and a third had close friends
who were using drugs. More than 25 per cent had been to a party where drugs were
being used, and the same proportion had been offered drugs. From the point of view
of preventive activities, this provided important confirmation of the well-known role
of teenage peer influence for the establishment of drug use.
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In the ten-school survey, the most common drug used was cannabis, which was
reported by 15 per cent. Of those who reported using drugs in this survey, marijua-
na was the most popular, reported by 79 per cent of the drug using students, fol-
lowed by hashish (33 per cent). Sixteen per cent reported using drugs such as stimu-
lants and hallucinogens, which is a new trend in the drug situation. Heroin and
cocaine were reported by 4 per cent of the drug users.
Such surveys can also provide summary information on students’ perceptions of rea-
sons for using drugs. When we examined reasons for using drugs, students viewed
their own drug use in a different way to that of their peers. For themselves, ‘curios-
ity’ was overwhelmingly mentioned as the most common reason – by two-thirds of
them – and only 6 per cent mentioned ‘escape’. When they were asked about rea-
Figure 1: First use of alchohol, cigarettes and inhalants among students (schools in 4 cities)
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sons why others used drugs, ‘escape’ was the most important. These attributions can
help in the design of educational materials.
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In Bulgaria, this type of information has been useful to describe the prevalence of
drug experience and for helping to encourage responsible institutions to develop
appropriately targeted preventive programmes.
Pompidou Group methods
In order to describe other aspects of the drug situation, especially regarding prob-
lematic and addictive use, we have drawn on data from multi-sectoral studies. A
good example for us has been the model promoted by the Multi-City Network
Project developed by the Council of Europe’s Pompidou Group. This model uses
a number of different indicators including treatment demand and first treatment
demand; drug-related morbidity; non-fatal drug emergencies; drug-related
deaths; HIV-1 and AIDS prevalence; and data from the customs, police and the
courts.  
The Multi-City Network approach gives an overall picture of the drug situation in each
respective city. Being a longitudinal study, this project provides an extremely impor-
tant source of information on the dynamic of the drug situation, which can be used to
encourage the development of long-term programmes for the health and criminal jus-
tice systems. Data from these studies provided policy makers with important evidence
to argue for new interventions, and helped them both to develop and enlarge a num-
ber of harm reduction programmes (including methadone maintenance, syringe and
needle exchange, and outreach) and to address issues of risk of infection with HIV and
Figure 2: Reasons for drug use (schools in four cities)
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hepatitis among hidden populations. The information was also used to improve edu-
cational programmes for students and professionals.
In-depth research
Both the planning and implementation of drug policy needs much more detailed
information about detailed aspects of problematic and addictive use of drugs than
can be provided by epidemiological surveys and indirect estimation. Such in-depth
information is important for designing and developing therapeutic approaches, harm
reduction programmes and rehabilitation. In order to propose suitable programmes,
there is a need for very concrete information. Such knowledge can only be obtained
from in-depth studies using, for example, social network recruitment of different
populations of drug users.
In 1995, we conducted a snowball sampling study among heroin addicts in Sofia,
using the methodology recommended by the Pompidou Group. Forty-nine people
were recruited from eleven network chains. They were all recruited from street
locations by specially trained interviewers. This approach gave important infor-
mation about the kinds of drugs being used, the age of onset of first and regular
heroin use and the quantity of drugs used. This study found that more than two-
thirds of the heroin addicts had started using heroin by injecting it. The most com-
mon age for commencing heroin use was between 16 and 18 (52 per cent). The
earliest age was 14 and the oldest was 37. Sixteen to 18 years was also the most
common age range for first regular use (52 per cent). The mean age for first use
and first regular use were 20.1 and 20.3 years respectively, with the mean skewed
by some people who started at an older age – 20 per cent were 25 or older. The
similar age for first use and first regular use indicates how quickly regular use was
adopted. About two-thirds continued to use by injection. Most (60 per cent) were
using between 0.50g and 1.00g a day (the mean was 0.87g), with the highest dose
around 2.50g a day.
Conclusions 
Data from such studies help policy makers develop programmes and activities in
a very sensitive area. Drug use – and drug problems – are increasing in Bulgaria,
in a situation where there is both attractive information about drugs for some sec-
tors, and a more general restrictive social attitude to their use. Surveys can help
supplement the work and experience of professionals such as doctors, psycho-
logists, social workers and their respective organisations. Policy makers can draw
on such data to help change attitudes and develop effective demand and supply
reduction activities.
Scientific studies in epidemiology – whether using direct estimates as described here
or indirect estimates as described elsewhere in this monograph – need to be com-
bined with in-depth studies of drug use and drug-related problems. This can help
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policy makers provide an expert assessment of the drug situation. This assessment
should cover the main aspects of the drug process in each respective country, city
or community, including: the dynamic spread of drug use and drug problems; trends
in average age of onset of drugs; the appearance of new drugs and new patterns of
use; developments of drug markets and drug-related crime; consequences of drug
use such as the prevalence of HIV-1 and AIDS, hepatitis and other harms; and the
establishment of specific drug sub-cultures. 
Such information is one of the cornerstones of effective policy making. On the basis
of such knowledge and expert evaluation, suggestions can be made on the devel-
opment of suitable measures, approaches and programmes directed at the different
levels of the drug system, including: the national level (e.g. legislation, national net-
works, etc.); the level of structures such as the community, schools and the family;
and the level of the individual.
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Introduction
by Matthew Hickman
ase-finding has a long and honourable history, starting with the first descrip-
tions of death and disease in the population – such as John Snow’s maps of
cholera in London. It is also the basis of many of our on-going surveillance 
systems. Alone, however, it is not an exact science. The increased use of statistics
and the development of sampling techniques have relegated it to a secondary role
for providing reliable estimates of the prevalence of ill-health or associated risk fac-
tors in the population.
Not all health problems, however, have a ready-made sampling frame or lend them-
selves to investigation by large population surveys. Problem drug taking (including
injecting behaviour and/or heroin use) – as a comparatively rare, illicit and oppro-
brious activity – is a classic example of one of these problems. 
The authors in this section respond to two problems. The first is the failure or inability
of large-scale population surveys to provide prevalence estimates. Here, Roland Simon
states the need for case-finding studies; Börje Olsson deals with this at a national level;
Conchi Moreno Iribas and Mikel Urtiaga Dominguez at a regional level; and Paul
Griffiths, Michael Farrell and Samantha Howes at a small area level. The second prob-
lem is that it is not only unlikely, but impossible, for any case-finding exercise to enu-
merate completely the population of problem drug takers (unlike, for example, diag-
nosed cases of lung cancer). Case-finding, therefore, plays a crucial role in providing
the raw material for indirect methods to estimate the total population (including unre-
ported cases and drug-takers unrecognised or unknown to any data source).
Good case-finding, as outlined by Simon, is systematic.  It involves appropriate and fea-
sible case-definition, the proper assessment of available data sources and potential
reporters, and validation of the quality of data obtained. Poor case-finding is likely to
lead to poor estimates of prevalence or, as Olsson says: ‘garbage in, garbage out’.  
Olsson highlights problems and solutions to collecting data on drug-takers with refer-
ence to the remarkable national case-finding exercises carried out in Sweden in 1979
and 1992.  These were prodigious in their scale, ambition and planning – but perhaps
also unique and not translatable as a national study to other countries in Europe.
Iribas and Dominguez illustrate the strategies outlined by Simon – clear case-defin-
ition and assessment of the availability and quality of data sources – for a region
(Navarra) in Spain. They show how data can be obtained on ‘visible’ drug-takers
from a number and variety of sources, mostly routine, by utilising their own data col-
lection or reporting systems. They reinforce the impressions gained from Olsson’s
chapter that, undertaken properly, case-finding is exhausting and time-consuming.  
C
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The outcome of prevalence estimation is often a single number or range. Of equal
importance, as shown by the work in Navarra, can be the opportunity case-finding
provides for describing the population of visible drug takers: their age, sex, area of
residence, occupation and pattern of drug taking. The value of this information is
also associated with the quality and thoroughness of the case-finding.
Griffiths, Farrell and Howes demonstrate how a sample survey to estimate the level
of drug-taking may be carried out – but at a small area level – at a housing estate in
a deprived area of London. Such an area is too small to generate a sufficient num-
ber of cases from legal or medical sources to use indirect estimation methods reli-
ably, but it is small enough to carry-out a comprehensive household survey and has
high enough levels of reported drug-taking to measure prevalence and provide some
further descriptive information.
However, as they admit, there was great difficulty in defining the sampling-frame,
and, at very best, the project achieved only a 50% response rate, which would need
to be improved for general use elsewhere. Also to be considered further is the
importance to policy-makers of determining small area variations in drug-taking,
over and above what existing data sources on numbers of arrests or drug-takers in
treatment can tell us about geographical variation.  
The difficulties with case-finding, and subsequent prevalence estimates, is that usu-
ally they are time-consuming, discrete, one-off exercises. Yet most of the data on
drug-takers are obtained from existing data sources – crucially treatment and law
enforcement agencies. One solution is to work on improving and co-ordinating
these main sources of data: to develop an information strategy, and to create an on-
going or periodic surveillance system. This should do away with the great deal of
work and energy that is currently expended on collecting data from different data
sources; will provide regular reports on the number and characteristics of visible
drug-takers; and will allow periodic estimates of prevalence with one or several of
the methods described in later chapters.
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Estimating Prevalence 
using the Case-Finding Method: 
an Overview
by Roland Simon
Case-finding is a standard epidemiological method for obtaining an adequate number
of cases for observation and research, especially when investigating rare health events
in a population (Pflanz, 1973). An extensive literature search of published studies
found few studies of illegal drugs citing this method (exceptions include Bishop, 1976;
Skarabis and Patzak, 1981; Frischer et al, 1992). However, case-finding is important,
as seen by the fact that nearly every study discussed in the Scientific Seminar (such as
those involving nomination techniques or capture-recapture) started with case-finding
procedures. Pure case-finding studies are rare, but the findings are used in different
ways to establish valid prevalence estimations.
As there is no single way or information source which can find all, or at least most of,
drug users, a combination of different strategies is needed. Multi-source enumeration
is one method widely used to overcome the lack of completeness and representative-
ness of single sources and can provide estimates of the prevalence of drug users.
Case-finding is applicable to studying drug use for several reasons. Firstly, drug use
is rare. Secondly, as an illegal activity, it is largely hidden. Therefore, general popu-
lation sample survey techniques will be too costly, inefficient, and may be ineffec-
tive for identifying drug users. Thirdly, a ready-made sampling frame or register does
not exist; which, in part, is the reason for carrying out a case-finding study.
Central methodological aspects and common information sources
Although several methodological aspects may be important and different strategies
may be employed to meet different requirements, the common and most important
aspects are described below:
Coverage and representativeness
It is unlikely that coverage will be complete (100 per cent enumeration). Ideally, the
subjects identified through case-finding are representative of the total population of
drug users under study, in order to enable the generalisation of characteristics and
other findings. The number of all existing drug users in a given population, which
can be found using one specific source, depends very much on the specific charac-
Chapter 4
46
Case-Finding Methods
teristics of this source, but it is likely that the number identified will be smaller than
the total number.
Sensitivity and specificity
It is important that strategies are used which enable all drug users under examina-
tion to be identified (sensitivity) and that no cases are included which do not meet
the definition of the target group (specificity).
Feasibility, reliability and comparability
The case-finding study must be acceptable to reporters and drug users. Information
sources and screening strategies may need to be assessed in order to test whether
they can provide the data required by the study. For example, it can be difficult to
involve more deeply in research studies subjects who are contacted by the police.
Also, obtaining reliable and comparable data (with other studies or countries) espe-
cially when using narrow definitions of the target group (e.g. based on ICD 10 or
DSM IV) may require specially designed procedures and trained and supervised
interviewers.
Double-counting
When different sources are combined, there is a considerable risk of over-estimating
the total number of cases unless personal identifiers are available in a reliable and stan-
dardised way in all of the sources to enable identification and removal of duplicates.
Cost
Total cost is directly related to the number and amount of staff and time spent per
case. This can be reduced if routine data sources are used, even when additional
efforts by staff working in these sources are necessary.
Target groups
The term drug user is often used as if it refers to a clear and homogeneous group of
people, whereas this is far from being the case. For example, therapeutic research
projects focus on subjects who have already developed considerable drug problems;
primary prevention studies focus on persons who are at risk of starting drug use or
of developing problematic drug use; and secondary prevention studies may include
ex-users. The typology of target groups becomes even more complex when different
types of drugs are considered.
Thus, as depicted in Figure 1, the target group could embrace subjects who are cur-
rent users defined in terms of frequency and recency of use; problematic drug users
defined in terms of the risk of medical, psychological and/or social problems arising
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directly or indirectly from drug use; or drug addicts defined in terms of specific sur-
vey instruments assessing tolerance, withdrawal syndrome and the inability to cease
drug use. These may vary in size and in the degree of overlap. In 1990, in Germany,
the range was between 0.5 per cent for drug addiction, 0.9 per cent for current drug
users and 2.0 per cent for ever use of ‘hard’ drugs.
Figure 1: Target groups
General Population
Lifetime Drug Users
Current Drug Users
Problematic Drug Users
Drug Addicts
It is essential that the target group should be clearly defined in advance of the case-
finding exercise. This will enable a strategy to be drawn up describing how this tar-
get group will be found and what biases may affect the representativeness of the
sample.
Visibility of drug use and problems of access
Although a proportion of the drug-using population will always remain hidden, there
are times when drug users are more ‘visible’. These instances include: the process of
buying and selling drugs; places where drug users meet; contact with law enforce-
ment as a result of the need to buy or sell drugs or generate income illegally to
obtain drugs; or when drug users seek attention for social, psychological or somatic
consequences of drug use. 
In each of these areas and situations, drug users may be contacted and asked to
participate in research projects. Alternatively, an existing information source may be
obtained.  
48
Case-Finding Methods
Direct access
Direct access (Figure 2) is usually carried out by interviewers who have special train-
ing or have some background in the field that enables the targeting of specific drug
users, especially for less problematic drug users who may not be in contact with any
drug-related agency.
For example, Holmberg (1985) selected cases of drug abusers from a fifteen-year-old
school population based on a school questionnaire, premature drop-out or participa-
tion in special classes. Such studies, however, are usually small and highly localised.
Figure 2:  Access to different target groups - direct access
Current Problematic Drug Comment
Drug Users Drug Users Addicts
Coverage + - - Less marginalised groups
are less visible
Sensitivity 0 0 0 Unknown
Specificity + + +
Feasibility + + + Difficult access
No additional information
available 
Costs - - - Many staff needed
for contacting
Comparability - - - Unclear 
For all figures: + = high; 0 = medium; - = low
Routine information sources
Data on drug users already collected by the agencies for their own purposes are
cost-effective to obtain. Often people working with these routine sources already
have a basic knowledge of drug users and drug use. It may be possible to contact
drug users through these sources for further information if necessary. Drug users
may be in contact for long periods allowing serial data to be collected over sev-
eral years.
However, collecting extra data may be burdensome. Data can be incomplete and
unreliable. Unless the target population is specific to the information source, it
usually offers a very partial picture of drug users in the population.
Some sources do not cater solely for drug users, for example general hospitals, and
the need for selection procedures can impose considerable practical, organisa-
tional and financial problems on the researcher.
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Law enforcement agencies
In most European countries, law enforcement agencies record the biggest number of
drug users (Figure 3). Coverage may be high for more marginalised groups of drug
users but not so effective for less marginalised groups, such as cocaine users who are
not part of the heroin scene. To interview cases personally is often difficult and may
not be possible, limiting the use of this information source for more demanding stud-
ies. For drugs other than heroin and cocaine, the practice of law enforcement varies
between different countries, reducing comparability.
Figure 3: Access to different target groups - law enforcement agencies
Current Problematic Drug Comment
Drug Users Drug Users Addicts
Coverage of 0 + ++ Less marginalised groups
total population are less visible
Sensitivity + ++ ++ Only relevant cases,
by definition
Specificity + - - No information
on patterns of use
Feasibility - - - Difficult access
No additional information
on patterns of use 
Costs + + + Limited additional costs
Comparability 0 + - Acceptable for 
heroin and cocaine
in most countries
No uniform definition 
of addiction 
Social services
Many drug users are in contact with social services agencies owing to their on-going
drug use and financial needs (Figure 4). In regions and city districts, where drug use
is more frequent, this can be a useful source to find relevant cases. Even if informa-
tion on drug use is not directly available, it may be possible to collect further infor-
mation or employ screening procedures to identify the target population.
Harm reduction projects
Harm reduction projects operate in many countries and are clearly targeted to drug
users (Figure 5). They include methadone maintenance and syringe exchange pro-
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grammes. In some countries these institutions are believed to be in contact with
more than 70 per cent of all addicts. Screening procedures may be required in more
general services.
Figure 4: Access to different target groups - social services
Current Problematic Drug Comment
Drug Users Drug Users Addicts
Coverage 0 ++ ++ Some are not visible
Sensitivity - + + Screening necessary
Denial
Specificity - + + Screening procedure 
necessary
Feasibility ++ ++ ++ Good 
Costs - - - High costs 
for the interviewer
Comparability - - - Difficult because of 
differences in national
structure of social services
Figure 5: Access to different target groups - harm reduction projects
Current Problematic Drug Comment
Drug Users Drug Users Addicts
Coverage - 0 ++ Primarily high risk groups
and heavy patterns of use
Sensitivity + + + Only contacted population
Specificity ++ ++ ++ No false positives
Feasibility 0 ++ ++ Good access via staff 
Costs + + + Small additional costs
Comparability 0 + - Acceptable 
for heroin and cocaine 
in most countries
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General health care
Contact with general medical facilities and emergency rooms is, on average, higher
among drug users than the general population (Figure 6). However, drug users may
not be identified routinely and screening procedures are important in order to cap-
ture the target population.
Figure 6: Access to different target groups - general health care
Current Problematic Drug Comment
Drug Users Drug Users Addicts
Coverage ++ + + More marginalised groups
may be less reached by
the general health care
system
Sensitivity - - - Only some cases detected
Specificity ++ ++ ++ No false positives 
Based on clinical 
and client information
Feasibility 0 0 0 Good for 
inpatient treatment 
Bad for GP 
and emergency rooms
Costs + + + Small additional costs
Comparability 0 + - Acceptable 
for heroin and cocaine 
in most countries
Specialist addiction treatment centres
In most European Union countries, a developed treatment system exists for addict-
ed people (Figure 7). According to national estimates, between 10 and 80 per cent
of the total number of addicts are in contact with these centres.
For example, in the Netherlands, more than 75 per cent are thought to be in contact
with treatment centres, while in Germany the proportion is estimated to be 10 to 25
per cent within a given year. Therefore, it is possible to gain a representative picture
of addicts as well as gain easy access to the subjects.
Also, when only basic information is needed, it is, in many cases, already avail-
able.
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Figure 7: Access to different target groups - specialist treatment centres
Current Problematic Drug Comment
Drug Users Drug Users Addicts
Coverage 0 + ++ Only part of population
seeks treatment 
Differences between 
total population 
and treated population
Sensitivity ++ ++ ++ 100% valid cases 
by definition
Specificity ++ ++ ++ No false positives 
Feasibility + + + Easy access via 
therapeutic staff
Costs ++ ++ ++ Small additional costs
Comparability - 0 0 Different national system 
of health care
Multi-source enumeration
Each information source used in case-finding studies gives only a partial picture of
the population of drug users and will severely underestimate the total number of
drug users. As a first step, therefore, different sources are combined to produce a
more complete and valid estimate.
The intention is to create a common frame where the relationship between different
data sets is clearly defined. Often the case definition in different sources is not exact-
ly the same, though there may be considerable overlap.
Diagnosis based on DSM or ICD may be available from the treatment sector but
might have to be inferred from patterns of drug use found in drug offenders.
Information on problematic drug use, however, could be obtained more easily from
both sources.
In Germany, a working group based their first estimates of the prevalence of hard
drug use on information on offenders, drug-related deaths and treatment demands
(Institut für Therapieforschung, 1993), which provided a much clearer description
and understanding of the different groups defined and used.
The simplest model of multi-case enumeration is based on a common register, where
personal information from several sources is collected. The bigger the number of
sources, the more complete the picture of drug use. Often only one incident – the
first contact of the drug user with law enforcement or social services – is registered.
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In time, some of these people will stop using drugs.
Information on current status may be available from central treatment-based regis-
ters if all treatment units are participating. For police data, an update can be a new
offence registered or – after a period without any more offences – an automatic dele-
tion from the register. As the use of a central register raises important questions on
data security and privacy, it is used only in some countries. 
Another option used for AIDS surveillance would be the use of personal identifiers
for all subjects contacted by different information sources, with some basic infor-
mation on the persons identified (sex, age, drugs) kept centrally. As only minimum
data are collected, it is not possible in practice to identify the person while also
allowing duplicate reports to be identified. Where data protection laws are very
strict, even this procedure might not be possible.
Dekker and Cohen (1993) have shown that the methods, as well as the selection of
sources used for prevalence estimation, differ considerably in Europe. In some coun-
tries the numbers of subjects treated or contacted by different institutions were sim-
ply added, in other cases estimations were based on different information or
assumptions.
Specific methods are dealt with elsewhere in this monograph. The basic problem
remains, however, that a model which integrates the different sources and links
them to the case definition has to be constructed.
The quality of the estimate depends very much on the success of the case-finding
as well as the validity of the model used. 
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A Case-Finding Study 
to Estimate the Prevalence of Heroin Users
in Navarra, Spain
by Conchi Moreno Iribas and Mikel Urtiaga Dominguez
Epidemiological studies in Spain, aimed at determining the number of heroin users,
are relatively recent and based on several indicators: the number of people starting
treatment, deaths from overdose, and drug-related emergency admissions. These
three indicators comprise the State Information System on Drug Addiction (Grupo de
Trabajo del SEIT, 1990) which is used in order to assess geographical differences in
the 17 regions within Spain (total population 40 million), as well as to monitor
changes in drug use, routes of administration and the introduction of new drugs.
Further work has been carried out in some of the regions to obtain more precise esti-
mates of the number of users. This chapter provides a practical example of the case-
finding method. It describes a case-finding study carried out in Navarra, an area in
the north of Spain with a population of half a million inhabitants, where all health
and social services are directed and managed at the regional level. It demonstrates
the kinds of data available from different sources, counts the number of cases in dif-
ferent agencies and the overlaps between agencies, and provides a final count of the
number of known heroin users.
Methods
Since 1984, responsibility for strategic planning and provision of treatment for 
heroin use lay with the mental health services of the region (Varo, 1991; Varo and
Aguinaga, 1984). Initially, the development of therapeutic services, although receiv-
ing public support, was in the private sector. In 1986, as part of the Mental Health
and Alcoholism and Drug Addiction Plan, provision of treatment for heroin use was
included in the mental health centres and integration with social services fostered.
This led to a broadening and diversification of the resources for the treatment of drug
users.
The support of the Public Health Management was vital for carrying out the study,
facilitating access to the hospitals, epidemiological service, social services and insti-
tutions dependent on the Justice Ministry (forensic doctors, prison medical service).
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Case definition
Information was sought retrospectively on all heroin users in contact with, or known
to, the above services during 1990, who were residents of Navarra. It was recog-
nised that some of the data sources would have no information about the frequency
of use (occasional, regular, etc.) and a few (clinical and social services) would be
expected to deal with more problematic heroin users.
Data sources
Table 1 shows the sources that provided information, outlined in more detail below,
including all the public centres for the treatment of drug dependence in Navarra. A
number of services which have contact with, or potentially have information on,
drug use were not included: these were GPs and private doctors; over half of the
social services; the press; private hospitals; courts and police stations; and non-psy-
chiatric hospital emergency departments.
Mental health centres for assistance to drug users
All services for treatment in public centres were included: eight mental health cen-
tres; two units for hospital detoxification; two day hospitals; and one day centre. All
relevant cases were extracted directly from computerised registers.
Therapeutic rehabilitation centres
Under the region-level National Drug Plan, data were requested on all residents of
Navarra who had requested public financial assistance for entry to a therapeutic 
centre, irrespective of whether funding was obtained.
General hospitals and psychiatric emergency units
Computerised summaries of patients’ clinical records for two of the three large hospi-
tals were extracted with the following ICD-9 admission codes: 304 – dependence on
drugs; 305 – drug abuse without addiction; 292 – psychosis due to drugs; 070 – hepati-
tis; 571.4 – chronic hepatitis; 573.3 – toxic hepatitis; 279 – immunity disorders.
All episodes occurring in 1990 were checked manually from registers held at the 
two psychiatric emergency units.
Criminal Justice
The prison register (admissions and releases) for 1990 was consulted and subse-
quently checked with the prison doctors’ individual clinical files to identify cases
with antecedents of opiate use.
Table 1: Information sources contacted during the study 
Sources N Coverage Observations
Mental health centres 100% of treatment Excludes treatment
for assistance to drug users: in public centres by private centres
- mental health centres 8 or doctors
- hospital detoxification units 2
- day hospitals 2
Therapeutic rehabilitation centres 11 In private sector, 
funded with 
public support; 
5 in Navarra; 
6 in other regions
General hospitals 3 Hospital admissions Drug-related
in 3 of 4 main centres admissions identified
from clinical codes
ICD. 9
Psychiatric emergency units 2 All emergencies Excludes
due to heroin non-psychiatric
emergencies
Criminal Justice: Total population Excludes arrests,
- provincial prison 1 for Pamplona Prison and offences
- social assistance to detainees 2 not resulting
in prison sentences
Forensic doctors 1 All heroin Deaths in 1990 with
overdose deaths cause of death due 
to heroin overdose 
Social services units 6 42% coverage Pamplona
of the population and environs
Hepatitis B case register, 1 All cases with
Public Health Institute injecting risk factor
HIV surveillance system Cases of HIV where
route of transmission
classified as injecting
drug use
Social assistance service of the Justice Ministry
Cases using this service, which aims to find employment and to provide economic
support in situations of provisional freedom, were obtained through the General
Director of Prison Institutions.
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Forensic doctors
Data were obtained on all the deaths in Navarra in 1990 which required forensic
reports where the cause of death was attributed to overdose of opiates.
Social services
Service users identified as heroin users were collected through the managing direc-
tor of the Navarra Institute of Social Welfare.
Hepatitis B records
Incident cases of hepatitis B attributed to injecting drug use were obtained.
HIV surveillance system
At the same time as this study, the epidemiological service was conducting a case-
finding study of cases of HIV infection from the Infectious Diseases Unit and
Hospital Laboratory, which carried out confirmatory testing of HIV infection and
provided treatment. Information was obtained on HIV positive persons fulfilling the
case definition, that is heroin users identified during 1990.
Study variables
Data gathering was retrospective and mostly made use of information routinely col-
lected by the centres themselves, though extra work was required in some cases (e.g.
in prison and hospital emergency services). The data items provided by the different
sources are shown in Table 2.
Table 2:  Data items available from different sources
Surname Initials Initials Sex Date Municipality
and first of of first of of
name surname name birth residence
Mental health centres no yes yes yes yes yes
Hospital detoxification units no yes yes yes yes no
Day hospitals no no no yes yes yes
Therapeutic centres no yes yes yes yes yes
General hospitals yes yes yes yes yes yes
Psychiatric emergency units yes yes yes yes yes yes
Prison yes yes yes yes yes yes
Social assistance  no yes yes yes yes yes
Forensic doctors yes yes yes yes yes yes
Social service units no yes yes yes yes yes
Hepatitis B register yes yes yes yes no yes
HIV surveillance no yes yes yes yes yes
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One problem encountered during the study was the large number of cases for which
it was not possible to confirm residence in the region. Where possible, non-residents
were excluded by matching case reports with the 1986 Municipal Census of
Inhabitants; alternatively additional information was requested from the sources.
Duplicates
Duplicate records from the same source and multiple records of the same person
between sources were identified manually and removed to compile a record of 
heroin users who had contacted the institutions participating in the study.
Confidentiality
Personally identifiable data (see Table 2) were dealt with only by the principal resear-
cher and were not made available to any person or institution outside the study project.
Results and discussion
Case-finding
Two thousand three hundred and fifteen records of heroin users were obtained,
2,088 of which met the case definition. Two hundred and eighty-eight records were
excluded as being non-resident in Navarra. Removing duplicate records left a total
of 1,231 individual cases. Table 3 shows the number of users collected from each
source and the number known exclusively to that source. Seven hundred and eigh-
teen persons (58.3 per cent) appeared in a single source; 245 (19.9 per cent) in two
sources; and 268 (21.8 per cent) in three or more sources. Nine hundred out of the
1,231 individuals were reported from one of the specific services for the treatment
or rehabilitation of drug dependence (mental health centres, psychiatric emergency
units and therapeutic centres). The remainder were reported from non-specific
health services, social assistance centres and prison.
Of the cases recorded in two sources, 50 per cent of those found in therapeutic cen-
tres and 67 per cent of those who attended psychiatric emergency units also appear
in one or another of the mental health centres. In contrast, only 28 per cent of those
found in the hepatitis B register were found in the mental health centres. In short, it
was feasible to carry out a case-finding survey in geographically distinct regions. If
possible, it would be desirable to widen the information sources to include police
detention centres, GPs, and hospital and outpatient emergency services. However,
the data collected can provide the basis for prevalence estimation using capture-
recapture methods.
Prevalence and profile of drug users
The prevalence of ‘known’ heroin users from the selected institutions is a minimum
estimate of visible drug use, given that several sources were not included which
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other studies have shown to be important (Hartnoll et al, 1985; Peveler et al, 1988;
Parker et al, 1987).
Table 3: Number of heroin users reported by source, 
and number reported from a single source
Number of users      Reported exclusively
Mental health centres 697 344
Hospital detoxification units 103 14
Therapeutic centres 334 111
Day hospitals 160 39
Psychiatric emergency units 341 65
Criminal justice (prison and assistance to detainees) 254 67
Forensic doctors 12 5
Social service units 46 17
Hepatitis B register 40 22
HIV surveillance 101 34
Total cases 2,088* 718**
* Before removal of duplicates; ** cases reported from a single source
Table 4: Prevalence of known heroin users by age and sex
Age                    Men           Men          Women       Women         Total            Total
(n)        (rate 1000)         (n)        (rate 1000)         (n)        (rate 1000)
Less than 15 3 0.05 1 0.01 4 0.03
15 to 19 23 1.1 23 1.1 46 1.12
20 to 24 253 11.6 108 5.2 361 8.47
25 to 29 421 22.2 124 6.9 545 14.72
30 to 34 168 8.9 36 2.0 204 5.51
35 to 39 43 2.4 8 0.4 51 1.40
Greater than 40 15 0.15 5 0.04 20 0.09
Total 926 3.63 305 1.18 1,231 2.40
The 1,231 heroin users identified represent a population rate of 2.4 per 1,000 or 1
in 417 residents in Navarra (Table 4). Among men the rate was 3.63 per thousand
and for women 1.18 per thousand. The highest prevalence rate was among people
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aged 25 to 29 at 14.72 per thousand (or 1 in 68), followed by those aged 20 to 24
at 8.47 per thousand (1 in 118). The difference in prevalence between the sexes was
lowest for the younger age groups, which may indicate that, in recent years, pro-
portionally more women are becoming heroin users.
Large differences were observed between urban (3.5 per 1000) and rural areas (0.96
per 1000), which we believe cannot be attributed to methodological issues alone,
for example the study was carried out with greater intensity in urban areas. Equally,
there were differences within Pamplona: Old Town, Chantrea and Berriozar had
rates of over 7 per thousand, while Iturrama had a rate of 2.0 per thousand, which
may reflect differences in income, facilities, education resources and so on. In sum-
mary, the majority of heroin users were men (3 to 1), aged between 20 and 29 (72.9
per cent), and resident in urban areas (3.4 to 1). The number of heroin users identi-
fied, though an underestimate of the total population and even of visible drug use,
still represents a considerable number.
For the Navarra region, the results of the case-finding study emphasise the impor-
tance of assessing need in relation to available resources, not only in fields such as
treatment of drug use and social services, but also to other strategies aimed at
improving quality of life and reducing morbidity and mortality.  We believe it impor-
tant to diversify the existing treatments on offer to include programmes such as
methadone maintenance and to begin initiatives aimed at preventing and treating
the important drug-related health problems, such as HIV, AIDS and hepatitis.
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Problems of Definition 
and Other Aspects of Case-Finding: 
the Swedish Nationwide Studies
by Börje Olsson
Case-finding studies are one of the most frequently used methods for providing the
empirical data for estimating the prevalence of drug use. The validity of these esti-
mates depends largely on the quality of the source data. This paper concentrates on
five key factors which influence the results of case-finding and draws upon the expe-
rience of two nationwide case-finding studies carried out in Sweden
(Socialdepartementet, 1980; Olsson et al, 1993).
• case definition;
• sampling procedures;
• informing and training reporters;
• attitudes and perceptions towards drug users, and towards prevailing drug poli-
cy misclassification.
Case definition
A prerequisite for proper case-finding is that we know what a ‘case’ is. However,
numerous definitions of drug users are available, covering biomedical, behavioural,
psychological and social aspects. For example, an earlier meeting of the Council of
Europe asked participating countries to estimate the number of ‘hard-core addicts’.
Two neighbouring countries of similar size reported there were one thousand and
over fifty thousand respectively. The difference did not lie in the prevalence of drug
use but in the definitions used: the first country considered a ‘hard-core addict’ to be
someone in long-term treatment while the other estimated the number of people in
need of treatment.
The lack of a common, clear-cut, widely accepted definition means that the investi-
gators must set the criteria themselves: the definitions depend on the interests of the
investigators. Of course, such a pragmatic approach does not preclude the impor-
tance of basic knowledge in medical, pharmacological, psychological and social
aspects of drugs or the necessity of clearly stating the purpose of the study. 
In practice, the choice is limited to drug users who are known or can be identified
and by the extent of information on the nature of the drug use possessed by the
reporters. Too lax a definition and reporters may construe a different case than oth-
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ers; too tight a definition and reporters may not have the information to know
whether a drug user fulfils the case definition and therefore may not report them.
One solution to this problem used by the Swedish studies is to use a minimal defini-
tion. These studies requested reports on every drug user known to have used drugs
during the last twelve months. Additional information, if available, was also request-
ed including: type of drugs used, dominant drug, main route of administration,
injecting behaviour, how long the person had used drugs, concomitant misuse of
other substances such as alcohol, hypnotics, sedatives and solvents, use of drugs
during the last four weeks, intensity of use during the last four weeks, and finally,
sex, age, area of residence, work, education and contacts with the authorities due to
criminality or drug use.
Since case-finding methods rarely cover sporadic or less severe forms of drug use, it
is not meaningful to assess the extent of these forms of use. In the Swedish case,
separate analyses were made for ‘heavy drug abuse’ defined as daily or almost daily
use of drugs, and any use (regardless of frequency) by injection.
Sampling procedures
In Sweden, the choice was between a study covering the entire country or a sample
of geographical units (cities, local communities, parts of a city, etc.). In 1979, a
national study was considered more appropriate because knowledge both of the
spread of drug use in the population and of the number and characteristics of drug
users in contact with services was limited. Furthermore, an important aim of the
Swedish study was to provide a comprehensive description of the extent of ‘heavy
drug abuse’ in different parts of the country. In 1992, the investigators chose to select
a sample of local communities and police districts because of the information pro-
vided earlier by the 1979 study. An additional advantage (and maybe the most
important factor) was that drawing a sample made the study cheaper to carry out.
The aim of the study was to estimate prevalence for the entire country, based on an
enumeration from the communities and police districts included in the sample. One
problem raised through sampling geographical areas was the mobility of drug users
over one year, with many reported users moving in and out of the sampled areas or
being reported in one area but residing outside that area. The problem was solved by
adding a question about area of residence but created new problems for the capture-
recapture calculations. Individuals reported from units belonging to the sample but
who lived elsewhere were excluded, among other reasons, because they were less
likely to be reported by other data sources in the sampled area and, therefore, would
erroneously inflate estimates of the ‘true’ number of ‘heavy drug abusers’. In 1992, the
final population estimate of the number of ‘heavy drug abusers’ for the whole of
Sweden was 17,000 (confidence interval 14,000 to 20,000). However, if all drug users
were included in the calculations irrespective of whether they were resident in the
sampled areas, the prevalence estimate would be 30 per cent higher, exceeding the
upper confidence interval of the officially accepted estimate.
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The two Swedish studies used two different criteria for reporting drug users. In 1979,
reporters were asked to record prospectively all drug users with whom they had con-
tact over a six-month period, while in 1992 they were asked to report retrospective-
ly all drug users with whom they had had contact over the last year. The first method
provides more up-to-date information but is more demanding on the reporters and
the investigators who must keep contact with the reporters to prevent ‘reporting
fatigue’. The second is faster but relies on patient files and other sources to compile
the data. The method employed by the second study was believed to have produced
a higher coverage rate, since the capture-recapture adjustment of the cases collect-
ed was only 14 per cent higher in 1992 compared to 45 per cent in 1979.
Informing and training reporters
Since case-finding depends upon the goodwill of reporters, the issue of information
and education becomes crucial. In the Swedish studies, information about the aim
of the study and education on how to participate were very important. If this phase
of the investigation fails, the resulting prevalence estimates will be highly question-
able.
Explaining that the information obtained will be used for policy and planning may
not, on its own, be a sufficient inducement for the reporters, unless the data can be
collected and analysed in a way that is relevant to them. Since priority is given most-
ly to routine daily activities, participation in a case-finding study should be integrat-
ed, wherever possible, with routine tasks. Besides providing basic information on
different drugs, types of use, doses and multiple substance use, it also may be con-
sidered worthwhile to set up a phone line during the study which reporters can use
to seek further information or clarification. 
Our experience from the Swedish studies also highlights the importance of making
the instructions to the reporters (however seemingly trivial) as clear as possible. In
both studies, reports were requested on all persons known (not suspected) to have
used drugs during the last twelve months. In 1992, additional instructions were
given to include people who, in their professional opinion, were drug users, in order
to recognise cases where definitive proof was not available. It is not my intention to
argue for or against either of these ways of phrasing the instructions, but I am con-
vinced that differences like this have a considerable impact on the overall result.
Unfortunately, it was not possible to assess the result of the extra instruction.
Attitudes and perceptions towards drug users 
and towards prevailing drug policy
The two Swedish case-finding studies illustrate some of the problems facing epi-
demiologists. Important changes occurred in public policy and in perceptions of
drug use between 1979 and 1992. In 1979, use of drugs had not yet been crimi-
nalised, and protecting the rights and confidentiality of the individual were the pre-
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vailing concerns of health and social workers. In 1992, the overall goal of policy was
to achieve a drug-free society and drug use was criminalised, reflecting harsher atti-
tudes towards drug use and drug users.
The difference in attitudes between the two studies may explain the higher non-
response rate in the 1979 study compared to the 1992 study and that a greater num-
ber of persons erroneously classified as ‘heavy drug abusers’ could be expected in
the 1992 study. Prevailing attitudes and perceptions should be borne in mind when
planning case-finding studies and interpreting the results.
Misclassification
Misclassification occurs in several ways. Firstly, the illegality of drug use militates
against full self-report, in particular, drug users may provide insufficient or false data
to distinguish ‘heavy’ drug use. Secondly, data may not be systematically or reliably
recorded in routine data sources. Thirdly, cultural attitudes towards drug use may
influence a reporter’s perception of a case. Some assessment of the level of misclas-
sification is very important, if not through separate control studies, then at least
through comparing data supplied by several sources on the same individual. 
In the 1979 Swedish study, a comparison of different reporters’ classification of the
same individual led to the conclusion that heavy abusers were four times as likely 
to be classified correctly than incorrectly. It is likely that the number of users is
between three and six times higher. Therefore, if we assume that the ‘true’ number
of heavy drug abusers and users is 10,000 and 40,000 respectively, the effect of mis-
classification would lead to a situation where approximately 17,500 heavy drug
abusers were reported. Though a hypothetical example, it shows that misclassifica-
tion is important and could lead to considerable over-estimation.
Conclusions
Case-finding is a practical exercise. Theoretical considerations are important, espe-
cially when employing statistical methods to estimate prevalence, but these should
not take precedence over the very practical aspects of carrying out a case-finding
study outlined above. In other words ‘garbage in, garbage out!’
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Local Prevalence Estimation: 
Can an Inner-City Prevalence Survey
produce Useful Information?
by Paul Griffiths, Michael Farrell and Samantha Howes
Patterns of drug use are characterised by acute local variation. In estimating the
prevalence of drug use amongst the general population such variations are often
obscured. Survey methods may produce reliable information on the extent of use of
drugs like cannabis where ‘lifetime use’ levels may be high and social stigmatisation
low. However, the combination of low prevalence rates and highly stigmatised
behaviour make such methods less suitable for providing convincing data on drugs
such as heroin and cocaine, or on the injection of these or other drugs.
For such behaviours, subjects may be hard to locate and unwilling to be inter-
viewed. Clustering also creates problems in these conditions; although overall
prevalence rates may be low, high prevalence rates may be found within small dis-
tinct geographical locations. These locations are often, but not exclusively, inner-city
areas characterised by high levels of deprivation. Such sites are notoriously difficult
to gain access to by conventional survey techniques.
In this paper, the rationale for conducting local prevalence estimation surveys will
be considered. Data from a pilot household survey of an inner London housing
estate of high drug prevalence will be explored. Of particular concern are the prac-
tical and methodological problems that researchers face when conducting a local
prevalence survey in an inner-city setting. The local prevalence survey may be
viewed as a special example of the case-finding study.
What is the purpose of local prevalence estimation? 
Much of the debate on the construction of satisfactory prevalence data is pitched at
the macro level, towards exploring overall prevalence of drug consumption for the
general population. However, such data, even if accurate, are not always helpful to
those planning or delivering drug services locally. It is not that national and local
estimation procedures are not complementary, but rather that the rationale for each
exercise is often different and may result in a separate set of methodological issues.
In this paper, our main concern is to consider variations in patterns of drug use
prevalence which occur within small inner-city areas. However, it is important to
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remember that variation in the scale and pattern of drug use may be found in any
exercise. Two indicators of United Kingdom cocaine consumption illustrate this
point. Police seizures are skewed toward two large urban areas. Sixty-four per cent
of cocaine seizures by police in England in 1994 were in London. A similar pic-
ture emerges from treatment indicators. Of the 1,373 new registrations of drug
users reported to the Home Office’s Addicts Index in 1993, 594 (43 per cent) were
from London. In total, only four other districts reported more than 100 new
cocaine users. These data suggest that cocaine use in the UK appears to show
marked geographical variation which, in turn, questions the utility of national esti-
mation rather than examining drug use prevalence within a more restricted geo-
graphical context. 
Important variations may still be missed if analyses are confined to a city. The meth-
ods presented here form part of a pilot study carried out by the National Addiction
Centre in London (Howes et al, 1995), which explores the feasibility of comple-
menting a capture-recapture methodology with a local prevalence survey. 
The starting point for this exercise was to consider existing prevalence indicators.
When the addresses of local drug treatment attenders were mapped, acute varia-
tion was evident with two local wards (small areas designated for voting purpos-
es) having much higher numbers of drug treatment attenders. Such clustering also
tends to occur in areas which pose the most serious practical problems for con-
ventional population survey methodologies, with the likely result that large-scale
prevalence surveys are unreliable and underestimate the number of certain types
of drug users.
Can survey methods produce useful prevalence data?
In recent years, conventional survey techniques have been regarded with some 
scepticism by drug researchers seeking to conduct prevalence estimation studies.
However, increasingly it appears that, for some drug types, these objections may be
overstated. As prevalence rates increase, estimation techniques are less likely to be
affected by sampling biases. Also, stigmatisation of those who use the drug may
decrease, which, in turn, may reduce reporting biases.
For example, in the United Kingdom, the Health Education Authority recently com-
missioned a survey of drug use amongst a national sample of over 5,000 people 
aged 11 to 35 (HEA, 1996). A stratified random location sample combining quota
and random sampling procedures was used. A range of innovative interview tech-
niques were used to increase response rates and improve the quality of the data col-
lected, including computer-assisted interviewing, allowing respondents to key in the
answer to sensitive questions.
The sampling procedures relied on a neighbourhood sampling schema grouped
according to their social characteristics, though some problems were experienced in
accessing subjects in more socially deprived areas, which were less well represent-
ed in the final sample. The data suggest an ever use of cannabis of 37 per cent, of
69
Chapter 7
amphetamines 15 per cent and of ecstasy 7 per cent. Far lower rates of use were
found for heroin, cocaine and crack cocaine use.
Other surveys, conducted at the same time, such as the British Crime Survey, broad-
ly support these findings. Although researchers may have some confidence in the
estimates for cannabis use and probably some of the other drug types, it is less clear
how reliable the data are for heroin, crack cocaine or the injecting of drugs. In some
circumstances, this may not matter (such as the HEA’s interest in the design of drugs
education material), and it may be sufficient to know that use of these drugs is rela-
tively less prevalent than that of other drugs. However, if the accurate estimation of
the prevalence of heroin use or other similar substances is important, other research
strategies are likely to be of greater utility.
Can survey techniques be used within a local context?
The London pilot study sought to complement a local survey with capture-recapture
methodology (the latter will not be considered here). One of the fundamental ques-
tions the research team wished to answer was whether a local survey was practicable
within a deprived inner-city area. A local housing estate was selected on the criterion
that it was in an area of high deprivation, likely to be considered unsuitable for con-
ventional survey methods, and was within one of the wards with a disproportionately
high number of treatment attenders. Police and other criminal justice system data also
suggested high levels of local drug problems within the sample area.
In addition to both practical and methodological problems, those wishing to under-
take local prevalence estimation studies are often handicapped by a lack of
resources. A number of market research companies were approached to cost the sur-
veying of the designated area. The average cost for a sample of 300 households was
£15,000, which was estimated to yield 150 interviews. The company would only
allow interviewers to work in daylight hours and in pairs. No direct drug use ques-
tions would be included in the face-to-face interview for ‘safety reasons’ but those
respondents who answered a drug screening question positively would be contact-
ed by telephone later.
Although the proposed methodology would have overcome some of the practical
problems inherent in the research task, it was felt that this method would compro-
mise data quality. Apart from the high cost per interview (£100), interviewing only
in daylight hours would be likely to increase non-response bias. Contacting drug
users by telephone, if they had one, was also considered unsatisfactory.
A survey design had to be developed that was inexpensive, minimised reporting and
non-response bias and was likely to deliver data of a sufficient quality to justify the
exercise. In addition to the general problems surrounding the elicitation of behav-
ioural self-reports, there were also concerns about interviewing drug users in their
own homes. The selection of a suitable fieldwork force was considered of critical
importance, since employing interviewers who might be seen by respondents as
‘threatening’ may increase response bias.
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Non-response errors are a widely documented problem in household surveys,
including concerns about whether the sampling frame adequately represents the tar-
get population and whether a young and mobile sample group is likely to be at
home during the interviewing period. But the most important practical issue was
ensuring the safety of the fieldwork team.
A questionnaire was designed which included general lifestyle questions, alcohol
and cigarette use, the use of illicit drugs and drug injecting. Attempts to develop a
sampling frame from the local council, which was responsible for the estate’s
upkeep, proved fruitless, as they did not know who was residing there, how many
people lived in each household or even whether the properties were occupied. It
was decided, therefore, to conduct a census style survey with blanket coverage of
the defined area. 
For both methodological and practical reasons, the survey used a central inter-
viewing point, a community centre at the base of one of the tower blocks, at
which respondents would be encouraged to attend. This procedure was cost effi-
cient and allowed the safety of the fieldwork force to be guaranteed. In addition,
the area acted as ‘neutral space’ where respondents could enter of their own free
will.
A fieldwork force of predominantly young interviewers was recruited from a
range of ethnic backgrounds and asked to dress casually. Security was provided
by a local agency who usually provided doormen for nightclubs and music
venues. The security team were also casually dressed and blended in with the
interviewers. Every attempt was made to make the interview area as relaxed and
non-threatening as possible, as well as to establish a safe working environment
for the interview staff.
Letters were sent to 400 households approximately one week before interviewing,
inviting one individual aged between 16 and 45 to attend an interview.
Interviewing would occur over a one-week period. Late night and weekend ses-
sions were also scheduled. Secondary invitations to other household members
were issued to respondents once they had attended for interview and their house-
hold’s composition had been established in order to increase the number of young
people included in the study. Respondents would be paid £10 for attending an
interview and, to be eligible for interview, respondents would be required to bring
their invitations with them. Originally, invitations were to be posted to households
but, since the postal service had been suspended to the estate area, they were deliv-
ered by hand.
It proved difficult to estimate accurately the survey response rate. It was known
that 80 flats in the estate were reserved for elderly people, making the maximum
possible response rate from 320 dwellings. However, it was not known how many
of these were occupied or if they included household members who were eligible
for interview. In total, interviews were conducted with 180 people from 161
households. The overall household response rate, therefore, was probably 50 per
cent. 
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This was considered disappointing, though the information collected was useful
both in terms of informing other methodological procedures and in describing pat-
terns of drug use in the area. Detailed survey results are presented elsewhere (Howes
et al, 1995). In terms of lifetime drug prevalence the figures were: cannabis 44 per
cent; hallucinogens 17 per cent; ecstasy 10 per cent; amphetamines 32 per cent;
cocaine 16 per cent; heroin 7 per cent and other opiates 8 per cent.
Four per cent of subjects had used heroin and 7 per cent had used cocaine in the
week before interview, confirming that prevalence figures for such drugs were far
higher than those found in national studies.
The inclusive cost per interview was £40.
Conclusions
The pilot study shows that it is possible to conduct a low-cost household survey in
a deprived and difficult-to-access inner-city community. Significant numbers of
problem drug users were interviewed and the findings were useful in describing
some hitherto unknown parameters of the existing drug-using population. The sur-
vey demonstrated that there is a need to develop sampling methodology techniques
to take account of the limited information available in such settings. The use of a
room in the community centre appeared successful: it provided a safe environment
for interviewers, a less intrusive atmosphere for interviewing and respondents could
attend in their own time.
Innovative methodological procedures may allow local surveys to become a useful
tool for those wishing to understand patterns of problematic drug use within small
areas. They may also have some value as booster samples to improve estimation of
prevalence when combined with surveys conducted on a larger scale.
The results of the London pilot study suggest that some of the practical and
methodological problems associated with this kind of study may be reduced by 
the development of appropriate methodological procedures. However, sampling
issues remain a paramount concern for those conducting both national and local
surveys. 
The challenge for researchers working in this area is to discover what gains can be
made. This survey formed part of a larger body of work exploring how different esti-
mation techniques can complement one another in calculating prevalence rates. In
our view, advances in improving the local estimation of drug prevalence will be like-
ly to involve the synthesis of different estimation procedures. As yet, the elements in
such a synthesis remain unclear, though it remains an area where innovative, sensi-
tive and rigorous research design is likely to bear fruit.
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Introduction
by Martin Frischer
n recent years the capture-recapture method (CRM) has become one of the
major methods used in epidemiology to estimate hidden populations. Indeed
Laporte (1994) regards CRM as being of such importance that it could ‘bring  
about a paradigm shift in how counting is carried out in all the disciplines that
assess human populations’.
The chapter by Antònia Domingo-Salvany introduces the main features of the
method. Beginning with simple applications involving two lists of drug users, she
illustrates the statistical reasoning behind CRM and the assumptions which must be
met in order to produce reliable estimates. Extending CRM to more complex sce-
narios involves greater statistical sophistication, for example, the fitting of log-linear
models and the calculation of confidence intervals. The chapter also provides
methodological guidelines covering a wide range of practical issues.
Clive Richardson considers lessons that may be learned from the studies of animal
populations. Whereas CRM applications in drug epidemiology focus on population
estimates, animal studies are often concerned with inward and outward migration
and survival rates. At the present time, available data in drug epidemiology preclude
the application of these more sophisticated models. However, as data in this field
improve, there will be opportunities to employ methods developed in the context of
animal studies.
Pierre-Yves Bello and Geneviève Chêne provide a further example of CRM as
applied in Toulouse, France. The authors describe difficulties in obtaining data and
the practical issues which are often encountered prior to data analysis. The authors
also use CRM in an innovative fashion to develop models which take account of
interactions between age, gender and data source.
Finally, Martin Frischer describes a CRM study in Glasgow, Scotland, and illustrates
how to proceed from simple two-sample models to complex models involving three
or more samples. A range of issues is considered, including case definition, case
matching, model selection and confidence intervals. The issue of external validation
of CRM estimates is also addressed.
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Estimating the Prevalence of Drug Use
using the Capture-Recapture Method:
an Overview
by Antònia Domingo-Salvany
One of the major methods used in drug addiction epidemiology to estimate preva-
lence of drug use is the capture-recapture method (CRM), sometimes known as
mark-recapture (Brecht and Wickens, 1993). CRM refers to a technique developed
over a century ago to estimate the size of wild animal populations and involves
‘capturing’ a random sample who are then ‘marked’ and returned to their habitat.
Subsequently, a second random sample are ‘recaptured’ and the number of
marked animals from the first sample are observed. The ratio of marked animals 
to the recaptured sample size is assumed to be the same as the ratio of the first
captured sample to the total population. Thus, if a ‘capture’ sample of 200 animals
is marked and released and a ‘recapture’ sample of 100 contains ten animals
which are marked, the estimate for the total population would be 2,000 (i.e.
10:100 = 200:2,000).
In human sciences, CRM was first used to ascertain completeness of census data by
assessing the degree of under-registration of births and deaths in the general regis-
trar (Sekar and Deming, 1949). It has also been used in studies to estimate the degree
of under-ascertainment of prevalence studies aimed at intensive case-finding (Hook
and Regal, 1992 and McCarty et al, 1993).
In view of the real or perceived problems of asking people directly about drug use,
CRM affords a means of estimating prevalence indirectly from data on known drug
users.
Methods and research strategies
CRM prevalence estimates are based on the analysis of incomplete multiway
tables. The term ‘incomplete’ simply refers to the fact that there is always a miss-
ing cell corresponding to individuals not recorded on any of the sample lists and
the term ‘multiway’ simply refers to the fact that there are two or more samples
(see Figure 1).
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Figure 1: Example of the simplest form of multiway table for CRM analysis
Sample 2
Sample 1
Present Absent
a+bPresent
Absent
a
c
a+c
b
d
In this way, we can estimate N with a confidence interval (CI) where CI = N ± 1.96 * SE.
If the number of observed individuals is small, formulae should be transformed into:
d = b* c/(a + 1) and N = [(a + b + 1) (a + c + 1) / (a + 1)] - 1
The assumptions of the method are important, particularly for this simplest model
(Neugebauer and Wittes, 1994):
• the samples/lists must be representative of the population under study, which has
to be ‘closed’, i.e. random samples of a closed population (closed refers to the
assumption that individuals do not enter or leave the population during the study
period);
• each list must be homogeneous, i.e. the probability of selection into a sample/list
must be constant for all individuals;
• the lists must be mutually independent, i.e. the individual probability of selection
into a list must not be influenced by the presence or absence of the person in
another list. 
These assumptions are interrelated, but each one has some specific features which
need to be taken into account in order to apply the method correctly and produce
plausible prevalence estimates. Representativeness of the population is crucial.
Individuals not seen (those that we wish to estimate) have to have similar character-
istics to those who are seen. This assumption is important, as CRM involves extra-
polation from available lists which are probably not random samples of the popula-
tion under study. To assume that the population is ‘closed’ is only reasonable for
short time periods (e.g. up to about one year). During longer periods there will be
some individuals who join the group of interest (i.e. initiate regular drug use) and
others who leave it (i.e. achieve abstinence or die). If prevalence is to be estimated
over a long period of time, other methods considering open populations need to be
applied. 
Independence between lists needs further clarification. Concepts used in ecological
studies may help to understand it (see Chapter 9 by Clive Richardson). ‘Trap attraction’
The estimate for the missing cell (d) is: d = b*  c/a
and for the total population: N = a + b + c + (b* c/a)
The estimate variance of this is: Var N = (a + b)* (a + c)* b* c/a3
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can arise when something appealing to individuals happens once they have been
caught, so they are more likely to be caught in another sample (positive dependence).
‘Trap avoidance’ may occur when individuals did not like what happened during the
first capture experience and can avoid subsequent captures (negative dependence). In
health services, positive dependence may occur when patients like the treatment given
at some services (i.e. opioid substitutes in emergency room wards) or because patients
included in one list are more frequently submitted to a procedure that is the basis for
another list (i.e. treatment patients on one list may be more likely to be easily tested
for HIV and appear on a second list – persons tested for HIV). Negative dependence
would arise when the fact of being on one list (i.e. in prison) reduces the chances of
being included in another one (i.e. attending outpatient clinics). A priori information
about samples can give an idea of possible dependencies and their direction.
The influence of dependence in the estimates can be understood if we apply these
concepts in the formula for ‘N’: when there is positive dependence the probability
of appearing in both samples is higher, thus ‘a’ (the denominator – see Figure 1) will
be higher and the estimate for the unseen population, smaller. Conversely, when
negative dependence occurs, the size of the estimate will be too big because ‘a’ is
smaller than it should be.
Heterogeneity has some relation with dependence as individuals likely to fall repeat-
edly into the ‘trap’ do not have the same probability as others not caught previous-
ly. Heterogeneity, however, is not directly related to the construction of lists.
Individuals may have different probabilities of being included in lists for several rea-
sons: severity of disease, geographical area of residence, socio-economic status, etc.
The effect that heterogeneity produces in the estimate is likely to be an under-
estimation since the overlap of sub-groups of people will be higher and some sub-
groups are likely to be missed.  When three or more samples are available, the inde-
pendence of samples can be verified by different means:
• calculating the estimate for the different combinations of two-by-two samples;
• pooling together the two dependent samples and comparing the estimate;
• applying a log-linear regression to the data.
Through log-linear regression, heterogeneity can also be analysed and, if necessary,
controlled for by dividing the whole group into sub-groups which are known to be
more homogeneous in relation to capture probabilities.
Log-linear approach
The log-linear regression model allows interaction terms representing dependencies
between samples. Thus, the assumption of independence can be tested and, if
dependence is found to exist, interaction terms will modify the estimates of the
unknown number of drug users (Cormack, 1989; Wickens, 1993). However, it is not
possible to test a saturated model with all possible interactions, as there is one miss-
ing cell in the model. Nevertheless, the aim is not to produce a very complicated
model but rather the simplest one that has a good fit with the data. The appropri-
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ateness of the model is assessed through the residual deviance and can also be
assessed through the residuals in each cell. A more formal strategy to select the
model, through its likelihood function, can be used following Akaike’s Information
Criterion (AIC) or the Bayes’ Information Criteria (BIC) (IWGDMF, 1995). 
It is important to take into account that more complex models may introduce insta-
bility and will always diminish precision as variance increases with more terms in
the model. If the estimate is sensitive to small modifications of terms in the model
(instability), caution is required when interpreting the results. If available statistical
packages provide the parameter estimates for the log-linear regression (e.g. GLIM),
it will be possible to calculate the missing cell size directly from the regression coef-
ficient. If the statistical package does not give the betas for each parameter and if
three samples are being used, it is possible to apply formulae given by Bishop et al
(1975). There are different formulae according to the number of interactions present
between the three samples. It is even possible to calculate an estimate taking into
account that all three samples are interdependent. Formulae can also be applied
after dependence of samples has been assessed through comparison between differ-
ent combinations of two-by-two samples.
Confidence intervals
One of the attractive features of CRM is the provision of statistical confidence inter-
vals (CI) for the estimate. The CI will be correct if the model is appropriate.
Traditionally, the interval has been calculated through the asymptotic standard error
of the estimate in the selected model (i.e. for 95 per cent CI: N ± 1.96 * SE).
However, this interval has been criticised for its lack of precision, especially when
sample sizes are small. In fact, CIs calculated in this way can give values for the
population estimate which are lower than the number of individuals actually seen.
A method proposed by Regal and Hook (1984), and also by Cormack (1992), takes
into account the goodness-of-fit of the log-linear model chosen to calculate the 
estimate. In order to apply it, an iteration process is needed. This process tries to find
the minimum and maximum missing cell values which produce a statistically sig-
nificant difference of the model (i.e. inputting differing values of the missing cell
until the model deviance changes by a specified criterion, usually p = .05).
With log-linear regression, heterogeneity can also be assessed (Darroch et al, 1993).
Some prior knowledge about the studied population is needed to be able to apply
correct statistical analysis. The structure of the captured population can be analysed
and some conclusion drawn about its representativeness of the population under
study. To control for different catchability between sub-groups (heterogeneity), strati-
fication built into the regression is used (i.e. break the total population into male and
female). However, this may lead to a problem since several strata will produce
greater variability of the final estimate achieved by summation and it will be more
difficult to obtain a CI for the global estimator.
Recently, Hook and Regal (1995) have proposed a method to ascertain the internal
validity of the model(s) used for the estimate. Four or more samples are needed. The
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test may help to ascertain whether the models used were able to incorporate the dif-
ferent dependencies of the data. In general, it should always be remembered that
models are simplifications of a more complex phenomenon and it is not enough
simply to achieve a good fit of the model. It is necessary that the unseen part of the
population has the same sampling characteristics and has homogeneous catchabil-
ity with those seen and that no hidden sub-groups exist (Hser, 1993).
Longitudinal data
CRM can also be applied to single samples over a longer time period, still assuming
a closed population. This involves subdividing the complete sample in time inter-
vals, considering each one as a separate sample, and then applying capture-recap-
ture to these different samples (Woodward et al, 1984). The same assumptions of
capture-recapture are needed. The most important problems with capture-recapture
applied to a unique sample divided in time periods are as follows:
• the source of information which provides the data may have a retention of the
patients not being allowed to appear several times;
• unequal catchability of the population leads to dependence between samples;
• some people have zero probability of appearing at the specific agency, thus the
estimate is only for those people likely to appear.
General considerations
In order to evaluate the adequacy of CRM as an estimation method, it is necessary
to have a clear understanding of the strengths and weaknesses of all the data used,
as well as of the process of data collection. The important points to consider are:
• definition of the disease under study - in the drug field, this refers to characteris-
tics such as type of drug, recency or frequency of use and route of administration;
• adequacy of registers, in terms of completeness and quality of data, especially in
relation to identification variables;
• matching difficulties can introduce bias in the overlap and thus in the estimate;
• time elapsed between initiation and appearance in registries (diagnostic delay)
can produce underestimation of recent initiates;
• it is desirable to include samples from both the medical care and criminal justice
system. The application of CRM should include as many types of list (e.g. med-
ical and legal) as possible;
• results obtained through capture-recapture should be compared with other meth-
ods, as a combination of methods may help to ascertain boundaries for the esti-
mate (even if there is inconsistency, this may help to understand the data and the
phenomena being studied).
Guidelines on methodological standards
Given the current state of knowledge about the technique, the following guidelines
are suggested:
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Assumptions of the method
Samples/lists are representative of the population under study:
• persons included in the lists must have similar properties to those not seen;
• the population should not contain hidden sub-groups;
• there should be consistent definition of people across samples in relation to time,
geographical area, drug use and age range.
Estimation involves a closed population:
• this requires a cross-sectional design of limited duration or a single longitudinal
sample.
Identifiers are required for individuals in all samples:
• information about sensitivity and specificity of identifiers is required;
• the completeness of identifiers must not be related to the number of times sub-
jects are captured in lists.
Homogeneity of the lists:
• severity of the drug problem may affect the likelihood of being captured;
• other variables that might affect homogeneity are geographical differences, route
of drug administration and socio-economic status.
Lists are mutually independent:
• this requires at least three samples;
• a priori knowledge about interrelation of sources has to be used to help interpret
the statistical interactions.
These issues should be addressed when describing a CRM study, i.e. whether the key
assumptions are fulfilled, and if they are not, whether they are controlled during the
analysis. If the key assumptions are not met, the direction of bias introduced into the
estimate should be explained.
Practical issues
When planning to estimate drug abuse prevalence through CRM, it is necessary to ensure
that several sources with reliable (and appropriate) data are available. This means that:
• high risk groups of the target population must be covered by the sources used;
• valid indicators of drug use are used in these sources (to allow definition of tar-
get population);
• unique individual identifiers can be obtained;
• consistency can be achieved among samples in relation to time, geographical
area, population age range and drug use categories (also consistency over time 
is needed if trends are to be estimated).
Small numbers of people in samples may preclude the implementation of the 
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method. To be confident of the results, it is necessary that there be some overlap
between samples. If one has collected a good set of data but one which is insufficient
to give a sensible estimate, at least the information gathered could provide a first
prevalence estimate through case-finding (lower range). If samples are big enough to
apply capture-recapture, the assumptions of the method need to be dealt with in the
analyses or at least in the final consideration of the results. The more relevant assump-
tions at this point are homogeneity of samples and independence between them.
• Cover different aspects of drug use
(health-related, legal system, etc.)
• Take three or more samples from different
sources
• Use an equivalent target population defi-
nition in all samples (in relation to drug
use, age range, geographical area and
time period)
• Consider representativeness and homo-
geneity of the samples in relation to the
studied population
• Consider the adequacy of the identifier
for individual matching
• Test for sample independence (at least
three samples are needed)
• Control for dependence when it exists (fit
log-linear models with interaction terms)
• Ascertain stability of the model
• Calculate confidence intervals with
goodness-of-fit method
• Calculate rates: the reference population
should be taken consistently according to
age range, geographical area and calen-
dar year
• Compare the resulting estimate with other
prevalence information
• Consider different settings as different
samples
• Consider a broad time period, as it is
then problematic to meet the assumption
of a closed population
• Consider a wide geographical area as it is
more difficult to have homogeneous pop-
ulation groups in it
• Take independence for granted
• Include too many parameters in the
model
• Calculate CI with the estimate standard
error, if sample sizes are small
Do Do not
Figure 2: Some recommendations for capture-recapture studies
In order to explore these issues adequately, sophisticated statistical analysis may be
required. The analysis may involve creating different log-linear models, for which the
help of a statistician may be needed. It is important to study the stability of the model.
Calculation of confidence intervals taking into account the goodness-of-fit of the
model can also be fairly complex. Confidence intervals should be calculated with this
method instead of through the standard error when some sample sizes are small. In
order to provide adequate prevalence rates, the reference population to be used in the
denominator should include the same age range and geographical area of the esti-
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mated number of drug users. This reference population should also correspond to the
year for which estimation was calculated. These guidelines seem reasonable in the
light of the present state of knowledge. Some ‘dos and don’ts’ are shown in Figure 2
above. Capture-recapture is a method still in evolution, particularly with regard to sta-
tistical analysis involved in overcoming the problems posed by assumptions.
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Lessons from Studies of Animal Populations
by Clive Richardson
Statistical analysis is employed in so many fields of science and social science that
it is not surprising that the same methods appear in various places. Sometimes this
means that the same methods are rediscovered and parallel literatures develop
almost independently. In other cases, techniques have been so well developed in
one area that the needs of another can be met by recognising what can be borrowed
and adapted from the existing material. This is more or less the situation with cap-
ture-recapture methodology (CRM). It has been applied in several fields, including
drug use epidemiology, but has been worked on so extensively in relation to the
study of animal populations that it is natural to look there for methodological tools
and discussions of problems such as the effect of departures from the assumptions of
each model. This paper highlights some of the key differences between applications
of these methods in drug use epidemiology and in animal studies, and adds some
comments on other areas of application.
Animal population studies
The review papers by Seber (1986, 1992) and Pollock (1991) are important in them-
selves and also give all the necessary references to the earlier literature. Much has
been published on fisheries and wildlife in books and in journals, which may not
easily be found by readers of this article. Methodological papers continue to appear
in almost every issue of the journal Biometrics, while the Journal of Wildlife
Management is the most important of the other sources.
Epidemiology
There are very recent, comprehensive reviews by Hook and Regal (1995) and the
International Working Group for Disease Monitoring and Forecasting (IWGDMF,
1995a, 1995b). The major outlets for both methodological papers and applications
are the American Journal of Epidemiology and the International Journal of
Epidemiology. Papers on application to the estimation of numbers of drug users
include the contents of a special issue of the Journal of Drug Issues, particularly
Wickens (1993) and Brecht and Wickens (1993).
Chapter 9
Census adjustment
For about fifty years, capture-recapture techniques have been applied to assess the
completeness of a census of a human population, particularly in the USA. Dual
record, rather than multiple record, systems have been the norm. In other words,
the analysis is based on the appearance of individuals in one or both of two lists,
one being the census itself and the other a sample survey conducted for the pur-
pose of this check. Thus, it becomes possible to estimate the number of individu-
als who have been missed by the census. A bibliography on this area of applica-
tion is given by Fienberg (1992), while Darroch et al (1993) discuss a three-sample
approach.
Studies of animal populations
Study design 
As a first step to understanding the difference between epidemiological and eco-
logical applications, consider the usual form of the study of an animal population
(see Figure 1). Each sample involves the capture of animals belonging to a popu-
lation under study. The first time an animal is captured, it is given a recognisable
mark and released. The nature of the mark depends on the animal. Birds are often
given rings around the leg, fish a tag attached to one of the fins, insects perhaps
dabs of paint. Except in studies involving very large numbers of animals (mainly
in fisheries research), the ring or tag usually carries a numerical or other code so
that the individual animal can be identified (I assume from here on that this is the
case). 
Figure 1:  Process of a typical capture-recapture study of an animal population
Sample                                   Time sequence                   Action
Capture 1       Mark and release animals
Recapture 2 Recapture and re-release
Mark and release animals
never captured before
Recapture 3 Recapture and re-release
Mark and release animals
never captured before
Recapture, etc. 4 etc. etc.
The samples are usually taken in the same place at different times (theoretically they
should be instantaneous; in practice, the sampling occupies a short time compared
to the intervals between samples). In most studies, the recaptured animals are
86
Capture-Recapture Methods
87
Chapter 9
released and may be recaptured again in subsequent samples. Many variations on
this basic theme are possible. In the first place, some animals may not be released
after recapture (for example, if they were injured, or if they were taken for further
study) and the basic equations allow for this. In fact, the design of the study may be
that there are never any re-releases – this would usually be termed a tag-recovery
study, since its essence would be the recovery of tags (marks) by recapturing the
tagged animals. Another variation is that no physical recapture need take place
except on the one occasion when the animal is marked. This tends to arise with ani-
mals large enough to carry marks visible to an observer from a distance and is often
termed a mark-resighting study. 
Study size
Applications can be found on all scales. The numbers of animals involved could be
tens of thousands, but this is hardly likely to arise other than in fisheries research.
Elsewhere, rather small population sizes are likely to be encountered. In a typical
ornithological study, the total population size at any time is usually well below a
thousand and the number of marked birds recorded in each sample below one hun-
dred (Richardson, Patterson and Dunnet, 1979). However, these smaller studies, as
well as many others, tend to be of long duration. The study by Richardson et al
employed data from eight years’ observation while Cormack (1989) used a 25-year
period in studying another species of bird.
Models
The basic model for the analysis of data from such a series of samples is known as
the Jolly-Seber model. It applies to an open population (i.e. allowing for inward and
outward migration), since the longitudinal nature of the study implies that the
assumption of a closed population is unlikely to be justifiable. Besides estimating the
population size at each sampling time, the analysis gives estimates of birth and death
rates between successive samples. ‘Birth’ includes immigration of an animal into the
population (this means that its range of activity has shifted to cover the geographi-
cal area covered by the sampling scheme) while ‘death’ includes permanent emi-
gration from the population. The model does not permit temporary emigration from
the population. This is because temporary absence at the time when a sample is
drawn means that this animal has zero probability of being captured in the sample,
in contrast to the non-zero capture probability of the animals which have remained
in the area. In other words, temporary emigration would introduce severe hetero-
geneity. The other assumptions of the basic model are familiar and obvious assump-
tions of homogeneity of survival probabilities and capture probabilities. A number of
models have been proposed that relax certain assumptions or impose constraints on
parameters. The work of Cormack, in particular, shows how many – although not all
– of these models can be fitted to the data by applying the standard statistical pro-
cedure of log-linear modelling (Cormack, 1989). Another full example of log linear
modelling may be found in IWGDMF (1995a).
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Differences between epidemiological and ecological applications
Are the similarities between the areas of application only superficial or are the prob-
lems essentially the same? The following seem to be the key points of difference:
Definition
Epidemiological and ecological studies face more or less the same problem of defin-
ing the geographical extent of the population, but they differ in their ability to define
members of the population within this area. Almost any epidemiological study has
to start by defining a case: for example, who, for the purpose of the present task, will
be defined as a drug user? The definition may be partly imposed by the nature of the
lists available to us, which will usually be biased in some way (probably, in most
applications, towards problematic users and users of certain classes of drugs). We
may be able to try different definitions and find that our methods work out better for
one than the other. Or we may define strata, such as frequency of use or main sub-
stance of abuse, and carry out a stratified analysis. This is a problem that does not
arise in studying an animal species, where there is seldom any difficulty at all in say-
ing whether or not an animal belongs to that species, since objective criteria have
been laid down elsewhere.
Matching
The issue of matching, a major problem in epidemiology, also arises in the applica-
tions to the census. It refers to our ability to identify correctly the presence of the
same individual in more than one list. Identifying information (names, birth dates,
addresses) may be incomplete and inaccurate. The problem is exacerbated in drug
use epidemiology where the identification information on certain kinds of lists is
deliberately restricted. The nearest equivalent problem in ecological applications is
tag loss, the loss of the mark (such as the numbered ring on a bird’s leg) that allows
the animal’s individual identification. In this case, matching is an ’all or nothing‘ sit-
uation, being either correct or impossible. In epidemiology, we may make mistakes
in matching and may need to try out different criteria.
Cross-sectional versus longitudinal study
Almost all epidemiological studies are cross-sectional; they employ samples that
refer to more or less the same time point (e.g. a one year period). In animal studies,
as already mentioned, the population is studied longitudinally by taking a sequence
of samples over a period of time. One consequence of this is that the log-linear
modelling of an ecological study is usually simplified by the fact that many inter-
action terms are implausible. In epidemiological applications, on the other hand,
nothing can be excluded.
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Observational study versus planned experiment
In epidemiology, the lists employed in a multiple-capture analysis have usually been
assembled for some other purpose. On the other hand, a study of an animal popu-
lation can usually be planned. In particular, the timing, location and duration of
sampling are, to a large extent, under the investigator’s control. One consequence 
of this is that some literature has developed on optimal sampling for particular pur-
poses. As most epidemiological applications are not able to control these factors,
they are not able to take advantage of knowledge gained from animal studies.
However, this may be an area for future development as epidemiological studies
become more sophisticated.
What is being estimated?
In Seber’s well-known book entitled ‘The Estimation of Animal Abundance and
Related Parameters’ (1982), and Pollock’s review (1991) referring to ‘demographic
parameters for fish and wildlife populations’, far more than population size estima-
tion is discussed. As pointed out above, an open population is usually being stud-
ied, so that birth and death rates are important. In fact, it is often the case that esti-
mates of population size are not even sought. 
My own paper cited above is just one of many examples to be found in which the
multiple-capture analysis is used solely to estimate survival rates. In contrast, most
epidemiological studies have no other purpose than to estimate the population
size. Thus, many of the methods, applications and discussions found in the eco-
logical literature are not currently relevant, although there may be scope in future
research.
Heterogeneity
It is well known that log-linear models make assumptions of homogeneity. For
example, every animal should have the same probability of capture in a given sam-
ple, which is equivalent to every drug user in our population having the same prob-
ability of appearing on a given list. The effects of departures from such assumptions
have been investigated and discussed in both literatures. The difference between the
two areas is that, while heterogeneity may or may not arise in an animal study, it is
almost certain that there will be severe heterogeneity in a study of drug users even
if this is not necessarily the case in all areas of epidemiology. 
Heterogeneity may be reduced in various ways, including the choice of a more
restricted definition of a user, but above all it should be handled by stratification.
Heterogeneity cannot be greater in a sub-population than it is in the whole popula-
tion and can usually be drastically reduced by wise selection of strata (see Chapter
8 by Antònia Domingo-Salvany for further discussion of this issue).
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Dependence between samples
It is also well known that log-linear models make many assumptions of independence.
In the extreme, but common, case of the two-sample study, we can only estimate the
population size if we assume that the appearance of a member of the population on
one list is independent of appearance on the other. The serious consequences of fail-
ure of this assumption are well known. Lack of independence is a problem that arises
in animal population studies too. There it has been discussed particularly as the prob-
lem of trap addiction or trap avoidance (other terms for the same phenomenon can be
found). The former means that an animal that has once been caught has an increased
probability of capture in the next, and perhaps in all, subsequent samples.
The equivalent in the study of a drug-using population is that a person who appears
on one list is more likely to be on another than a person who is not on the first list.
This is highly likely to happen, for many reasons. Trap avoidance refers to the pos-
sibility that an animal once captured has a reduced probability of subsequent cap-
ture, probably because it has learnt not to repeat the experience. The equivalent
would be that a drug user who appears on one list has a smaller chance of being on
the other than a drug user who did not appear on the first. This should not be a prob-
lem in practice because if, for example, users tend to go to one service or another
for treatment but not both, this would often be known beforehand to the investiga-
tors, due to their familiarity with the area and the population. The lists could be com-
bined into one for analysis, assuming that there are also other lists available.
Although correspondences on this point can be identified between ecological and
epidemiological applications, it should be observed that the features usually arise for
quite different reasons. As indicated, it is essentially a behavioural problem among
animals. If the drug user, on the other hand, is not going to a second service because
he or she has been to the first, or is going to the second because of going to the first,
this is again most likely to be a known feature of the structure of the services and so
this source of heterogeneity could be avoided by selecting and merging the initial
lists. For drug users, in fact, the dependence between lists is usually a reflection of
heterogeneity. For example, the heavier users may be more likely than lighter users
to be on both a police and a treatment list, or on two treatment lists. Stratification
could, therefore, be a better way of handling this dependence than attempting to
adapt the models that allow for the phenomenon in the form in which it arises in
studies of animal populations.
Supplementary information
In every kind of multiple capture study, there is usually further information available
on the members of the population, beyond the simple record of their individual cap-
ture histories. This may permit a stratified analysis. For example, male and female
animals, or adults and juveniles, may be analysed separately. One purpose of this
stratification is to obtain greater homogeneity and thus fulfil the assumptions of the
statistical analysis more closely. 
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The difference between ecological and epidemiological applications is that, in the
former, there will not usually be much supplementary information available – prob-
ably sex, perhaps age, and also location, if the sampling is not all at the same site.
In epidemiological applications, on the other hand, there will usually be many
pieces of supplementary information. For drug users, depending on the purpose for
which the lists have been drawn up, we will probably know not only sex, age and
place of residence, but might also have information on treatment history, drug use
history, substances of abuse and other behavioural items. How can all these be
exploited in the analysis? (Some may already have been used in the matching.) 
There is a difficulty to be considered in deciding how to use this supplementary
information. Our data are generally not totally reliable, so an item which appears on
two or more lists may not agree. This seems to be a problem with no real equivalent
in the study of animal populations.
Conclusions
Epidemiological applications of CRM differ from their use in animal population stud-
ies in many and important ways. Perhaps the key items are that, in the former type
of analysis, we are interested in methods applicable to a small number of cross-
sectional (rather than longitudinal) samples. There is likely to be a high degree of
heterogeneity, but there is the potential advantage of exploiting extra information on
the individuals in our population. By and large, papers on CRM in animal popula-
tion studies are not written with this situation in mind and it is doubtful if much is
going to be added to that literature in the future that will be of use in epidemiology.
Is the application to census adjustment more relevant? In many ways, yes. Many of
the similarities are stronger and the differences fewer. However, there is an emphasis
here on the two-sample case, and there is also the difference that sampling is
planned.
CRM techniques are important in estimating numbers of drug users because this is
the way in which it is possible to make use of partial lists. It seems that, from now
on, the special circumstances of this and other epidemiological applications will
lead to a more specialised literature. Let us never forget, however, the need for cross-
fertilisation and the possibility that what we need can be found elsewhere. Here is
one example. The notorious need for independence between lists in a two-sample
study can be dropped, at the expense of making other assumptions, by stratifying the
data and then imposing some constraints on the parameters of the different sub-
tables. For example, tables can be drawn up for each of the two sexes and valid esti-
mates of population sizes obtained for men and women separately, without assum-
ing independence but assuming that the degree of dependence is the same for both
sexes. The idea was developed by Wolter for census adjustment (and employed by
Choi, Steel and Skinner, 1988) but published in the biometrical literature (Wolter,
1990) and provides a method which could have utility in drug epidemiology.
92
Capture-Recapture Methods
References
Brecht M.L. and Wickens T.D. (1993) ‘Application of multiple-capture methods for estimating
drug use prevalence’, Journal of Drug Issues, 23, 229-250.
Cormack R.M. (1989) ‘Log-linear models for capture-recapture’, Biometrics, 45, 395-413.
Choi C.Y., Steel D.G. and Skinner T.J. (1988) ‘Adjusting the 1986 Australian census count for
under-enumeration’, Survey Methodology, 14, 173-189.
Darroch J.N., Fienberg S.E., Glonek G.F.V. and Junker B.W. (1993) ‘A three-sample multiple-
recapture approach to census population estimation with heterogeneous catchability’, Journal
of the American Statistical Association, 88, 1137-1148.
Fienberg S.E. (1992) ‘Bibliography on capture-recapture modelling with application to census
undercount adjustment’, Survey Methodology, 18, 143-154.
Hook E.B. and Regal R.R. (1995) ‘Capture-recapture methods in epidemiology: methods and
limitations’, Epidemiologic Reviews, 17, 243-264.
IWGDMF (1995a) ‘Capture-recapture and multiple-record systems estimation. I: History and
theoretical development’, American Journal of Epidemiology, 142, 1047-1058.
IWGDMF (1995b) ‘Capture-recapture and multiple-record systems estimation. II: Applications
in human diseases’, American Journal of Epidemiology, 142, 1059-1068.
Pollock K.H. (1991) ‘Modelling capture, recapture, and removal statistics for estimation of
demographic parameters for fish and wildlife populations: past, present and future’, Journal of
the American Statistical Association, 86, 225-238.
Richardson S.C., Patterson I.J. and Dunnet G.M. (1979) ‘Fluctuations in colony size in the
rook, Corvus frugilegus’, Journal of Animal Ecology, 48, 103-110.
Seber G.A.F. (1982) The Estimation of Animal Abundance and Related Parameters, 2nd edi-
tion, London, Griffin.
Seber G.A.F. (1986) ‘A review of estimating animal abundance’, Biometrics, 42, 267-292.
Seber G.A.F. (1992) ‘A review of estimating animal abundance II’, International Statistical
Review, 60, 129-166.
Wickens T.D. (1993). ‘Quantitative methods for estimating the size of a drug-using popula-
tion’, Journal of Drug Issues, 23, 185-216.
Wolter K.M. (1990) ‘Capture-recapture estimation in the presence of a known sex ratio’,
Biometrics, 46, 157-162.
93
A Capture-Recapture Study to Estimate 
the Size of the Addict Population
in Toulouse, France
by Pierre-Yves Bello and Geneviève Chêne
Estimates of the number of ‘hard’ drug users in France are not very precise, vary-
ing between 150,000 and 300,000 (Lert, 1993). Using health data and a demo-
graphic model, Costes (1995) estimated that there were at least 160,000 current
heroin users in France and discussed the use of epidemiological information in 
formulating policy.
As in other countries, there is also a need to estimate the size of the drug-using pop-
ulation at regional or local level. In particular, such estimates enable some assess-
ment of the proportion of drug users using social and health care facilities. The use
of a denominator, together with additional specific investigations, can also provide
estimates of the prevalence and possibly the incidence of morbidity (HIV, hepatitis,
overdose) and mortality. This information can also be useful for epidemiological sur-
veillance of drug addiction and for health and social planning at local and regional
level (Frischer et al, 1993).
The unusual and clandestine nature of addictive practices is, however, an obstacle
to obtaining data, and it is therefore very difficult to carry out studies covering the
general population. Methods such as population surveys which work well for alco-
hol, tobacco and cannabis are not effective for hard drug consumption (heroin,
cocaine, LSD, crack). Large samples are needed to identify an uncommon behaviour
pattern, and the response is largely dependent on the interviewer/interviewee rela-
tionship. The prevalence of drug addiction is highest among marginal populations 
(in prison or with no fixed address), and it will be difficult to reach such groups with
a standard sampling procedure. Several ‘indirect’ methods of estimating the size of
addict populations have been proposed, including the Markov model, synthetic esti-
mation and the capture-recapture method (CRM) (Wickens, 1993).
CRM is increasingly being used to solve estimation problems in ‘marginal’ popula-
tions (Fisher et al, 1994). Recently, CRM has been used to estimate populations of
drug addicts (Domingo-Salvany et al, 1995; Frischer et al, 1993; Mastro et al, 1994),
prostitutes (McKeganey et al, 1992) or persons with no fixed address (Fisher et al,
1994). The number of cases can be estimated by this method on the basis of two or
more case sources, which may be hospital outpatients or inpatient agencies or any
Chapter 10
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other point of contact (specialised care centre, syringe exchange point, police sta-
tion, etc) as explained elsewhere in this monograph.
In this chapter, we describe a practical case study of the application of CRM to esti-
mating the size of the drug-using population in the Toulouse conurbation.
Subjects and methods
Case definitions and data sources
Toulouse is the capital of the Midi-Pyrénées region (population 2,430,663) and the
Haute-Garonne département (population 925,000). The Toulouse conurbation is a
young and dynamic area containing 37 per cent of the region’s jobs, unlike the rest
of the region where the population is mainly rural and ageing. The conurbation is an
urban zone with a population of over 650,000 (360,000 in the actual city and
290,000 in the suburbs) (INSEE, 1991).
In this study, the term drug user was definied as ‘any person residing in the Toulouse
conurbation for at least three months who habitually used, and was dependent
upon, substances taken orally, nasally, or by injection, at the time of first contact 
with the source’. The three-month residence stipulation enabled us to exclude per-
sons treated in the conurbation but originating from another place of residence as
well as persons with no fixed address who were not ‘settled’ in the conurbation. The
terms ‘habitual user of’ and ‘dependent upon’ were intended to exclude one-off
users of drugs (for example, attempted suicide by means of psychotropic sub-
stances). Drug use must have commenced at least three months prior to the date of
contact with the facility; non-injection users must have taken the drug at least once
a week over the previous month.
The drugs taken into consideration were heroin, morphine and its derivatives (par-
ticularly codeine, buprenorphine, methadone), cocaine, crack, amphetamines, psy-
chotropic drugs other than for therapeutic purposes, hallucinogens (LSD, ecstasy
[MDMA] and other dysleptics) and solvents. 
The information collected in respect of each person included in the study was as fol-
lows: first initial of the surname; forename; date of birth; sex; home address post-
code; whether without any fixed address; whether residing in the Toulouse conurb-
ation for more than three months; date when care commenced in 1994; date when
care ended; main substance used; secondary substance; main method used (injec-
tion, oral, nasal); number of doses during the previous month; and whether by injec-
tion. The study covered the year 1994. Data were collected retrospectively, from
March to July 1995.
A list of agencies able to treat drug addicts in the Toulouse conurbation was drawn
up, which included specialised treatment agencies for drug addicts, hospital agen-
cies (infectious diseases, gastro-enterology, general intensive care and psychiatry),
the drug addiction unit of the prison, the urban police narcotics squad and the
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Toulouse syringe exchange bus. The head of each agency and, in some cases, his or
her assistant, was contacted in order to explain the project, its purpose, method and
aims. This enabled the agreement in principle of all heads to be secured and the pos-
sible data collection arrangements for each agency to be discussed. In some agen-
cies, case selection was difficult, reducing the quality of data collection. Finally,
twelve agencies were actually asked to collect data: the drug addiction unit; four
specialised care services for drug addicts; two psychiatric agencies; two intensive
care services and three medical agencies. At least one person was trained in data
collection at each site.
Data collection
A data collection form was standardised and tested by agency heads and corre-
spondents, and a handbook was produced setting out the objects of the study and
the procedure for filling in the form, together with some examples of completed
forms. In each participating agency, one person was responsible for collecting data
and compiling a form for each addict with whom the agency dealt during 1994. The
case selection arrangements were adapted to each agency. When all the forms had
been completed, they were sent to the doctor co-ordinating the study. All forms were
read and validated before computer acquisition, which was effected with Epi-Info
(WHO-CDC) software.
Cases common to several sources were identified by means of a computer file con-
taining all the forms from all the agencies. This file was classified first by alphabeti-
cal surname initial and forename, then by alphabetical forename and surname ini-
tial, and lastly by order of birth date and surname. Identification variables were the
surname initial, the forename, the birth date and the sex. In this way, it was possible
to identify both exact overlaps (identity of surname initial, forename, birth date and
sex) and inexact overlaps. It was considered, therefore, that two forms could be
regarded as identical if there was a single-digit difference between the birth dates, if
the forenames were phonetically similar, or if the surname initial was different in the
case of a woman (all other variables being identical).
Submission of the collection form and the accompanying handbook provided an
opportunity to determine the data actually available for each agency. It proved to be
difficult to identify retrospectively cases in agencies not specialising in the care of
problematic drug users, since individuals attend such agencies for organic patholo-
gy such as HIV or hepatitis C. Clinical files concentrate on this pathology and data
regarding drug use are often fragmentary. It was therefore decided that data collec-
tion in three clinical medical agencies was too time consuming in relation to the
number of potential forms. One specialised care agency was unable to compile the
data by the required date because its active caseload was too great and it had diffi-
culty in releasing staff for the task. The Toulouse police narcotics squad did not have
enough information for proper completion of the forms retrospectively, and the
Toulouse syringe exchange bus was also unable to take part owing to a lack of data
concerning its work in 1994. This left nine participating agencies.
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All the forms for consumers of substances defined as drugs in the study were
recorded, a total of 947 forms covering 721 persons. Forms which did not meet
the inclusion criteria, or where the main substance used was not specified, were
rejected, as were those where the variables were insufficient to identify overlaps.
A series of choices was made. After cleaning the file and selecting the most rele-
vant data for persons attending more than one agency, those not resident in the
Toulouse conurbation, i.e. 90 individuals, were excluded. Owing to the difficul-
ties connected with the concept of drug dependence, the 47 persons who used
only psychotropic substances were also excluded, leaving only oral drug users
(662 forms covering 577 persons), of whom 487 persons (575 forms) were inject-
ing drug users.
The nine agencies were grouped as follows for the purposes of the CRM analysis: (a)
University Hospital Centre (UHC), comprising an infectious diseases unit, a psychi-
atric emergency unit, a psychiatric unit, and two general intensive care agencies; (b)
Joseph Ducuing Specialised Care (JDSC), comprising the two specialised care ser-
vices for drug addicts (AAT and Clémence Isaure) and the medical agency at the
Joseph Ducuing Hospital; and (c) the drug addiction unit at the prison (DAU).
Analysis
Estimation of the number of injecting drug users resident in the Toulouse conurbation
Overlaps amongst the three sources were identified and a contingency table drawn
up (Table 1). There are eight possible combinations for the whole population, one of
which is unknown.
J yes                                                    J no
C yes                       C no                      C yes                    C no
A yes        A no         A yes      A no         A yes        A no     A yes     A no
Men 1 38 7 116 12 109 84 -
Women 0 21 2 47 0 49 7 -
15-29 years 1 37 5 76 8 79 61 -
30-44 years 0 22 4 81 4 79 30 -
Total 1 59 9 163* 12 158 91 -
Six people could not be included in the study stratified by age for lack of information.
J = Joseph Ducuing Specialised Care
C = University Hospital Centre
A = The drug addiction unit at the prison.
Table 1:  Distribution of injection drug users by sex, age and presence 
at the sources in the Toulouse conurbation in 1994
Log-linear analyses (see Chapter 8 by Antònia Domingo-Salvany and Chapter 11 by
Martin Frischer) were used to estimate the number of unknown injecting drug injec-
tors. The most effective model for this population comprises interactions between 
the drug addiction unit at the prison (DAU) and the Joseph Ducuing Specialised Care
(JDSC); and the drug addiction unit at the prison and the University Hospital Centre
(UHC). It enables the number of missing cases to be estimated at 437. The total
population is estimated at 930. This model presupposes the absence of interactions
between UHC and JDSC. If UHC and JDSC are used for making an estimate by the
capture-recapture method for two sources, the result is a population estimate of 923
(CI 95 per cent 752-1,094), very close to that given by the log-linear model.
Table 2:  Estimation of the number of injecting drug users in the Toulouse conurbation
in 1994 for different groups, using the most effective log-linear model
Population Model df** X2 p Missing Total
Overall AJ, AC* 1 0.03 0.87 437 930
Men AJ, AC 1 0.00 1.00 333 700
Women J, AC 1 0.24 0.62 114 240
Sex (S) AJ, AC, AS 5 4.64 0.46 M=228 M=595
W=102 W=228
15-29 years AJ, AC 1 0.12 0.73 429 429
30-44 years AJ, AC 1 0.94 0.33 511 511
Age (V) AJ, AC, AV 6 5.06 0.54 <30=216 <30=483
>30=205 >30=425
* = AC, AJ corresponds to a log-linear model comprising an interaction between A and C, and between A and J;
**= Degrees of freedom.  Key; as for Table 1.
The population size was also estimated for each sex by means of the same procedure
(Table 2). The same model was identified for men as for the general population. The
best model for women contained a single interaction between the DAU and UHC.
A more complex analysis was also conducted with the inclusion of the sex variable
in order to take account of possible interactions between sex and the various
sources. The best model (see Table 2) contained an interaction between the UHC 
and DAU, between the JDSC and DAU, and between the sex variable and DAU. We
can thus identify an interaction between sex and the DAU, indicating that the prob-
ability of being imprisoned differs according to sex.
The injecting drug user population was also divided into two age groups, the first
being 15-29 years (267 persons) and the second 30-44 years (226). A further analy-
sis covering the whole population was conducted incorporating the over-30s vari-
able into the model, then separately for each age group. The best model (Table 3),
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both for the under-30s and for the over-30s, is identical to the one for the whole
population. For the five-variable model, we identified an interaction between age
and DAU, indicating an imprisonment probability differing according to age.
Table 3:  Estimations of the prevalence of injecting drug use
in the Toulouse conurbation in 1994 for the population aged from 15 to 54 years
Estimation 95% CI Population Prevalence 95% CI
IDUs 15-54 years (per thousand) (per thousand)
All 930 777-1,083 404.059 2.30 1.92-2.68
Men 700 558-842 200.834 3.49 2.78-4.19
Women 240 171-309 203.225 1.18 1.00-1.52
Men and Women 940 404.059 2.33
15-29 years 429 270-588 205.529 2.09 1.31-2.86
Over 29 years 511 356-667 198.467 2.57 1.81-3.37
All ages 940 404.059 2.33
Table 4:  Estimations of the prevalence of opiate use 
in the Toulouse conurbation in 1994, for the population aged from 15 to 44 years
Estimation 95% CI Population Prevalence 95% CI
opiate users 15-54 years (per thousand) (per thousand)
All 1,156 962-1,350 332.654 3.48 2.89-4.06
Men 875 692-1,058 164.134 5.33 4.22-6.45
Women 301 213-389 168.520 1.79 1.26-2.39
Men and Women 1,176 332.654 3.54
15-29 years 570 461-679 192.520 2.96 2.39-3.53
Over 29 years 574 400-748 140.134 4.10 2.83-5.34
All ages 1,144 332.654 3.44
After calculating the variance of N for each model selected, we obtain an estimation
of the size of the IDU population of the Toulouse conurbation, with its confidence
interval. The estimation (Table 3) varies from 777 to 1,083 people for the whole pop-
ulation. Prevalence among the 15-54 years population is 2.30 per 1,000. It is 3.49 
per 1,000 for men as against 1.18 per 1,000 for women.
The opiate user population 
The most effective models for opiate users have the same interactions as for IDUs.
These models were used in order to estimate the sizes of the various opiate user
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populations (Table 4). The number of opiate users is estimated to be 1,156 (CI 95 per
cent 962-1,350). The overall prevalence is 3.48 per 1,000 (5.33 per 1,000 among
men and 1.79 per 1,000 among women).
Discussion
The data collection phase of the study involved obtaining many authorisations and
agreements. In strictly legal terms, it was the authorisation of the Commission
Nationale Informatique et Libertés (CNIL) that allowed work to begin in earnest. The
identification variables used were the same as for compulsory notifications of AIDS
cases. They enabled a reliable search for overlaps to be made while respecting the
ethical and legal requirements of confidentiality.
Obtaining the agreement of all potential data sources was a particularly long process
because of the number of agencies. All the agency heads showed interest in the
problems raised by the project and all gave their agreement in principle. However,
collection was not possible in all agencies, either because of a lack of data (from the
exchange bus and the narcotics squad) or because of the difficulty in choosing cases
which could be recorded on a form (several clinical agencies). The institutional net-
work for the care of drug addicts in the Toulouse conurbation offers an advantage 
for a study of this type. It provides all forms of care, but the number of agencies is
low enough to allow personal contact as well as the adaptation of the collection
method to each facility. Several facilities have already been working together for a
long time, and this generates an excellent momentum for developing new thera-
peutic research and projects.
Although data were obtained, there were several problems, particularly with regard
to the inter-agency consistency of the cases selected. The case selection procedure
varied from one agency to another and this introduced some selection bias. In some
agencies the procedure seemed effective in finding all the relevant cases, while in
others it might have led to the loss of several cases suitable for inclusion in the study.
Clinical agencies treating drug addicts for an organic problem often record little
information about the characteristics of drug addiction, so it is not always easy to
obtain relevant data. The only way of limiting this distortion is to have a wide selec-
tion of cases and a data registration form with exclusion factors.
Case definition proved to be a complex problem. We used a rather restricted defin-
ition in exploiting the data, in order to limit ourselves to a study of injectors and opi-
ate users. It proved impossible to produce an estimate by this method for all indi-
viduals using only psychotropic substances. Interpretations of psychotropic depen-
dence varied from one agency to another, and the inclusion base therefore varied
too.
The identification variables authorised by the CNIL permitted high quality identifi-
cation of overlaps between sources without prejudice to confidentiality. This is a 
particularly important factor for the relevance of the estimations obtained. In the
Barcelona study (Domingo-Salvany et al, 1995) the weakness of the identifiers
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forced the investigators to develop a probabilistic model for identifying overlaps.
Defective identification of overlaps involves overestimation and a widening of the
confidence gap.
Perpetuating the feasibility of this type of data collection involves formalising the
information network created. Facilitated access to data, which has usually already
been collected, depends on the establishment of a permanent data storage system in
each of the participating agencies. This information will be available when new esti-
mations are needed. The initial phase for such a study will, in this way, be consid-
erably shortened, and the data collected should be more relevant, hence improving
the accuracy and quality of estimations. 
Our calculations probably suffer from underestimation. Several sources did not
make a fully exhaustive collection of data, and we lost some cases which theoreti-
cally could have been studied. Our ‘survey base’ was not as wide as we would have
liked and thus our sample was not altogether representative. Several potentially sig-
nificant data sources were unable to participate including the police, the methadone
centres, the network of general practitioners and the neighbourhood services
(exchange bus, low threshold agency). Though the drug addiction unit in a prison
presented a negative dependence in comparison with the other sources, it is proba-
ble that police agencies are statistically independent of other services. In Glasgow,
where this was found to be the case, the estimates including the police sample were
considerably higher than when this sample was omitted.
The Toulouse estimates given here cover the population represented by our sample.
Sub-groups of the addict population are probably not represented. Thus, socially
integrated addicts, who seldom resort to health and social facilities, are probably
underestimated. A stratification according to other variables, such as no fixed
address, length of addiction and frequency of doses, would have been desirable.
Unfortunately these variables were not sufficiently well indicated to permit such
analyses. In order to find the most stable population possible, we confined ourselves
to addicts having resided for at least three months in the Toulouse conurbation.
Toulouse is a stopping point for people travelling to or from Spain; moreover, its care
facilities treat people from the Midi-Pyrénées region and sometimes from the
Parisian area. These cases, therefore, are not included in our estimation.
This is the first local estimation of the size of the addict population in France. It pro-
vides an assessment of the prevalence of addiction to opiates and injected drugs in
the general population as well as offering useful denominators for all prevalence
studies concerning the target population. It is possible, for example, to use a preva-
lence study to estimate the number of persons suffering from a disease (HIV infec-
tion) or having a specific problem. There are several estimations of this type, notably
in Glasgow (Frischer et al, 1993), Bangkok (Mastro et al, 1994) and Barcelona
(Domingo-Salvany et al, 1995). It may be noted that the estimated prevalences in the
two European studies seem higher than in the Toulouse conurbation. In Glasgow in
1990, Frischer et al estimated the prevalence of injected drug use at 13.5 per 1,000
among people aged 15-54, i.e. six times greater than in Toulouse. In Barcelona in
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1989, Domingo-Salvany et al estimated the prevalence of opiate use at 9.2 per 
1,000 among people aged 15-44, i.e. almost two and a half times greater than the
Toulouse estimation.
Estimations of the size of addict populations is a matter of concern for national
authorities, for the Observatoire Français des Drogues et des Toxicomanies and local
health and social action agencies, as well as for all practitioners in the Toulouse
conurbation. A study of the prevalence of addiction to injected drugs by the capture-
recapture method is feasible in France. This is a particularly useful method of study-
ing populations which are difficult to reach. However, it involves close contact with
a network of people professionally concerned with drug addiction, who are aware
of the difficulties involved in collecting data and are keen to take part in research
projects. Such people should, therefore, be regarded as full partners in the investi-
gation. If the network is stable, it may very well serve as a basis for a local/regional
system for the epidemiological surveillance of drug addiction.
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More Complex Capture-Recapture Models:
an Illustrative Case Study 
using Data from Glasgow, Scotland
by Martin Frischer
While the previous chapters in this section have addressed theoretical issues
involved in using the capture-recapture method (CRM), this chapter illustrates more
complex models using three or more samples. It gives a practical illustration using
data collected in Glasgow, Scotland, for a one year period (1990). The purpose of
the study was to estimate the prevalence of drug injecting in the city in order to fur-
ther determine the number of HIV positive injectors (Frischer et al, 1993).
The prevalence study began with multi-enumeration. Partial identifier information
(gender, initials, date of birth, first part of postcode) was obtained from the sources
shown in Table 1. Data collection varied from computerised records to manual
searching through case reports. Many prevalence studies have ground to a halt at 
this early stage because agencies have refused to divulge, or to allow access to, iden-
tifier information. Although very few agencies in Glasgow took this view, there is
concern that European directives will make future access to named data more diffi-
cult (Wald et al, 1994).
Table 1: Data sources used to estimate the prevalence of injecting drug use
in Glasgow, 1990
Drug treatment agencies 1,476
- Non residential community projects 630
- Psychiatric hospital inpatients 231
- General hospital inpatients  194
- Addicts reported to the Home Office 264
Scottish HIV test register 507
Police (non-cannabis drug offences) 508
Needle and syringe exchanges 1,179 
Total number of cases reported 3,670
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The simplest scenario: two-sample capture-recapture
An example of a simple two-way CRM multiway table is shown in Table 2. The first
sample consists of 1,276 individuals who received some form of treatment for drug
use. The second sample consists of 507 people who had an HIV test and whose risk
category was given as injecting drug use. Of these 169 were people who were also
recorded in the first sample. Using the method described in Chapter 8 by Antònia
Domingo-Salvany, the total population estimate is 3,238.
HIV sample      (recapture)
Treatment sample (capture) Present Absent Total
Present 169 1107 1276
Absent 338 unknown
Total 507
104
Capture-Recapture Methods
For this simple method to produce a reliable population estimate, the following crite-
ria must be met: all individuals must have the same defining characteristics; identifi-
cation of individuals must be accurate; detection of an individual in a sample cannot
change the individual’s behaviour with respect to another sample; all individuals must
have the same probability of being sampled; and unobserved individuals must behave
in a similar way to observed individuals. However, in the example shown in Table 2,
it is unlikely that any of these criteria has been fully met, for the following reasons:
Defining characteristics
Treatment for drug use is heterogeneous, ranging from one-off attendance at a drug
project to inpatient psychiatric care. Injecting drug use (IDU) as a risk factor for an
HIV test does not specify any time period (i.e. a person could have an HIV test with
risk factor ‘IDU’, although they stopped injecting several years ago). 
Identification of individuals
Errors can be made in recording identifier information or people can give false
information.
Individual behaviour
If somebody has treatment for drug use, they may be referred for an HIV test or might
find out about testing facilities; thus people who received treatment for drug use may
have been more likely to have taken an HIV test than those who were not in treatment.
Table 2: Number of individuals recorded in two lists of drug users in Glasgow, 1990
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Probability of being sampled
If there are many drug users who, for whatever reason, never come into contact with
treatment agencies or HIV testing, the estimate of the drug-using population may
well be wrong since it is entirely based on those who do.
More complex scenarios
As already discussed in previous chapters, simple models are easy to use, they do
not require much data and it is easy to understand the effect of violating assump-
tions (e.g. if the samples are not independent). However, they are likely to mis-
represent the population and introduce bias into population estimates. On the
other hand, sophisticated models using more than two samples can provide a bet-
ter representation of the population but they require more data. Such models can
require a considerable degree of statistical expertise and population estimates can
be unstable (i.e. slight changes in the model can result in large fluctuations in esti-
mates). 
As with the two-sample example shown in Table 2, there are definition problems for
all samples shown in Table 1 with the exception of needle and syringe exchange.
Discussion with drug treatment agencies provided further information, e.g. about 90
per cent of those seen were thought to be injectors. The police data were more prob-
lematic at this stage, although some checks were made during analysis (i.e. com-
parison of known injectors and overlaps between police and other samples).
Checking for false identifiers was not feasible. The likelihood that the HIV test reg-
ister may be contaminated by false identifying information was considered, but the
high level of overlap between this source and the treatment sample provided some
assurance on this issue.
Matching procedure
Where there is incomplete identifier information (e.g. initials rather than full name)
it is probably best to use a ‘probabilistic’ matching strategy whereby a computer pro-
gramme uses specified criteria to determine the probability of two cases being the
same individual. In this study, probabilistic matching based on gender, date of birth,
initials and the first part of the postcode was used to identify overlap cases. Clearly,
matching on limited identification information may introduce error when identifying
overlaps in two ways; ‘false positives’ could be recorded when two cases are thought
to be the same individual while ‘false negatives’ could arise when overlaps are
missed due to errors in recording identifier information. Careful checking of records
at source and during the matching procedure was conducted to minimise these types
of error. While the impact of errors in the present analysis is likely to be marginal, it
is impossible to rule out the possibility that errors in the four samples could result in
a different model being selected and consequently affect estimates of the number of
unknown users.
Sample interaction
This term is used to describe a situation where detection of an individual in sample
A alters the individual’s behaviour with respect to sample B. For example if drug
users arrested for drug offences then attend treatment agencies, the two samples will
not be independent. In other words, drug users who are not arrested by the police
may have a lower probability of being detected in the treatment sample than those
who are. With only two samples there is insufficient information to detect interac-
tions which could bias estimates. However, it is important to examine the range of
two-sample estimates (see Table 3). In this case, the range is 3,828 to 8,642 and if
the two extreme estimates are excluded the range reduces to 6,037 to 8,308. This
relatively narrow range is not an inherent feature of the method – different sample
sizes and overlaps could have resulted in widely discrepant two-sample estimates.
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Table 3: Estimates of the number of drug injectors in Glasgow, 1990
based on information from two samples
Samples n1 n2 Overlap Total Estimated Total 95 per cent CI
observed unobserved population
hiv & tr 507 1,276 169 1,783 1,428 - 2,323 3,828 3,211 - 4,106
hiv & ne-ex 507 1,179 99 1,686 4,252 - 5,294 6,037 4,896 - 6,980
ne-ex & tr 1,179 1,276 205 2,455 3,824 - 5,532 7,338 6,279 - 7,987
ne-ex & pol 1,179 508 75 1,687 4,576 - 7,871 7,985 6,263 - 9,588  
hiv & police 507 508 31 1,015 4,460 - 10,064 8,308 5,475 - 11,079
tr & pol 1,276 508 75 1,784 4,996 - 8,571 8,642 6,810 - 10,355
hiv = Scottish HIV test register; ne-ex = Needle and syringe exchanges; tr = Drug treatment agencies;  pol = Police -
non-cannabis drug offences.
Where three (or more) samples are available, it is possible to assess if there are any
interactions between samples using a more sophisticated form of CRM. The three-
sample method does not require complicated statistics or computing (Bishop et al,
1975). With more than three samples, estimating population size requires the use of
log-linear modelling. This is not a particularly complex procedure: Cormack (1992)
describes how to perform the analysis using the statistical computer program GLIM
(Payne, 1986) and how to calculate confidence intervals. 
Table 4 gives key summary statistics for various models. Model 1, assuming inde-
pendence between samples, does not fit the data well, judging from the X2 statistic.
Various combinations of sample interactions are then tested in order to see whether
the model fit can be improved. The ‘best’ model, as judged from the X2 statistic is
model 3, with an estimate of 8,494 injectors.
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Although the model has acceptable statistical properties (i.e. low X2), it does not neces-
sarily follow that the estimate for the number of unknown injectors is correct, since this
estimate is based on the behaviour of known injectors. One way to verify the model is
to repeat the analysis for stratified sections of the population and summate the results. If
the sum of the stratified estimates is approximately the same as the un-stratified estimate,
it is reasonable to suppose that the latter is about right. If the stratified total is not simi-
lar this would indicate heterogeneity among sections of the population. Table 5 (over-
leaf) shows that, in this case, the stratified and un-stratified estimates are very similar.
Although stratification provides a form of ‘internal’ validation, external validation
requires some independent measures. One possible method for external validation
is to compare the predicted and actual number of HIV positive injectors. The HIV
prevalence rate among 503 injectors tested in a multi-site survey (in and out of treat-
ment) was 1.4 per cent (95 per cent CI 0.4-2.5 per cent). If there were 8,500 current
injectors, there would be 119 HIV positive current injectors in Glasgow. Data to the
end of December 1990 shows that there were 100 known HIV positive injectors
from Glasgow, twelve of whom had died. As there are likely to have been several
unknown HIV positive injectors (either to themselves or the register), the compari-
son provides some validation of the drug-injecting prevalence estimate.
Another form of external validation could be provided by the 1992 Drug Use and Drug
Prevention Survey conducted in four UK cities including Glasgow (Leitner et al, 1993).
The 1992 DUDP estimate of 2,000 current injectors is obviously much lower than the
1990 CRM estimate of 7,500-9,700. Apart from the observation that prevalence could
have declined between 1990 and 1992, there are many reasons for exercising caution
in comparing the two estimates. The DUDP estimates are based on the positive reports
Table 4: Analyses of log-linear models used to estimate 
the number of injecting drug users in Glasgow, 1990
Model   Type of Model                           X2 DF        p Value          u             N
1 All samples independent 101.5 10 0.00 3,844 6,710
2A Interaction between samples 19.3 8 0.11 5,189 8,055
1&2, 2&4
2B Interaction between samples 11.6 8 0.41 5,276 8,142
1&2, 1&4
2C Interaction between samples 6.8 7 0.56 6,000 8,866
1&2, 1&4, 2&4
3 Interaction between samples 2.9 6 0.83 5,628 8,494
1&2, 1&4, 2&4, 1&2&4
Samples: 1 = Scottish HIV test register; 2 = Drug treatment agencies;  3 = Police - non-cannabis drug offences; 4 =
Needle and syringe exchange; u = Fitted value for missing cell (unknown injectors); N = Total number of injectors.
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of three individuals, whereas the CRM estimates are based on 2,866 known drug users.
It is easy to adduce reasons which would lead one in the direction of supposing that
the DUDP estimates are too low; conversely it could be argued that the CRM figure is
too high. As both methods depend on a large number of assumptions, it is largely a
matter of personal preference. The authors of the DUDP note that drug professionals
in Glasgow were more inclined to accept the higher estimate from the CRM study.
However, this is a rather dubious form of validation since drug professionals might rea-
sonably be expected to favour the higher estimate.
Table 5: Estimated prevalence of drug injecting in Glasgow, 1990
Known     Known     Estimated no.  95 per cent     Population     Population 
injectors   injectors     of injectors           CI                               prevalence
(N)          (%)                                                                            (%)
All cases 2,866 34 8,494 7,491 - 9,721 628,000 1.2 - 1.5
Males 1,977 35 5,544 4,847 - 6,412 315,000 1.5 - 2.0
Females 889 28 3,238 2,364 - 4,689 313,000 0.8 - 1.5
Male/female 8,782
Age-group
15-19 264 29 904 634 - 1,384 88,000 0.7 - 1.6
20-24 1,137 41 2,750 2,287 - 3,317 104,000 2.2 - 3.2
25-29 878 33 2,602 2,043 - 3,438 96,000 2.1 - 3.6
30-34 342 30 1,138 792 - 1,762 81,000 1.0 - 2.2
35+ 245 16 1,518 805 - 2,595 259,000 0.3 - 1.0
All ages 8,912
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Introduction
by Colin Taylor
he opening chapter of this section is Martin Frischer’s clear methodological
description of the principles of prevalence estimation through the use of the
Mortality Multiplier Method. Frischer identifies the two main components of
the prevalence estimation procedure: the establishment of a mortality rate amongst
drug abusers, and the establishment of the number of drug abusers who die. The
combination of these two figures to calculate an overall estimate of the prevalence
of drug abuse is explained, and his discussion brings out the assumptions that are
required if this estimate is to be valid.  
A range of studies are cited to show the various applications of the method and to
highlight the interpretational difficulties that arise in different circumstances. In this
first chapter, Frischer also takes the reader further afield and illustrates more
advanced applications of the technique in the context of survey analysis. From the
examples, he draws out a set of methodological guidelines for good practice in sett-
ing up such studies, with highly relevant and important caveats concerning depar-
ture from the assumptions that make the estimation procedure valid.  
A very detailed contribution from Klaus Püschel subsequently focuses attention on
the problems and difficulties in determining whether a death is drug-related or not.
Citing the German experience and registration systems, he describes how a pathol-
ogist might identify such deaths. Whether a death ever reaches a post-mortem exam-
ination stage is clearly important in whether or not the death will be classified as
drug-related, as are all the stages of administration and registration following the dis-
covery or declaration of death. In that they affect the information that is gathered and
produced, these issues are important in their own right, over and above the impor-
tance of any formal definitions of what constitutes a ‘drug-related death’ that may be
subsequently applied to the findings. The implications for researchers using such
data are discussed and a plea is made for more uniform procedures to be put in
place across different countries.
Marina Davoli’s contribution outlines the general procedures for a cohort mortality
study and argues for their central usefulness in measuring mortality. The important
distinction between studying the mortality of drug abusers and studying drug-relat-
ed deaths is highlighted in this chapter. Drug abusers may die of causes unrelated,
or not directly related, to their drug abuse and a drug-related death does not neces-
sarily imply the dead person was abusing drugs - both ‘therapeutic’ drug users and
innocent children may suffer deaths that are drug-related.
A cohort study - that is, the study of a carefully defined group of people over a peri-
od of time - is one of the most common ways of estimating the death rate amongst
T
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drug abusers and Marina Davoli’s chapter uses as an example the multi-city study in
which she is involved. The discussion highlights the usefulness of standardising pro-
cedures and definitions in order to make the results comparable across different
studies. Without this, the various types of cohort study that can be carried out may
easily lead to differences in estimated mortality, induced simply by different meth-
ods of implementing the studies rather than by variation in mortality or drug abuse
prevalence itself. The multi-city study that Davoli describes sought specifically to
remove this additional and unwanted source of variation by using standardised
definitions of cohort methods.
Denmark possesses a long-running national register of all drug-related death nation-
wide. Henrik Sælan’s thoughtful contribution uses these data to illustrate and illu-
minate many of the difficult issues that are pointed out in Martin Frischer’s opening
description that may affect the interpretation of the resulting prevalence estimates.
His chapter complements that of Marina Davoli in only briefly referencing the 
cohort studies he uses to derive the death rates amongst drug abusers and concen-
trating instead on the second element of the prevalence estimation calculation, the
number of deaths to drug abusers. His conclusion that the drug-related death regis-
ter is very much over-inclusive in identifying deaths for use in the prevalence esti-
mation exercise is, of course, particular to the Danish system but, nonetheless, indi-
cates useful lessons for other countries.  
Equally useful is his discussion of identifying trends over time, from at least two dif-
ferent points of view. Firstly, he points out the implications of needing to estimate
prevalence by using death rates and numbers dying, both of which are calculated as
averages over an extended period of time. Secondly, he emphasises and strongly
demonstrates the usefulness of studying drug-related deaths in their own right as an
indirect indicator of the prevalence of drug abuse.
Taken together, these four chapters, with Martin Frischer’s as the methodological
centrepiece, offer a wealth of detail and information on the application of the meth-
ods and principles in practice.
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Estimating the Prevalence of Drug Abuse
using the Mortality Multiplier Method:
an Overview
by Martin Frischer
The addict deaths multiplier method for estimating the prevalence of drug use was
developed in the United States during the 1970s. The method involved determining
the annual number of drug-related deaths in New York City and assuming that these
deaths represented a proportion (0.5 per cent) of active heroin users in the city
(Baden 1971, 1972). The proportion was obtained from a follow-up study of addicts
receiving treatment, and was crudely estimated by the death rate observed amongst
those users. Clearly for this method to be accurate, two assumptions must be met:
that the number of deaths due to all causes must be accurately ascertained, and that
the mortality rate must apply to all active drug users, not simply to those who were
followed up.
While in the case of New York it is plausible that these two assumptions were met,
in practice, the use of multiplier techniques has become much more elastic. For
example, the number of all-cause deaths in a city may be ascertained and an aver-
age mortality rate obtained from the literature may be used to derive a multiplier.
Thus, a third assumption is introduced: that the mortality rate in the specified city is
within the range reported in the literature. In more extreme cases, the number and
rate of deaths among, for example, injectors, may be inappropriately used as a mul-
tiplier for the number of, for example, opiate users.
This paper describes the main features of Mortality Multiplier Methods (MMM) and
provides guidelines on methodological standards.
From drug-related deaths to prevalence estimation
It is evident from the introductory remarks that this method could have wide
applicability since, at first appearance, a relatively small amount of information is
required. First, most countries have statistics on drug-related deaths. Second, it
might plausibly be assumed that mortality rates vary within fairly narrow limits.
However, in order to understand the method fully, it is necessary to consider issues
relating to the definition of drug-related deaths and the determination of mortality
rates.
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Defining drug-related deaths
Most European countries have national and/or regional mortality registers where
deaths are coded using the International Classification of Diseases (ICD). However,
as Table 1 indicates, there are many types of deaths (and consequently ICD codes)
which can be considered as ‘drug-related’.
Table 1:  Types of drug-related mortality 
Drug refers to any substance (licit or illicit, excluding alcohol and tobacco) taken purely
for psychic effects.
Related mortality refers to all direct and indirect fatalities, not necessarily pertaining to the
person(s) using the drug. Interest is usually focused on drug abuse where abuse refers to
use of illicit substances and, for licit substances, use without prescription and/or in con-
travention of the specified dose.
The main type of drug-related deaths are:
- overdoses (accidental, intentional or undetermined)
- deaths due to diseases connected with long-term abuse of drugs
- suicide related to dependence on drugs
- accidents influenced by drug use
- deaths due to behaviour associated with drug use e.g. violence or internal concealment.
Unfortunately this classification is only one of many, and even ‘cause’ of death is not
always defined in the same way. For example, a death ‘caused’ by a drug overdose
could be coded as such or, alternatively, as due to respiratory failure. Furthermore,
without additional information, it is not possible to detect deaths among drug users
where no ICD codes relating to drug or drug use are recorded. Thus, the number of
deaths from a national or regional death register is likely to be an underestimate. A key
factor in determining the extent of this problem will be the proportion of suspected
drug-related deaths which are subject to pathological investigation. In areas where this
is common or standard, it may be possible to get some idea of how drug-related deaths
are coded. For deaths among drug users which are not directly drug-related, possible
sources of information include legal/police departments and HIV registers.
The range of cause-specific deaths, and the environments in which these deaths
occur, are considered in detail by Weiss (1993) who recommends that even if a com-
mon definition is not possible, there should at least be a common classification in
order to distinguish ‘direct’ and ‘indirect’ causes of death. This could be achieved by
adopting an American proposal whereby deaths are classified according to the
directness of the drug’s action (e.g. drug alone or in combination with other internal
and external events) and the mode of administration; however this approach proved
to be problematic in comparing nine American cities (Gottschalk et al, 1979). In
cases where drugs are held to be directly responsible for death, there is also consider-
able debate regarding appropriate terminology. The term ‘overdose’, although widely
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used, can be misleading since, in many cases, it is not clearly established that death is
a direct consequence of excessive drug dosage. Complicating factors include loss of
tolerance (e.g. after treatment episodes or release from prison), environmental cues not
previously associated with drug use and pre-existing medical conditions.
There are also reports of ‘overdose’ deaths where toxicological analyses indicate low
drug levels not capable of inducing severe toxic phenomena (Tunving, 1988). In such
cases, assuming that there are no other complicating factors, hypersensitivity (i.e. pre-
disposition to respond abnormally to certain substances) might be the mechanism
responsible for causing death. To complicate matters further, ‘overdose’ deaths may arise,
not as a result of illicit substances per se, but because of diluents which increase the vol-
ume of a substance, additives added to enhance the effect of the primary substance or
impurities which originate during the manufacturing processes in the case of synthetic
substances. In addition to these factors, the administration of substances in combination
may produce synergistic effects which, at the present time, are not well understood.
In the tenth revision of the International Classification of Diseases, overdoses can be
classified, either in the ‘poisoning’ section for cases of accidental intake, or in the ‘acute
intoxication’ section for cases of intentional drug-taking. However, given the foregoing
remarks on overdoses, there will be many cases where this is not an easy distinction to
make and the section chosen will depend on the information available to ICD coders.
Causal factors in drug-related deaths
Studies with differing perspectives on the relationship between HIV and mortality
are summarised in Table 2.
Table 2:  Impact of HIV on non-AIDS related mortality
Soellner et al, (1992)
Germany, 1991–92. An analysis of drug-related fatalities in forensic institutes found fewer
HIV positive cases died of unintentional overdose compared to HIV negative cases.
Possible explanation – HIV positive cases have more control over their drug use.
Barbarini et al, (1993)
Italy, 1986–91. Among injectors in treatment centres, the incidence of deaths from over-
dose among HIV positives (3.8 per cent) was significantly higher than among HIV nega-
tives (2 per cent). Possible explanation – HIV infection may predispose to overdose-relat-
ed death from the use of street heroin.
Mientjes et al, (1992)
Amsterdam, Netherlands, 1986–89. A prospective cohort study of injectors found that HIV
status was not an independent risk factor for non-AIDS mortality.
Eskild et al, (1993)
Oslo, Norway , 1985–91. A prospective cohort study found that HIV positive cases were twice
as likely as HIV negative cases to die from non-AIDS causes. Possible explanation – selection
of high frequency injectors to HIV positive group. Important to examine non-AIDS mortality.
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Taken in conjunction with the list in Table 3, which compares two studies with dif-
fering views on the relationship between methadone and mortality, this helps to
illustrate further the dangers of generalising findings reported in particular environ-
ments to other settings.
Table 3:  Impact of methadone on mortality
Gronbladh et al, (1990)
Sweden, 1990. Comparison of mortality among 115 ‘street’ addicts and 166 receiving
methadone maintenance therapy (MMT). The mortality rate for street addicts was 63 times
that expected for comparable age/sex distribution compared to eight times for addicts
receiving MMT. The authors conclude that MMT exerts a major improvement in survival
rate of heroin addicts.
Harding-Pink, (1993)
Review of MMT, 1993. Reports from Melbourne (Australia) and Geneva (Switzerland) of an
unexpectedly high level of mortality among people receiving MMT. Reports from the US in
the early 1970s, when MMT was widely adopted, indicate high levels of methadone-related
mortality – most victims were not receiving MMT but had obtained the drug illicitly. The
author comments that methadone is highly toxic to anyone not tolerant to opioids. Death can
occur when tolerance is incorrectly assessed and during maintenance when doses are com-
bined. However, MMT programmes are often not in a position to monitor mortality.
Mortality rates
Research into mortality rates among drug users has been conducted almost exclu-
sively among drug users receiving treatment (Perucci et al, 1991, 1992; Davoli et
al, 1993). The reasons for this are straightforward: in order to calculate mortality
rates, it is necessary to have identifier information on a group of people who are
known drug users of a particular type; this information is then linked to a mor-
tality register. Various types of mortality proportions and rates may then be cal-
culated.
• annual mortality rate: percentage of deaths per year among groups of drug users;
• mortality rate per 100 years risk among a cohort of drug users (calculated from
entry into the cohort or commencement of injecting): in international compar-
isons this rate may be adjusted to take account of age and gender variations;
• standardised mortality rate: ratio of cohort mortality rate to general population
mortality rate adjusted for age and gender;
• cumulative hazard rate: probability that a case has survived a given number of
years of injecting will die during the subsequent year (e.g. see Figure 1).
The first type of mortality rate has the advantage of being highly specific. However,
the number of deaths in a particular year may, for example, be concentrated among
a sub-group of drug users and it is, therefore, important to clearly define the popu-
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Figure 1: Kaplan-Meier hazard function for cohort of Glasgow injectors 
by age at cohort entry and HIV status
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lation of drug users (e.g. heroin users). In many situations, this rate may be the most
appropriate, although experience has shown that the annual mortality can vary con-
siderably from year to year. For example, in Hamburg, the mortality rate among
‘hard drug users registered by the police’ was reported to be 1.32 per cent in 1983,
0.65 per cent in 1984 and 1.21 per cent in 1985 (IFT, 1994).
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One way of avoiding fluctuations is to use a rate derived from many years of fol-
lowing up a group of drug users. However, an overall mortality rate for a cohort will
take no account of changing patterns of mortality and, in some situations, it may be
more appropriate to use an annual rate. In areas where annual data are available
on an on-going basis, it may be advisable to use a moving average, e.g. over three
years.
As indicated above, the rate in the New York study was 0.5 per cent. However, this
rate was based on only one year of observation. A wide range of European studies
conducted between 1970 and 1990 have reported annual mortality rates of between
1 and 2 per cent. It is possible that this rate will increase due to the impact of HIV
on mortality among drug injectors. There is some evidence that a rate of about 3 per
cent may be more appropriate in many locations (Frischer et al, ms.a).
Mortality rates have only been calculated for certain types of drug use and drug
users, e.g. heroin users in New York, opioid injecting addicts attending hospitals or
clinics in London (Oppenheimer et al, 1994). While there are case study reports of
fatalities associated with particular drugs or drug users, these cannot be translated
into rates. It is only meaningful to apply the Mortality Multiplier Method (MMM) to
those types of drug use for which mortality rates have been calculated. Where it is
not possible to ascertain the total number of all-cause deaths among drug users, it
should be noted that the MMM will under-enumerate the population of drug users.
The type and extent of under-notification of drug-related deaths will determine the
degree of under-enumeration.
Applying the Mortality Multiplier Method
The best way of understanding MMM is to consider how the method has been used
in practice.
Case Study A: District of Columbia, USA, 1971
Dupont and Piemme (1973) used the multiplier rate from the New York study to esti-
mate the number of drug injectors in the District of Columbia (DC). They noted three
reasons for caution: not all heroin-related deaths might be identified in DC; cultur-
al patterns among addicts might influence the overdose rate; and the concentration
of street heroin use outside NYC is likely to be different.
Ascertainment of mortality related only to heroin overdose. Other types of drug-
related deaths were not included. After applying the New York mortality rate of 0.5
per cent to the 75 heroin-related deaths to obtain a figure of 15,000, they added the
number of known heroin addicts receiving treatment to arrive at a figure of 17,700.
The paper also reports two two-sample capture-recapture estimates of 19,900 and
20,400 which provide cross-validation for the MMM estimate.
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Case Study B: Inner London, UK, 1982
This study differed from the previous study in two crucial respects (Hartnoll et al,
1985). First, deaths from all causes among drug users were ascertained. Second, a
1-2 per cent mortality rate, derived from previous UK studies of opioid-injecting
addicts attending hospitals and clinics was used. With 22 deaths, the MMM result-
ed in an estimate of 1,100-2,200.
As in the American study, there were also two concurrent capture-recapture esti-
mates: 2,148 and 2,435. There was a further estimate of 1,900 from the nomination
technique. The similarity of these estimates suggests that the upper MMM estimate
based on a mortality rate of 1 per cent produced a reliable estimate of the number
of opioid injectors.
Case Study C: Greater Glasgow, UK, 1992/1993
The definition of drug-related death in this example was intermediate between that
of New York and London: toxicological analyses in Glasgow of 52 deaths where
‘drugs were implicated as a cause of death either through circumstance or toxicol-
ogy’ (Hammersley et al, 1995). Deaths of drug users from other causes such as infec-
tious diseases and accidents while intoxicated were not included. MMM was
applied assuming a 1 per cent mortality rate, suggesting 5,200 injectors/heroin users.
In 1993, the number of drug-related deaths rose to 102 which yields an estimate of
10,200 injectors/heroin users.
It seems unlikely that prevalence would double in one year and other evidence indi-
cates that incidence of injecting has remained fairly stable in the 1990s (Frischer et
al, ms.b). Hammersley and colleagues rule out artefactual explanations, such as
changing reporting procedures, and suggest that the rapid increase in drug-related
deaths is due, not to increasing prevalence of drug use but to increasing poly-drug
use involving heroin with benzodiazepines and alcohol. It is possible that the mor-
tality rate did change between 1992 and 1993. Concurrent analyses of a cohort of
injectors, followed since 1983, revealed a 1992 mortality rate of 1.67 per cent and
a 1993 annual mortality rate of 1.98 per cent (Frischer et al, ms.c). Using these rates,
the prevalence estimates are 3,113 and 5,151 for 1992 and 1993 respectively.
However, a four-sample capture-recapture study in Glasgow, 1990, indicated 7,500-
9,700 current injectors, only 15 per cent of whom were in treatment at some point
during the year in 1990 and only 47 per cent had ever received any form of treat-
ment (Rhodes et al, 1993). Clearly, if non-treatment injectors have a lower mortali-
ty rate, the prevalence estimate might be very different.
Multiplier method and population surveys
Although the Mortality Multiplier Method can be used without reference to other
methods, the previous section shows the value (and sometimes the complications)
of cross-validation. Another use of the method is to supplement population surveys,
where the prevalence of injecting and other forms of drug use is thought to be under-
estimated.
This is well illustrated by the 1990 survey of drug use among people aged 12-39 in
the former West Germany (IFT, 1994). In this survey, a representative sample of
31,363 people was drawn from the residents’ register and sent a self-completion
questionnaire. 19,208 (62 per cent) participated in the survey after several follow-
ups. Various prevalence estimates were made; for current purposes we will focus on
two groups: those who had taken opiates, amphetamines or cocaine at least 20 times
in the last 12 months, and hard drug users who had also injected. 
Whereas the proportion of respondents who took large quantities of alcohol or
cannabis remained stable throughout the survey, the proportion of hard drug users
increased with each additional follow-up. Detailed studies of non-responders in
the USA (Turner et al, 1992) indicate that a proportion of non-responders do not
differ from responders with respect to the use of cannabis or cocaine (neutral non-
responders). However, some non-responders (18 per cent in the American study)
were more likely to be taking these drugs. This group is referred to as critical non-
responders. The ‘true’ prevalence is an additive function of the behaviour of three
groups: responders (R1), plus neutral non-responders (R2) plus critical non-respon-
ders (R3).
Prevalence rates among responders (P1) of ‘hard’ and ‘injecting’ drug use were 0.18
per cent and 0.04 per cent respectively. These rates also apply to neutral non-
responders (P2). Prevalence among critical non-responders is:
P3 = P1,2 * X
where X is a multiplicative factor derived from information about non-responders.
The number of drug users (N) is therefore: N = P1*R1+P2 *R2+P3 *R3
Determining factor X is crucial to the prevalence estimation procedure. One way of
estimating the magnitude of factor X is from mortality data. In 1991, there were
2,100 drug-related deaths in West Germany which is assumed to be a mortality rate
of 2-3 per cent per year. Application of the MMM yields an estimate of 70,000-
105,000 injectors which, in turn, yields an estimate of factor X = 35 to X = 57. For
the hard drug users the plausible range of X is 23-36 (Table 4).
Table 4:  Variation in number of estimated drug users in Germany, 1990
X=1                X=23                  X=36               X=57
Hard drug users 42,000 206,000 304,000 461,000
Injectors 10,000 47,000 70,000 105,000
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The use of MMM to correct under-reporting in a population survey is a new depar-
ture and further work is required to assess the validity of this approach.
Other substances and modes of administration
While there is a range of mortality rates for categories of drug use such as injecting
and addicts attending treatment agencies, there are no published rates for the large
number of other drugs taken for psychic effect. This section provides a brief 
overview for selected substances taken from an unpublished 1994 review on
Substance Abuse Related Mortality: A Worldwide Review (Frischer et al, ms.c.).
Volatile substances
In comparison to injecting drug use, there is very little surveillance or research on
this topic and the activity, being largely confined to teenagers, is less well docu-
mented. In ‘Fuel of the Forgotten Deaths’, Russell (1993) suggests that solvents are
mundane products lacking the glamour of drugs such as heroin or cocaine which 
are associated with more defined counter-cultures. However, the low cost and rela-
tive ease of obtaining solvents and fuels has led to their widespread abuse.
In the UK, more deaths have been attributed, in recent years, to butane and volatile
substance abuse (VSA) than to heroin and cocaine overdoses. There are also reports
of VSA deaths in many other countries, but as a monograph from the US National
Institute on Drug Abuse indicates, there is very little comprehensive surveillance of
VSA (Beauvais, 1992). Thus, it is very difficult to estimate the number of VSA-relat-
ed deaths. If the British data are indicative of trends elsewhere, then VSA could be
associated with as much mortality as heroin and cocaine overdose.
Cannabis
Although cannabis is generally thought to be one of the least harmful substances
known to mankind (Gossop, 1993), recent studies indicate that cannabis use may be
associated with an increased risk of certain types of cancer. A study in Sweden found
that cannabis abuse may be more strongly associated with violent deaths than pre-
viously supposed (Rajs et al, 1993), while a longitudinal follow-up of Swedish con-
scripts, found higher levels of cannabis use were associated with higher levels of
mortality (Andreasson and Allebeck, 1990). Overall, this type of drug abuse does not
appear to have a marked impact on users’ mortality, except perhaps in certain envi-
ronments (e.g. violence associated with drug dealing, road traffic accidents).
Crack cocaine
The use of crack cocaine, although at present more localised in the American con-
tinent, is associated with high levels of (mainly indirect) mortality. With an estimated
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314,000 regular crack users in the USA, there have been widespread media reports
of violent deaths associated with crack dealing and research indicating elevated risks
of Sudden Infant Death Syndrome among infants of crack-addicted mothers. In areas
where there is an increasing trend towards crack injection, increasing mortality is a
likely consequence, in view of the greater risks of injecting crack relative to opiates
(Pickering et al, 1993).
Designer drugs
During the 1980s, new drugs were synthesised and, as with crack cocaine, the
uptake of these drugs has been rapid in areas of availability. Drugs such as 3-
methylfentanyl (‘china white’) are many times more potent than heroin and conse-
quently their addictive capacity and potential for causing mortality is higher. This
drug is already reported to have caused more than 100 deaths in California and there
have been reports from north-eastern USA of deaths related to china white (Hibbs et
al, 1991). In the UK, 3,4-methylenedioxymethamphetamine (‘ecstasy’), taken
mainly in recreational settings associated with youth culture has been implicated in
a number of deaths (Henry et al, 1992).
Using the Mortality Multiplier Method with other indices
Given the limitations of mortality data, it might seem plausible to apply a multiplier
to some other indicator such as the number of arrests for drug offences. However,
extension of the MMM is probably ill-advised for the simple reason than any multi-
plier is likely to be arbitrary. The MMM is plausible because of the wide range of
studies which have reported similar mortality rates. Rates for activities such as drug
arrests are likely to vary within and between locations, and these rates are likely to
change over time due to changing policies. 
Conclusions
Although MMM is a simple method of prevalence estimation, its use is appropri-
ate in situations where the basic assumptions outlined above are met. Guidelines
are summarised in Table 5.
Unlike other methods which require extensive fieldwork or statistical analyses,
MMM is simple to conduct and should be a rapid and inexpensive method for
prevalence estimation. However, unlike, for example, capture-recapture analysis,
it is not possible to provide statistical confidence intervals; the plausibility of
MMM estimates depends on the context in which the method is applied. 
Currently, there are two main difficulties in applying MMM. The first relates to
ascertaining all-cause deaths among drug users. Unless a special study is con-
ducted, it is likely that the all-cause ascertainment will be underestimated.
Furthermore, there is also the probability that, in many cases, even drug overdoses
will be coded under some other category (e.g. respiratory illness), which will not
normally be detected as drug related, unless for example, drug dependence is
recorded as a secondary cause of death.
The second difficulty is in deciding what mortality rate to apply. For drug injec-
tors, a rate of 2-3 per cent per annum will probably provide a reasonable estimate,
although the World Health Organisation collaborative cohort study shows consid-
erable variation over time and between centres (Perucci et al, ms.a). The East
European centres in particular reported rates of 3 per cent and upwards from 1990
onwards.
Table 5: Guidelines for conducting mortality multiplier studies
Establish the number of all-cause deaths among population of interest, e.g. drug injectors,
opiate addicts.
• The usual starting point for this will be a national or regional mortality register;
understand how the register operates i.e. who completes death certificates (patholo-
gist or other medical practitioner); find out customary practices for coding primary
and secondary causes of fatalities associated with drug overdoses. If it is not feasible
to establish the number of all-cause deaths, clearly define some subset, e.g. drug
overdoses.
Establish the most suitable mortality rate from which to derive the multiplier. 
• This rate could be from a variety of sources, e.g. the mortality rate among registered
addicts, a cohort study, literature from previous studies, or a discussion with local
experts.
Derive the multiplier from the mortality rate. 
Multiply the number of drug-related deaths by the multiplier. 
• It would be prudent to use an appropriate range. There are variations of the basic MMM
whereby the results of the multiplication may be added to, for example, the total num-
ber of addicts in treatment.
Compare MMM results to other studies, e.g. population survey, capture-recapture analysis.
State all the parameters of the study when presenting the results.
• Although this may seem obvious, many MMM estimates are presented in documents
which do not describe how the estimates were obtained nor do they clearly specify the
group of drug users to whom the estimates relate.
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To summarise, the Mortality Multiplier Method is probably the simplest way of esti-
mating the prevalence of drug use. The method does not require statistical expertise
and, in some situations, requires only routine data. Where more extensive data col-
lection is required, there may be resource implications. However, if the number of
drug-related deaths can be accurately determined, careful attention to simple guide-
lines should ensure a reasonable prevalence estimate.
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Determining the Number 
of Drug-Related Deaths
by Klaus Püschel
Experts in this field know about the long-standing and seemingly never-ending
debate about regional, national and international statistics and trends concerning
drug-related fatalities, which relates particularly to the standardisation, validation
and comparability of data. There is no generally accepted definition of the terms
‘drug’, ‘drug-related’ and ‘drug-related death’, so there is some confusion concern-
ing terminology and classification systems. Different terms (such as drug-related
death, drug abuse-related death, drug-induced death, poisoning, overdose, intoxi-
cation) have been introduced (WHO, 1994). In reviewing drug-related mortality, the
lack of common terminology or classification systems is revealed as a major prob-
lem when making international comparisons of data. Even within Europe, countries
use different definitions. Moreover, they have established different registration strate-
gies and the list of the substances associated with drug-related death includes a wide
variety of legal and illegal substances with regional idiosyncrasies.  
Drug-related death is a rather heterogeneous concept. It occurs under varying cir-
cumstances and covers different patho-anatomical and toxicological characteristics.
In some cases, there is no hint or clue at all that a death is drug-related, in others, it
is quite obvious. The thoroughness of police investigations at the scene of death, the
quality of post-mortem external and internal medical investigations and the inci-
dence of toxicological analyses varies considerably. A full list of factors and activi-
ties influencing the determination of drug-related deaths would need to include:
• anamnestic information;
• death scene investigation;
• external investigation of the dead body;
• validity of death certification;
• frequency and intensity of toxicological and morphological investigations and
autopsy rate;
• specialist discipline of the investigator (e.g. concerning hair analysis);
• socio-demographic, forensic and medical data exchange between institutions;
• validity of registration and documentation procedures;
• representativeness and long-term stability of the data sampling, handling and
retrieval strategies.
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The consequence seems to be that the identification, classification and registration
of drug-related deaths are open to manipulation. Moreover, it sometimes appears
that politicians, police, health care institutions and drug aid organisations present
and interpret statistics, not according to a realistic scientific approach, but largely
according to lobbying interests.
For about two decades, our own strategy as forensic-medical scientists in Hamburg
has been to acquire facts concerning the drug scene through long-term, reproducible
and scientifically-orientated investigations, based mainly on morphological and tox-
icological findings and using constant definitions.
Definitions and statistics
In Germany, a drug is defined by the Narcotics Act (the so-called
‘Betäubungsmittelgesetz’). The term ‘narcotic’ is purely a nomen juris. It is not iden-
tical with pharmacological or medical terminology and can be changed by decrees
to bring it up to date. The main headings of substances and derivatives coming with-
in the legal meaning of the term narcotic in the Betäubungsmittelgesetz are:
• illegal narcotics – e.g. cannabis, heroin, LSD;
• legal, but not prescribable narcotics – e.g. codeine, dihydrocodeine (except in
divided doses in antitussive medicaments);
• legal and prescribable narcotics – e.g. cocaine (for local analgesia), methadone,
morphine, opium.
In addition, many drugs which are used as alternative or substitute drugs for those
listed are registered.
In Hamburg, we have a very close co-operation between the police and the Institute
for Forensic Medicine. Every unexpected sudden death and every unnatural death is
brought to our morgue and submitted at least to a thorough external investigation. It
is a routine procedure that blood, urine and hair of all fatalities aged between 15 and
50 years are screened for drugs. Autopsies with intensive chemical-toxicological
analyses are common.
Since 1979 in Germany, a death is registered as drug-related if it satisfies the fol-
lowing criteria, which were developed by the police (definition of the
Bundeskriminalamt, IFT, 1994):
• death due to intentional or accidental overdose;
• death due to long-term abuse of drugs;
• suicides connected with drug dependence;
• fatal accidents influenced by drugs.
A death is registered as drug-related if a causal connection to the use of illegal drugs
or substitutes is evident. Group 1 represents about 70 to 90 per cent of all drug-relat-
ed deaths. Groups 2, 3 and 4 are extremely heterogeneous in their related morpho-
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logical and toxicological findings, and, in particular, differentiation between acci-
dental and suicidal overdose or even homicides may be rather difficult. Generally
the combined effects of internal disease and relative overdose can be responsible for
the fatality, although in our experience adverse drug effects play no important role.
Homicides and internal concealment fatalities are not registered as drug-related
deaths in Germany.
During the early 1980s, the number of drug-related deaths in Hamburg lay between
30 and 50 cases yearly; from 1988 it increased dramatically until 1991; it is now
decreasing slightly (Figure 1). The situation is the same as in the Federal Republic of
Germany as a whole where we had about 1,500 to 2,000 drug-related fatalities in
recent years. A comparison between different regions in Germany shows that the
rate of drug-related deaths per 100,000 people differs widely. 
Figure 1: Drug-related fatalities in Hamburg 1976-1995
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High mortality rates can be found in the city states of Hamburg (about ten drug-relat-
ed deaths per 100,000 inhabitants), Bremen and Berlin. As is found almost every-
where, male drug abusers predominate, the sex ratio being about five to one. The
average age of the drug victims has increased during the last two decades from 25
to approximately 30.
Phenomenology, morphological findings, internal diseases
Drug deaths mostly occur in city centre areas. However, a decentralisation of drug
dealing and drug use and a movement to the suburbs has occurred. Most drug addicts
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die in an apartment; others are found in hospitals, toilets, public places and hotel
rooms.
The attendant circumstances of the death can sometimes be clear, e.g. a syringe in
a vein and injecting paraphernalia near the corpse. On the other hand, there might
be no hint of preceding drug abuse at all. For example, ex-users may die in hospital
after long-term abuse because of an acquired internal disease. The scene of death
when a drug-related death is involved may not always be as straightforward as it
appears: the paraphernalia of drug abuse may have been cleared away by the
deceased’s associates and death made to appear ‘natural’ (Vanezis and Busuttil,
1996).
Injection marks are the most important indications of intravenous drug addiction
and must be recognised during the external examination of the corpse. Injection
tracks are mostly found in the cubital area and on the forearm. Sometimes drug
abusers inject themselves in places which make recognition difficult, e.g. in the
mouth, neck, feet, or lower legs. Dissection of the cubital veins shows cribriform
scars of the vascular wall and adjacent bleeding. In about 10 to 20 per cent of
cases, no injection marks are found, since many users nowadays use very small
insulin syringes. And, of course, some abusers die after sniffing or inhaling the
drugs. 
Sometimes tattoos, the design of which give a clue to drug addiction, e.g. a syringe,
are found. The tattoos often reflect the existential views of the drug abuser: impend-
ing danger of death connected with the use of heroin. Sometimes the tattoos are
broadly coloured, spiritual and very expressive and the clue to intravenous drug
abuse may be hidden. Tattoos are also a common means of concealing needle
tracks. 
With long-term narcotic abuse and progressive social collapse, a lack of dental
hygiene leads to vigorous caries, dental defects and periodontal lesions. Infections,
dermatological diseases, signs of neglected nutrition and hygiene are common
(Janssen et al, 1989; Karch, 1993; Robin and Michelson, 1988). However, reliance
on stereotyped ideas concerning the outward appearance, nutritional status and
obvious morphological signs of a drug user should be avoided because fatalities do
not necessarily fit into schematic classifications.
Histological investigations have to be carried out in every case to determine the
severity of the accompanying diseases and their importance in causing death
(Heckmann et al, 1993; Karch, 1993; Kringsholm, 1993; Püschel, 1993). The most
important organs for histological investigation in drug deaths are the liver, the
lungs, the heart and the brain. The findings can relate either to the direct effects of
the drugs or to concomitant infections, hypoxias or bleeding. The finding of
foreign-body granulomas at the site of injection marks and in the lung is of special
diagnostic importance in indicating intravenous drug abuse. Multiple pulmonary
foreign-body granulomas can lead to lung fibrosis and lethal pulmonary hyper-
tension. With the help of electron microscopy and X-ray micro-analysis, we were
able to identify the foreign body material such as talc and cornstarch which are
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auxiliary substances used in the production of tablets and which are sometimes
used for ‘cutting’ the drugs.
Accompanying inflammatory diseases play an important role in the health status
(Levine and Sobel, 1991; Püschel, 1993). They are mostly due to non-sterile injec-
tion practices and needle sharing among drug addicts. Tetanus and other anaerobic
infections with septic complications are not frequent in our material, but endo-
carditis, myocarditis, meningitis and encephalitis are occasionally found.
Pneumonia may be caused by respirative disorders, coma, aspiration and depression
of the immunological system, and it is a common finding in about 15 per cent of all
drug-related fatalities. About 20 per cent of the fatalities are accompanied by an
inhalation of vomit, which is then found in the lungs.
About 70 to 80 per cent of the drug victims exhibit inflammatory liver changes.
These are mostly unspecific reactive or chronic types of hepatitis. Chronic aggres-
sive hepatitis, liver cirrhosis and acute viral hepatitis make up about 10 per cent of
all cases. Co-infections with hepatitis B and C are often detected and post-mortem
serological investigations demonstrate high prevalence rates for both types of hepati-
tis. Calculating the high prevalence rate of 50 per cent or more and the malignant
clinical course of hepatitis C, it can be predicted that this infection will turn out to
be a severe medical problem for intravenous drug abusers. Currently the prevalence
rates in Germany are about ten times higher for hepatitis C than for HIV (Lockemann
et al, 1995).
The myocardium sometimes shows degenerative and inflammatory changes and this
is found in about 5 to 10 per cent of cases in our experience, mostly with non-spe-
cific scattered mononuclear infiltrates and focal myocardial fibrosis (the so-called
‘borderline’ myocarditis, according to the Dallas classification). Active myocarditis
is rare; and active infectious endocarditis, especially right-sided valve vegetations, is
scarcely found in our material.
The impact of HIV and AIDS
Special attention is paid to the spread of HIV infections and AIDS among the high
risk group of injecting drug users (Frischer et al, 1993; Pompidou Group, 1994;
Korf, 1995; Püschel et al, 1995). The morphological alterations found in drug
deaths have broadened enormously in scope because of the HIV infections. Kaposi
sarcomas and opportunistic infections are characteristic findings. It should be men-
tioned, however, that only very few HIV-infected drug addicts in Germany have
died from full blown AIDS up to now – these cases have a higher risk of dying from
unnatural causes, especially intoxication. In our experience, the route of infection
can be through sexual intercourse as well as through needle sharing.
The WHO reports on AIDS cases clearly show that, in some countries, a great pro-
portion of the cases derive from this group, particularly in Southern European coun-
tries – for instance, Italy and Spain – where the percentage of intravenous drug
addicts among the AIDS cases is very high. Previous epidemiological research has
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pointed to an explosive spread of the disease. We tried to develop a monitoring sys-
tem for HIV-1 prevalence among intravenous drug addicts by HIV screening of the
drug-related deaths (Püschel et al, 1995) – to a certain extent, these drug-related
deaths may be considered a random sample of the intravenous drug addicts in any
particular region. It should be pointed out that post-mortem serological investiga-
tions have proved to be a safe and reproducible procedure even in cases with
advanced autolysis.
HIV-1 prevalence has decreased and now seems to be stabilising in German cities
(Figure 2). In Hamburg the prevalence rate is the lowest among the big cities in
Germany, about 5 to 10 per cent, but regional differences are obvious and preva-
lence generally lies between 0 per cent and a maximum of 20 per cent. The figures
for drug-related fatalities are similar to our figures from living users who have been
investigated during clinical therapy.
Figure 2: HIV-1 prevalence among drug-related deaths in the FRG 
from 1985 to 1994 (n = 7708)
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Fatalities caused by diseases acquired from drug addiction (like AIDS or chronic
hepatitis B or C) are underestimated categories of drug-related deaths. The responsi-
bility can be directed at the physicians performing the necroscopy who fill out the
death certificates inadequately. In comparisons with the official data from the AIDS
centre, we found some AIDS deaths not registered as drug-related in Hamburg, even
though the infection had been acquired by intravenous drug abuse.
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Toxicological findings
Toxicological investigation is indispensable in all questionably drug-related deaths
and it mostly determines the diagnosis of cause of death.
The spectrum of morphine concentration in the blood of the corpse is quite wide.
The lethal concentration depends on the actual individual disposition of the inject-
ing drug user. Relatively low doses are frequently found in the blood. The extremes
for morphine and morphine conjugate levels in blood lay between 0.003 and 10.0
µg/ml. Suicidal overdose is characterised by extraordinary high concentrations
(Heckmann et al, 1993; Püschel, 1993).
The term ‘overdose’ is highly relative and depends on actual susceptibility (Püschel
et al, 1993a). Accidental death cases sometimes occur after periods of abstinence
(e.g. after abstinence therapy or withdrawal, or in prison) or by combined action of
different substances, e.g. alcohol, pills and drugs. The percentage of acute intoxica-
tions by heroin in Hamburg is rather high; about 70 to 90 per cent of the drug vic-
tims had monoacetylmorphine in their body fluids and tissues. Combined intoxica-
tion, especially with alcohol, barbiturates and benzodiazepines, is common. The sit-
uation in Hamburg is not representative of Germany in general. Some other substi-
tute drugs predominate in other cities. Deaths from cocaine – mostly after intra-
venous injections and in combination with heroin – are relatively rare.
About 20 per cent of the drug-related deaths showed a blood alcohol concentration
(BAC) of 1 per cent or more (including 6.4 per cent with 2 per cent or more) and
about 20 per cent had a BAC of less than 1 per cent. Our medical and sociological
investigations showed that a group of older opiate consumers – about 5 to 10 per
cent – are primarily alcohol addicts using heroin additionally after long-time alco-
hol abuse (Püschel et al, 1993b).
Special investigations and observation are required for proof of opiates and cocaine
in the nose – in cases of sniffing. Hair samples undergo toxicological investigation
for narcotics from root to tip. By sectioning the hair, conclusions as to the drug
career and the drugs consumed can be drawn. These hair analyses are of special
value in the diagnosis of former drug consumption and pathogenic aspects of inter-
nal diseases. Nowadays methadone maintenance treatment is very widespread in
Germany. Consequently, methadone was – not unexpectedly – found in the body 
fluids and tissues of about 20 per cent of all drug-related fatalities in 1995, mostly
in combination with other drugs.
Violent deaths
Finally, the definition of drug-related death includes accidents and suicides under
the influence of drugs. With reference to external force as cause of death, the mor-
phological findings may also be present as injuries after traffic accidents, stran-
gulation, drowning, burning, etc. The category of accidental and suicidal trau-
matic deaths does not normally undergo forensic investigation for the exact mech-
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anism of death. Drug screening of all of the cases which were brought to the mor-
tuary of our institute revealed narcotics in the blood and hair of a considerable
number of cases without any hint of drug use in the police files. Especially after
periods in hospital, where a clinical toxicological investigation is unusual, there
is no chance to discover the involvement of narcotics at the time of the accident
or suicide attempt. This is why we cannot estimate the whole number of accidents
and suicides under the influence of narcotics (Schulz-Schaeffer et al, 1993).
Conclusions
Our experiences with morphological, toxicological and serological investigations of
drug-related deaths over a period of years lead us to the following recommenda-
tions.
Drug-related death is a very broad concept. Many cases are obvious, others may
be revealed only by extensive investigations. Every questionably drug-related 
death should be subjected to an autopsy and detailed micro-morphological, toxi-
cological and serological investigations.
The epi-critical analyses should be carried out by morphologists and toxicologists
– not by police officers or epidemiologists.
Although a high morbidity is associated generally with intravenous drug abuse, the
fatalities are mostly caused by heroin overdose, at least in our region. The supply of
heroin has increased hugely, and the changing purity of the drug appears to be a
danger with respect to accidental or unexpected overdoses.
Detecting every case of drug-related death helps to determine the extent of drug
abuse, the effectiveness of social and medical treatment programmes and changes 
in the drug scene. However, the quality of statistical calculations and conclusions
cannot be more accurate than the standard of the underlying case work and analyt-
ical findings.
Serological screening can be useful in the epidemiology of infectious diseases. To
the extent that drug-related fatalities may serve as an unbiased sample, continuous
monitoring of the HIV prevalence gives a representative impression of HIV spread
among living intravenous drug addicts. Regional variations are obvious, and hepati-
tis C has turned out to be a considerable medical problem for intravenous drug
addicts.
What we try to do is to convince the authorities that post-mortem investigations are
an important reference for all kinds of medical, social and juridical interventions in
the fields of drug abuse and drug deaths.
Detailed examination of the deceased and the life-threatening conditions of abuse
helps the living addicts to survive. One can obtain much objective information from
a dead body, sometimes even more than from living addicts.
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There is no doubt that it is difficult to distinguish between drug-induced deaths and
deaths among drug addicts, therefore an international agreement about a definition
for drug-induced (or drug-related) death and standardised investigation protocols are
absolutely necessary for international analyses.
So far we are not convinced that drug abuse fatalities are a rational basis for a multi-
plier estimation method: a prerequisite should be a set of established guidelines for
conducting such multiplier studies in order to allow comparability.
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Establishing Mortality Rates
from Cohort Data
by Marina Davoli
Measures of mortality in the general population are easily available in most coun-
tries; in a mortality rate, the denominator is an estimate of the size of a specific pop-
ulation for a defined period and place, and the numerator is the number of deaths
generated by this population during that period. This mortality rate can be made spe-
cific to a given time, place, age, sex, and so forth, depending on the availability of
information for the relevant specified sub-groups. The requirements for measuring
mortality rates in the general population are:
• the availability of an estimate of average size of the study population during the
study period;
• a comprehensive ascertainment of the number of deaths in this population for the
corresponding period, and;
• the coding of causes of death, in particular circumstances, such as requiring
cause-specific death rates.
Most countries worldwide currently produce estimates of total and cause-specific
mortality in the general population (WHO, 1992); nevertheless, the validity of the
data varies, especially where cause-specific mortality is concerned (United Nations,
1991). Routine estimates of the size of the population of drug abusers and compre-
hensive ascertainment of both deaths and cause of death are generally unavailable. 
Drug-related deaths data
As far as the issue of the number of deaths of drug abusers is concerned, figures are
often derived from data on drug-related deaths. There is no specific code in the
International Classification of Diseases for injecting drugs use and, therefore, it is
only possible to measure deaths classified as relating to drug dependence (ICD-9:
309) or relating to injury and poisoning (ICD-9: 965) (Frischer et al, 1993). Other
sources of data for overdose deaths are sometimes available, but their validity is
unknown. In Italy, information on overdose deaths derives from the National
Mortality Register (under the ICD-9 code 304) and from the Ministry of Interior
Affairs (deaths attributed to overdose found by the police). These two sources of data
not only produce different figures but, more importantly, they often do not refer to
the same persons. The agreement between these data sets was examined for the
Chapter 14
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Lazio region between 1987 and 1992. Linkage was possible for between 60 per cent
and just under 80 per cent of cases, and agreement of diagnosis of death ranged from
just over 40 per cent to 90 per cent.
A second limitation in using ‘drug-related’ deaths to approximate mortality of drug
abusers, comes from the fact that drug abusers also die from other causes. The pro-
portion of ‘drug-related’ deaths (ICD-9: 304; 965) out of the total number of deaths,
estimated in the World Health Organisation (WHO) Multi City Study of Mortality of
Injecting Drug Users, ranged from 0 in New Haven to 46.7 per cent in Liverpool dur-
ing the period 1980-1992 (Injecting Drug Users Mortality Study Group, undated).
As a result, an alternative method is often chosen to establish mortality among drug
abusers: a mortality cohort study of this population.
Defining a mortality cohort study
Definition of case
The exact definition of ‘drug user’ for enrolment in the cohort needs to be clearly
stated. The definition of drug user requires a specification of:
• the type of drug (cannabis, alcohol, amphetamines, heroin, cocaine, etc.);
• the route of administration (intravenous, inhaling, smoking, etc.);
• the frequency and recency of use.
Most of the studies available to date relate to injecting drug users for at least two rea-
sons. Firstly, drug injection is currently the most risky drug-using behaviour; and sec-
ondly, the more feasible way to enrol drug users to be followed up for a mortality study
is through treatment centre records, and a majority of drug users attending treatment
centres in Europe are drug injectors. As a result of using treatment centres as contact
points for enrolment, there is almost certainly a selection bias in the populations usu-
ally studied in relation to the population of drug abusers as a whole, since entering
treatment is probably less likely for non-injecting drug abusers than for injecting drug
users. Even if inferences are restricted to injecting drug abusers only and there is no
attempt to make inferences about the whole drug-abusing population, additional bias-
es might well still occur. The likelihood of a drug injector entering treatment is a func-
tion of choice of study time – the longer the enrolment period, the more likely it is that
an injecting drug user entered treatment at least once and so the more likely it is that
at least some infrequently treated injecting drug users will be enrolled. It is clearly also
a function of choice of place – the proportion of injecting drug users reporting having
ever entered any treatment programme during their lifetime of injection varies from
47.7 per cent in Glasgow to 77.1 per cent in Rome.
Definition of cohort
Longitudinal studies can be defined according to the timing (as well as the length) of
the period of follow-up, the time period of enrolment and the criteria for enrolment. 
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According to timing of follow-up it is possible to design:
• retrospective cohort studies, with follow-up of subjects from the past to the pre-
sent, and determination of disease rates (or mortality) during the time period;
• prospective cohort studies, with follow-up of population from the present into the
future and determination of disease rates during the time period. 
According to timing of enrolment, there are two main cohort study designs:
• fixed cohort, with a study population that includes individuals enrolled only at a
single point in time or during some specified brief time interval;
• dynamic cohort, with a study population that includes individuals who were
enrolled, terminated or died at variable points in time.
Regarding criteria for enrolment into a cohort study of injecting drug users, sev-
eral different study designs might be identified: 
• ‘prevalence’ cohort in respect of injecting behaviour: the subjects enrolled in the
cohort are already injecting drugs;
• ‘incidence’ cohort in respect of injecting behaviour: the subjects are enrolled in
the cohort at the time of their first injection;
• ‘prevalence’ cohort in respect of treatment: the subjects enrolled in the cohort are
already in treatment;
• ‘incidence’ cohort in respect of treatment: the subjects enrolled in the cohort are
those entering treatment for the first time.
These different types of study are often combined with one another. In cohort stud-
ies of drug abusers, the most likely combination is to use a retrospective/prospective
dynamic cohort, ‘prevalent’ in respect to injecting behaviour, with both a ‘prevalent’
and ‘incident’ component in respect to treatment. Note that it is not usually feasible
to enrol an ‘incident’ cohort in respect to injecting behaviour.  
With reference to using a combination of types, the mortality rate derived from a
study of a cohort including both drug users already in treatment and drug users
entering treatment for the first time represents a weighted average of the two differ-
ent mortality rates, one for those previously treated and one for first-timers. If the mix
of types is ‘natural’, that is, no over- or under-weighting of the two groups is purpo-
sively included in the design, this should not create problems of interpretation gen-
erally, provided this enlarged definition is consistent throughout the study.
Otherwise, and specifically when comparing results with other cohort studies that
may be different in this respect, this weighted nature of the mortality rate should be
taken into account in the interpretations of the results. In this context, it should be
noted that any rate is an average of different sub-groups: different treatment histo-
ries, different injection careers, and so forth; interpretation of results should always
be made bearing this in mind.
An example: the WHO Multi City Study of Mortality 
of Injecting Drug Users
In 1990, a WHO Multi City Study of Mortality of Injecting Drug Users (Injecting
Drug Users Mortality Study Group, undated) was conducted in Liverpool, Glasgow,
Warsaw, Moscow, Rome, Turin, Naples, Barcelona and New Haven. A standardised
protocol was developed to enrol and follow up different cohorts of drug injectors.
This study illustrates the steps that need to be taken to ensure consistency in the
design of a multi-site study.
Inclusion and exclusion criteria
Inclusion rules must be clear and explicit. For each individual, the date on which
observation begins must be well defined; after that date the individual contributes
person-years of observation and is at risk for contributing events of interest to the
study (e.g. death). An individual does not enter the cohort and does not contribute
person-years at risk until all entry criteria have been satisfied. The date of exit from
the study is the last date on which an individual could contribute observable per-
son-years at risk. In every study, a date has to be specified as the end of the fol-
low-up period for the analysis to begin. It is important to note that date of entry
into the study and date of first exposure to risk are not necessarily the same and
will often be different; it is the number of years of exposure to risk while in the
study that is required in the final analysis. Inclusion criteria for the Multi City
cohort were the following:
• ever injecting drugs;
• entering treatment during the defined recruitment period (different periods across
cities);
• availability of personal identifiers.
Table 1 shows the size and the characteristics of the study populations enrolled in
each city along with the corresponding recruitment period.
Follow-up procedures
The follow-up process needed to be able to detect the disease or death events that
are the defined endpoints of the study for an individual; that is, to determine the
numerator information for the rate calculation. It also had to detect which cohort
members were currently under observation and how many person-years at risk
they contribute, by recording when deaths and losses due to migration occur; that
is, to determine the denominator information for the calculation of the mortality
rate. Further information required on the cohort members included cause of
death. 
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Table 1:  Multi city study of mortality of injecting drug users - study population
City              Recruitment    Number       Male       Mean age     Mean age    Injection
period        of IDUs   to female       at first         at entry     of opiates
ratio        injection        (years)          (%)
(years)
Liverpool 1984-92 815 2.6 20.5 25.3 94
Glasgow 1983-92 367 1.8 16.3 23.6 59
Barcelona 1987-91 4,201 2.9 19.4 26.5 80
Turin 1978-92 6,975 4.4 na 23.4 95
Rome 1980-91 4,660 4.2 20.2 24.3 95
Naples 1980-92 3,785 11.9 19.5 23.1 100
Moscow 1980-92 505 2.6 22.1 28.6 52
Warsaw 1983-92 656 2.9 18.2 25.6 100
New Haven 1985-90 1,588 1.7 na 30.4 46*
*  = Information available only for 30% of the subjects; na = not available
Sources of vital status data in cohort studies
Several different sources can act as the potential source of vital status data (record-
ing of death). In particular, for the Multi City Study, vital status as of 31 December
1992 was ascertained at the last municipality of residence or through record linkage
with national or local mortality registries. In using the latter source, it was assumed
that all subjects not found in the mortality registry were alive.
Migrants might have a mortality different from that of stable residents in the area.
For example the overall mortality rates (per 100,000) for the general population in
Italy during the period 1981-84 were 1,026 among males stable in the areas as
opposed to 1,139 among males who migrated between areas; the corresponding
figures for females were 872 and 928 respectively. Major efforts should therefore 
be invested in tracing migrants in a cohort study, especially since it is possible that
migration might be a more serious problem among drug users, with an even bigger
effect on mortality. 
Calculating years at risk in the study
The validity of a cohort study depends on both the complete ascertainment of the
events of interest (i.e. deaths, migration, etc.) and on the correct computation of the
population at risk (or, more accurately, the person-years at risk). Individuals leave
the population at risk either through death or through migration to a country or
region where follow-up mechanisms of the study cannot be made (or are not)
operative. 
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There are different options for dealing with losses to follow-up in the analysis. For
the purpose of the analysis of the Multi City Study, we applied the most conserva-
tive approach, which consisted in assuming that losses to follow-up were alive at the
end of the study period and in taking the full study period as contributing years at
risk for these people. The opposite approach, giving a higher death rate, would be 
to assume that losses to follow-up were dead at the end of the study period. This
option would normally lead to unnaturally high rates and is unsuitable when losses
to follow-up are high, as they often are. A more acceptable alternative to the Multi
City approach would be to curtail the number of years at risk contributed by indi-
viduals who are lost to follow-up at the point of loss and to count their vital status
as that which obtained at the point of loss. This, in effect, assumes that mortality after
being lost to follow-up is the same as for similar individuals who are not lost.
Another problem arising in the computation of person-years at risk in a cohort of
drug users is the assumption that drug injectors entering the cohort never stop inject-
ing; this would inflate the amount of person-years of injecting risk that is estimated.
For this reason, the interpretation of mortality rates for drug injectors should be to
consider it as applying to their drug-injecting ‘career’ rather than to the precise num-
ber of years (or even months or days) during which they actually injected. 
Determination of cause of death
Cause of death information for an identified death can be obtained in Italy by
requesting copies of death certificates from state or municipal vital statistics offices.
A 90-95 per cent or higher cause of death determination rate is a desirable target.
Coding the causes of death reported on the certificates should be done by a nosolo-
gist trained in the rules specified by the International Classification of Diseases (ICD)
volumes compiled by the WHO. Revisions to the ICD are made roughly every ten
years and changes in coding for some causes may influence the mortality findings of
the study. In the Multi City Study, causes of death were coded routinely according 
to the ninth revision of ICD in all countries, except Russia, where a local coding sys-
tem was used and then adapted into ICD-9.
Problems in making comparisons of mortality rates over time 
and between countries 
Although a large number of different mortality studies have been published, the lack
of a standardised methodology impairs the interpretation of the possible compari-
sons among these studies. Despite many limitations, the Multi City Study, using a
standardised methodology, allowed for temporal and geographical comparisons of
mortality among injecting drug users. For making such geographical and temporal
comparisons, it is clearly advisable to use age-specific or age-standardised rates. The
age-standardised overall mortality rates in the Multi City Study showed marked tem-
poral and geographical differences as shown in Figure 1. Problems still existed when
cause-specific mortality was considered (see Table 2).
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Table 2: Proportional mortality for major categories of cause of death 
among injecting drug users
City                   AIDS                Mental            Diseases of        Injury  and         Ill defined      Other causes   Total
(042-044;           disorders           circulatory         poisoning          conditions        of death    number
279)*             (290-319)             system             (800-999)          (780-799)                       of deaths     
(390-459)                                                                            
N              %               N            %               N           %               N           %            N               %            N            %             N
Liverpool 1 0.0 3 20.0 0 0.0 8 53.3 0 0.0 4 26.7 15
Glasgow 1 3.4 4 13.8 0 0.0 19 65.5 0 0.0 5 17.3 29
Barcelona 121 26.3 6 1.3 21 4.6 239 51.9 2 0.4 71 15.5 460
Turin 99 17.6 66 11.7 14 2.5 274 48.7 26 4.6 84 14.9 563
Rome 188 29.4 177 27.8 38 5.9 94 14.7 13 2.0 129 20.2 639
Naples 35 7.5 32 16.0 6 3.0 50 25.0 41 20.5 36 18.0 200
Moscow 0 0.0 1 2.0 14 28.6 20 40.8 0 0.0 14 28.6 49
Warsaw 0 0.0 4 4.9 4 4.9 26 31.7 35 42.7 13 15.8 82
New Haven 16 27.6 0 0.0 4 6.9 11 19.0 15 25.9 12 20.6 58
* = ICD 9 coding of cause of death.
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Figure 1: Time trends in age-standardised mortality for injecting drug users, 
Multi City Study, 1985-6 to 1991-2
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There is, in fact, a wide variation in ascertainment of causes of death across differ-
ent cities; problems resulting from varying validity of cause of death ascertainment
and classification cannot be ruled out. This should be considered both in the inter-
pretation of results and in the potential use of cause-specific mortality rates as addict
death multipliers.
Conclusions
In conclusion, cohort studies are a frequently chosen method to estimate mortality
among drug users and so to derive addict death multipliers for estimating the preva-
lence of drug abuse. A standardised methodology should be applied for the method
to be used across different countries. In summary, the main issues to be addressed
and clearly stated in a protocol of a cohort study of mortality among drug users are:
• definition of case;
• cohort definition;
• effective follow-up procedures;
• determination and coding of cause of death;
• computation of person-years at risk;
• computation of mortality rates.
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Drug-related Deaths 
as an Indirect Indicator, 
based on the Danish Experience
by Henrik Sælan
This chapter gives a practical example of the use of drug-related deaths to estimate
prevalence, using a case study from Denmark. Comparison and validation of differ-
ent data sources suggests that the rising mortality among 25-49 year olds indicates
an increasing prevalence of problem drug use.
Case counting exercises
In 1976, the first effort was made to count the number of drug addicts in 1975 in
Greater Copenhagen by case-finding (Council on Alcohol and Narcotics, 1977).
Greater Copenhagen consists of the County of Copenhagen and the municipalities
of Copenhagen and Frederiksberg, which together have a population of about 1.2
million inhabitants.
The following institutions and registers with information about contacts with a drug
abuser were approached in 1975 in Greater Copenhagen:
• social service offices, 31 in all (15 responses);
• hospital wards, 7 in all (5 responses);
• general practitioners, about 1,000 in all (665 responses);
• the National Board of Health Register regarding prescription of methadone and
other opiates;
• the National Register on Psychiatric Admissions;
• the Copenhagen Prison;
• the Prison Service;
• the Social Treatment Services for drug addicts, 6 in all (all responded).
This gave a total of 2,981 different persons known as drug abusers or drug addicts
under 30 years of age with a registered address in the area. In the study question-
naire there was no definition of the concept of drug abuse or drug addiction. It was
concluded that there was a minimum of 3,000 drug abusers in Greater Copenhagen
in 1975.
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As drug-related deaths until then had always shown an even distribution between
the capital and the provinces (see Figure 1), and as there was no better estimate
regarding the provinces, an estimate of the total number of drug addicts in Denmark
was calculated by doubling the Copenhagen number, giving a figure of between
5,000 and 10,000 drug addicts, allowing for methodological uncertainty. With a
total of 2.7 million 15-49 year olds, the estimate amounts to 0.19 per cent to 0.38
per cent of the population at risk.
In 1982, a similar case-finding study was carried out in the County of Vejle in Jutland
(Misfeldt and Byskov, 1983). The prevalence estimate was 0.18 per cent of the 15-
34 year olds in the county.
Drug-related deaths
In 1970, the Minister of Justice decided that in all cases where there was a medico-
legal inquest following a death suspected to be connected with drug abuse, there
should also be a medico-legal autopsy and toxicological analysis. This means that
almost all unnatural and unexpected deaths in Denmark suspected to be connected
with drugs are submitted for forensic investigation. In the case of natural deaths,
mostly in hospitals, this happens less frequently. Every year, in a meeting between
the police authorities and representatives of the forensic institutes, difficult cases are
discussed and the number of drug-related deaths is decided upon. The number is the
published in a Yearbook by the police. In 1982, a study was undertaken 
(Kringsholm, 1982) where the proportion of undetected drug-related deaths was esti-
mated, and it appeared to be 5 per cent of the official number.  
Figure 1: Drug related deaths in Denmark and Copenhagen 1974-1995
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Figure 1 shows the number of deaths which have occurred in Denmark, including
Copenhagen, since 1974. There was a rising tendency in the 1970s, a stable period
in the 1980s and then again increasing numbers in the 1990s. Note that the number
of deaths in Copenhagen, the capital, has not increased since 1980. The recent
changes have mainly taken place in the provinces. 
As drug-related deaths had been used as a key indicator together with other mea-
sures in estimating changes in the size of the drug-abusing population since the early
count in 1976, the question arose of how the mortality experienced in the 1990s
should be interpreted. There was a sudden rise in drug-related deaths, from about
140 deaths per annum in the 1980s to about 240 per annum since 1992.
Was this an indication of rising prevalence of abuse or of rising lethality? The 
question could not be easily answered because, at that time, there had been major
changes in treatment services and it was generally believed that the social condi-
tions for drug addicts had been deteriorating. The treatment had changed from sta-
tionary to ambulatory care and there had also been severe budget cuts. To add to
this, the numbers of people in methadone treatment had tripled to about 3,000.
The methadone was mainly prescribed by general practitioners and delivered from
pharmacies and was not taken under controlled conditions. As a result, there were
large amounts of illegal methadone on the drug market and the proportion of
methadone poisonings rose to about 30 per cent of all drug-related deaths
(Steentoft, 1994).
Mortality rates
In 1995, there was a review of Danish follow-up studies on drug addicts giving infor-
mation on deaths (Sælan, 1995). Of ten reports reviewed, three were found to give
valid information. Of the three, one was very old and the study material consisted 
of persons addicted in the earlier contexts preceding the present wave of addiction. 
A 1972 study, on a cohort which had been followed for six years, found an annual
death rate of 2.5 per cent (Green, 1986). In a second study which started in 1973,
the figure was 2.4 per cent at the eleven year follow-up ( Haastrup and Jepson, 1988)
and 1.9 per cent after 20 years (Sørensen, Jepsen and Haastrup, 1966). But even if
we regard the annual rate as more or less constant at about 2 per cent over the years,
the causes of death changed over time. Poisoning was the cause of death in 90 per
cent of the cases in the first five year period, but only 40 per cent in the last. AIDS
was the cause attributed to 10 to 30 per cent of annual deaths between 1989 and
1993. In general, various infectious diseases and violent injuries replaced the poi-
sonings in later periods of observation.
It is clear that, when using cohort studies, these should be undertaken at suitable
time intervals in order to monitor any changes in lethality and pattern of causes of
death among drug abusers, both as a source of information in itself and as a means
to validate the use of death registers in this field.
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Prevalence estimation
Using the deaths multiplier method, the 2 per cent annual death rate suggested by
the cohort studies in the 1980s, taken together with about 140 drug-related deaths
(see Figure 1), produced a central estimate of 7,000 addicts, which was in accord
with the estimate resulting from the early case-finding study. In a very recent study
(not yet published) from the County of Vejle in Jutland, 175 addicts were followed
up for 15 years, and the annual death rate was 1.6 per cent. This result and the 20
year follow-up data give no reason for believing that mortality rate among drug
addicts has been rising in any significant way in the last ten to twenty years in
Denmark. This means that a new central estimate of the prevalence of drug abusers
in Denmark, using the multiplier method, would be 12,000.
Further information and analysis of drug-related deaths
A detailed study of data in the Danish Death Register was carried out with regard
to further information on drug-related deaths (Juel and Helweg-Larsen, 1996). In
Table 1: Drug-related deaths in Denmark 1970-1993
Manner of death                         Underlying cause  Addiction     Number of
ICD codes,                      indicated **        deaths
8th edition
A Poisoning E853-E854 Yes 845
A Suicide by poisoning E950 Yes 483
A Accident, suicide or homicide E980, N965, N978 Yes 338
by poisoning
B Poisoning E853, E854 No 362
B Accident, suicide or homicide E980, N965, N978 No 124
by poisoning
C Other accident E800-E852, E855-E949 Yes 755
C Other suicide E951-E959 Yes 342
C Homicide E960-E969 Yes 38
C Accident, suicide or homicide E980-E989 Yes 873
D Natural 303.8, 304 No 298
D Natural 000-303.7, 303.9, Yes 1,771
305-796
Total 6,229
A = poisoning with addictive substances with addiction indicated as contributing cause (303.8, 304); B = poisoning
with addictive substances, addiction not indicated as contributing cause; C = violent deaths among addicts (addic-
tion contributing cause, 303.8, 304); D = natural deaths among addicts. ** Addiction indicated as contributing cause
with codes 303.8 or 304. Source: Juel and Helweg Larsen, 1996.
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the Danish Death Register, three codes from the death certificate are recorded, but
only the underlying cause of death is published in the routine statistics. The codes
for contributing causes and different manners of death can be analysed separate-
ly if required. Table 1 summarises the 6,229 deaths found by each sub-category of
cause and manner of death in the period 1970 to 1993. This was the last year that
Denmark used the 8 Edition of ICD codes; from January 1994, ICD 10 Edition has
been used.
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Figure 2: Drug related mortality in Denmark 1970-1993, men by age and period
Figures 2 and 3 show the age-specific mortality per 100,000 in the age-group for males
and females from 1970 to 1993. The picture is somewhat different for males and
females but the 25-49 age group shows rising rates for both sexes. Among females, the
older age group, over 50 years, also have high rates. When the birth cohorts were
analysed, a rising mortality rate was observed for younger birth cohorts. At the same
time there seemed to be a stagnation in the trend as the youngest birth cohorts had
lower mortality rates. This was clearly seen for males but not as evident for females. 
In Figure 4, the development over time in different categories of causes is shown for 25-
39 year old males. The causal categories are those summarised in Table 1. The figure
shows rising rates in all except category C, mainly comprising violent deaths.
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Figure 4: Drug related mortality in Denmark 1970-1993, men 25-39 by cause of death
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Figure 3: Drug related mortality in Denmark 1970-1993, women by age and period
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Validation of the drug-related deaths data
The Death Register data were validated by comparisons with two other sets of data,
using the same codes as previously described and shown in Table 1. In the first
case, Death Register data for 1992 were compared with police statistics for the
same year. There were 393 deaths in all; of these 169 (43 per cent) were common
to the two registers whereas 185 (47 per cent) appeared only in the Death Register.
After examination of the original death certificates only 34 of these 185 (18.4 per
cent) deaths were found to be drug-related, in the sense that these persons
belonged to an addicted population using illicit drugs. The remaining 151 deaths
(185-34) consisted of older persons, with a majority of females, suffering from
chronic conditions and having addictive use of legally prescribed addictive
painkillers. These deaths were almost all excluded when only deaths of people up
to 39 years of age were considered.  
In the second comparison, the cohort of 300 addicts described earlier (Haastrup and
Jepson, 1988; Sørensen, Jepsen and Haastrup, 1966) was searched for in the Death
Register by their personal identification number. Of the 119 deaths known to have
occurred among this cohort, 102 (85.7 per cent) appeared in the register under the
codes listed in Table 1.
On the basis of these two studies, the Death Register in Denmark appears to have 
an acceptable coverage of drug-related deaths when contributing causes of death 
are also included.
Conclusions 
In conclusion, cohort studies do not show significant rises in annual death rates.
However, mortality among 25-49 year olds in the Death Register is rising (and
incidentally so is the number of drug-related deaths in police statistics).
Consequently, in the face of non-increasing death rates, there is evidence of rising
prevalence of drug abuse in Denmark when drug-related deaths are used as an
indirect indicator.
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Introduction
by Martin Frischer
omination techniques involve direct contact with samples of drug users who
provide access to and/or information on their peers. This section considers
the use of such information in estimating the prevalence of drug use.
Colin Taylor’s chapter begins by noting that nomination estimation is a form of the
multiplier method (which has been described earlier in Part IV). The chapter con-
tains a detailed theoretical overview of the statistical basis for nomination estimation
and considers the various ways in which access to samples may be gained. Critical
to the success of nomination methods is the randomness of the samples.
This issue is further developed in the subsequent chapter by Dirk Korf. He notes that,
in practice, snowball methodology is often employed to gain access to drug users and
considers the advantages and disadvantages of this particular method. His argument
is supported by evidence from a wide range of field studies. The chapter raises-
important methodological issues for any study which relies on recruiting drug users
in the community.
N
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Estimating the prevalence of Drug Use
using Nomination Techniques: 
an Overview
by Colin Taylor
The use of nomination methods as a means of obtaining information about difficult-
to-reach populations dates back many years having enjoyed a certain amount of
fame and notoriety in the 1970s. Interest in these methods is now developing again
in drug use epidemiology, its main virtue being its usefulness in dealing with rela-
tively rare events. This paper considers the use of nomination methods specifically
in estimating the size of a drug-using population which, in many instances, is a rel-
atively small proportion of the general population. The term ‘nomination tech-
niques’ refers to sampling methods which attempt to gather data not just from the
respondent to the initial sample, but also from individuals nominated by these
respondents. This includes methods in which data about nominees are gathered not
simply from the respondents, but from these nominees directly.
Principles of population estimation using nomination estimation
The principles involved in using nomination techniques specifically to estimate
prevalence of drug use are the same as those described elsewhere for the multiplier
method. This procedure is characterised by:
• a benchmark – the total number of the drug-using population who were in treat-
ment at some point during the year in question, e.g. 3,000;
• a multiplier – an estimate from some sample survey of the proportion of the drug-
using population who were in treatment that year, e.g. 20 per cent (one fifth).
By applying the same benchmark-multiplier calculation to these figures, the overall
drug-using population size would be: 3,000 / (1/5) = 3,000 x 5 = 15,000.
The variety of ways in which the sample estimate of the treatment ratio of 20 per 
cent may possibly be obtained will constitute the body of this chapter. Even without
specifying these for the moment, there are clearly many other definitions in the
above procedure that need to be tightened and various compromises that must be
made. For instance, we need to specify exactly what sort of treatment we mean: per-
haps ‘in methadone treatment’ is a precise enough definition, or perhaps a list of spe-
cific treatment agencies would be preferable, depending upon how the data are to
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be collected. Note again that the definition of this sub-group – those in treatment –
is primarily for the convenience of the researcher, and it is simply a stepping stone
to the answer we want to calculate. Any clear and precise definition will do, pro-
vided it is the same definition that is used in both the enumeration of the benchmark
sub-group and in the sample data collection. Note too that this definition should
include specification of the geographical extent of the locality or region being con-
sidered, as well as the precise time-slot to which the data apply.
Estimating the multiplier value
Obtaining a core sample
Ideally, to estimate the ratio we need a random sample of drug users of the type we
are interested in – all drug users, opiate users, injectors and so on. The practical con-
sideration of obtaining a full sampling frame – a list of all drug users from which to
draw the sample – in advance of the sample being drawn makes it a complete
impossibility. Indeed, if it were possible it would clearly make the exercise of esti-
mating the population size a waste of time. Alternative methods of sampling are also
available. For instance, various ‘capture lists’ can be used, although care and inge-
nuity is often required in using them correctly (by capture list we mean one of the
data sources of names or other identifiers discussed in the capture-recapture sec-
tion). ‘Site sampling’ can be used, and perhaps an extended network sampling pro-
cedure (by site sampling we mean a procedure that selects drug users at one or more
geographical locations, where they are likely to be found). Random samples can be
generated from sample surveys of the general population, although with reservations
(by population sample survey we mean a full probability sample drawn in the tradi-
tional manner from a sampling frame covering the general population).
These sampling procedures are discussed later with specific reference to their useful-
ness in nomination procedures. To begin, however, in order to focus on the nomina-
tion procedures themselves, we will assume that we have generated a random sample
of drug users by some means or other, for instance, by simple site sampling. Note that
because we have not used traditional methods of statistical sampling, we do not know
what fraction of the total drug-using population our sample comprises. This random
sample is, in many contexts, referred to as the ‘core sample’ of respondents.
Nomination ratio methods
‘Nomination methods’ are generally thought of as estimation methods based on
information which individuals in a sample provide about their network of acquain-
tances. We are using the term ‘nomination ratio methods’ to apply specifically to
prevalence estimation by benchmark/ratio methods that estimate the required ratio
from nominee information.
Broadly put, sample members are asked to name or nominate drug-using acquain-
tances and to say whether these acquaintances have been in touch with drug treatment
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centres, health services or any other similar body, within a stipulated time period. The
proportion of treatment attenders nominated by the sample is then used as a multiplier
(as described above) to give an estimate of the total number of drug users in conjunc-
tion with the benchmark known attendance figures at the drug treatment agencies. 
Given a core random sample of drug users, typically we ask two questions of our core
sample respondents, broadly of the following sort: ‘How many of your acquaintances
have used drugs regularly in the last year?’ and ‘How many of these have been for
treatment in the last year?’ From these two answers the proportion of drug users in
treatment can be calculated. Of course the questions will need rather more precise
definitions of ‘drug user’ and ‘treatment’. Respectively these will vary according to:
the aim of the study and the target population, and the type of benchmark data source
available. Whether one year or another time span is more appropriate also needs to
be determined, as do the geographical limits of the study.
It is evident that we are making a trade-off here: the greater number of drug users that
the nomination technique uses in its calculations is bought at the expense of informa-
tion accuracy. The respondent’s personal impression of the drug-using population and
their treatment is actually what is being recorded in the survey, and accuracy will
depend upon how well the respondent answers, or can be encouraged to answer, the
two questions. It is important, therefore, that the definitions used (for ‘drug user’) and the
benchmark choice (‘treatment’ in this example) are elements that a respondent is likely
to know about their nominees. Whether they are injectors or not, whether they have had
an overdose episode, and so forth, are all relatively ‘knowable’ characteristics; precise
frequency of use or polydrug use, being tested for HIV and many others would proba-
bly not be as reliably known by respondents about anyone other than themselves. Note
too that since we are effectively asking each respondent for their estimate of the ‘in treat-
ment ratio’, whether there is some double-counting of particular nominees across
respondents or not is not critical; the respondents’ estimate of the ratio is all that is used.
A direct question technique
An adaptation is to ask a direct question such as ‘What proportion of your drug-using
acquaintances have been for treatment?’ This is almost certainly less useful. It is like-
ly to be a more difficult question to answer, and the answer may be subject to more
rounding off than when it is asked in two stages; secondly, it would be usual to
weight each respondent’s answer by its statistical reliability, namely the number of
drug users on which the respondent’s estimate was based, and this we would not
know. In effect, a weighted estimate of this sort is simply the total number of treated
drug users nominated in ratio to the total number of users nominated. 
Errors in reporting nominees’ status
Note that in the first of the two questions, the respondent may not know that a num-
ber of his/her acquaintances were taking drugs regularly that year. This omission is
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not actually important, since what we wish to know is the proportion of those who
have been for treatment that year. If this is known accurately then the answer will be
good enough for our purposes, but it is important that the respondent does know the
treatment status of their nominated acquaintances. Failing to know that a drug-using
acquaintance has been for treatment will distort downwards the proportion of those
reported as having had treatment; and following through the calculation procedure,
this will lead to too large a multiplier value and a final over-estimation of the size of
the total drug-using population. The reverse reporting error is also quite possible. If
the respondent has the drug use of an acquaintance brought to their attention only
because of an overdose or treatment episode, this is likely to distort their estimation
of the proportion in treatment upwards, with a corresponding downward error in the
final estimate of the population size. In this ratio estimation procedure, there is clear-
ly considerable room for error, but it is difficult to say that there would be a consis-
tent upwards or downwards bias. 
Reliability of nomination methods
Verification of nominee information
Although the term ‘nominee’ has been used in describing the preceding method of
estimating the ratio we want to know, it is evident that no identification of these
nominees is required. All we need to know are the numbers of acquaintances in
response to the two questions, not who they are. When we consider the possibility
of the respondent identifying the nominee, either by full name and address, or by
some code-matching label such as initials and date of birth, or Soundex code (a cod-
ing method for scrambling the name of an individual to preserve confidentiality but
still to allow cross-matching), then the possibility arises of verifying the information
given by the respondent about the nominees. There are three obvious methods of
acquiring the relevant nominee information:
• without identification: nominee counts – take report of respondents in sample;
• with identification: nominee record checking – check treatment status directly with
treatment records;
• with identification: nominee tracing and interview – check both treatment status
and drug-using status directly with nominee.
The pros and cons of requesting identifier information on nominees from the respon-
dents can be debated at length. But the main objections are that asking for potential
breaking of confidentiality by asking for identification of the nominees can lead to
disruption of the sampling and the sample information provided, with the possibili-
ty of a refusal to co-operate; and partial identification, such as initials or Soundex
coding, can be difficult to match against other information and may give a mislead-
ing impression of accuracy. The main points in favour are that there can be verifi-
cation to some extent or other of information supplied about nominees, and that
interviewing identified nominees opens the way to chain referral sampling with a
relatively easy access to many more drug users.
161
Chapter 16
Bias in reporting 
When, for example, the numbers of users in treatment is the benchmark, it is clear-
ly important in estimating the treatment proportion/multiplier that there should be
no general preference for treated drug users as opposed to untreated drug users to
be reported as nominees by the respondents. It is possible that such a preference
exists in some subset of respondents, for instance, amongst treated drug users them-
selves there may be a tendency to know a higher proportion of treated acquain-
tances. Other similar biases can be present in the reporting: males may be more like-
ly than females to know other males, and drug users will be more likely than will
non-users to know other users. The estimation procedure is, perhaps surprisingly,
robust to many such biases, provided that the core sample is a random representa-
tion of the drug-using population. The resulting estimates may be more variable –
that is, have a high sampling variability – than otherwise, but no necessary bias aris-
es from this in the result provided the sample is representative.
One bias that will disrupt the estimation procedure is the first of those listed: a pos-
sible tendency for those in treatment or who have been in treatment, to nominate
preferentially others who have been in treatment. The central assumption that this
will not be so is a reflection of similar assumptions in the other methods of preva-
lence estimation which have been discussed in other papers and, in that sense, is
common to all estimation methods. In using the number of drug user deaths, for
example, in conjunction with a multiplier estimated from drug user death rates, it
was shown to be necessary to assume that the estimated death rates apply appro-
priately to the overall number of deaths – that is, that the number of deaths in the
observed sample cohort is neither over nor under-stated. Similarly, in capture-recap-
ture studies, it was necessary to assume that the two sources were independent cap-
ture points – that is, that the proportion of people captured at the second source,
who were also first-source captures (i.e. in the ‘overlap’ of the two sources), repre-
sented fairly the overall proportion of the overall total population who were first-
source captures. 
It should be noted that, even when reporting is unbiased, there is a small technical
bias present in all standard ratio estimation methods. It is, however, only apparent 
in small samples, and is correctable by a slight amendment to the multiplier/bench-
mark calculation. Therefore, it will be disregarded in what follows.
Multiple benchmark methods
An immediate and useful generalisation of the benchmark-multiplier techniques is
to employ multiple benchmarks, if overall data are available. Thus, besides using
those in treatment as a benchmark group, it would be possible to use those arrested
by the police as well, for example. Both questions would then need to be asked of
the respondents about their nominees, giving two chances of calculating a multi-
plier. This calculation becomes a little more complicated under these circumstances,
since it is necessary to ensure consistency between the results of the two calcula-
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tions. (In fact, technically, the calculation mirrors the analysis of a multi-source cap-
ture-recapture study.)
It is also possible to extend this further to more benchmarks, giving a ‘profile’ of drug
users categorised by many characteristics rather than a single benchmark. Further-
more, it is possible to include in this ‘profile’ demographic breakdowns such as the
number of females in treatment, the number of young males arrested, and so forth.
Any information which can be collected in the sample from the respondents about
the nominees, or by any other means, can be used in this way, greatly strengthening
the power and potential accuracy of the procedure.
An example: the Wirral study
A study in four towns in the Wirral area of England in 1986 (Parker et al, 1988) used
a variety of these techniques to estimate the size of the opiate-using population and
remains one of the few comparative studies of these methods. These techniques 
were used on a focused sample of 60 drug users. The way the sample was obtained
is not our main concern here at the moment – in fact it was obtained by snowball
sampling, with a sketchily-documented selection of the zero-stage sample members.
We will consider the base sample of 60 referrals as a core sample that is used to gen-
erate further nominees. Of particular interest are the nomination methods and the
methods of calculation that were used.
A benchmark of 237 drug users who were known to various stipulated agencies in
the region – including treatment registers and drug-related arrest lists – in a stipu-
lated year was established. The multiplier was established by sample several tech-
niques from the (same) core sample of 60 people.
A. Respondents only: direct question (n-dq)
The 60 members of the core sample of drug users were asked whether they had been
in treatment during the study period. The self-report was that 19 had done so in the
stipulated period. A simple variant of the basic procedure was also used, in which it
was possible to verify that the respondents, who were identifiable (either by name 
or by an initials/age/sex combination) were in fact recorded as having been to the
agencies. In this particular study, it appears that there were no discrepancies in the
self-reported status of the respondents. The 19 identified as being part of the bench-
mark group give a proportion of 19/60 and an overall multiplier of 3.2. This tech-
nique has been described above and does not use nomination methods in the sense
that the sample has been described here – it uses only the core sample respondents.
B. Reported nominee proportion (n-pr)
The 60 core referrals were asked to nominate their five closest acquaintances who
regularly used heroin during the year. They were confined to acquaintances of the
same sex as the respondent themselves, to provide a narrower focus for the poten-
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tial nominee list. Of these 300 nominees, the respondents were asked to report how
many had been in contact with stipulated agencies, in order to compute the appro-
priate multiplier. The final reported figures were adjusted for double-counting in
both the number of nominees and the number of those reported known to agencies,
using a crude form of the simple identifier information that was available. The final
figures were overall 170 nominees of whom 55 were known in the benchmark
group, giving a multiplier of 3.1.
C. Nominees with identification for verification (n-id)
The 60 core sample members were asked to name up to ten nominees who were
regular drug users, and to supply identifying information on them. This resulted
in a proportion of refusals (seven of the 60 sample members). The remaining 53
nominated 297 drug-using acquaintances. This was reduced to 163 unique users
by making use of the identifier information. Further checking of the identifiers
against the benchmark lists showed 66 were known in the benchmark sub-group,
yielding a multiplier of 163/66 or 2.5. It should be noted that an additional check
was introduced in this method, namely that a nominee had to be nominated by
at least two respondents to give greater certainty that they were in fact a drug
user.
The different types of benchmark/multiplier calculations given above (n-dq, n-pr, n-
id) were computed separately within each of the four townships that comprised the
study. The results for the separate townships are given in Figure 1, where towns are
ranked by level of drug use (Town A = high, Town D = low).
Towns Ordered by Known Drug Use (hi-lo)
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Figure 1: Multiplier values in four towns (re-constructed from Parker et al. 1987) 
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The evident trend for towns with higher known drug use to have lower multiplier 
values may have many explanations. The simplest is probably a selection bias: 
namely, that, if a town is selected because it has a low number of known drug users
there is a greater chance that it reflects a low ratio of known drug users than a high
ratio. Hence the multiplier might well tend to be greater in these areas where drug
use is least.
When looking at the different estimates of the multiplier supplied by the different
methods within each town, it can be seen that a certain amount of consistency in
the answers has been achieved. Moreover, the different methods give a similar pat-
tern of answers across the four towns, suggesting that distinctive properties and pos-
sible minor biases pertain to the three methods. The smallest multiplier generally
occurs when method C (‘Nominate up to ten drug-using acquaintances ...’) is used,
whereas the tighter question of method B (‘Nominate five closest same-sex drug-
using acquaintances ...’) is consistently the largest. Many explanations can be pos-
tulated for this; it is worth noting that the results certainly agree with the theory that
respondents who have a wider choice of potential nominees might tend to name
more in-treatment nominees – these perhaps being higher-profile drug users and
more readily brought to mind.
Some limitations of the methods
With specific reference to some drugs such as cocaine, there are difficulties in using
drug treatment programmes, other health service agencies and police and court
records to provide a benchmark figure for these users. People who use only cocaine
often do not readily figure in these sources, and there is a danger that the estimation
would be inadvertently directed too much towards multiple drug users. The tech-
nique, therefore, can provide only a rough estimate of cocaine use prevalence, with
a considerably large sampling error. In general, the principal limitations of the tech-
nique will arise from: (a) the core sample that provides the nomination data for esti-
mating the multiplier needs to be representative; (b) the method requires a fairly
accurate benchmark figure for numbers in treatment over the time period in ques-
tion. These may be incorrect if the same set of treatment agencies is not used in the
nomination question and in the benchmark, or if there is serious tendency for some
drug users to register at more than one treatment agency in the same period, or if
drug treatment agency records are not fully accurate; (c) the proportion of nominees
attending treatment programmes can be erroneous because respondents may not
know with any great degree of reliability whether their nominees have attended a
treatment programme or not. There is also a danger of people deliberately providing
wrong information about their acquaintances.
The potential double counting of nominees (that is, the same person being nomi-
nated by more than one respondent) does not, in itself, influence the total of those
in treatment in proportion to all nominees. This proportion is effectively calculated
for each respondent individually and then averaged (with weights) across all respon-
dents, successfully avoiding such complications (Hartnoll et al, 1985).
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Focused core samples
Sampling issues
We now turn to issues in drawing a sample by which to estimate the multiplier
through nomination methods, assuming it is impossible or inefficient or otherwise
inadvisable to launch a general population survey as a basis. Note that all we
require is a random sample of drug users, and this can be obtained by filtering them
off a general population survey or by more direct methods. The term ‘focused core
sample’ indicates that the aim is to sample drug users directly, rather than simply
identify them amongst a general population sample, and to indicate that this sam-
ple can be the initial wave (sometimes called the zero stage) to be used in a multi-
wave chain referral procedure (snowball sampling). The sample should be such that
it is efficient at finding as many (drug-using) nominees as possible; and it gives no
preference to finding nominees who are treated users over those who are non-treat-
ed, and vice versa (or whatever benchmark group is being used, if it is not treat-
ment figures).
Bias in focused sample selection
The main problem in drawing a focused sample will be the need to find a mecha-
nism by which to draw the sample in the absence of the complete sampling frame
required by classical statistical survey methods. Two options arise. The first is to use
any lists of drug users which are available, knowing that these are partial and often
self-selected lists of drug users; these are the ‘capture lists’ used in capture-recapture
studies discussed in previous sessions. The second is to use some form of ‘binomial
sampling’ (Goodman, 1961) or ‘site sampling’ (TenHouten, 1971).
Capture lists
To supply the core sample, it is possible to use, as a sampling frame, lists of drug
users who are in treatment and to use their nominees to provide the information on
the treatment ratio. In this case, the treatment proportion amongst respondents is not
useful (being 100 per cent) and the multiplier calculation must be confined to the
nominees only. However, lists of drug users who are in treatment, or who have been
in treatment recently, might well not satisfy the bias criterion of no treatment prefer-
ence with respect to their nominees.
One option is to use a ‘site sampling’ (or ‘binomial sampling’) method. Such sam-
ples have difficulties of their own in practice, which we will not discuss in detail
here, but we simply note that such a sample is not a priori going to have a bias
in preferentially yielding nominees who are treated as opposed to untreated.
Again, if one of the sites chosen is the treatment clinics themselves, some bias
may arise. 
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Crossed capture lists 
An ingenious elaboration which tries to safeguard against this possibility of bias is to
do a double-study, one using the treatment subset as its benchmark and the other
using police arrests as its benchmark subset. It then becomes possible, records per-
mitting, to use the police records as a sampling frame to provide a sample ratio for
the ‘treatment benchmark’ calculation. Hopefully, this reduces to a minimum any
potential tendency for sample respondents to have any obvious bias in nominating
treated users. Then, by using the treatment lists for the ‘arrests benchmark’ calcula-
tion, the obverse is also true. Hopefully, the potential bias in each is considerably
reduced by this cross-over technique, and each should provide an improved esti-
mate of their respective ratios.
Selection control in site sampling
Stratification has often been discussed as a potential way of controlling the sample
selection. Stratification of the population under study is the easiest and surest way to
improve representativeness of the sample. Multi-site sampling offers an opportunity to
stratify the sample if the researcher has, or can collect, information on the population
numbers in the intended strata. Such strata might be different physical locations, such
as clubs, pubs and so forth, or they might be circles of social cohesion, such as stu-
dents, musicians and golf club members. The difficulty is not in devising strata – these
usually spring readily to mind – but in defining strata that can be enumerated during
the data collection or have been enumerated beforehand. TenHouten discusses the
idea of extending such site samples to a plurality of sites, in order to sample more 
effectively from the whole population under study. Hendricks et al (1992) describe
using the principle by sketching out a map of the city’s likely centres of cocaine use in
order to draw a multi-site sample from these centres.
The heavy reliance on random (binomial) selection to obtain a core (or zero-wave)
sample throws up several aspects of the procedure which need to be considered in
relation to site sampling. These relate to the implications for assessing the sampling
probabilities of any population member. Apart from the need for careful procedures
in the sampling process to ensure that no immediate interviewer preference causes
individuals to be sampled differentially, there are questions concerning the ‘cover-
age’ of the sites – how far do they encompass the entire target population – and ques-
tions concerning frequency of attendance – how often do different individuals attend
the site or sites. The final line is that everyone in the population is assumed to attend
the sample points and, if the sample is intended to be drawn by a simple random
sampling (SRS) procedure, to attend with the same frequency.
Clustering and its effects
Clustering normally implies the congregating together – at least from the point of
view of selecting sample members – of groups of similar people and, as such, is an
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inefficiency factor. When they are clusters of similar people, they reduce the effec-
tive spread of the sample across the variety of people in the population. Clustering
is clearly of particular importance in snowball sampling, where chaining from one
sample member to the next implies the inclusion of several possibly similar people
as a result of including any one of them. Clustering in itself does not of itself pro-
duce a biased sample, it produces an inefficient sample; inefficiency from the point
of view of keeping sampling error variance to a minimum. 
Chain referral (snowball sampling) procedures 
Once we accept the possibility of obtaining identification of the respondents’ nomi-
nees, it becomes possible to follow up these nominees personally and to obtain from
them a second wave of nominees. The multiplier calculations can make use of all
such nominees in the second wave as well as those in the first. Any number of waves
may be added in a similar way, with the intention of obtaining as many drug users
as possible on which to base the estimate of the required ratio.
The statistical analysis of a snowball sample requires careful consideration and is
fraught with many potential pitfalls generated by the sampling procedure. These 
have a considerable literature relating to them, grounded in the theories of sampling
on a network of individuals. Requirements of calculating sampling probabilities and
of analysing weighted non-independent observations make the procedures poten-
tially complex. However, we note here that the simple overall calculation of the
required proportion of people in the benchmark group (e.g., treatment during the
year) is adequate for our immediate purposes, if we are prepared to assume that
there is no reason for nominees in the chain referral procedure to nominate people
in the benchmark group at a greater rate than is their natural frequency of occur-
rence. Whereas this assumption can be violated in many ways, it may, nonetheless,
not be an unreasonable approximation to the truth in many circumstances.
Defining the snowball procedure
The snowball procedure is defined statistically by the number of nominations (links)
the zero-wave respondent is asked to give and by the number of waves (stages) that
the link-tracing procedure completes. This method of definition of the snowball pro-
cedure will hold whatever the actual nature of the link, that is, whatever the ques-
tion by which the respondent is asked to make nominations, and whether or not the
link relationship is necessarily mutual (e.g. ‘Who have you used cocaine with,
ever?’) or is potentially uni-directional (‘Who are the people you most often use
cocaine with?’). 
There is a variety of different ways of treating the number of links and the number of
stages in a snowball procedure, the first and foremost being whether they are fixed
to be the same for everyone in the sample or whether they are allowed to vary nat-
urally as the sample waves progress. In spite of ground-breaking work by Goodman
168
Nomination Methods
(1961), in practical terms for a study wanting to make even approximate statistical
inferences about population parameters, it is not at all clear what the theoretical
consequences are in terms of efficient use of a given sample size or collection effort,
or in terms of the bias of the resulting estimates. There are no theoretical statistical
guidelines on what type of snowball procedure to adopt, except to make the core
(zero-stage) sample as large as possible. 
Apart from the lack of any theoretical statistical considerations, for most purposes it
would seem inefficient to fix in advance the number of nominees or the number of
stages. Usually, the primary consideration is to obtain enough people by the proce-
dure to allow reasonable numbers for analysis/description. It seems preferable for
efficiency of effort and for administrative ease to let the nomination process proceed
without imposing constraints on its format. The procedure could be terminated 
either by reaching a predetermined number of sample members or, more likely, a
predetermined financial resources limit, or by sampling to extinction – that is, until
the last wave adds no further new nominees. 
In practical terms, the reporting of the proportion (or number) of acquaintances who
have used drugs and who have been treated for drug use is probably best kept as
focused and directed as possible. The more leeway allowed to a respondent in the
phrasing of the appropriate questions, the more opportunity there is for the respon-
dent to answer in a loaded or selective way. This is probably a principal source of
potential bias in the procedures and, therefore, limiting or controlling it is desirable.
Strictly speaking, there is no need for the nominee linking question in the chain
referral procedure (e.g. ‘Who are the people you regularly use drugs with?’) to be the
same as the question used as the base in the ratio calculation (‘Who are your five
closest drug-using acquaintances? How many have been in treatment this year?’).
The ability to trace, interview and verify information given about the nominees is
compromised, however, when the two sets of people differ.
Alternative nomination strategies 
In order to determine the number of stages in a snowball sample, the decision can
be made ad hoc as the sampling procedure progresses or until no further stages can
be made. In order to determine the number of links for selecting nominees, the
options are: (a) tracing all links nominated by the respondent; (b1) tracing a selec-
tion made at random which is a fixed proportion of the respondent’s nominees; (b2)
tracing a selection made at random which is a fixed number of the respondent’s
nominees (a method studied in Goodman’s original 1961 paper); (c) tracing links in
a predetermined importance order from the list of the respondent’s nominees, taking
either a fixed number from or a proportion of the list, for example ‘first best friend’
and ‘second best friend’; (d) tracing links in a predetermined reverse importance
order from the list of the respondent’s nominees, taking either a fixed number from
or a proportion of the list; for example taking the list in the order the respondent
nominates, but bottom first. 
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Hendricks et al (1992) list these alternatives and have noted that the theoretical impli-
cations of these different alternative strategies is still unclear and that it is perhaps best
for the choice to depend upon the goal of the study. For different purposes, each of
these alternatives has advantages and disadvantages in terms of rate of growth of the
sample, the risks of a restricted (biased) sample, etc. Hendricks et al (op. cit.) specu-
late tentatively on some guidelines. If the purpose of ‘snowballing’ is to obtain a snow-
ball sample that is closest to a simple random sample (in terms of the equiprobability
of subjects selected from a defined population), then option (b) or (d) may be good
choices. Option (b) introduced a strong randomisation factor in each nomination step,
as is necessary for the application of Goodman and Rapoport’s formulae (1980) for
estimating population parameters. Option (d) may also produce a relatively unbiased
sample, given Rapoport’s observation that a tracing through ‘loose ties’ (‘eighth best
friend’) between nominators and nominees will yield a sample that is very similar to
that derived from the completely randomised model. 
With respect to predetermination of the number of stages, only one-stage snowball
samples seem to offer any useful results. Since all snowballs will contain this stage, any
results can be applied to this subset of the overall sample, ignoring later stages. It
would suggest that, if these estimation procedures are important to the study, then the
initial zero-stage sample should be as large as possible (something which is always and
in all conditions a good idea) and all available links should be traced at stage one.
Nomination ratio techniques in multi-wave snowball samples
As we have seen, it is possible to ask the relevant questions about how many drug-
using associates a respondent has within the snowball nomination structure as a
matter of course, and to then use the benchmark-multiplier calculations described
above to estimate population size. An elaboration of the procedure which is avail-
able in snowball samples is as follows. For each respondent, both in the zero-stage
sample and in the subsequent stages snowball sample, the proportion of nominees
attending drug abuse treatment centres is calculated and these proportions averaged
(pooled) across all respondents. These proportions can then be compared for each
successive wave of the snowball, to chart any tendency to decrease as the sample
spreads further from the core zero wave. This tracking might be particularly useful if
the initial sample was not an attempt at being randomly drawn, or even representa-
tive, but was, for example, a treatment site-sample.
It may be hoped that the better estimate is provided by the later, more remote waves
of the sample but, in fact, the hope is not justified. To the extent that these later
waves differ, they unquantifiably play down the contribution those members near the
core zero-wave sample would make to the overall average.
Rigour in fieldwork versus rigour in sampling
Many authors have stressed the need for rigour in fieldwork when constructing a snow-
ball sample. The following much quoted problem areas were originally put forward by
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Biernacki and Waldorf (1981, p. 144): finding respondents and starting referral chains;
verifying the eligibility of potential respondents; engaging respondents as research
assistants; controlling the types of chains and number of cases in any chain; pacing 
and monitoring referral chains and data quality.
It is salutary to note that only two of these are concerned with the statistical-
theoretical aspects of snowball sampling and that the remainder deal with practical
ground-level considerations.
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The Tip of the Iceberg: Snowball Sampling
and Nomination Techniques, 
the Experience of Dutch Studies
by Dirk J. Korf
It is not easy to obtain a representative picture of developments in heroin use by con-
sulting general household or school surveys. The prevalence of heroin use is nor-
mally too low to permit any reliable conclusions to be drawn on trends in the size
and composition of heroin-using populations. As an alternative, researchers some-
times opt for ‘captive’ samples of institutionalised heroin users, such as prisoners,
probationers, methadone patients or addicts undergoing inpatient treatment.
Heroin users are also studied by qualitatively oriented researchers, mostly ethno-
graphers. A common method in the latter studies is snowball sampling, but
methodological problems are often ignored and ethnographic field studies of hero-
in users are mostly limited to street samples. From an epidemiological viewpoint, it
is often questionable whether findings from either institutionalised or snowball sam-
ples are representative of the total population of heroin users. Sometimes institu-
tionalised populations of heroin users are compared to street populations. Data on
HIV prevalence among Amsterdam methadone clients have been compared to find-
ings from street samples. When the rates turned out more or less the same, the
researchers concluded that methadone clients can be taken to be a representative
sample of the Amsterdam heroin-using population (van Ameijden, 1994). Such a
conclusion is, of course, far too hasty. The most visible sub-group may be in no way
representative of the population. The tip of the iceberg does not, by definition,
resemble the part under water.
What matters in typological and ethnographic studies is usually the theoretical
generalisability of the findings rather than statistical representativeness. Most
respondents are drawn from institutionalised populations or street scenes, although
theoretically they could also come from other environments. One benefit of these
types of studies is that they have helped to systematise snowball methodologies. In
principle, the combining of institutional and street samples makes it possible to
reduce selection bias in studying the entire population of heroin users. But both
types of studies generally fail to make clear to what degree their samples are statis-
tically representative of that overall population. They find similarities between two,
possibly overlapping, segments of the tip of the iceberg. The underwater part could
prove altogether different in nature.
Chapter 17
Nomination techniques in practice
Since nomination techniques are discussed in Chapter 16 by Colin Taylor, this chap-
ter focuses on field experiences. In several field studies we applied nomination tech-
niques, for instance by asking respondents whether they had received methadone
through a standard provision programme and/or at a police station following arrest.
However, we did not actually estimate prevalence using a multiplier.
Application of nomination techniques has to fulfil at least three criteria, namely sta-
tistical representativeness of the field sample, reliable self-reported data and an
unambiguous definition of the target population.
Sampling bias must also be reckoned with in applying nomination techniques.
Although we endeavoured to eliminate it, it will always be a factor to some degree.
Table 1 summarises schematically the effects sampling bias can have on estimations
derived using nomination techniques. As snowball sampling is one of the most widely
applied methods for collecting nominee data, we focus on this method in more detail.
Table 1: Effects of sampling bias in nomination estimates
Sampling bias  Denominator Effect on estimate 
of population size
Over-representation Over-inclusion Enlarged Under-estimation
Under-representation Over-exclusion Reduced Over-estimation
A four-stage model of snowball sampling
Snowball sampling involves researchers first orientating themselves in the target
population, then making contacts and interviewing respondents. At the end of each
interview, respondents are asked to assist in finding new respondents. Chains of
respondents are thus generated through referrals from earlier respondents. The sam-
ple can be extended on and on by interviewing new referrals. Theoretically, the
snowball sampling method is well suited for research within hidden populations of
heroin users. It may even make it feasible to recruit a sample that is statistically rep-
resentative of the entire heroin-using population.
In practice, many so-called ‘snowball’ studies appear to be site surveys, i.e. surveys
among small networks of friends, colleagues, etc. Whilst snowball sampling has
been widely used in the social sciences, Biernacki and Waldorf have warned that
‘the procedures and problems entailed in its use have received only cursory atten-
tion’ (Biernacki and Waldorf, 1981). These researchers applied snowball sampling
methodology in studying the process of ‘natural recovery’ from heroin dependence,
in order to construct a theoretical model for this phenomenon. They distinguished
five different problems in the application of snowball sampling. A later publication
by Watters and Biernacki devoted more attention to statistical representativeness
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(Watters and Biernacki, 1989). This study is more quantitative and epidemiological
in nature. In an outreach experiment on harm reduction, intravenous drug users
were issued with bleach which they could use to disinfect used needles. To ensure
that no gaps would fall in their field knowledge about the population of users,
Watters and Biernacki developed a five-stage strategy they call targeted sampling. 
I have integrated the various steps of snowball sampling which appear in the works
cited above into a model consisting, ideally, of four successive stages: preparation 
of the fieldwork; initiating snowballs; chain referrals and controlling quality. These
four stages are outlined in Table 2. The model contains all the elements referred to
in the above publications as well as some additional components of my own.
Table 2: Structure and analysis of snowball sampling
Preparation Initiating snowballs Chain referrals Controlling quality
of the fieldwork
Defining target 
population
Initial mapping
Finding 
and training field
research assistants*
Ethnographic 
mapping
Initial plan by
neighbourhood
Finding respondents
Verifying potential
respondents
Engaging 
respondents
as referral assistants
Starting
referral chains
Controlling chains
and number of cases
Pacing and monitoring
referral chains
Interim findings
shaping questions
and instruments
Revision of Revision
of target plans of target plans
Monitoring data quality
Testing self-report
reliability *
* Elements not explicitly mentioned by Biernacki et al which have been added by the author.
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Preparation of the fieldwork
Preparation begins by tentatively defining the target population. The researcher
determines which people are to be studied, in what geographical area and with what
objective. Then the whole area to be studied (a city, for example) is divided into
appropriate smaller areas (neighbourhoods), and these are charted in more detail
(initial mapping). Next, potential research sites are explored more thoroughly by
means of field observations and other qualitative methods (ethnographic mapping).
The preparatory stage is finished off by deciding at which sites and with which
respondents the snowball sample will be initiated (initial plan).
Both preparation and execution of the study demand that the researchers be famil-
iar with the geographical area (city or neighbourhood) and the population to be
studied. The recruiting and training of competent field research assistants is there-
fore a critical element of the preparatory stage. They are of the utmost importance
for adequate ethnographic mapping.
Initiating snowballs
The key issue in achieving a statistically representative sample using the snowball
method is: where, and with what, potential respondents will the snowballs be
started?  Potential respondents must be checked for membership in the population –
whether they really are frequent heroin users, for example.
Chain referrals
The practicability of snowballing stands or falls with the co-operation of respondents
in their role as ‘referral assistants’. They must be willing to provide names of poten-
tial new respondents and they must be prepared to assist in finding them. This makes
extra demands on field research assistants. It is important, too, to verify that the new
respondent is indeed the person to whom the researcher has been referred.
Controlling quality
This phase involves the monitoring of the process of chain referrals. On the basis of
regular intermediate analyses, it is decided whether or not to extend chains, and
ideas are developed about other networks which may be thought to exist within the
population, but have not yet been located. Strategies are worked out to establish
contacts with them.
‘Control is exercised in an attempt to ensure that the sample includes an array of respon-
dents that, in qualitative terms, if not rigorous statistical ones, reflect what are thought to
be the general characteristics of the population in question.’ (Biernacki and Waldorf,
1981, p. 155).
Besides quality control of the sampling procedure – the focus of Biernacki and his
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colleagues – monitoring the quality of the data reported by respondents is also a
must. One way we do this is by testing the consistency of their self-reporting.
My classification into four successive stages is, as I noted, an ideal model. In reality,
snowball sampling is a dynamic process, in which findings in later stages can have
retroactive consequences for an earlier stage. In this way, for instance, the original
definition of the target population (early in Stage 1) may later be adjusted on the
basis of information gained during the ethnographic mapping (later in Stage 1). Or
interim findings (Stage 4) can give cause to revise target plans (Stages 2 and 3). This
feedback mechanism is shown in Table 2 by arrows drawn between stages.
Preparing the fieldwork
Having defined the target population, the next problem was to find it. Our first step
was to map the research terrain and explore it ethnographically. We ensured the
quality of this geographic and ethnographic mapping by recruiting and deploying
field research assistants at an early stage. They were selected on grounds of famil-
iarity with sites and networks of the targeted groups. During this first stage of field
orientation, we spoke informally with individuals from the target population. We
soon learned that both researchers and field assistants must be more than just skilled
interviewers. They must also be well known to the drug users or at least well
informed about their social worlds, and they must be prepared to hang about exten-
sively day and night no matter what the weather. In putting together the field teams,
we paid special attention to team members’ familiarity with specific categories of
potential respondents (gender, age, ethnic background and nationality) and with
local sites in order to ensure that the scope of the investigation would be as broad
as possible. Some field assistants worked on more than one of the studies. All field
teams included at least one experienced current or former heroin user.
Initiating snowballs
Researchers who employ snowball sampling must first and foremost establish a rela-
tionship of mutual trust and respect with their initial respondents (at the zero stage
of the snowball chain). These initial contacts are often key people such as experi-
enced drug users who will go on to vouch for the researcher to their friends and
acquaintances, guiding the newcomer safely through the social group under study
(Morrison, 1988). Key contacts can also help dispel worries of respondents about the
confidentiality of the information given (Hammersley and Morrison, 1987; Morrison,
1988; True and True, 1977). Such worries are not always easily allayed. Ultimately
the burden is on the researcher to come across to the respondent as trustworthy.
Familiarity with the research population, patience and tact are crucial.
Our goal of statistical representativeness posed specific problems for us in initiating
snowballs. Some of them related to the size of the research populations. Especially
in dealing with large populations of heroin users, as in Amsterdam, we had to take
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a whole variety of sub-populations into account. The less these sub-populations
overlapped with one another, the smaller the chance that a snowball started in one
of them would lead us through referrals into another sub-population. The danger 
was always present that we would get stranded on top of the iceberg and fail to
access hidden users. If we only started snowballs with visible users, we would not
automatically wind up meeting hidden ones. The problem is even trickier in places
where scarcely any visible users are present. The researcher must then rely entirely
on hidden users for initiating snowballs. This type of predicament arises especially
in rural areas.
Chain referrals
Respondents were asked to nominate by name or nickname the other users they
knew who satisfied our criteria, such as using heroin several days a week. From this
list of nominees, we chose the next respondent-to-be and asked the ‘referral assis-
tant’ to help us find him or her, thereby lengthening our chains of respondents.
The advantage of chain referrals, either randomised or non-random, is that the
researcher is introduced to new respondents by someone they know, or at least that
the previous respondent can be used as a reference. Such an introduction, of course,
is no watertight guarantee of the co-operation of the new respondent.
An important point in the lengthening of chains is which nominee(s) the researcher
will choose. If you pick the first person the respondent names, you run the risk of
getting stranded in a small sub-group. I have noted above that random selection of
respondents at the zero stage of snowball sampling is feasible in theory and some-
times in practice. Why not apply random sampling, we reasoned, at later stages of
the chain as well? We worked out this idea into a procedure which was easy to 
apply in the field. At the close of the interview the respondent was asked, ‘What
other foreign heroin users do you know personally?’ The respondent was to make a
numbered list of their names or nicknames, up to a rather arbitrary maximum of 25.
The next potential respondent was then chosen on the principle of chance. As the
number of nominees per referral assistant could vary, and the random selection had
to be performed in a wide range of places, we adopted a flexible procedure. From 
a pack of playing cards we counted out cards equalling the number of nominees. 
For the first ten nominees, hearts were used (ace of hearts = nominee 1, two of hearts
= nominee 2 etc.). For nominees 11 to 20 clubs were used, and for nominees 21 to
25 diamonds. The next step was to shuffle these cards and draw two of them ran-
domly, corresponding to two of the nominees. We then asked the interviewee to
help us find the two randomly selected potential respondents. The first one located
was asked to take part.
Since 1985, we have applied the same technique of random chain referral in sever-
al field studies. The only variation was that nominees from the appropriate target
group were asked for. Obviously the chain referral technique takes a good deal of
time, not so much for the interviews (approximately one hour) but for finding the
new respondents once drawn. This involves hanging around, making and sustaining
contacts with respondents and key informants in the scene, and the targeted search
for the new respondents.
Quality of sampling
The main quality criteria are: (i) the extent to which snowballs actually develop from
initial contacts through successful referrals; (ii) the length of the chains. I compare
the outcomes with those of two other studies of hard-drug users which also applied
randomised chain referral.
The degree to which snowballs are actually generated from initial contacts is reflect-
ed by the percentage of loners within the samples. Loners are zero stage respondents
who failed to refer us successfully to another respondent in a chain. As shown in
Table 3, almost a quarter (22 per cent) of the respondents in the Heroin Tourist (HT)
study were loners. Fewer loners were encountered in the Gooi study (13 per cent),
and only 5 per cent in the Conson and the Homeless Youth (HY) studies. The large
majority of respondents in all four studies belonged to snowballs.
Table 3: Length of snowballs in four field studies compared to two Dutch cocaine studies
Study                           N            Zero        Loners    Number   Respondents   Average
stages                    of chains     in chains       chain
length
(loners
excluded)
Heroin tourists 382 162 22% 78 78% 3.8
Conson 202 46 5% 35 95% 5.5
Het Gooi 119 34 13% 18 87% 5.7
Homeless youth 137 30 5% 23 95% 5.7
Cocaine Amsterdam 160 81 27% 39 73% 3.0
(Cohen, 1989)
Cocaine Rotterdam 110 84 76% 15 24% 1.7
(Bieleman
and De Bie, 1992)
The snowballs in the four field studies ranged in length, i.e. number of cases in the
snowball, from two (‘two-stage snowball sample’) to 14 cases (‘14-stage snowball’).
Leaving the loners aside, we found that the total number of snowball chains in the
four studies varied from 18 (Het Gooi) to 78 (HT). The average length of the chains
was shortest in the HT study (3.8 respondents) and longest in the Gooi and HY stud-
ies (5.7).
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Why, then, did proportionally fewer heroin tourists belong to snowball chains (78
per cent), and why were their chains shorter than in the other studies? It would
stand to reason that network formation among the foreigners was less extensive
(fewer and/or smaller networks of users) than amongst the resident populations in
the other three studies. A large proportion of the heroin tourists had not been in
Amsterdam for long. It is worth noting, however, that the Italian respondents,
whose average stay was comparatively short, were the group most likely to be
found in longer chains.
Our four studies with randomised chain referrals are also compared in Table 3 with
two other Dutch studies in which similar methodology was applied. In one of them,
on non-deviant cocaine use in Amsterdam, 73 per cent of the 160 respondents
belonged to chains of referral (Cohen, 1989). In the other, on the nature and extent
of cocaine use in Rotterdam, only 24 per cent of the 110 respondents belonged to
chains (Bieleman and De Bie, 1992). 
In our studies, from 78 per cent to 95 per cent of respondents were in chains, and
the chains in our studies are also longer. The Rotterdam cocaine study had an aver-
age chain length of 1.7 (loners excluded) and the Amsterdam cocaine study 3.0,
compared to 3.8 to 5.7 in our studies. (Calculated for Rotterdam from Bieleman and
De Bie (1992, p. 21) and for Amsterdam from Cohen (1989, p. 66).)
In principle, two kinds of explanation can be offered for the fact that we were more
successful in building snowballs than the cocaine researchers. One involves possi-
ble differences between populations of cocaine users, on the one hand, and the
drug-using populations in our studies, which in most cases consisted exclusively or
predominantly of heroin users. Differences in chain length could be a consequence
of a lower degree of network formation among the former, as we also saw among
the heroin tourists. 
It would seem plausible that recreational cocaine users are not integrated into net-
works of other users to the same extent that heroin users are, and furthermore that
they would be more reluctant to label themselves as cocaine users in the presence
of strangers such as researchers. These factors, of course, would impede the build-
ing of snowball chains. Our own experience with cocaine users in the Alkmaar 
study would seem to confirm this explanation: it took longer to gain access to their
network and to induce them to be interviewed than it did with the heroin users (see
the ‘pub scene’ in Figure 1).
The second type of explanation for our more successful snowball chains relates to
the quality of the work of the field assistants, for instance their ability to gain the
confidence of respondents, or their perseverance when candidate respondents are
hard to trace. The fact that in the Amsterdam cocaine study more and longer chains
were generated than in the Rotterdam study may imply the influence of such fac-
tors. Within the Amsterdam study, interviewers with more experience in drug
research succeeded in building more and longer chains than their less experienced
colleagues.
August September OctoberNon-IV Ex-IV IV
PLAZA
VILLAGE
PUB
CANAL
HOME
November
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Figure 1: Snowball sampling in five Alkmaar drug scenes, by time of interview
Statistical representativeness
The key problem in the representativeness of snowball samples of heroin users is
that even the best models will always express relationships in terms of probabili-
ties rather than of certainties (Edwards, Arif and Hodgson, 1981). We can there-
fore never be completely sure that a statistically representative sample has been
achieved. As each study progressed, we asked ourselves repeatedly whether we
had overlooked potentially existing sub-populations and, if so, how we could still
gain access to them. 
Here we were heedful of Glaser and Strauss (1967) and later elaboration by
Biernacki and Waldorf (1981), Biernacki (1986), and Watters and Biernacki (1989).
Researchers and field assistants met at least once a week to discuss how the research
was progressing. We also used these meetings to check whether anyone had been
interviewed twice. If that was the case, no snowballs were allowed to originate from
the second interview. Also, no new snowball was to be started within networks or
scenes where we knew one already existed.
One way of testing whether a sample of heroin users is statistically representative is
to compare it to another sample. Towards the beginning of this paper, I cited an
Amsterdam study in which institutionalised heroin users were compared with a
street sample of users and I aired my reservations that both types of sample may have
tapped the same part of the iceberg and failed to consider hidden users. In our
Alkmaar study we tested this supposition. 
As previously noted, our goal there was to reach the entire target population. We
started with the most visible and accessible members and only gradually came into
contact with the hidden users. This progression can clearly be seen in Figure 1. The
most visible users in the Plaza Scene could be interviewed at a relatively early stage
(light shading), while the more peripheral users tended to be interviewed later (dark
shading).
Figure 2 reveals further that members of the Plaza Scene in particular can be char-
acterised as institutionalised users. In this illustration, the dark-shaded respondents
had taken part in the local methadone dispensing programme, Brijder, within the
past six months. The black symbols represent users who had been involved both
in the methadone programme and in other local drug care activities. The light-
shaded ones took part in the latter activities but not in the methadone programme,
while the white symbols refer to respondents who made no use at all of local drug
care programmes during the period in question. The distinctive character of the
Pub Scene is revealed here once again: no respondents from this scene had been
in touch with local drug care during the six-month period. The same applied to 
the Village Scene members, who were from smaller communities in the vicinity of
Alkmaar. 
Comparison of Figures 1 and 2 shows that the most publicly visible users are large-
ly identical to the institutionalised users, whereas the hidden users are institution-
alised to a very limited extent.
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Figure 2: Contacts with Alkmaar drug care services in past 6 months, by scenes
Social structures of snowballs
As we have known since the classic studies of Becker and Zinberg, patterns of drug 
use depend heavily on the settings in which the drug use occurs (Becker, 1963;
Zinberg, 1984). Social actors such as friends play a crucial role in these settings. The
evolution of drug careers is also strongly dependent on users’ social environment.
In employing snowball samples we cannot rule out that certain sub-groups will be
over- or under-represented. To assess better how representative our field studies were
of the target populations, I have analysed the structure of the snowball chains on the
basis of the variables ‘age’, ‘gender’ and ‘nationality/ethnicity’ and compared the
respondents in long chains (5 or more respondents) with other respondents who
were ‘loners’ or members of short chains (2 to 4 respondents). These findings are
illustrated in Table 4, which depicts typical examples of chains of referral.
Table 4: Chain referral structure of longer snowballs
Age-1                    46  34  23  44  25  28 
Age-2                    21  21  21  20  28  23  26  24  21  23  31
Age-3                    34  35  36  36  42
Gender-1               M  M  F  M  M  F  M  M  M  M 
Gender-2               M  M  M  M  M  M  M  M  M
Gender-3               F  F  F  F  F
Ethnicity-1             NL  NL  NL  NL  NL  NL  NL  NL  NL
Ethnicity-2             NL  NL  Sur  NL  Oth  NL
Ethnicity-3             NL  Mor  Mor  Sur  NL  NL  NL  Ind  NL  NL  Ind
Nationality-1         Ger  Ger  Ger  Ger  Ger  Ger  Ger
Nationality-2         Ger  US  Ger  Ger  Ö  Ö  Ger
Nationality-3         It  It  It  It  It  It  It  It  It
Nationality-4         It  It  SA  Por  It  It
The analysis of the snowballs suggests that the social networks of most heroin users
are mixed in age and gender. Age differences have no evident determining influence
on their social structure. Loners and short-chain respondents do not appear to be
over- or under-represented in the field samples. This would seem to favour the sta-
tistical representativeness of the samples.
As for gender, networks of street prostitutes could be a source of disproportionate rep-
resentation of women or certain types of women in samples, thereby threatening statis-
tical representativeness. This problem arises especially in urban areas where street pros-
titution is practised. In those urban areas with bigger populations of heroin users, such
as Amsterdam, there is a stronger tendency towards homogeneous social networks
based on ethnicity and language. This is also an obvious threat to representativeness.
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Networks and friends
Analysis of social networks directly on the basis of our snowball chains would have
the limitation that we imposed certain restrictions on referrals. Therefore, we also
asked respondents to tell us about some characteristics of the nationality or ethnic
background of the five persons they were in closest contact with (Table 5).
Table 5: Networks of friends: ethnic background and nationality in five field studies     
Study                      No. of               Ethnic          Resident                  Other                       Hard             Non
friends               Dutch           ethnic                nationalities                 drug            user
minorities        Own            Other            user
Heroin 885 24% 5% 45% 26% 78% 22%
Tourists**
Conson 1002 59% 30% 3% 7% 63% 37%
- Dutch 588 79% 13% - 8% 60% 40%
- Surinamese 279 22% 76% - 2% 67% 33%
- Moroccan 45 29% 71% - - 71% 29%
- Other 90 60% 21% 19% 70% 30%
Homeless 543 76% 6% 14% 4% n.a. n.a.
Youth
- Dutch 413 88% 6% 7%
- Surinamese 34 68% 32% - -
- Moroccan 75 33% 62% 5%
- Other 21 29% 10% 62%
Het Gooi 530 79% 17% 4% 60% 40%
Alkmaar 642 85% 15% - - 51% 49%
* chiefly Surinamese and Moroccan ** recorded only in 1986.
We may conclude that the social networks of frequent heroin users are composed in
large part of fellow heroin users. Degree of urbanisation has no significant influence
on the proportion of users in networks: more or less the same network composition
obtains among local Amsterdam users (Conson) as among users in Het Gooi and
Alkmaar. We can interpret this, at least in some measure, as the same strong orien-
tation to one’s fellows that we encounter among other citizens (work mates, profes-
sional colleagues). However, a further explanation is that frequent users of heroin
find themselves isolated from the rest of society. This can account for why the hero-
in tourists are the most strongly isolated. Their stay in Amsterdam is comparatively
short and they are unlikely to have contacts there from their pre-heroin days.
183
Chapter 17
184
Nomination Methods
Like the snowballs analysed above, the friendship networks of most drug users and
homeless youth, especially in Amsterdam, are based heavily on their own national
or ethnic background. The populations studied constitute relatively closed networks.
Within them we find sub-populations which are ethnically rather homogeneous and
which overlap one another only slightly.
Conclusions
When applying a nomination technique, snowball sampling will frequently be used to
collect data. However, snowball sampling itself requires more than just interviewing a
sample of persons which is easy to catch. Since populations of heroin users (and users
of other drugs as well) are often hidden, a well-structured sampling procedure is a pre-
requisite. It is advised to stratify the nomination data (e.g. by ethnicity or gender). 
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Introduction
by Alan Quirk
he previous sections of this monograph have focused on elaborating the
strengths and weaknesses of particular estimation techniques. The chapters
comprising this section examine the use of two or more estimation methods
combined, in order to compare the results obtained by different methods and to
improve the estimation of drug problems within a city or country. Drug use is not a
static phenomenon. The history of drug use across Europe shows major changes,
with some periods experiencing a rapid rise of problem drug use and others a lev-
elling of new cases.
Ludwig Kraus examines the applicability of ‘classical’ statistical estimation
approaches, which generally provide a cross-sectional estimate of prevalence at a
point in time, and ‘system dynamics’ models which attempt to show changes in the
extent of drug use over time. He uses examples drawn from studies of heroin and
‘hard’ drug users in Germany. Kraus also describes how system dynamics models, by
integrating various sources of data, simulate the time-related processes of drug use.
It is argued that this approach is particularly useful in that it provides estimates of
both the incidence and prevalence of drug use in different periods.
Dirk Korf provides a useful summary of the range of methods which can be used to
estimate the number of heroin users in a country. These are household and school
surveys, extrapolations from drug seizures, drug deaths and other indirect parame-
ters, ethnographic mapping, case counting, capture-recapture (CRC) and nomina-
tion techniques.
The relative utility of each method is discussed using data from various European
countries. In particular, he highlights the limitations of trying to draw conclusions
from a correlation of trends in an indicator such as drug seizures and a measure of
harm from drug use – drug-related deaths. In some countries there is a positive cor-
relation between these indices, in others, the correlation is absent. Korf goes on to
compare CRC with nomination techniques. While it is acknowledged that no exact
estimate can be reached, CRC nonetheless seems to offer a reasonable estimate of
the numbers of resident problem drug users.
Findings from a more localised study in Germany are presented by Wolf Kirschner.
Kirschner presents a Berlin study which compared the results obtained by CRC with
those obtained from a system of anonymous monitoring undertaken by a sample of
physicians (ANOMO). The statistical requirements and assumptions are discussed,
and the findings derived from them are presented. Methodological problems asso-
ciated with ANOMO are examined, particularly those of documentation bias and
double- or multiple-reporting of cases.
T
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Kirschner concludes that such a combined approach can improve our understanding
of local populations of injecting drug users.
The success of estimation projects will depend not just on the technical compet-
ence of the investigators and the appropriateness of the estimation techniques, but
also on the quality of the data available and the co-operation of agencies and
subjects from whom data are collected.
Estimations made under conditions of limited resources for epidemiological resear-
ch, a comparative lack of prior knowledge about the phenomenon, or an inhospita-
ble socio-economic environment, are described in the final three chapters.  
Zsuzsanna Elekes gives an honest account of the practical difficulties she encounte-
red in estimating the prevalence of illicit drug use in Budapest. The quality of data
available from the police, health institutions and foster homes was found to be poor,
which casts doubt on the validity of estimates derived from these sources.
Elekes describes the considerable mistrust which the researchers encountered when
dealing with institutional staff. Similar suspicions characterised key informants in the
snowball study, making it difficult for it to be carried out. Elekes concludes that, in
such a context, snowballing may be an ineffective way of mapping non-registered
opiate users. It is argued that the greatest problem facing epidemiological research
on drug use in Hungary is the widespread tendency for negative attitudes towards
illicit drug users.
Janusz Sierosl´awski and Antoni Zielin’ski describe the methods they used to 
estimate the prevalence of opiate injection and addiction in Poland. The authors
describe how, in a changing political environment, their scientific estimations have
had to compete with those from advocates and an alarmist media.
The authors discuss the three types of estimation undertaken: a snowball study in
two regions; estimates derived from in-patient drug treatment data; and CRC. Their
estimates strongly suggest that those presented in the media overestimated the extent
of opiate addiction. The authors argue that the increasing sophistication of epide-
miological techniques is making it hard for politicians to ignore their findings.
The importance of producing good quality epidemiological information is also stres-
sed by Dusˇan Nolimal. He describes the methods of secondary data analysis, key
informant estimation and snowballing which were used to estimate the prevalence
of heroin use in Slovenia.
Although the primary goal of the three studies was to identify high risk groups for the
purposes of targeting appropriate interventions, the data nonetheless allow for pre-
valence estimations to be made. The problems encountered in the studies are 
discussed. It is argued that, in light of an economic and political environment which
may be conducive to further increases in the prevalence of heroin injection, it is
essential that the intervention response be based on sound epidemiological data
rather than anecdotal evidence.
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In the final chapter, Richard Hartnoll concentrates on how to assess the validity of
prevalence estimates, especially when the prevalence drug use patterns are chang-
ing, and how to interpret what the resulting prevalence rates mean within the con-
text where they may be used. These questions are addressed through examples from
the author’s research on drug indicators and prevalence estimation methods in
London in the 1980s, supplemented by more recent experience.
The first question is approached by comparing different estimation methods over
successive years to reach a ‘best estimate’ of ‘real’ prevalence levels and trends in
opiate dependence based on an analysis of the probable direction of error of each
estimate.
The second question is approached by comparing the prevalence estimates for the
years concerned with a ‘package’ of other indirect opiate indicators (treatment,
police arrests, seizures of heroin, mortality, morbidity) over a longer period of time
spanning the years for which prevalence estimates were obtained. This analysis indi-
cates that although the combined package of indirect indicators do not add infor-
mation about absolute prevalence, they are very useful for validating the trends
observed over time. This analysis also provides valuable insight into how indicators
behave with respect to the time-lag between changes in ‘real’ prevalence and the
point when these changes are reflected in the different indicators.
The inclusion of the results of simultaneous sociological research on local drug use
patterns was essential for interpreting the figures and trends reflected in the estimates
and indicators.
The chapter concludes that prevalence estimation is not just a scientific procedure
of applying formulae, but one that also involves a creative process of fitting togeth-
er different types and levels of information and testing if they are consistent so as to
achieve a coherent picture of the whole that best accounts for the diversity of the
available data.
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and System Dynamics Models
by Ludwig Kraus
Only a minority of drug users will establish contact with a drug surveillance system.
The majority will remain undetected, never using available counselling services,
treatment centres or making contact with law enforcement agencies. These users
form a ‘hidden’ population.
In this chapter, I will discuss two methods used to estimate the size and composition
of the hidden population of heroin injectors and hard drug users (all drugs except
cannabis) in Germany: ‘classical’ statistical estimation methods, which generally
provide a ‘snapshot’ of prevalence at a point in time, and system dynamics models,
which attempt to show changes in the extent of drug use over time. 
A taxonomy of methods
We can make three general distinctions between statistical estimation methods and
system dynamics models which are helpful in establishing which is the most appro-
priate method to use.
Firstly, the dynamic nature of the population has to be considered. System dynamics
models produce estimates by simulating the interaction of multiple data indicators
over a specified period of time in an ‘open’ study population. Here, the possible
departure and entry of individuals into a drug-using population is modelled within
the estimation process. Statistical estimation methods, by contrast, commonly assess
the size of a population by extrapolating a single data indicator at a single point in
time. These do not usually allow for significant changes within the study population,
such as death or rehabilitation, and are best used in estimating ‘closed’ populations.
Secondly, the type of data used in each estimation method will often be different.
The aim of system dynamics models is to construct an interrelated network of indi-
cators which will estimate or describe changes in the study population. Often, if
such indicators are not available as either direct or indirect data, ‘unobserved’ varia-
bles will be used. These are assumed values, usually based on educated insights,
which are used to carry out the estimation. Statistical estimation methods, however,
are normally based upon direct and indirect data.
Thirdly, an awareness of the integration and ease with which data from different report-
ing systems can be compared should be maintained. If such data contain explicit iden-
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tifier information and if it is possible to gain access to this information across a number
of reporting systems, then CRC methods can be used. However, if political and ethical
reasons dictate that such a direct exchange of identifier information is not possible,
system dynamics models can accommodate for this by again using unobserved variables.
In short, the main difference between the two approaches is that statistical estima-
tion methods extrapolate their assessments from the observable properties of indivi-
dual drug users at a single point in time, whereas system dynamics models build up
an interrelated network of data indicators whose interaction over a period of time is
simulated through a series of calculations (Wickens, 1993).
National prevalence estimations
In Germany, a variety of national data sources is available for estimating the num-
ber of drug users. These sources are outlined below in Table 1. 
Table 1:  National prevalence estimations in Germany
Method               Data                    Assumption          Target                     Estimation
Population
Population           Sample Dark-field Injecting 70,000 -
survey and heroin users 105,000
Mortality
Multiplier Drug-related Mortality
Method deaths
Multiplier Drug-related Dark-field Hard drug 91,000 -
benchmark deaths users 143,000 
method Hard drug users
Register of Duration of
drug use drug use
System Register of Age at onset Heroin users 100,000
dynamics drug use of drug use Heroin users
model by age
Termination of
drug use
Registration in
surveillance
system
Statistical estimation methods
Population surveys and the Mortality Multiplier Method
Although we could have estimated the number of heroin injectors using drug-rela-
ted deaths statistics and a multiplier alone, we decided to combine such estimates
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with data from the German population survey of 1990 in an attempt to calculate to
what degree the survey underestimated the total number of injecting heroin users.
The 1990 German population survey used self-completion postal questionnaires in
a sample of 19,208 individuals representatively drawn from the German population.
These individuals, aged between 12 and 39, were asked about their drug use.
Although the survey achieved a satisfactory response rate (62 per cent), only eight
respondents reported having injected heroin in the last twelve months. This repre-
sented only 0.042 per cent of the total sample and, consequently, could not be used
to generate accurate estimations of the total heroin-using population (IFT et al,
1994).
To calculate the factor by which this population survey underestimated the total
number of injecting heroin users, that is the ‘hidden’ population, a series of assump-
tions were made about those individuals who had not responded to the survey and
the probability of their using heroin (Table 2). On the basis of a previous study in
America (Caspar, 1992), it was assumed that a small proportion of the non-respon-
dents would display the same prevalence of drug use as those who responded to the
survey. However, it was also assumed that the substantial proportion of non-respon-
dents would have a higher prevalence of drug use.
These assumptions were then related to estimates derived from the drug-related
death multiplier and a series of possible values were calculated (IFT et al, 1994). 
Table 2: Estimation based on a population survey
M: Population of size N
Z: Subset of injecting drug users
S: Representative sample
S1: Respondents (proportion of responders Q1 = 0.62)
S2: Neutral non-respondents with the same prevalence 
as the responders (proportion Q2 is assumed to be 0.2)
S3: Critical non-respondents with a higher prevalence
(proportion Q3 is assumed to be 0.18)
S3: Estimated probability of a positive case of S1 or S2 (0.00042)
P1,2: = X * P1,2:  Estimated probability of a positive case of S3
Estimated size of Z:  N * [P 1,2 * (Q1 + Q2)  + P3 * Q3]
Given that the number of drug-related deaths in 1991 equalled 2,100 and assuming
a mortality rate between 2 to 3 per cent each year, it was estimated that there were
between 70,000 to 105,000 German drug users. At X = 1 the number of injecting
users yielded an estimate of 10,000 people. 
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These estimates indicate that the German population survey underestimated the
number of injecting heroin users by a factor of between seven and ten.
Estimates based on police drug register and drug-related deaths statistics:
multiplier benchmark method
In Germany, law enforcement data collected on the number of drug offenders
include information on the substances consumed by an individual (excluding can-
nabis). However, drug offenders are only included in the data the first time they
are charged and no distinction is made between drug-dependent and episodic
users. Additionally, the regular comparison of national drug-related deaths stati-
stics and the registered drug user data allows the German police to keep a record
of previously unknown individuals. In the last ten years, this disparity has ranged
from 30 per cent to 55 per cent.
To estimate the number of first registered hard drug users, the number of cases
known to the police between 1982 and 1991 (n = 65,000) were counted. This ten-
year period was chosen to reflect the findings of studies based on treated drug users
which suggest this to be the mean duration of an individual’s drug use (Robins, 
1979; Bschor, 1987; Marks, 1990). A multiplier was then estimated using a ratio of
the total number of drug-related deaths to the number of these deceased individuals
previously registered by the police as hard drug users. Again, this comparison was
made over a ten-year period.
The resulting figures ranged from 70 per cent to 45 per cent, which related to a
factor of between 1.4 to 2.2. From this we were able to estimate that the number
of hard drug users in Germany was between 91,000 and 143,000 individuals
(Table 3).
Table 3: Estimation based on police drug register and drug-related death statistics
K: Number of current users of hard drugs
E: Number of first registered drug users in past 10 years
F: Dt/Dn, ratio of total number of drug users in the population
and the number known to the police
Dt: Number of all drug-related deaths in a given year
Dn: Number of drug-related deaths registered by the police in a given year
The total number of hard drug users registered by the police 
for the years 1982-1991 was E = 65,000.
K = E*F
With E = 65,000 and F = 1.4, K = 91,000
F = 2.2, K = 143,000
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System dynamics model estimations
To derive an estimate of the annual incidence of heroin use, a system dynamics
model originally used to investigate the changing age distribution of initial drug use
over the last two decades was employed (Herbst and Kraus, 1995). In order to simu-
late the annual number of first registered heroin users who are classified by age
according to their incidence of first registration, the number of users who started
using heroin in each year had to be calculated. If the annual number of new heroin
users is known, the prevalence can be calculated.
Assumptions
Although data on the number of registered heroin users in Germany did exist, a
system dynamics model required any unobserved variables to be given assumed
values. In this case, these unobserved variables related to the onset and termination
of heroin use, the registration of heroin use and the age distribution of the onset of
heroin use. The resulting assumptions are summarised below:
• the age at onset of heroin use is log-normal distributed with a peak at age 18-20;
• heroin consumption started in the late 1960s and initially affected younger age
groups;
• the time period in which heroin is taken is Weibull distributed, beginning with
the onset of heroin use, includes any registration of the user into police drug
offence records and finishes with the termination of heroin use;
• process parameters remain constant over time.
Three other assumptions were also integrated into the system dynamics model.
These, however, were taken from previous academic research which arguably
improves the validity of the model and its resulting estimates:
• the average duration of drug dependency reported in the literature was estima-
ted at ten years (Robins, 1979; Bschor, 1987; Marks, 1990);
• only 45 per cent to 70 per cent of drug-related deaths are recorded in the police
register of drug offenders (Bundeskriminalamt, 1994);
• the age distribution of the onset of drug use has a risk function which is positi-
vely skewed with a long tail and a maximum at age 18 to 20 (Herbst et al, 1994;
Chen and Kandel, 1995).
Data
The annual number of registered heroin users was split into five age groups. To allow
for any changes in the age distribution of the population, the incidence of registra-
tion was divided by the population size in each calendar year. Those users younger
than 14 years of age and older than 39 years of age were excluded from the simu-
lation because of missing lower and upper limits. However, heroin incidence rates
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in both age groups were small and no significant bias was encountered.
Simulation process
The final estimation was accomplished in three steps:
Firstly, the initial values for the parameters of the termination and registration func-
tions were chosen. Given the total number of registered heroin users in each calen-
dar year, the total incidence of heroin users at time t was calculated.
Secondly, parameters relating to the age distribution of the onset of heroin use were
chosen. From this, the number of heroin users in each age group over successive
years was determined. Additionally, the registration process of those starting heroin
use was simulated and those heroin users who were assumed to have terminated
their drug consumption were subtracted from the population.
Thirdly, the estimated incidence values for each age group in each year were com-
pared with the observed data. In an iterative procedure, the model parameters were
systematically varied with the aim of minimising any differences between predicted
and observed data.
Results
Figure 1 shows the best results for the simulation. There is a peak incidence in 1976
followed by a peak prevalence between 1978 and 1980. There was a further peak
incidence between 1989 and 1991, with a corresponding peak prevalence in 1992. 
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Figure 1: Number of registered heroin users, estimated incidence of heroin users 
and estimate prevalence of heroin users
The mean duration of heroin consumption was found to be twelve years and the
mean duration period until the user was registered was seven years. This corre-
sponds to the respective mean duration of drug use stated in the literature. The decli-
ne in the number of estimated drug users between 1980 and 1986 is corroborated
both by treatment statistics (Simon et al, 1994) and drug-related deaths statistics
(Bundeskriminalamt, 1994).
Conclusions
This chapter has examined the applicability of statistical estimation and system
dynamics models in estimating the total population of heroin and hard drug users in
Germany. Although no single method is perfect, and although a multiple-method
and multiple-data approach are recommended at all times, the use of system dyna-
mics models appears to be particularly promising in a country such as Germany.
Dynamics models simulate the time-related processes connected to drug use by
integrating different sources of data and other available information. Consequently,
a system dynamics model can only be as good as the data it utilises. The variety of
direct and indirect data available on a national level in Germany from law enforce-
ment, health, education and social service agencies makes such an approach parti-
cularly suitable for national prevalence estimates.
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Comparison of Different
Estimation Methods in the Netherlands
by Dirk J. Korf
Statistics on trends in heroin use are of general interest for the planning of socio-
medical and legal control facilities and for evaluating the effects of formal control
strategies. Is it possible to estimate how the number of heroin users has evolved in 
a country? To answer this question, I will discuss several methods that can be used
to estimate the numbers of heroin users:
• household and school surveys;
• extrapolations from drug seizures;
• extrapolations from drug deaths;
• extrapolations from other indirect parameters;
• ethnographic mapping, case counting and nomination;
• capture/recapture.
Household and school surveys
Household and school surveys and censuses are the most common ways of mea-
suring the prevalence of licit and illicit drug use. However, especially when it
comes to heroin use, population surveys are mainly studies of non-users (Hartnoll,
1993). Self-reported lifetime prevalence of heroin use in school and household sur-
veys is commonly around or below one per cent, and the rate of recent use is far
lower (Table 1). Such a low rate reflects the low prevalence heroin use in the gene-
ral public. But because heroin users are so rare in general populations, probability
sampling methods can seldom yield accurate approximations of the prevalence of
heroin use. These are extremely costly, with huge samples needed, and hence are
rarely feasible. The validity of estimates of heroin use based on population surveys
is further undermined by high non-response and denial rates within the target popu-
lation.
Sometimes prevalence rates within certain age groups or geographical areas may still
be high enough to allow estimates to be made. In the 1994 Amsterdam household
survey, the highest lifetime prevalence rates for heroin (3.1 per cent) were found
among 30-39 year-olds (Sandwijk et al, 1995). By the end of the 1970s, young males
in five health districts in Harlem (New York) were reporting opiate use seven to ten
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times higher than in the city as a whole (Clayton and Voss, 1991). Results of four field
studies that we have conducted in Amsterdam since 1988 also indicate that site sur-
veys among ‘high-risk’ populations may yield higher prevalence rates (Table 2).
Extrapolations from drug seizures
In the case of licit drugs, extrapolations can be made from direct parameters, such
as production figures or tax data. Average consumption – e.g. litres of pure alcohol
per capita per annum – can be computed, and the number of frequent or problem
users can be estimated by means of mathematical formulae. These kinds of macro-
data are not available for illicit drugs.
As an alternative, quantities of confiscated drugs or other criminal justice data on
drug offences could be used as indirect parameters. Since data on amounts of illicit
drugs seized by customs and police are available in many countries, they seem to 
be the most appropriate source for cross-national comparisons.
If we know what percentage of an illicit drug destined for consumption is being con-
fiscated, we can extrapolate the total consumption within a certain geographic area,
for example a country (for formulae, see Korf, 1995). Assuming we also know the
average consumption per user in the same area, we can calculate the total number
of users there by dividing the total consumption by the average consumption per
user. Where the average consumption is unknown, but may be assumed to be sta-
ble, we can still extrapolate trends in the size of the drug-using population: an
increase or decrease would then correlate linearly with the extrapolated total con-
sumption. Furthermore, if the proportion being impounded also remains unknown,
but may nevertheless be presumed stable, fluctuations in drug seizures will corre-
late linearly with the number of users.
Heroin seizures
Assuming now that both the average consumption and the percentage confiscated
are indeed stable, what can we then conclude from heroin seizures as predictors
of trends in the size of heroin-using populations? Figure 1 shows annual heroin
seizures from 1981 until 1990 in five EC countries (the United Kingdom, West
Germany, Denmark, Belgium and the Netherlands). In these countries, the amount
of confiscated heroin soared from around 400 kg in 1981 to some 2,300 kg in
1990. Thus, if seizures are indeed valid indicators for trends in heroin taking, the
number of users in 1990 would have been nearly five times higher than in 1981.
A closer look at the heroin seizures reveals marked differences between countries.
During the period in question, the amount of heroin confiscated in the Netherlands
was substantially higher than that in other ‘small’ countries such as Denmark and
Belgium. One possibility is simply that more heroin was being transported to the
Netherlands than to these countries.
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With reference to the assumptions formulated above, the difference could also be
explained by three other factors or a combination thereof:
• in the Netherlands a larger share of the total amount of heroin brought into the
country was seized;
• the number of heroin users there is much higher;
• the average consumption per user there is much higher.
Between 1981 and 1985, Dutch heroin seizures fluctuated considerably, but from
1986 to 1990 the annual amount confiscated was rather stable (around 500 kg). In
Germany, by contrast, it increased sharply during the latter period. Assuming that in
Germany average consumption and proportion of the total amount of heroin being
confiscated has likewise been stable over the years, this would point to a rising num-
ber of heroin users in Germany alongside a stable number in the Netherlands.
Comparison of heroin and cocaine seizures
Another way of verifying the validity of extrapolations based on the amount of con-
fiscated heroin is to look at trends in seizures of other drugs, both cross-nationally
and longitudinally. If we posit a linear relationship between seizures and consump-
tion, the seizures would indicate a sharp increase in cocaine use (Figure 2). One
could conclude that cocaine use in the five countries more than doubled in just one
year, between 1989 and 1990. An overall rising trend is evident for the three illicit
Figure 1: Confiscated heroin (Kg) in five countries, 1981-90
Source: Korf and Verbraeck (1993).
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drugs illustrated. This is not, however, the case for all drugs, as we showed for
amphetamines in another publication (Korf and Verbraeck, 1993). For this drug, fluc-
tuations appeared within such a narrow time window that a constant linear correla-
tion between national seizures and national consumption would be highly dubious.
Figure 2: Confiscated cocaine (Kg) in five countries, 1981-90
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In 1990, the Netherlands accounted for over half of all the cocaine seized in the five
countries being considered. However, longitudinal trends in cocaine use in the
Netherlands show, at least for Amsterdam, a rather stable pattern since the late 
1980s (Sandwijk, Westerterp and Musterd, 1988; Sandwijk, Cohen and Musterd,
1991; Sandwijk et al, 1995). The vast differences in the scale of drug seizures
between the Netherlands and surrounding countries may also reflect the function of
the former as a port of transit for the European drugs market (Korf and Verbraeck,
1993). Moreover, the amount of drugs seized can depend on differences in drug 
control strategies. 
We may conclude that while trends in drug seizures may sometimes parallel trends
in other criminal justice indicators, this by no means guarantees the validity of drug
seizures as indicators of drug consumption. The correlation could be spurious, the
co-variation being caused by a third variable. Trends in both drug seizures and drug
use could even be causally related to criminal justice interventions. This leads us to
the conclusion that fluctuations in drug hauls correlate linearly with neither drug
consumption nor the number of users, all other factors being equal. Drug seizures
would therefore not appear to be a valid indicator of trends in drug use.
Source: Korf and Verbraeck (1993).
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Extrapolations from drug deaths
Other indirect parameters also suggest a growing number of heroin users in
Germany during the late 1980s and early 1990s. One of these parameters is the
number of registered drug fatalities. Extrapolation from overdose death statistics is a
well-known and, perhaps the most widely applied, procedure to estimate the num-
ber of heroin users. In the international literature, mortality rates amongst heroin
addicts are normally estimated at one to two per cent per year (Brinkman, 1985). A
constant, linear relationship has often been posited between registered deaths and
total number of users (Brinkman, 1985). Given this assumption, extrapolation makes
it possible not only to estimate the size of local, regional or national populations, but
also to make cross-national comparisons.
During the first half of the 1980s the number of registered drug deaths in Germany
was roughly 400 per year, but it has risen sharply since then to over 2,000 per year
in the early 1990s. As noted above, the amount of heroin confiscated annually in
Germany has also increased. Heroin seizures show a significant positive correlation
with the annual number of registered drug deaths in Germany (r =.985; p<.05)
(Figure 3). It would thus appear at first glance that heroin seizures do linearly reflect
trends in numbers of heroin users. This seems to be supported further by the fact that
the number of cases noticed and registered by German police as heroin users for the
first time climbed from around 2,000 per year in the early 1980s to some 8,000 at
the start of the 1990s (Bundeskriminalamt, 1993), which also correlates with drug
mortality (r =.937; p<.05). German statistics indeed seem to support the hypothesis
‘the more drug deaths, the more drug users’.
There are some considerable complications, however. First, in the Netherlands in 
the same period, there was a negative, though not significant, relationship between
heroin seizures and resident drug fatalities (r = -.481) (Figure 4). Second, there is no
direct correlation between incidence of heroin use in Germany and the annual
number of new registered cases. Registration is a very complicated and time-depen-
dent process which is influenced by the annual incidence rate of heroin users, mor-
tality, the termination rate of drug users and police activity. Also, there are a number
of major potential flaws in the assumption of a constant linear relationship between
the number of drug deaths and the number of heroin users. Mortality ratios may vary
(i) within a population (ii) over time and (iii) between geographical areas.
• mortality rates mainly involve intravenous users, as death rates are much lower
for smokers or sniffers (Brinkman, 1985; Hartnoll et al, 1985); numbers of drug
deaths can also be affected by changes in heroin purity (Ruttenber and Luke,
1984), or by the number of new users in a given period, as they are thought to
run a greater risk of lethal overdosing (Reuband, 1988);
• variations in definition and in the reliability of registration of drug deaths can
cause additional complications; for example, towards the end of the 1970s the
number of registered drug deaths in Germany increased following a change in
the official definition (Püschel et al, 1984; Heckman et al, 1992).
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Figure 3: Confiscated heroin and drug deaths in Germany, 1980-92
Figure 4: Confiscated heroin and drug deaths in the Netherlands, 1980-92
Source: de Zwart and Mensinck (1993).
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• an epidemiological study in Amsterdam has shown that clients of methadone ser-
vices have a far lower mortality rate than non-clients (Cobelans, Scharder and
Sluijs, 1990).
Each of these points could explain the difference between the Netherlands and
Germany. In the Netherlands, heroin is not usually taken intravenously, in Germany
it is. The Netherlands has relatively few new users; and furthermore, it applies a dif-
ferent definition of drug deaths and a different registration method than Germany.
Finally, methadone is dispensed to drug users on a far greater scale than in Germany.
Extrapolations from other indirect parameters
Other types of administrative data have been taken to correlate with the number of
users. In San Francisco, for example, researchers extrapolated the number of heroin
users from registered local crime on the assumption that a certain percentage of
users support their habit by burglary (Newmeyer and Johnson, 1976). Burglary rates
are thus seen as reflecting the prevalence of heroin use.
Besides crime statistics, general health statistics other than the aforementioned death
rates, such as viral hepatitis or HIV for drug users and cirrhosis of the liver for 
alcohol users, can be employed as indirect parameters. One problem with health
parameters, such as viral hepatitis and HIV, is that again they are linked predomi-
nantly or exclusively to injecting drug use, leaving out other ways of taking heroin
like ‘chasing the dragon’ (chinezen). The validity of extrapolation is strongly enhan-
ced if the indirect parameter adopted is one which appertains to drug users in a spe-
cific population of interest. 
A constant multiplier has also often been assumed in dealing with client registrations
at drug agencies. Criminologists, for instance, have extrapolated the number of
heroin users in Rotterdam from client registrations, presuming that the estimated
client/non-client ratio for Amsterdam would be representative for the rest of the
country (Bieleman et al, 1989). Field studies we have undertaken in several cities
and regions in the Netherlands, however, have uncovered significant variations in
service utilisation between different parts of the country (Korf, Mann and van
Aalderen, 1989; Korf and Hoogenhout, 1990; Korf et al, 1990). Other Dutch resear-
chers have tried to solve this ratio problem by making corrections based on estima-
tes made by welfare professionals of the proportion of opiate addicts being reached
by their service in their area, taking into account any estimated overlap with servi-
ces in other regions (Driessen, 1990, 1992). Obviously this procedure stands or falls
with the validity of the ratios reported by the individual welfare workers.
A final method for estimating heroin users from administrative data is capture/recap-
ture (CRC), a technique originally stemming from biology. According to Hartnoll et
al, CRC should preferably be used in combination with other estimating techniques;
together they should result in the ‘best appropriate estimate’ of the number of heroin
users in a given area (Hartnoll et al, 1985).
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Ethnographic mapping, case counting and nomination
The simplest method computationally of estimating the number of heroin users in a
community is to count them all. Ethnographic field studies in towns and rural areas
in the Netherlands have been shown to achieve a rather complete mapping of users’
networks and to yield reliable prevalence data (Korf, Mann and van Aalderen, 1989;
Korf, Hes and van Aalderen, 1992).
Such a method is not applicable in the case of big cities, however, where the abso-
lute number of heroin users is many times that of less urbanised areas, and where
the social structure of the population is far more complex.
Intermediate conclusions
From this review we can conclude that while survey data may reflect trends in
heroin use prevalence, they do not normally permit accurate estimates of the num-
ber of current users. Ethnographic mapping of heroin users is an alternative in
small communities, but it is not a reliable method for large cities. Extrapolation
methods seem most appropriate there. A general problem in extrapolation from
one parameter is that the ratio of registered to non-registered cases often has not
been empirically verified, and/or cannot be assumed a priori to be constant.
Alternatively, a ratio can be generated from ‘nomination’ of institutional contacts
by users interviewed in field studies (see below).
When two or more client registrations of users are available, the size of a heroin-
using population can be estimated with the CRC technique, which does not rely
on data from field samples. Should several field samples from the same population
be available, the CRC technique could be applied to them as well. But field stu-
dies among heroin users (and other hidden populations) are time consuming and
hence costly, especially if data must be collected more than once.
A key advantage of CRC is that it does not depend on an assumption of constant
linearity. The extrapolation factor is calculated from the population under study
and not from other sources. CRC thus promises more validity than extrapolations
from any single parameter. Therefore, I shall now explore this method in more
detail. Given that CRC requires more than one official registration, I consider the
nomination technique to be a good alternative. I shall focus on this later in the
chapter.
Capture-recapture: three criteria for application
Application of the CRC method ideally assumes a closed population during the time
frame studied. That is, no new subjects should enter the population within the 
period under analysis (no new incidence) and also no subject should die, stop taking
opiates or otherwise cease to be part of the population. 
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Samples chosen for application of CRC must satisfy three criteria:
• subjects should be uniquely marked;
• the samples must be drawn randomly and be mutually independent i.e. inclusion
in a first sample should not affect inclusion in the second;
• time frame and target population should be defined consistently across samples.
Regarding the independence of samples, it should be noted that registrations of
heroin users are seldom perfectly independent in practice. To some extent, the
subjects found in one registration will, by definition, be excluded from the second.
Such negative dependence reduces natural overlap between registrations and cau-
ses overestimation. In the most extreme case, all subjects in one registration would
belong to one population and all persons in the second would be from a separate
population. Then mutual exclusion is complete, overlap is nil and CRC will yield an
infinite population. Examples of such a situation are services for female prostitutes
on one side and male prison inmates on the other; or inpatient drug-free treatment
and outpatient after care. Conversely, presence in one registration can also increase
the chance of being included in a second, for instance, due to referral by professio-
nals. Such positive dependence will enlarge overlap between registrations and cause
underestimation. The effects of dependence between registrations are summarised in
Table 3.
Table 3: Effects of dependence between registrations in CRC estimates
Sampling bias Overlap Effect on estimate
(denominator)  of population size
Positive                       Mutual inclusion  Enlarged  Under-estimation
dependence
Negative  Mutual exclusion  Reduced or zero          Over-estimation
dependence
Independence  None  Unbiased  Unbiased
With regard to the third criterion for application of CRC – consistency in time frame
and target population – it is implausible that registered methadone clients or arrestees
who receive methadone in police stations would represent a random sample from the
total population of heroin users. Frequent users will be over-represented, as metha-
done is dispensed only to daily opiate users (‘heroin addicts’) who suffer considerable
withdrawal symptoms after several hours of abstinence. In most countries, lower-rate
users like ‘chippers’ (Zinberg, 1984) will fall outside methadone programmes.
Application of CRC will be invalid if samples are heterogeneous with regard to traits
which affect chances of both capture and recapture. Full homogeneity of populations
is usually not a viable assumption. If the chance of being recaptured differs for sub-
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Application of CRC also presumes that the population to be estimated is closed during
the time frame in question. This, of course, is rarely the case. Since year estimates
include anyone coming and going during an entire year-long period, they are neces-
sarily larger than estimates per quarter. An obvious example of subjects who do not
belong to the heroin-using population for extended periods are ‘heroin tourists’.
Annual estimates put persons born outside the Netherlands and not belonging to resi-
dent ethnic minorities at nearly half the total population of heroin users in Amsterdam;
from 1989 to 1992 the figure was 44 per cent (van Brussel et al, 1994). Such a high
percentage is, however, quite inconsistent with systematic field observations and also
with institutional data (Korf and Biemond, 1992). 
populations, this heterogeneity can be corrected by sample stratification. Epidemio-
logical field studies in the Netherlands have shown that heroin-using populations are
socially structured by various characteristics, such as injecting versus non-injecting
drug use and differences in economic behaviour (Grapendaal, Leuw and Nelen,
1991; Grund, Adriaans and Kaplan, 1991; Korf, Hes and van Aalderen, 1992).
Ethnicity and nationality appear to be the most important structuring traits for heroin-
using sub-populations in Amsterdam. The three major sub-populations are: ethnic
Dutch and ethnic minorities (the resident sub-populations) and foreigners (officially
non-resident and mostly European). Figure 5 shows the effect of accounting for this
stratification in applying CRC. Discrepancies between stratified and unstratified total
estimates turn out to be relatively small, but the stratified estimates do reveal that the
overall fluctuations are due primarily to the foreign sub-population.
Figure 5: CRC estimates of opiate addicts in Amsterdam (1984-93), stratified for ethnicity
210
Combining and Comparing Different Estimation Methods
It may thus be concluded that CRC year figures overestimate the number of users on
an average day, because the population is not entirely closed. For the more fluid
foreign sub-population the overestimation will be greater than for resident users. 
Nomination technique
Sampling bias must also be reckoned with in applying the nomination technique.
Table 4 summarises schematically what effects sampling bias can have on estima-
tions derived using the nomination technique.
Table 4: Effects of sampling bias in nomination estimates
Sampling bias Denominator Effect on estimate
of population size
Over-representation        Over-inclusion Enlarged  Under-estimation
Under-representation      Over-exclusion Reduced  Over-estimation
Discussion: capture/recapture versus the nomination technique
Extrapolation from nomination samples came out lower than CRC estimates for both
resident sub-populations in Amsterdam. Since no criterion variables are available, it
cannot be established beyond doubt which method yields the most valid estimate.
If we take nomination estimates to be the more accurate, then CRC generated over-
estimation. In this case, mutual exclusion from standard methadone provision after
arrest was not entirely counterbalanced by increased participation in the metha-
done programme due to encouragement while in custody (mutual inclusion). If, on
the other hand, we take CRC estimates as being more accurate, nomination has pro-
duced under-estimation. In that case, registered users would be over-represented in
the field sample (over-inclusion). Another possible explanation is that respondents
over-reported their institutional contacts, for instance due to telescoping. In the for-
eign sub-population, comparative analysis of CRC and nomination estimates generated
contradictory findings. In one year, extrapolations from self-reported methadone treat-
ment (nomination) were lower than CRC estimates, but a year later they were higher
(Korf, 1987). This could be due to the fact that a larger share of the 1986 respondents
had been in Amsterdam for a short time, implying a smaller number than had previou-
sly participated in a programme. The findings for foreign heroin users underscore once
again the specific problems of estimating the size of highly floating populations.
From the preceding overview of methods, we may conclude that extrapolation with
CRC from subject registrations is the most feasible method for estimating the size of
heroin-using populations in large cities. The reliability of CRC strongly depends on
accuracy of registration. Since inaccuracy usually arises from incorrect registration
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of the same subject under different names, the method will generally yield estima-
tes which are too high. Such errors can be substantially reduced by improving regi-
strations (as was shown for Amsterdam) but full elimination of bias is too much to
hope for. The possibility of the same person giving aliases at low threshold pro-
grammes, or even at police stations, cannot be fully ruled out. In short, there will
always be some underestimation. In the strictest sense, CRC can be applied only to
data from independent sources. In the drugs field, full independence of samples
(registrations) is not a realistic prospect. Some degree of dependence is unavoidable.
Depending on which direction it takes, it will produce overestimation due to mutual
exclusion from registrations or underestimation due to mutual inclusion. Certain
combinations of registrations are, by definition, unsuitable for CRC. 
As has been shown, heroin-using populations are not homogeneous, and overlap
between registered samples may be of a different nature for different sub-groups
within a local population. Stratification can be helpful in identifying and explaining
such variations. From various sets of data, it has been concluded that ethnicity cor-
relates with rates of capture and recapture in Amsterdam. Ethnicity will most proba-
bly figure heavily in the use of this method in other cities in Europe. However, in
other European cities, populations may be more ethnically homogeneous and/or
they may include far fewer ‘heroin tourists’ than in Amsterdam. Therefore, stratifica-
tion of CRC estimates by ethnicity may not always be necessary. Gender or age
could be more relevant in other cities or countries, but other variables should be
explored too in order to find the ‘best fit’ stratifications.
Application of CRC also assumes a closed population. This condition will generally
be violated to some degree due to mobility within the population. If registrations are
independent, CRC will then produce overestimation. In Amsterdam, the biggest pro-
blems created by this third criterion for CRC were within the sub-population of 
foreign users, a group of a highly floating nature. Structural fluctuations within a resi-
dent population due to voluntary or compulsory drug-free periods should be taken
into account as well. Even when CRC findings are not biased by dependence of sam-
ples and/or marking irregularities, the number of current heroin users will commonly
be lower than year estimates imply.
Comparison of CRC estimates with those calculated from nomination data from our
field study suggest that CRC estimates are generally too high. Though rigorous atten-
tion was paid to statistical representativeness in the field sample, the possibility that
methadone clients were nonetheless over-represented cannot be ruled out. If that was
the case, underestimation will have occurred. The reasons for this are: an excess of
less sociable users at the zero stage of the snowball chains and bias in chain referrals
– clients may have more mutual contacts than non-clients. Another potential source
of underestimation under the nomination technique is that respondents may recall
certain treatments or arrests as being more recent than they really were (telescoping).
But even if nomination estimates are judged to reflect better the true number of
cases, the stability in year estimates produced by CRC (methadone/arrest) for the
resident sub-populations of heroin users in Amsterdam (approximately 4,000) is
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striking. Stronger fluctuations would imply less validity, unless other sources like-
wise suggested major changes. A clear disadvantage of CRC (and nomination) is that
they can be applied only when subject registrations are available. When they are
not, estimation will be problematic, if not impossible. Since most registrations in
Europe are still confined to, or dominated by, opiate users, application of CRC in
other drug-using populations – e.g. cocaine, MDMA – will not normally be feasible.
As regards heroin, recreational and infrequent users are generally under-represented
in, or even excluded from, registrations. As a consequence, the CRC method will
continue to be applied predominantly to estimate numbers of problem heroin users
in urban settings.
Although I have referred to nomination as an alternative method, it should be
applied in at least some cases as a complement to CRC. Nomination may, at an early
stage, reveal biases in CRC estimates. Later, it may help to explain inconsistencies
that arise in such approximations.
Conclusions
In this paper I have described various methods which can be used to estimate numbers
of problem heroin users. School and household surveys show that no more than a tiny
segment of the population has ever used heroin. Such surveys cannot be used to make
estimates sufficiently accurate to map trends in the scale of heroin consumption. 
Therefore, I proceeded to review indirect parameters such as drug seizures and drug
mortality rates. Both in the Netherlands and in Germany, an ever-growing amount of
heroin has been confiscated since the early 1970s. In Germany, a sharp rise in heroin
deaths was recorded particularly in the late 1980s and early 1990s. The positive corre-
lation between the larger heroin hauls and the greater number of fatalities implies a
growing number of heroin-dependent people in Germany. Such a correlation was enti-
rely absent in the Netherlands, however. Statistics on heroin deaths and heroin seizures
therefore cannot serve as unequivocal universal indicators of the size of heroin users’
populations. One complicating factor is the degree to which heroin is being used intra-
venously. That is much more often the case in Germany than it is in the Netherlands. 
I have devoted a good deal of attention here to CRC. Applying it to the heroin popu-
lation is a tricky business, given that counting heroin users is not immediately com-
parable to counting fish in a lake on the basis of several catches. I have made clear
that certain circumstances among heroin users foster over- or under-estimation. The
direction in which such conditions bias the estimates is known, but determining the
exact degree of bias remains a problem. For estimating the scale of populations of a
highly ‘floating’ nature, such as ‘heroin tourists’, the reliability of capture/recapture
was shown to be too low. For resident populations I have compared capture/recap-
ture estimates to those derived from nomination. Population size was estimated on
the basis of registration figures from methadone provision and from arrests, process-
ing them with self-reports of provision or arrest. For the nomination technique, too,
conditions came to light that can cause over- or under-estimation.
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Although no exact estimate of the size of the heroin-using population can be rea-
ched, I have argued that CRC furnishes a reasonably trustworthy picture of the evol-
ution in the numbers of resident heroin users. 
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Case-Finding, Capture-Recapture
and Double Counting: a Berlin Case Study
by Wolf Kirschner
In the Federal Republic of Germany, reliable data on the prevalence of illicit drug use
are scarce. To date, estimates of the number of ‘hard’ drug users have been derived
mainly from indirect parameters such as drug-related deaths and drug users first registe-
red by the police. These methods estimated the number of hard drug users in Germany
in 1992 to range between 90,000 and 150,000 (IFT, 1994). From these figures, we also
have regional estimates. In Berlin (West), for example, the estimated number of injecting
drug users in 1992 was between 10,000 and 12,000. Such data serve as the basis for
allocating financial or personnel resources in drug prevention and drug treatment.
In 1992, the department for drug control in the Berlin Senate was interested in obtain-
ing more accurate data on the city’s injecting drug user population. The research 
commissioned (Kirschner et al, 1994; Grünbeck et al, 1993) had two goals:
• to estimate the total number of injecting drug users (IDUs) in Berlin (West) by
combining two estimation approaches;
• to describe the population according to socio-demographic and epidemiological
parameters.
In this chapter, I will describe the study and some of the methodological problems
encountered. In particular, I will discuss problems of double-counting.
Methods and assumptions
In epidemiological field research there are several approaches for reaching target
populations. These include population-based approaches, such as representative 
surveys and snowball samples of hidden populations, where data are gathered on
the target population itself; institution-based approaches, where information is
gathered from institutions with which the target population has contact (e.g. health
care and criminal justice agencies); or a combination of these two methods, for
example the nomination technique. This technique is used to estimate prevalence
rates of events in small and hidden populations. For example, the number of drug
users may be estimated by multiplying the number of drug users in treatment (known
from institutional statistics) by the proportion of users in treatment at a given time
(known from snowball surveys). It is in this way that the nomination technique com-
bines institution- and population-based methods (Kirschner, 1993).
Chapter 20
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In this study, comparison is made between capture-recapture and estimations from
treated populations adjusted for non-attendance and double-counting.
Capture-recapture
The first ‘arm’ of the study used a capture/recapture (CRC) approach for estimating
the number of injecting drug users in Berlin. This replicated the method used in a
Berlin study in 1981 (Scarabis and Patzak, 1981). 
From August to December 1992, 41 institutions were enrolled in the study. These
included hospitals, welfare institutions, drug treatment centres, prisons and AIDS
and drug-counselling services. The participating institutions (n = 22) were asked to
complete a short document for each client known to use ‘hard’ drugs. The docu-
ments carried the following information:
• personal identifier;
• date of first contact with the institution;
• date of last contact with the institution;
• date of onset of hard drug use;
• date of onset of injecting drug use;
• type of drugs used.
A total of 6,742 documents were produced for the study. Of these, 1,361 (20 per
cent) were identified as having been double-counted within single institutions. This
left 5,281 documents for use in the CRC estimations. The estimations were under-
taken by a collaborating institute, Intersofia Berlin.
The basic requirements of CRC are that:
• each injecting drug user will be known to at least one of the institutions during
his or her drug-using career;
• the institutions have a comparable probability of being contacted by the drug
consumer;
• the size of the population is stable.
Anonymous Monitoring (ANOMO)
The second arm of the study utilised the ANOMO approach. The aim here was to
elicit reliable information on the socio-demographic and epidemiological parame-
ters of the population, as well as estimating of the number of injecting drug users.
ANOMO is a sentinel-surveillance system based on a representative sample of phy-
sicians in ‘free’ practices. In the German health system, medical services – besides
those in the hospital sector – are offered by general practitioners and other special-
ists who run them in private (‘free’) practices. The method was first developed in our
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institute for monitoring the spread of (diagnosed) HIV infections in Germany, as a
complement to the administrative reporting systems (AIDS Case Registry, Lab
Reporting System). The acronym ANOMO is derived from the practice of
‘Anonymous Monitoring’ of the target population by physicians (Kirschner and
Schwartländer, 1996).
At the end of 1991, there were 1,450 physicians in free practices in Berlin (West),
working as general practitioners or internists. From these, a sample of n = 550 (34
per cent) was chosen at random. The physicians were contacted in the last quarter
of 1992 and asked to participate in the study. They were required to complete a 
practice questionnaire – which gathered data on practice size, number of patients
and risk groups – and to document each patient whom they knew to be in the tar-
get population (i.e. injecting drug users). 
Data from these sources would thus allow the target population to be screened and
provide information on each patient (e.g. age, sex, HIV status). All data relate to the
year 1992.
By the end of the fieldwork in March 1993, 402 physicians (79 per cent) had taken
part in the study. Physicians who did not take part were checked to see if they belon-
ged to practices which saw a high number of injecting drug users, but this was not
the case.
The number of patients seen by participating physicians serve as the basis for
ANOMO estimates. These need to be adjusted due to a proportion of the population
not attending the practices and to possible double-counting.
Reasons for selecting physicians for ANOMO monitoring
Given the range of institutions which have contact with injecting drug users, why 
did we choose physicians in free practices to monitor this population? The two 
major problems of employing institution-based methods of estimation relate to atten-
dance and selection bias. An institution had to be chosen which is ‘visited’ by a high
proportion of the target population in a given time period and which is subject to
minimal selection by different types of users. 
For the purposes of this study, the institution also needed to be able to provide relia-
ble epidemiological and medical information. 
Compared to institutions such as hospitals, self-help groups, drug treatment centres,
criminal justice and social service agencies, we rated physicians in free practices as
the most appropriate institution to be involved in the study. The decision to choose
these as the monitoring institution was also made in the light of findings from pre-
vious studies which show high annual attendance rates by current or former inject-
ing drug users and people with experience of illicit drug use. The attendance rate in
these groups of approximately 90 per cent (EFB, 1989; IFT/Infratest, 1990) is signifi-
cantly higher than in the Berlin general population of a comparable age structure (74
per cent of 18 to 39-year-olds) (EFB, 1993). These high attendance rates have also
been found in other countries, such as the Netherlands (Korf, 1995).
While high attendance rates will lower the chance of selection bias, some bias may
remain. For example, people with a long drug-using career may be more likely than
recent initiates to have a poor health status and, consequently, may visit their doc-
tor more frequently. However, the qualitative interviews we conducted with physi-
cians suggested that this hypothesis was implausible.
Identifier coding systems
The alphanumeric coding system used to identify cases in ANOMO was the same 
as that used for the AIDS Case Registry. Each identifying code is derived from the
case’s surname, first name, age and sex. 
A different coding system was used in the CRC study. Here, only the case’s surname
was incorporated into the code, along with the age and sex. Less sophisticated codes
were used because of the higher data protection conditions applying in some of the
CRC institutions. Also, we assumed that subjects’ first names might be documented
incorrectly or incompletely in certain settings.  
Statistical requirements and assumptions of CRC and ANOMO
Table 1 summarises the main statistical requirements of CRC, and the possible pro-
blems and consequences for estimates derived via this method.
Table 1:  Statistical requirements and assumptions of CRC, 
possible problems in the study and consequences for estimation
Assumption/                               Possible                               Possible consequences
requirements                              problems                               for estimation
Each IDU has a probability        A small proportion                 Under-estimation
> 0 to attend one of the             will not attend
institutions at least once
IDUs have to be marked             Missing data                           Over-estimation
completely and identically
Independent random                  Overlap of populations           Over-estimation
sampling                                                                                or under-estimation
Stable population                       Unlikely with an annual         Over-estimation
reporting frame                       or under-estimation
Target population must be          Missing data                           Over-estimation
identified completely                                                              or under-estimation
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The reasons for possible biases in ANOMO estimations are shown in Table 2. To
summarise, there will be overestimation (i) if the annual rate of non-attendance of
physicians by injecting drug users, derived from previous surveys, is much higher
than the assumed 10-20 per cent, and (ii) if double-counting control methods are
ineffective.
Taking all these factors into consideration, we assumed that CRC estimations would
be higher than the ANOMO estimation.
Table 2: Statistical requirements and assumptions of ANOMO, 
possible problems in the study and consequences for estimation
Assumption/         Possible                   Possible consequences
requirements                            problems                              for estimation
Each IDU has a probability       Not given e.g. for people        Under-estimation
> 0 to attend the physicians       in prisons ≥ 1 year                  (correctable)
at least once a year
Not given for the population
not attending (10%-20%)
Random sampling                    Clustering of typical IDU         None
of physicians groups in single practices
may affect the description
of population but not
the estimation
Patients can easily be                Few problems with respect      Under-estimation
identified as IDU by                  to IDU                                 
the physicians
Information gathered on the     No problems with respect        None
population must be reliable       to estimations
and complete
Problems with respect to
description as not all
physicians are documenting
all patients completely
Double counting must be          Methods to control double      Over-estimation
excluded or reduced                 counting may be insufficient
Results
CRC estimates
Twenty-two data samples (n = 5,381 documents) were used as the basis for CRC cal-
culations. Estimations were made for different populations: users of ‘hard’ drugs and
the sub-population of injecting drug users. This was because data on mode of drug
administration were missing on some of the documents used in CRC.
The CRC estimation of Berlin hard drug users in 1992 was 8,923. Of these, 6,335
(71 per cent) were injecting drug users. A further CRC estimation was made which
excluded people in continuous detoxification treatment. This resulted in a ‘worst
case’ estimate of 7,123 and a ‘best case’ estimate of 5,780. The former estimate
was based on analysis of 16 of the 41 institutions (90 per cent of documents) while
the latter estimate incorporated documents from all participating institutions.
ANOMO estimates
Approximately one third of the free practices taking part in the ANOMO study
(128/402; 32 per cent) saw at least one injecting drug user in 1992. The average
number of injecting patients seen in these practices was 7.9 although this varied
considerably. For example, 21 per cent of the practices had ten or more injecting
patients, with an average of 26.5.
The total number of injecting drug users in the ANOMO practice questionnaire sam-
ple was 1,013. Of these, 475 (47 per cent) were documented individually. 
The projection of cases is based on the total number of drug users identified by the
practice questionnaire. The average number of injecting drug users for each prac-
tice in Berlin (West) is 2.88. Multiplied by the total number of physicians in the
city (n = 1,450) this results in an estimate of approximately 4,200 injectors, with
a wide confidence interval between 2,600 and 5,800. The large confidence inter-
val is determined by high standard deviation, based on 21 per cent of practices
having 10 or more patients (mean = 26.5). A double counting rate of 10 per cent
(discussed below) produces a revised estimate of 3,795 patient contacts (min. =
2,351, max. = 5,238). 
To estimate the total population of injecting drug users in Berlin, we must also consi-
der those injectors who do not attend a physician over the course of a year. The assu-
med non-attendance rate in this population of 20 per cent produces an estimate of
4,744 injectors in total (min. = 2,939, max. = 6,548, 95 per cent confidence interval).
Table 3 summarises the estimates derived via CRC and ANOMO. We can see that
the CRC ‘best case’ estimate (5,780) lies within the confidence-interval of the
ANOMO estimate. The maximum ANOMO estimate (6,548) and the CRC estimates
lie closely together. 
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Table 3:  ANOMO and CRC estimates of IDU in Berlin, 1992
Estimate        Range
CRC 6,335 5,780-7,123
ANOMO     4,744                                2,939-6,548
Given that the ANOMO estimates exclude drug injectors serving long-term prison
sentences, they will be lower than those derived through CRC which included this
sub-population. On a fixed day in the study period (30 October 1992), there were
approximately 700 injecting drug users in prison in Berlin.  
From these analyses, we estimate the total number of injecting drug users in Berlin
in 1992 to have been between 5,000 and 7,000. This is approximately half the num-
ber estimated by other methods. 
Methodological problems 
Before describing our procedure for analysing double-reporting in the ANOMO
study, we must first consider the possibility of documentation bias. 
Documentation bias
Studies using the ANOMO approach must consider the possibility of documentation
bias. The approach requires participating physicians to complete a practice
questionnaire and a separate document sheet for each patient who is known to 
inject drugs. In this study, document sheets were completed for only 47 per cent of
the cases identified by questionnaire (475/1,013). The question, then, is whether the
documented cases are a representative sub-sample of the total recorded patient
population.
Our analyses showed a comparatively high documentation rate in practices which
had contact with a small recorded number of injectors. For example, 68.2 per cent
of cases were documented in practices with one or two injecting patients, compa-
red with 39.6 per cent of cases in practices with ten or more injecting patients. This
means that injecting drug users from ‘small’ practices are over-represented in our
sample of documented cases (n = 475).
Documentation bias will only occur if the structure of the injecting population varies
according the ‘size’ of the practice. This was not the case in this study. There were
no significant differences between attenders of ‘small’ practices (one or two patients
who inject) and ‘large’ practices (ten or more patients who inject) with regard to:
mean age; percentage <29 years; percentage male; current injecting status; and per-
centage HIV positive. The only significant difference was that, at small practices,
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injectors tended to have been in contact with the practice for a longer period of time.
Of patients at practices with one or two recorded injectors, 41.1 per cent had atten-
ded since 1989 or before. This compares with 13.3 per cent of patients in practices
seeing ten or more injectors.
These analyses lead us to conclude that the variable documentation rates in the
ANOMO study do not imply documentation bias and that the population docu-
mented was indeed a representative sub-sample of the total population.
Identifying double- or multiple-reported cases in ANOMO
Cross-referral between practices. To help us identify double- or multiple-reported
cases in the ANOMO study, participating physicians were asked to record referrals
of injecting patients to other physicians. In 33 per cent of cases (n = 475) this was
unknown. Not surprisingly, doctors’ knowledge of their patients’ use of other practi-
ces was correlated with their overall knowledge of the patient.
The proportion of patients with known referrals who visited more than one practice
in 1992 was 20 per cent. Assuming that this group does not differ from patients with
unknown referrals, the 20 per cent cross-referral rate pertains to the total ANOMO
sample.
Double-counting of the same person. Turning to personal identifiers to calculate
double-reporting, we are first confronted by the problem of non-response. Of the
475 documentations in the ANOMO study, 430 (91 per cent) had a complete code. 
Calculating the probability of two injecting patients having an identical code as
1:6,536, and taking into account that 430*429/2 = 92,235 pair comparisons will be
carried out, the expected number of pairs would be n = 14 (probability 95 per cent).
This assumes a Poisson distribution with 92,235/6,536 = 14 (confidence interval: 
7-22). 
Analysis of codes for identical pairs and triplets produced nine pairs and three tri-
plets (2.8 per cent). This is in the expected range. Checking additionally for sex and
age (tolerable range +/- 2 years) left five pairs remaining (1.2 per cent) which are pro-
bably identical.
Applied to the estimate of approximately 4,000 patients in contact with free practi-
ces, it can be expected that 500 pairs are probably identical persons. This means that
12.5 per cent of contacts are due to double-reporting. 
Identical codes for different persons. A sometimes neglected fact is that different per-
sons in ANOMO may be allocated an identical code. Double-counting estimates
must therefore be corrected for this. This is important because even a small number
of wrongly detected double reports will affect estimations dramatically.
The question of how many identical identifiers may be expected for different per-
sons was addressed in a study for the Robert Koch Institute. Cases from three inde-
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pendent, representative population samples were coded and analysed. In each of the
three samples (each containing approximately 5,000 cases), the proportions of iden-
tical codes for different persons was about 0.9 per cent. While this proportion is low,
the analysis showed the number of identical codes to rise quadratically with rising
sample size. 
To illustrate how such identical codes may affect estimations, we can analyse a sample
of n = 450 in which n = 15 have an identical code. Uncorrected for identical codes for
different persons, the estimate would be 13,500 (n = 450* 450/15 = 13,500). The cor-
rected estimate, assuming a rate of 1 per cent, would be 18,409 (n = 450* 450/11 =
18,409).     
The difference between the estimates will be smaller if the capture rate is higher.
Nevertheless, this problem should be considered carefully in any study design and
analysis of data.
Conclusions
This study shows how combined methods of prevalence estimations can improve
our understanding of local populations of injecting drug users. Every method has
specific limitations and assumptions. Given that some of these assumptions are dif-
ficult to test empirically and that study designs may be affected by hard-to-detect
selections and biases, congruent estimations may be more reliable.
Nevertheless, it is necessary to have more precise data to test the assumptions. In
ANOMO, for example, accurate data on the proportions of injecting drug users not
attending practices are required. For CRC, the assumption that each institution has a
comparable probability of being seen by clients needs to be investigated more tho-
roughly.
Besides improving the scope and quality of data available, regional prevalence esti-
mations may also be improved by incorporating indirect parameters, such as drug-
related deaths and drug notifications, into the combined approach.  
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Difficulties in Estimating
Prevalence in Budapest
by Zsuzsanna Elekes
In Hungary, illicit drug use is a comparatively recent phenomenon, and it has only
been over the last decade that attempts have been made to map the extent of the pro-
blem. However, the small amount of data available has been questioned as to its relia-
bility. During the 1990s, general population surveys have asked respondents if they
have ever taken drugs, but have not provided information on regular drug users. Very
few attempts at estimating the total number drug users have been made.
This paper presents two studies conducted by the Epidemiology Research Group of
the Sociology and Social Policy Department at the Budapest University of
Economics. Both attempt to throw light on the situation regarding illicit drug use in
Budapest. The first study uses institutional records to ascertain the number of regi-
stered drug users. The second uses snowball methodology to locate opiate users
who are not registered in institutional records. 
Case-finding: enumerating drug users in contact with institutions
The first study, conducted in 1991, attempted to estimate the spread of drug con-
sumption in Budapest and the number of drug users in contact with institutions,
using records from different drug treatment institutions (Elekes and Paksi, 1993). It
also aimed to assess the content, reliability and validity of institutional records on
drug users which are available.
Data collection methods
On the basis of our previous research, institutions having contact with drug users
were classified into three types: the police, health institutions and foster homes.
Offices of these institutions were contacted to determine those which had come into
contact with drug users in the preceding year. Data sheets were then completed for
each person recorded as being a drug user. The sheets recorded socio-demographic
information (e.g. place of birth, address, educational qualifications, occupation and
marital status) and data relating to the subject’s drug use (e.g. current use, reason for
contacting the institution, and the date and duration of the contact). Individuals were
assigned an identifier derived from their initials, date of birth and sex. To establish
Chapter 21
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the authenticity of the data, interviews were conducted with directors of the partici-
pating institutions.
Difficulties of data collection
Difficulties in collecting data were encountered in each of the three types of institu-
tion.
Police data: the main difficulty noted was that only the primary offence is recorded
in police records. This means that the number of offenders arrested for drug-related
crime will be underestimated. For example, if someone was arrested breaking into a
pharmacy, the crime would be recorded as ‘burglary’ or ‘breaking and entering’,
without any indication of whether the crime was drug-related.
Health records: at the time of the research, there were four types of health institution
which treated drug users in Hungary – drug treatment centres, alcohol treatment
centres or departments, psychiatric departments and crisis intervention or emer-
gency departments. The records from non-specialist agencies were particularly poor,
as doctors’ initial diagnoses were often inaccurate. For example, patients were fre-
quently recorded as being psychotic, alcoholic or suicidal rather than as having a
problem with drug misuse. If a patient was subsequently diagnosed as a drug misu-
ser, this information was seldom recorded. Our research suggested that this was
because staff were trying to protect patients from stigmatisation within the institu-
tions.
In institutions where prejudice towards drug users was minimal, or where confi-
dentiality was respected, a patient’s drug use was sometimes recorded. However,
there was still reason to doubt the reliability of diagnoses as staff were insuffi-
ciently trained to recognise drug users. This was particularly the case in crisis
intervention and emergency departments and alcohol treatment centres. For
example, one doctor commented, ‘One of my patients stated that he was a drug
abuser and handed over something and said it was marijuana. But I didn’t know
what it was.’
Difficulties with specialist drug treatment agencies lay in staff suspicion about the
research or their general antipathy towards ‘statistics’. As a result of these difficulties,
only small amounts of data were available from public health institutions.
Records in foster homes: the records kept in foster homes were incomplete. Again,
staff rarely recorded clients’ drug use in order to protect children from stigmatisation.
This could happen when personal files were seen by other institutions. Similarly,
school registration records did not hold information about pupils’ drug use because
other pupils could have access to them. Often drug use went unrecorded because
there was no appropriate document to record the information. It became apparent
that often drug use was only recorded when it occurred concurrently with other
deviant behaviour, such as criminal activity or a suicide attempt.
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Findings
Data were collected on 290 drug users: 233 were recorded from health institutions,
30 from the police and 27 from foster homes. Data on types of drugs used were not
recorded in emergency departments and outpatient drug treatment centres.
However, from health records, it was found that solvents were the only substances
used by individuals in foster homes. For illicit drug users identified through police
records, opium or cannabis tended to be the most commonly used substances. Data
on drug users from health institutions showed the most commonly used drugs to be
tranquillisers (24 per cent), opium derivatives (23 per cent) and solvents (17 per
cent). The use of cannabis and hallucinogens was found in only a small number of
cases.
Concluding comment
The records were found to be unreliable, thereby casting doubt on the validity of the
findings. They were incomplete for numerous reasons, but in most cases it was due
to institutional staff seeking to protect patients or clients from the stigmatising and
legal implications of disclosing their illicit drug use. There also seemed to be consid-
erable mistrust among health personnel towards epidemiological research.
Attempt to estimate the prevalence of opiate use by snowball methods
The second project, undertaken in 1995, was an attempt to locate opiate users who
were not registered in any institutions (Elekes and Paksi, 1996). Its aims were:
• to collect data on frequent opiate users;
• to improve the validity of data collected from police and medical records;
• to assess the usefulness of the snowball methodology which had yet to be used
in Hungary.
The study focused on the use of all opiates rather than just heroin. This was because
previous research indicated the use of other opiates to be more characteristic of drug
consumption in Hungary. In 1992, it was found that 3.1 per cent of schoolchildren
had taken opiates at least once. A 1990 study showed an equivalent figure of 2.2 per
cent for the adult population. Data gathered from police and medical records also
indicated that opiate derivatives (along with cannabis) were the most commonly
used drugs (Elekes, 1993).
The first stage of the research involved dividing the city into appropriate geographi-
cal districts. There was no information to guide this task, other than data from the
1993-4 Budapest School Survey (Elekes and Paksi, 1994). These included demo-
graphic variables such as educational qualifications and parental occupation,
neither of which were correlated with patterns of drug use. There were relationshi-
ps between drug use and other variables, such as the way respondents spent their
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leisure time, and their smoking and drinking habits. However, a general lack of geo-
graphical information meant that the data could not be used as a basis for demarcat-
ing districts in the capital. 
To overcome these difficulties, we used data on registered drug users. First, we cate-
gorised users according to the institution where their drug use was recorded.
Criminal records were of little use since, as noted above, only the primary cause of
arrest was recorded by the police, so medical records were our source of informa-
tion. Medical institutions are not required to report information about drug users, so
we had to check through the case files in every institution to identify those in con-
tact with opiate users.
Five institutions were identified as treating drug users. For reasons of confidentiality,
one of these would not release any information to the study. In the remaining four,
our objective was to collect data on all opiate users registered during 1994, includ-
ing their address, profession and level of education, although the last two items were
often missing.
Data were collected on 240 cases, and there was great variation in the numbers regi-
stered at different institutions (two of the institutions accounted for 95 per cent of
cases). Thirty-three per cent of cases were identified as having been double-coun-
ted, leaving 161 cases for the analysis.
The amount of information recorded was limited and varied between institutions.
This made it impossible to obtain correlations between demographics and opiate
use. The selection of districts was therefore based on data detailing the subject’s
district of residence.
Our analyses showed the rate of opiate use per thousand inhabitants in Budapest to
be 0.08 (range = 0.01-0.23). On the basis of these data, districts were assigned to
one of three groups: ‘below average’ districts (rate of known opiate users =
<0.06/thousand); ‘average’ districts (rate = 0.06-0.1/thousand); and ‘above average’
districts (rate = >0.1/thousand).
Using information on the population density and the profile of inhabitants, a district
was then chosen from each group and a key informant was selected for each of the
chosen districts. The criteria for the selection of informants required them to:
• be in contact with registering institutions;
• be representative of the average drug user in terms of age and reflect the pre-
dominant gender (data from health institutions indicated users were predomi-
nantly male, and had a mean age of 27 years);
• have used opiates in the year prior to the research;
• agree to be interviewed;
• have connections with other regular opiate users in their respective districts;
• agree to name their contacts. 
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Difficulties with data collection
We experienced numerous difficulties in using the snowballing method. First, gene-
ral mistrust of the research made it difficult to recruit people. Individuals were reluc-
tant to offer information about their contacts as they knew that they would be afraid
of such information being released or would suspect the key informant of being con-
nected with the police. This problem was difficult to overcome as we were unable
to reassure the informant’s contacts directly. Informants also feared they would be-
come ostracised by fellow users. These problems were not alleviated by using ex-
drug users and social students in the research.
Informants often failed to maintain contact with us. This meant we had to work with
several contacts before the snowball sample could start ‘rolling’. The chains of con-
tacts tended to break down easily, normally after the second or third connection.
The main reason for this was that individuals declined to be interviewed or wanted
to remain anonymous. These difficulties meant that informants often led us only to
regis-tered users rather than to those not in contact with institutions.
It proved difficult for contacts to name people from their own districts. To overcome
this, we increased the number of districts to include all areas within the three origi-
nal groupings rather than simply concentrating on one area. This did not make the
procedure any easier.
Other obstacles included: difficulties in obtaining users’ initials as many were known
only by their nicknames; the fact that people often moved away from the city or 
were imprisoned; or informants sometimes not knowing whether their contacts were
registered users. This last factor obviously hindered attempts to estimate the preva-
lence of opiate use. 
These difficulties led us to conclude that snowball methodology was an ineffective
way of mapping non-registered opiate users in Budapest and we were unable to use
it to produce a prevalence estimate. The overriding obstacle, encountered in every
district and with each interviewer, was drug users’ mistrust and fear of becoming
involved in the study. We would argue that this problem is not peculiar to this
project, but stems from the general stigmatisation of drug users by the rest of society.
Conclusions
This paper has outlined two methods for estimating the number of drug users in
Budapest. Despite differences in approach, and a three-year gap between the
projects, similar problems were encountered.
First, the reliability of institutional records on drug users was poor. This can be solved
by improving the way records are compiled and by increasing the knowledge of staff
working in these institutions. Second, we were confronted by a general suspicion of
epidemiological research. It is possible that, if this type of research is undertaken
more frequently and is seen to be useful, the suspicion may subside to some degree.
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Finally, we would argue that the greatest problem facing epidemiological research is
the widespread negative attitude towards illicit drug users in Hungary. A survey of
secondary school students, conducted in 1995, shows this attitude to be on the
increase compared with earlier studies (Elekes and Paksi, 1996). This was also found
in a survey conducted with an adult sample. Respondents indicated that the idea of
having a drug user as a neighbour was more disturbing to them than living next
door to people with AIDS, homosexuals, convicted criminals or gypsies. Another
survey indicated that the population was less tolerant towards drug users than it was
towards people who had committed suicide or who were alcoholics.
Under these circumstances, it is perhaps not surprising that illicit drug users do not
trust treatment institutions and that the institutions, in turn, do not register patients
as drug users, for fear of stigmatising them. The implication of these attitudes for our
research was that drug users would not talk to interviewers or name their contacts.
All these factors combined to make it particularly difficult to undertake epidemiolo-
gical drug research in Hungary.
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Comparison of Different
Estimation Methods in Poland
by Janusz Sierosl´awski and Antoni Zielin´ski
Prior to the beginning of the 1980s, drug use was not a publicly acknowledged prob-
lem in Poland. Although statistics throughout the 1970s indicated an increased con-
sumption of the home-produced opiate ‘Kompot’ (a heroin derivative prepared 
locally from poppy straw), painkilling drugs and tranquillisers, this went almost
unnoticed by the media. Those articles which did address the issue emphasised the
‘capitalist’ origin of the phenomenon and did not consider drug dependence to be
the problem of a then socialist Polish society. 
With the first legal Solidarity period of rule in 1980, all former restrictions on public
discussion were lifted. This prompted a series of alarmist media articles on adoles-
cent ‘Polish heroin’ use and wild estimations of the number of drug users in Poland
became rife. Initially, this mood was also mirrored in epidemiological estimations
and, at one point, it was suggested that there were 460,000 drug experimenters and
35,000 regular consumers living in Poland (Bielewicz, 1984). As with earlier esti-
mation efforts undertaken in the late 1970s, these assessments were methodologi-
cally limited in their appreciation of national data and often combined them with
multipliers taken from Western studies (Godwod-Sikorska, 1988).
This chapter describes an attempt to use a number of estimation methods not only
to assess the size of the opiate-injecting population in Poland, but also to negate the
influence of mass media and advocacy estimations on national drug policy. The
resulting assessments were based on statistics from drug treatment clinics and poli-
ce operational data from the wrocl´awskie and kieleckie regions, and from national
data on drug-related deaths.
Data sources for estimation methods
Four data sources were utilised for the study: results from a snowball study, drug
treatment data, police operational data and statistics on drug-related deaths.
Snowball study data
In 1993, a snowball study of drug users was carried out in two regions of Poland:
wrocl´awskie and kieleckie. The areas were deliberately chosen as they represented
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the two extremes of Polish drug use. In wrocl´awskie, drug consumption had been
reported as high, whilst in kieleckie there was a relatively low reported rate of use.
Although the aim of the study was to estimate the number of opiate injectors in both
regions, the logic of the snowball method dictated that both opiate users and indi-
viduals who used any drug on a regular basis should be contacted. The rationale
behind this was that non-opiate users could have introduced researchers to opiate
users. 
Contacted individuals were interviewed about their pattern of drug use in the 30
days prior to the interview, the age at which they first started using drugs, their pre-
sent health status and any previous treatment they had received. Socio-demographic
data were also collected.
In wrocl´awskie, the study was implemented by staff in a drug dependency counsell-
ing centre which also undertook outreach work. Here, selected individuals treated
in the centre or contacted during outreach were asked to introduce staff to other
drug users they knew. In kieleckie, the study was carried out by students and indivi-
duals attached to a prevention centre operating within the educational system. Here,
individuals familiar with other drug users introduced these to staff. 
The study lasted six months. During this time 169 drug users in the wrocl´awskie
region and 48 in the kieleckie region were interviewed. From this number, 107 indi-
viduals (63 per cent) in the wrocl´awskie region and 27 individuals (54 per cent) in
the region of kieleckie were found to be opiate users, the majority of which, in both
regions, used opiates every day (70-80 per cent).
Drug treatment data
In Poland, the drug dependency treatment system was set up in the late 1970s and
is part of the psychiatric care system. There are two separate clinical systems: in-
patient and outpatient.
Inpatient services are found in psychiatric hospitals, detoxification units and rehabil-
itation centres. These also include services run by non-governmental organisations
(NGOs) which have a medical centre status. 
The Institute of Psychiatry and Neurology collates all records relating to inpatient
services. These are collected individually (the record being sent when a patient is
discharged from treatment) and, at the beginning of each year, all clinics send infor-
mation on patients in treatment on 31 December of the previous year. All records
are marked with the initials and birth date of the patient. On the basis of these
records, we were able to construct three indicators relating to the total number of
patients: the numbers admitted, discharged and treated in a given year. 
Inpatient records also provided a drug use profile for each patient. This is contained
in the primary and secondary diagnoses. In accordance with the ICD (9) classification
system, the first diagnosis is coded with four digits whilst the secondary diagnosis
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only receives three digits. The first three digits of either diagnosis denote whether the
patient is drug dependent (code 304) or non-drug dependent (code 305). The fourth
digit of the primary diagnosis denotes the main type of drug consumed.
Consequently, no information was available within the secondary diagnosis
concerning the patient’s drug of choice and this had to be excluded from the analy-
sis regarding the type of dependency. The above limitations result in minor errors,
which do not exceed 2-3 per cent with regard to the first group and 10 per cent with
regard to the latter.
Outpatient services are found in drug treatment, mental health and alcohol treat-
ment centres. NGOs are not included. Aggregate reports are kept on patients’ sex,
age and primary diagnosis according to ICD (9).
Police data on drug users
In Poland, the personal use or possession of drugs is not a criminal offence.
However, the cultivation or production of a drug, including its import, export and
supply to other individuals, is punishable by imprisonment. This is laid out in the
Prevention of Drug Abuse Law passed in 1985.
There are no official statistics on police arrest rates. However, socio-demographic
data are recorded on drug users who may become involved, or are already suspec-
ted of being involved, in crime. These are collected through local police operations
penetrating drug environments which are then reported to regional headquarters.
These data do not include any information on the type of drug used.
There are two main problems with such data:
• as there are no official procedures on how to collate the data, we cannot assume
that every local police operation utilises the same definition of what a drug
dependent individual is;
• as drug users are geographically mobile, they may be included in the register
more than once.
Despite these difficulties, the long-term trends indicated by law enforcement and
drug treatment data were remarkably similar; this may support the value of such an
indicator. 
Data on drug-related deaths
The basic source of information concerning deaths in Poland is the electronic data-
base and archive at the Central Statistical Office (GUS) where every death is recor-
ded. The database records the date and location of death, the socio-demographic
details of the deceased and three contributing causes of death (one primary and two
secondary).
The GUS database and archive were not, however, used for this study for three
reasons:
• death from intoxication with opiates rarely appears in the GUS data, mainly due
to the death classification system which does not allow for such a precise distinc-
tion;
• studies have suggested that a significant proportion of deaths regarding drug
dependents are often classified as being of an undefined cause (Moskalewicz and
Sierosl´awski, 1992; 1996)
• no names or initials are recorded in the electronic database. Only the date of
birth and sex of the deceased can be used as identifiers. This would compound
the problem of double counting when attempting to compare a number of dif-
ferent data sources. Although the archive death records contain given names
and surnames, obtaining this information is difficult due to confidentiality regu-
lations.
The main source of information on deaths of drug dependents used for the study
were police records on drug overdoses. Again, these were based on non-standar-
dised reports from local police stations to regional headquarters. They contained
no information on the type of drug implicated nor any socio-demographic data.
The completeness of such collected data also remains unclear. For instance, 
deaths involving volatile substances may be neglected by some police stations if
the local police does not include glue sniffing into the concept and definition of
drug dependence.
Assessment of validity and reliability of data sources
The reporting systems detailed above should be evaluated in terms of the quality of
the data they produce. This, and other salient indicators of quality, are outlined in
Table 1.
Table 1: Quality of data sources in Poland
Validity     Reliability     Early     Analytical   Confidentiality
warning   capability
In-patient clinics         good good         poor     satisfactory       good
Out-patient clinics  satisfactory      good         poor         poor           good
Police (drug users)       poor        unknown    good       poor            good
Police (deaths)            poor        unknown    good       poor            good
HIV register              good         good         poor     satisfactory       good
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Primarily, this assessment is undertaken in terms of its validity and reliability. By validi-
ty, we refer to the degree of confidence one can have in the data produced as being
reflective of what it proposes to measure. Reliability refers to the data being collected
according to a standardised procedure or definition, for example ‘drug dependency’.
‘Early warning’ ability refers to the regularity by which data become available, and
the month of the year when data become available. It is assumed that the earlier the
data are available the easier it is to target policy interventions effectively.
‘Analytical capability’ is coterminous with the type of data available. Therefore,
those systems which collect data on an individual’s socio-demographic background
and their drug use profile are deemed as more desirable.
Estimations
Three different types of estimation were undertaken: (a) estimations based upon the
snowball study, using treatment experience as a multiplier and applying this to city
and national treatment statistics; (b) drug-related deaths statistics, using mortality
rate multipliers; (c) capture-recapture approach, using data from the snowball study
and drug treatment and police data.
Snowball study estimates
Data collected in the wrocl´awskie and kieleckie regions through the snowball pro-
cedure were used to estimate the number of opiate users in Poland. This estimation
was based on the number of opiate users who had undergone inpatient treatment in
the previous year (1993).
It was found that in the region of wrocl´awskie, 49 per cent of all opiate users inter-
viewed were treated as inpatients, whilst this was the case for only 19 per cent of
opiate users in the kieleckie region. Of course, this may have been due to the lesser
availability of treatment in kieleckie and it could also have been influenced by the
different starting points of the snowball in each region. However, if generally repre-
sentative, then the total population of opiate dependent individuals in wrocl´awskie
is approximately twice as big as the number of individuals who had received inpa-
tient treatment. The total number of opiate users in kieleckie would be five times
higher than the number of treated individuals.
In 1993, 250 residents of the wrocl´awskie region and 60 residents of the kieleckie
region were treated as inpatients because of opiate dependency. Therefore, the total
number of opiate users would amount to approximately 500 in the wrocl´awskie
region and to 300 in the kieleckie region.
If we apply these two multipliers for estimation using national inpatient statistics, the
following results are obtained: on the basis of the wrocl´awskie findings the number
of opiate users in Poland may be estimated as being around 8,300 and on the basis
of the kieleckie findings around 20,000. 
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Estimates derived from drug-related death statistics
Estimations were also made on the basis of police statistics on the number of drug
overdoses in Poland in 1995. This employed a multiplier constructed from three pre-
vious studies. 
The first two studies examined the mortality rates of drug dependent individuals in
inpatient clinics over a four-year period beginning in 1974 and 1984 respectively
(Moskalewicz and Sierosl´awski 1984; 1992). These yielded mortality rates of 1.6
and 1.7. 
The third study assessed the mortality rate of injecting drug users from a detoxifica-
tion unit in Warsaw between 1983 and 1992. The study was a part of an inter-
national project initiated by the World Health Organisation and revealed a mortality
rate of 2.6 for men and 1.4 for women (Moskalewicz and Sierosl´awski, 1996).
From these findings, it was possible to estimate the mortality rate to be approxima-
tely 1-2 per cent. A more sophisticated measure was not available for two reasons.
First, the mortality rate has significantly increased in the last couple of years.
Consequently, those studies addressing an earlier period are perhaps out of date.
Second, the study conducted in Warsaw is limited to only one centre and in the last
period of this study (1991-1992) only 34 deaths were notified. This is too small a
number to use as a base for a multiplier. However, if 1-2 per cent is adopted as the
mortality rate, the 177 cases of deaths reported by the police in 1995 produce an
estimate of 9,000-18,000 opiate users nationwide.
Capture-recapture estimate
The capture-recapture (CRC) method entailed the use of various data sources to pro-
duce an estimate. This was the first time that drug treatment and operational police
data had been combined to produce a national estimate (Moskalewicz and
Sierosl´awski, 1995). Furthermore, unlike in previous studies, the presence of identi-
fiers in the original snowball study, drug treatment and operational police data
meant it was possible to avoid including an individual more than once.
The estimation was broken down into five steps. First, a single health register com-
prising the total population of patients undergoing treatment for drug use was crea-
ted. To avoid the problem of double-counting, all records collected from in- and out-
patient clinics were compared. It was found that 40 per cent of the number of indi-
viduals treated in out-patient clinics had been treated in in-patient clinics in the
same year. From this, the total number of individuals treated in a single year was esti-
mated by adding 60 per cent to the number of patients treated solely in outpatient
clinics. 
Second, all opiate users were selected from this single health register and also from
the snowball sample. Although the operational police data did not contain informa-
tion which allowed this, it was assumed for the purposes of the study that opiate
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users constituted the majority of individuals registered by the police. This could
result in an overestimation of the number of opiate users.
Third, the opiate users from the single health register, the snowball study and operational
police data were compared. Adjustments were made to these figures if any opiate user
appeared in more than one data source. These comparisons are shown in Table 2.
Table 2:  Capture-recapture estimates of the number of opiate addicts in the population
wrocl´awskie        kieleckie
Snowball-police 1,200 401
Snowball-Treatment     907 140
Police-treatment 1,435                                      258
Source:  Moskalewicz and Sierosl´awski (1995).
The number of opiate users in wrocl´awskie was estimated to range between 900 and
1,400 individuals. The estimate for kieleckie was approximately 140-400. The
median of these assessments, i.e. 1,200 individuals in wrocl´awskie and 258 indivi-
duals in kieleckie, were then used as the figure for those regions.
Fourth, a multiplier was created. The estimated number of opiate users in
wrocl´awskie and kieleckie was compared with individual datasets from inpatient
treatment clinics and police operational data. 
From this, it was found that the median assessment of the number of opiate users in
both regions was, on average, 2.4 times higher than the number of drug users regis-
tered by the police. This figure rose to 4.6 times higher when compared with the
number of drug dependent patients at inpatient treatment clinics.
Finally, this multiplier was applied to national statistics from inpatient clinics and
police operational data. The results are shown in Table 3.
Table 3:  Estimated number of opiate addicts
based on police and treatment statistics in Poland
Treatment        Police
Statistics 4,232 16,598
Multipliers     4,6                                        2,4
Final estimate result 19,467                                  39,835
Source:  Moskalewicz and Sierosl´awski (1995).
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It was estimated that the total number of opiate users in Poland can be located within
the range of 20,000-40,000. The lower figure was calculated on the basis of inpatient
treatment data and the higher number was based on operational police data.
Assessment of estimation methods
Although the estimation methods described in this section are reflective of an
increasing sophistication in Polish epidemiology, they must be considered as only
the beginning of an attempt to construct a set of valid estimators. It is possible to
identify three main areas where improvements could be made.
First, in conducting the snowball study, the zero-stage point was not randomly selec-
ted: this could influence the final results. In the region of wrocl´awskie, for example,
the zero-stage point consisted of patients in a dependency treatment clinic. This
could explain the high proportion of treated individuals in the snowball sample.
Equally, the smaller number of treated individuals in the kieleckie sample could be
explained by the zero-stage point being established among individuals without
experience of drug treatment.
Second, the comparison of the treatment register, the police operational data and the
snowball study resulted in three different estimations. On the basis of common sense
this resulted in a median figure for each region. A model for all three sets should be
developed instead.
Third, the multipliers used in the CRC studies were derived from only two regions.
However, regional variations of drug use in Poland are high, as indicated by the regio-
nal rates of hospitalisation for drug addiction (Figure 1). This ranges from 42.0 per
100,000 of the population in Jelenia Góra region to 0.97 in Nowy Saçz region. Rates
for wrocl´awskie region and kieleckie region are 23.5 and 7.1 respectively (Sierosl´awski
1995). To improve the validity of the findings and the multiplier on a nationwide basis,
it is desirable to undertake further CRC studies in other regions of Poland.
Summary of estimation methods
The attempts to estimate the number of opiate users in Poland have produced a 
number of assessments: 8,300-20,000 individuals when using the snowball method;
9,000-18,000 users when using police overdose data; and 20,000-40,000 persons
with the CRC approach. The best estimate is approximately 20,000 individuals.
Conclusions: relevance of estimation to drug policy
Large numbers will always appeal to the imagination and it would be unrealistic to
expect media estimations to have changed much from the early days of Solidarity.
Indeed, according to Wprost Weekly, for example, not only are there now 300,000
addicts in Poland but the number will rise to 3,000,000 in a few years (Szumin´ska,
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Figure 1:  Rate of hospitalisation due to drug dependence
per 100,000 inhabitants by region, 1994
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1994; Mazur, 1994). In the past, the role of epidemiologists has been encroached
upon by activists and advocates. Unlike those derived from the media, epidemio-
logical estimates do not evoke immediate interest and often refer to situations over
the past couple of years. Consequently, politicians have often preferred to listen to
the ‘estimates’ presented by activists and journalists.
However, due to their increasing methodological sophistication, presentations of
epidemiological estimates are becoming increasingly difficult to ignore. At the 1996
meeting of the Inter-Ministerial Commission of Co-ordination of Drug Control, the
latest epidemiological data regarding the situation in the country in 1994 were pre-
sented. Although neither the exposition of the systematical methodology nor the
accurately presented figures provoked any significant discussion, it did, for the first
time, discourage activists from presenting their own opposing assessments based
predominantly on intuition and selective interest. This growing reputation has also
been partly recognised by the inclusion of a government representative and several
epidemiologists in the Pompidou Group.
Poland is currently engaged in a public debate over the proposed content of a new
law addressing the status of personal drug possession. Although the mass media will
always be prone to publishing inaccurate estimates and advocacy groups will con-
tinue to lobby the government, it is likely that, more than ever, attention will be paid
to epidemiological estimates of the number of Polish drug users.
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Comparison of Key Informant
and Multiplier Estimates in Slovenia
by Dusˇan Nolimal
It is only comparatively recently that illicit drug use in Slovenia has been perceived
as a problem. In the last five years, media attention to this issue has rapidly grown
and there has been mounting public concern. This has been accompanied by a con-
siderable growth in the number of governmental and non-governmental bodies set
up to deal with illicit drug use. Heroin injecting, in particular, has become an impor-
tant political issue, not least because of its association with HIV transmission. This
concern culminated in 1991 with the opening of the first specialist treatment
services for heroin users. 
The planning of these services was made in the absence of reliable epidemiological
information. The data which were available indicated the number of problematic
heroin users in Slovenia to be between 2,000 and 10,000 (Nolimal and Premik,
1992; Flaker et al, 1992; Nolimal et al, 1993; Nolimal and Onusic, 1993). While the
figures indicate fewer heroin users than may be found in Western European coun-
tries, they were still deemed significant, given the comparatively small size of the
country and its population.
The paucity of epidemiological data led the National Institute of Public Health to ask
some basic questions such as: What data are available for estimating the number of
heroin users? How reliable are these data? Are the numbers of users likely to 
change? How many users will continue to use drugs over time? What proportion of
users have suffered social or health consequences of drug-taking? What proportion
of the drug-using population are seeking treatment?
To answer these questions satisfactorily, a number of practical, methodological and
conceptual problems needed to be addressed. This paper reviews these issues and
presents three methods we used to estimate the prevalence of heroin use:
• secondary data analysis;
• key informant estimation;
• snowballing.
It should be emphasised that the primary goal of all three studies was to identify high
risk groups in order to help target interventions for problem drug users, rather than
to estimate prevalence.
Chapter 23
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Secondary data analysis
The first systematic attempt to collect data on illicit drug use was undertaken in 1989
by the National Institute of Public Health. Some useful data were available from 
health and social services, pharmacies, law enforcement agencies, schools and pri-
sons. These allowed us to provide an approximate estimate of the size of the problem.
Statistics on the prescribing of methadone and other psychoactive substances provi-
ded an indicator of the extent of heroin use. The increasing number of methadone pre-
scriptions was one of the first warning signals that heroin use was on the increase. The
number of prescriptions for methadone rose from 2,943 in 1989 to 7,656 in 1991.
The police held information on people arrested for drug-related offences. Available
from the Ministry of Interior Affairs were data on the number of people arrested for
drugs possession and on the quantity of drugs seized. Between 1989 and 1996 the
number of heroin seizures increased significantly, indicating a rise in the quantity of
heroin entering the country. The quantity of heroin seized in Slovenia rose from 494g
in 1989 to 8,723g in 1991. Other sources of data included the courts, which held
records on people charged with drug-related offences, and schools, which recorded
data on drug use among pupils. Finally, there were the epidemiological data on AIDS
and HIV infection, collected by the National Institute of Public Health. These showed
a comparatively low number of drug injecting-related HIV cases through the 1990s.
Comments
Access to the secondary data was dependent upon the co-operation of agency repre-
sentatives. This made it important to explain the study to them and to earn their trust.
The quality of available information was found to be lacking in most instances, 
thereby undermining the validity of prevalence estimates derived by this method.
Nonetheless, analysis of secondary data pointed to a rapid increase in the extent of
heroin use since 1989-90.
Key informant estimation
Having identified the available secondary data, we interviewed a range of profes-
sionals who had contact with drug users. These included doctors, pharmacists, 
social workers, teachers, community workers and police officers. The aim of the
interviews was to obtain impressions of the nature of drug-related problems in
Slovenia. The qualitative data were used to inform the design of a standardised que-
stionnaire on drug use, which was distributed to key informants in the nine Public
Health Institutes and eleven regional Criminal Investigation Bureaux. Those invol-
ved drew on data from their own networks of key informants. Participants were
asked to consult their records and use these to estimate the number of registered
heroin users in their respective areas and to make informed ‘guesstimates’ as to the
numbers at regional or local levels. The issues addressed via the questionnaire inclu-
ded: the extent of illicit drug use; community perceptions of drug use; the number
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of heroin users; the proportion of these who are known to the police; the number
who had received treatment; the number of current and former heroin users; and the
prevalence of HIV infection. Estimates from police personnel generated an aggrega-
ted estimate of 1,026-1,226 heroin users. The aggregated estimate from public 
health informants was 743-1,045.
The study produced other information which was useful for the planning of inter-
ventions. For example, two of the country’s largest cities – Ljubljana and Koper –
were identified as holding a high proportion of the country’s heroin users; heroin
was highlighted as the drug associated with the most acute health and social pro-
blems; a general awareness of the link between injecting drug use and HIV was indi-
cated; and a large number of problem drug users were found to have only sought
treatment once the country’s first methadone programme had opened.
Comments
Key informant estimation has an obvious weakness, namely that it relies entirely on
‘guesstimates’ of local experts whose reports may be distorted by incomplete know-
ledge or personal bias. However, it can provide useful data on ‘visible’ heroin users
for minimal cost. 
Snowballing and multiplier estimation 
The third study was conducted in 1993 by the Institute of Public Health in Koper and
the National Institute of Public Health (Krek et al, 1995). Its aim was to identify high
risk groups and to examine drug users’ risk behaviour. The data were used to gene-
rate a retrospective prevalence estimate of heroin addiction. 
Method
The first part of the study was designed to estimate the proportion of heroin users
who had been treated. The existence of the methadone maintenance programme in
Koper, which treated 263 heroin users between 1991 and 1993, helped us gain access
to illicit drug users. Twenty-six of its patients were selected as ‘indigenous fieldworkers’
for the study. The main selection criterion was area of residency as we wanted to en-
sure that fieldworkers would recruit nominees from throughout the country. The task
was made easier because, at the time of the research, there was only one other metha-
done treatment centre, so the Koper centre clientele was drawn from across Slovenia.
Those selected were knowledgeable about, and respected by, heroin users. This ena-
bled them to gain access to other heroin users relatively quickly and smoothly, col-
lect first-hand information on local drug scenes and recruit ‘hidden’ heroin users.
Their role was to nominate individuals whom they knew used heroin regularly. A
questionnaire, exploring risk behaviour and previous treatment experiences, was
then administered by the fieldworker. To minimise double-counting, participants
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were assigned a unique identifying code. This part of the study produced estimates
of the proportion who had received treatment at some time. In the second part of the
study, existing documents relating to drug treatment were also reviewed. Most of
these were available at the two methadone maintenance treatment centres. The
National Institute of Public Health kept documentation on patients who had been
hospitalised through their heroin use (e.g. cases of overdose) rather than on those in
treatment for their addiction. These documents provided benchmark information on
the number of treated heroin users and were used for the prevalence estimation.
Results
A total of 890 heroin users completed the questionnaire.  The study consisted of at
least 21 sub-samples. One fieldworker recruited 139 nominees (19 per cent),
although most recruited approximately 15 to 20. Of the total sample, 616 (72 per cent)
were male and 241 (28 per cent) were female. Respondents were recruited from dif-
ferent areas of the country, but most lived in Koper (24 per cent). Forty per cent of the
sample (362) had received treatment at least once in their lifetime. This percentage
was used as the multiplier for the prevalence estimations. In addition to those who had
ever received treatment, 160 were reported in the same period to have been hospita-
lised as a consequence of their heroin use. These figures were used as the benchmark
for the calculation. It was assumed that most of those who had received treatment in
the past would have done so after the first treatment centres were opened in 1991. The
following approximate estimate was produced applying the benchmark-multi-
plier calculation to the figures:
E = (n1 + n2) x 100
m
E = prevalence estimation for the period 1991-1993
n1 = total number of the treated methadone patients (approximately 360)
n2 = total number of heroin users hospitalised (160)
m = multiplier (% of heroin users who were in treatment – 362/890 = 0.40)
E = 520 x 100 = 1300
40
In this way, the population of heroin users in Slovenia between 1991 and 1993 was
estimated to be 1,300. However, the confidence limits within which this estimate
lies are extremely wide.
Comments
There is insufficient information to assess the quality of the data, for example with
regard to the consistency of fieldworkers’ approaches to recruitment and the reliabi-
lity of self-reported data. We had to review the fieldwork process retrospectively,
relying on anecdotal information and using the indicator of missing data. Given the
data at our disposal, simplifying assumptions also had to be adopted for the preva-
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lence estimation. But, despite the methodological limitations, the analysis offers a
reasonable first answer regarding the size of the heroin-using population in Slovenia.
The recruitment of drug users as the indigenous fieldworkers was critical to the success
of the study. It enabled us to gain access to hidden heroin users and to map areas where
heroin use is most prevalent. The fieldworkers made this possible through having cred-
ibility with other drug users and their ability to establish trusting relationships with
them. Drug users in the treatment programme also offered the study a wealth of infor-
mation and ideas. We would recommend, therefore, that future studies of this type
should actively seek the help and support provided by indigenous drug users.
The snowball sampling method is not without its problems, however. We have been
unable to ascertain how many successive stages of snowballing were produced by
different fieldworkers or to assess, retrospectively, double-counting in the nominee
sample. There was also a lack of information on nominee refusal rates, as well as
errors in the reporting of nominees’ treatment status. The medical records reviewed
for the study were incomplete and double entries of patients were not excluded.
There were also considerable variations in the way treatment centres recorded infor-
mation. For example, some records did not distinguish between different types of
addictive drugs nor did they differentiate between patients who had ever used a drug
and those who were current problem users.
Conclusions
Two recent reports estimate that there are between 2,000 and 4,000 heroin users
nationwide (Nolimal 1996; Kastelic and Kostnapfel, 1996). The snowball and multiplier
approach, presented above, generated a lower figure of 1,300 for the period 1991–93,
although, as stated, the confidence limits are extremely wide. Using the systematic key
person approach, the maximum number of heroin users in 1992 was estimated to be
between 1,045 and 1,226. These two methods, therefore, produced similar estimates.
Both procedures used treatment population as the source group, so it is likely that the
treatment population is over-represented in our samples. From these studies, compara-
tively little is known about users who have never had contact with statutory institutions.
The Pompidou Group assistance programmes in 1993-96 were the first to introduce
basic concepts in drug use estimation (Council of Europe, 1994). The introduction of
standardised methods and indicators has heightened awareness about drug issues in
public health and emphasised the importance of collecting drug-related information,
including information on addiction prevalence (Hartnoll, 1995). One of the results of
this programme is the research described in this paper which presents the first attempt
to use scientific approaches to estimate the extent of illicit drug use in Slovenia. 
In the light of growing public concern about illicit drug use and competition for
public funds, we should be sceptical of prevalence estimates based on anecdotal
evidence. It is important to increase the number of epidemiologists and, we argue,
there is a fundamental need to establish a national unit which would be responsible
for collecting, processing and analysing information on the use of drugs. The unit
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could monitor trends over time and take responsibility for improving the quality and
relevance of information used to inform drug policy.
The economic and political climate in Slovenia is conducive to further rises in the
prevalence of drug use. The increasing availability of heroin, limited economic pros-
pects and the loss of traditional values have encouraged heroin use among the popu-
lation. The development of policies and services concerning drug misuse has been
handicapped by the lack of reliable epidemiological information. If knowledge
about methodological and conceptual issues is limited, and if the resources are
scant, the response to drug problems will be based on inadequate knowledge. Given
the preliminary nature of the research presented in this chapter, it is hazardous to
speculate about the true extent of heroin use in Slovenia and on the adequacy of exist-
ing services. If drug policy and treatment services are to be well informed, and not
merely the product of wishful thinking, it is vital that the quality of the epidemiolo-
gical research is improved so that we can collect reliable information on visible and
hidden drug-using populations.
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Cross-validating at Local Level
by Richard Hartnoll
This final chapter concentrates on how to assess the validity of prevalence estimates,
especially when prevalence and drug use patterns are changing, and on how to
interpret the prevalence rates that are obtained in terms of what they mean within
the context to which they refer.
All methods for estimating prevalence are based on assumptions and have important
limitations and sources of error. The problem is that there is no method that gives a
‘gold standard’ against which to validate any particular estimate. An alternative
approach is to compare estimates based on different methods that make different
assumptions. If it is possible to assess the likely direction of error of each estimate
(i.e. whether it is likely to be too high or too low, or whether certain sub-groups of
users are excluded) then it may be possible to define a range within which the ‘best
estimate’ is likely to lie. During periods when the prevalence is changing, it is nec-
essary to obtain separate estimates for successive years, rather than combine data
from a period of several years. This is the subject of the first section of this chapter.
Even a series of ‘best estimates’ obtained from several different estimates over suc-
cessive years remains a rather abstract figure (or range) based on assumptions and
inferences that may or may not be valid. Such estimates should not be accepted in
isolation from other information on the situation to which they refer. Otherwise there
would be no way of knowing whether they are indeed reasonable estimates that
make sense, nor any means of understanding how to interpret and use them within
the wider, dynamic picture of problematic drug use and responses to it. A comple-
mentary approach is thus to examine the relationship between prevalence estimates
and other indicators and sources of information on the drug situation, including indi-
rect indicators of drug trends and consequences, and more descriptive information
on drug use patterns and on the activities and responses of agencies that are the basis
for those indicators. Although this, in itself, may not improve the validity of any esti-
mate in terms of giving a more precise figure, it does set estimates within a more
meaningful context so that they can be useful. This is addressed in the second sec-
tion below.
The examples that are used to illustrate these points are drawn from a broader series
of detailed studies of drug use and drug indicators carried out by the author and his
colleagues in London in the 1980s. These included: studies of the utility of data on
drug problems available from different agencies and other sources of information as
possible indicators of drug trends; pilot studies to estimate the prevalence of prob-
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lematic drug use (with an emphasis on regular opiate use); and fieldwork studies of
drug users both in and out of treatment (Hartnoll et al 1985a, 1985b).   
The purpose of this chapter is not to discuss the data themselves, but rather to draw
out some of the lessons that can be learned about assessing the drug situation from
an epidemiological point of view. It must be noted that this is facilitated by the bene-
fit of hindsight. It should also be noted that the original studies were of an explorato-
ry nature and aimed at identifying feasible methodologies that could be applied at
local level. Estimation techniques have become increasingly sophisticated since
then, and other researchers, including many of the contributors to this monograph,
have played an important role in this. However, the main theme of this chapter is 
not to add to the discussion of specific methods but rather to emphasise that no level
of technical development is adequate unless it is accompanied by critical reflection
on the relationship between the data and the phenomenon they are assumed to
reflect, and by adoption of a holistic approach in which the consistency between dif-
ferent methods and the coherence of the different parts in terms of the whole are
carefully analysed. 
Although these principles are as relevant at national level as at local level, it is often
more feasible to apply them locally, where context and relevant circumstances can
be taken into account. The researchers involved in the examples given below had
been working in London with a range of services and drug users since the early
1970s, especially in the area selected for intensive epidemiological investigation in
the 1980s. This local knowledge undoubtedly made it easier to assess the results of
each method or indicator within the overall local setting. 
Cross-validation of different prevalence estimation methods
This section describes how a series of ‘best estimates’ for the prevalence of regular
opiate use in inner north London was derived for successive years based on esti-
mates obtained from four different methods: capture-recapture, addict-death multi-
plier, nomination, and extrapolation from a survey of GPs (Hartnoll et al, 1985a).
Where it was possible to apply different methods to the same year, then the differ-
ent methods indicated relatively similar prevalence levels, though differences also
emerged that need to be discussed more closely, especially regarding the death
multiplier. 
As far as we are aware, apart from a case-finding and capture-recapture study in
Sweden (Socialdepartementet, 1980) and apart from several case-finding studies 
in the United Kingdom (Arroyave et al, 1972; Bishop et al, 1976; de Alarcon and
Rathod, 1968) and an application of nomination methods (Blumberg and
Dronfield, 1976), this was the first systematic attempt to apply simultaneously dif-
ferent prevalence estimation methods in Europe, although various methods had
been used in the United States (DuPont and Piemme, 1973; Greene, 1974;
Greenwood, 1971; Hughes, 1977; Hunt and Chambers, 1976; Newmayer, 1976;
Person et al, 1977). 
249
Chapter 24
Since these estimates were feasibility sub-studies rather than major research investi-
gations of prevalence, the detailed data are not reproduced here. As with all initial
efforts, more can be learnt from mistakes and careful reflection on the nature and
direction of the likely errors in the estimates rather than from the results themselves.
For the purpose of these estimates, the operational definition of a case was a person
aged 16 to 44 years who had used an opiate on a daily or almost daily basis (6 days
per week) for at least a month during the course of the calendar year and who was
living in the Inner London boroughs of Camden and Islington (population around
300,000). It was not always easy to apply these definitions precisely and some of the
problems are described below. 
Capture-recapture
For the capture-recapture estimates, four different samples of opiate users were
obtained from sources covering the defined population. The sources were: a spe-
cialised outpatient drug treatment centre, a hospital for infectious diseases, the death
records at a Coroner’s Court, and court cases identified through local newspaper
reports. 
There were few problems in applying the case definition at the outpatient treatment
centre. This was due to the fact that treatment was aimed primarily at opiate depen-
dents, that all those attending had been carefully assessed, and that clinical records
were systematic and of high quality. The situation was similar at the hospital for
infectious diseases (cases were opiate injectors with acute hepatitis). At the 
Coroner’s Court, it was necessary to review in depth the records of all unnatural
deaths between the ages of 16 and 44 where there was a possibility of drug involve-
ment, since death certificates or Coroners’ verdicts were not usually adequate for
deciding if the criteria for a case had been met. Relatively extensive information was
often available from these records on dependent or regular opiate users who died
through a variety of causes although, if there were any arising from road traffic acci-
dents, then these would have been missed. 
In order to include a sample drawn from law enforcement sources, it might have
been preferable to use records based on arrests of opiate users by the police.
However, it was not possible to obtain data that identified individuals. In any case,
it is unlikely that police data would have provided information on most of the opi-
ate users they arrested, since usually the alleged offence involved theft rather than a
drug offence such as possession of opiates. Similar limitations applied to court sta-
tistics. 
As an experimental alternative, we used reports from the local newspapers, which
routinely covered the local courts and which, every week, would contain pages of
cases including names, age, street or district of residence, offence and, when applic-
able, whether the accused was described as an addict. The (coincidental) fact that
the fieldwork office was based above one of the two local newspapers was useful in
verifying the unorthodox sampling procedure! Even if coverage of court cases was
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not comprehensive, we could find no indications of systematic bias in the resulting
sample, though it was clearly an assumption that this was a representative sample of
opiate users passing through the local courts. Cases were included only where there
was information to justify a reasonable assumption that they met the study criteria,
although it is quite possible that some did not. In these respects, however, the sam-
ple was probably no worse than any other drawn from law enforcement sources. 
For all four samples, full names, as well as other information, could be obtained for
research purposes, thus making the task of identifying overlaps between samples rel-
atively easy. Since this was an exploratory study of the capture-recapture method in
a fairly restricted area, the samples were relatively small and the overlaps between
pairs of samples in single figures. It was thus only possible to apply the two-sample
model, albeit for different combinations of sources taken two at a time. The confi-
dence intervals (estimated subsequently by Colin Taylor) were also too large to allow
reliable comparison between the estimates produced by different pairs of samples.
However, one can use this experience as a basis for discussing how one might try to
understand whether combinations of given pairs of sources might lead to a higher or
lower estimate. Even when samples are large enough to apply three or more sample
models and allow for positive or negative dependency between pairs of samples, it
is also valuable to reflect, in non-statistical terms, on how case definitions, as actu-
ally applied in the different samples, as well as the possible dependencies between
samples, might affect the estimate. At the same time, the reader should be warned
that this can lead to serious headaches!
Thus, during the period of this study, it was observed in a separate sub-study of opi-
ate users not in treatment that sniffing or smoking heroin was becoming more com-
mon. At first, with some exceptions, this was not reflected in the treatment sample,
though subsequently the proportion of non-injectors in treatment increased. 
Throughout the study, the sample from the Coroner’s Court consisted largely of 
injectors, again with a few exceptions, and the sample from the hospital for infec-
tious diseases contained only injectors. Thus, if injecting users were more likely to
go for treatment and also more likely to die and/or to be admitted to hospital for
drug-related diseases such as acute hepatitis, then capture-recapture estimates based
on overlaps between treatment and deaths or drug-related infectious diseases would
underestimate the extent of opiate use by other routes. An under-estimate would also
have arisen if cases were referred from the hospital for infectious diseases to the
treatment centre. However, when the number of non-injectors in treatment subse-
quently increased, then the estimates also increased, since non-injectors had a lower
probability of dying or contracting drug-related infectious diseases and the overlap
was therefore lower.
Conversely, estimates based on the overlap of treatment and court samples might be
expected to give lower overlaps, and thus higher estimates, if the case definition in
the court sample was broader and included cases of individuals who were not so
heavily dependent and thus less likely to go for treatment, or if a significant propor-
tion were sent to prison and thus unable to go for treatment.
251
Chapter 24
It is not always possible to describe the effect on the estimate of differences in the
application of the case definition in practice, nor is it easy to assess the likely direc-
tion of error resulting from dependence between samples in the simple two-sample
model. Attempting to do this does, however, force the researcher to think hard about
how the case definition is applied in practice and about whether inclusion in one
sample means that cases are more or less likely to be included in the second. Many
of these effects are likely to be rather specific to local circumstances. Such reflec-
tions thus push one towards trying to understand the relationship between different
sources of information and the conditions under which drug users are more or less
likely to be identified by those different sources.
Addict death multiplier
The second estimation method applied was based on a projection from the number
of regular opiate users who died each year - the addict death multiplier described 
by Martin Frischer and Henrik Sælan in Chapters 12 and 15 of this monograph.
Several studies in the United Kingdom had suggested that the mortality rate from all
causes for opiate-injecting addicts was between one and two per cent per year. The
mid-point of this range was taken as the basis for the multiplier that was then applied
to the annual number of regular or dependent opiate users who had been living in
the area when they died and who were identified through the comprehensive review
of Coroner’s Court records described above. 
Two possible sources of error in these estimates were the assumption that all relevant
cases were identified in the review of the Coroner’s records, and that the mortality 
rate was correct and constant. As noted earlier, if there were any deaths of regular opi-
ate users due to road accidents, then these may have been missed. In such a case, the
estimates would have been too low. Furthermore, the rise in the use of heroin by sniff-
ing, and especially by smoking, over the time period concerned meant that the annu-
al mortality rate based on injecting drug users became progressively too high as non-
injecting modes of use increased, leading to a growing degree of underestimation. It
is thus likely that estimates derived from the death multiplier tended to be too low 
and by an increasing margin in the years following 1980. A further factor, described
below in the second part of this chapter, also reinforces this interpretation.
Extrapolation from a survey of general practitioners
The third estimation method used was an indirect form of capture-recapture. Rather
than identify the overlap between two sources (agencies) by counting individuals,
we attempted to estimate the overlap, in this case between general practitioners and
the drug treatment centre. Surveys of general practitioners gave estimates of the
number of cases whom they saw for whatever reason and of the proportion who had
been in treatment at the treatment centre during the previous year. Since the num-
bers treated at the centre each year were known, the same two-sample capture-
recapture formula was applied to give an estimate of total prevalence. 
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One should be especially cautious about estimates derived in this indirect manner.
In this particular example, there was also good reason to assume that there was a
positive dependency between the two sources, since some addicts had been referred
to the treatment centre by the GP and others became known as addicts to their GP
as a result of going to the treatment centre. It is quite likely that this led to an under-
estimate.
Nomination technique
The fourth and final estimation method was based on nomination techniques. Over
100 opiate users interviewed in an ongoing community-based fieldwork study in the
area served by the treatment centre were asked to nominate friends who were also
regular opiate users and to indicate whether those friends had been in treatment at
the centre during the previous year. The ratio of ‘attended treatment centre’ to ‘not
attended’ was averaged across all respondents and the ratio was used as a multipli-
er to extrapolate the estimated prevalence from the known figures for the number
attending the treatment centre. 
As with all other methods, there are biases. If interviewees were unaware that some
of their friends had been to the treatment centre, then the multiplier would have been
too large and the estimate too high. Conversely, if respondents included as ‘attend-
ing’ the friends who had only been referred to the treatment centre but who had not
actually attended, or who had attended but only in the past, prior to the specified time
period, then the multiplier would have been too small and the estimate too low. It 
was not possible to assess which direction of error was more likely. At the time, the
services offered by the treatment centre often included methadone. It was apparent
from the interviews and observations made during the fieldwork study that regular
opiate users were very aware of the drug use patterns of their friends. Also, one of the
salient topics for conversation amongst them was whether or not these friends were
receiving a ‘script’ (prescription for methadone) and from whom. 
Even if the nomination information used to obtain the multiplier was reasonably reli-
able, there remained problems of sampling, discussed in Chapter 16 of this mono-
graph by Colin Taylor, and also of case definition as it was understood by the inter-
viewees. In particular, among the interviewed sample, the proportion of injectors
was lower than at the treatment centre and, furthermore, many respondents knew
larger numbers of intermittent or occasional users (who did not inject). 
Whilst the interviewers stressed that they were interested only in nominations of
friends who were regular, probably dependent opiate users, and excluded occa-
sional users, it was not easy to be certain how strictly the case definition was applied
in practice. It was nonetheless interesting, and reassuring, that the estimates given 
by a multiplier obtained from opiate users were rather similar to those achieved
through capture-recapture. Beyond this, the sub-study was valuable for indicating
that estimates based on samples biased towards injecting users would understate the
population of regular opiate users who were not injecting.
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The ‘best estimate’
Figure 1 shows the results of the prevalence estimates for the age range 16 to 44
years derived from the different methods from 1980 to 1982. For 1980, five esti-
mates were obtained, and four for each of the remaining two years. As would be
expected, there was a range of estimates for each year, but the ‘best estimate’, which
was taken as a simple average of all the estimates for that year, showed a near dou-
bling in prevalence between 1980 and 1982. In retrospect, as described below, it is
clear that the period from the late 1970s through to the mid 1980s did indeed wit-
ness a major rise in the prevalence of opiate use and dependence in London (and in
other parts of the country). The trend in Figure 1 can thus be considered to be vali-
dated to a degree that is acceptable for the practical business of policy making and
planning, even though considerable uncertainty surrounds each individual estimate. 
Several provisional comments can be made on the value of the different methods. It
can be noted that the death multiplier did appear to underestimate prevalence as non-
injecting modes of administration of heroin developed, emphasising the message that
the mortality rate on which the method depends must not be assumed to be constant
over time or between places. Extrapolations from the estimated overlap between gen-
eral practitioners and the treatment centre also gave lower estimates, adding to the dis-
cussion of statistical interdependence between samples and the value of looking in
non-statistical terms at the relationship between the clientele of different agencies. The
overlap between treatment and reported court cases gave a higher estimate, suggest-
ing, although not conclusively, that covering both health and law enforcement sources,
as suggested by Antònia Domingo-Salvany in Chapter 8, is preferable in that it gives
an estimate of a population that is broader than that which may utilise health services.
Finally, we would agree with the conclusion of Dirk Korf in Chapter 19 that nomina-
tion methods offer an acceptable alternative to capture-recapture, with the proviso that
it is always preferable to apply at least two different methods rather than rely on one.
It might have been interesting to have had the possibility of comparing the estimates
obtained through the indirect methods described above and elsewhere in this mono-
graph with the results of surveys based on random population sampling. This was 
not possible, since no such surveys were conducted over that period which would
have allowed comparisons to be made. In any case, it is unlikely that the results
would have added much information, since traditional population surveys are not
usually sensitive to rare, socially marginalised groups. 
A final comment in this section is that, in a period when incidence is rising and
prevalence is changing fairly rapidly, it is necessary to derive estimates based on rel-
atively short successive time periods. If this is not done, then the assumption of a
closed population is seriously compromised. In this example, it would not have 
been appropriate to combine data from several years in order to increase sample
sizes and statistical power. An alternative strategy, especially when sample sizes in
local studies may be relatively small, is to set the estimates in a wider context that
includes other trend indicators, a longer time perspective, and the findings, both
qualitative and quantitative, of research studies on drug use patterns and drug using
groups. This is the topic of the second section of this chapter.
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Figure 1 - Heroin Prevalence Estimates (Inner North London)
Relationship between prevalence estimates and other indicators
A variety of different agencies and institutions generate information that can be used
as indirect indicators of trends in drug use, or at least of certain aspects, conse-
quences or correlates of drug use. These indicators include the demand for treatment
for drug dependence or other problems, drug-related emergencies treated in hospi-
tal emergency rooms, drug-related infectious diseases notified by public health ser-
vices, drug-related deaths, police arrests of drug users or arrests for offences against
the drug laws, seizures of illicit drugs made by the police and so on. The same prob-
lem arises for individual trend indicators as for single prevalence estimates - there is
no ‘gold standard’ against which to validate the trends observed in any given indi-
cator. Thus, a strategy is required to analyse the different indicators as a package and
to cross-refer between them rather than treat them individually in isolation. Even if
the validity of a particular indicator is doubtful, greater confidence can be placed if
several relatively independent indicators all point in the same direction.
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Multiple indicator analysis of trends in regular opiate use in London
Figure 2 shows a selection of different indicators of trends in opiates (or in some cases
only heroin) in London from 1977 to 1985. The data were collected as part of the same
series of exploratory epidemiological studies of methods, including prevalence esti-
mation, that could be used to assess local patterns of drug use and drug-related prob-
lems (for full data, see also Hartnoll and Grey, 1987; and Hartnoll, Perera and 
Gorman, 1992). The indicators refer to London as a whole (apart from drug-related
deaths) and not just to the population of the area to which the prevalence estimates
described above refer. This is because it was not possible to disaggregate the data for
all indicators for inner north London alone. This should not affect the broad thrust of
the analysis developed in the rest of this section, since the analysis focuses on relative
trends rather than on absolute prevalence and because it is clear (again with the ben-
efit of hindsight) that the increase in heroin availability, use and dependence was not
limited to one area of London alone, but was a more widespread phenomenon occur-
ring across London and in other parts of the country as well.   
In Figure 2, 1979 is taken as the reference or index year with a value of 100 for all
indicators. The figure thus shows the relative changes in each indicator over time
compared to other indicators. Where relevant, the indicators, like the prevalence
estimates, are based on data for the 16 to 44 year age range. The indicators pre-
sented in Figure 2 are: first notifications of new heroin addicts requesting treatment;
drug-related deaths of opiate users or involving opiates identified from reviews of the
records of the three Coroners’ Courts covering inner London (acknowledgements to
Mr. John Harvey for his data); the number of seizures of heroin made by the
Metropolitan Police; and the retail (‘street’) price of heroin per gramme based on
fieldwork studies (Lewis and Hartnoll, 1985 ) and other sources. The thick line refers
to the estimates of total prevalence of regular opiate use described in the first sec-
tion, with additional estimates for the years before and after the 1980-1982 period
included. 
We also collected data for other indicators, including in-patient hospital admissions
with a primary or secondary diagnosis of drug dependence (morphine type), drug
injection-related cases of hepatitis B, arrests by the police for possession of heroin,
the total quantity of heroin seized each year, and, for some years, the purity of hero-
in at user level. For the sake of visual clarity, these are not included in the figure, but
are commented on in the text below. 
It can be seen that the number of new addict notifications from treatment centres
and doctors (treated incidence) showed very modest changes from 1977 to 1980,
but then increased rapidly from 1981 to 1985. Hospital admissions (not shown) of
patients with a diagnosis of opiate dependence also increased from 1981 but at a
much slower rate. Drug-related cases of hepatitis increased from 1983, though again
the increase was not dramatic. Concerning law enforcement indicators, the number
of seizures of heroin made by the police increased at the same rate as first treatment
notifications, especially from 1981, though unlike treatment notifications, they had
also shown an increase from 1977. The number of people arrested for possession of
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heroin (not shown) followed an almost identical curve to that for the number of
seizures. The quantities of heroin (not shown) also increased over this period whilst
the street price of heroin fell sharply in 1979 and continued to fall until 1984. 
The indicator of opiate-related deaths generally paralleled the increases observed in
the number of seizures and new treatment notifications until 1981-1982, but then
decreased whilst seizures and treatment indicators were rising rapidly. Closer exam-
ination of death data showed that deaths involving heroin continued to increase 
after 1992, and that the fall was due to a large drop in deaths involving a synthetic
opiate (dipipanone) which caused particularly dangerous complications when
injected and which was involved in as many deaths as heroin in 1982. Stronger
restrictions were placed on the prescribing of dipipanone and deaths related to the
use of this drug dropped sharply, producing a fall in the overall number of deaths.
This indicator subsequently stabilised from 1984.
Interpretation of the relationship between indicator trends and prevalence
How is one to interpret the changes in the different indicators described above? In
what way do they reflect changes in incidence and prevalence? Considering the first
question, it is possible that changes in an indicator such as treatment notifications
reflects the availability, type, attractiveness or capacity of treatment centres, or that
police arrests and seizures reflect the priorities of the police and the resources they
devote to drug enforcement. 
There was little change in the overall level of provision of drug treatment in London
from the second half of the 1970s to 1983. One change that was taking place, how-
ever, was a shift in treatment policy towards substitute prescribing - away from main-
tenance (usually on methadone) and from the prescribing of injectable drugs (also
usually methadone, sometimes heroin) towards a more confrontational, abstinence-
oriented approach in which prescribing was often limited to oral drugs only for a
period of, for example, six months during which the dose was steadily reduced. 
It is very unlikely that this change increased the proportion of heroin addicts going
for treatment, and possibly the reverse. The most likely explanation for the increase
in treatment notifications was an increase in prevalence. Subsequently, in 1983,
additional resources became available to expand treatment services, but this could
not have had a major impact on treatment demand until 1984. 
Similarly, there were no major changes in police priorities and resources regarding
drugs in London until around 1983. Furthermore, the increase in the number of
seizures was not observed for other illegal drugs, but only for heroin. This suggests
that there was no general increase in police drug enforcement. Taken together with
the absence of a significant switch of priorities to target heroin users by the
Metropolitan Police across London, it also suggests that the best interpretation of the
rising number of seizures, at least in the latter 1970s and beginning of the 1980s,
reflected a rise in the availability of heroin amongst drug-using groups encountered
by the police (it should be added that the large majority of seizures involved small
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quantities found in the possession of individual consumers, rather than large quan-
tities seized from dealers).
The increasing number of seizures, and the rising quantities that were being seized by
customs officials over the same period, could have reflected an increased success rate
by law enforcement authorities. Set against this, however, was a sharp fall in the street
prices of heroin from 1979 onwards, suggesting rather that increasing figures for
seizures reflected greater availability of heroin. The reasons for this have been 
described elsewhere (Hartnoll 1987) but included political developments in heroin
producing countries of South West Asia and conditions within Britain, and especially
London, that facilitated the expansion of heroin use and especially heroin smoking. 
Thus, taken as a ‘package’, these indicators were strongly suggestive of a large rise
in heroin use and addiction from the latter 1970s through to the mid 1980s, a con-
clusion confirmed by subsequent experience.
The second question concerns the relationship between these indicators and
changes in ‘real’ prevalence. The estimates of the prevalence of regular opiate use 
in London suggested that heroin use had started to increase from 1977, a couple of
years before the trend became apparent in the indicators. The first indicators to show
a change were drug-related deaths (though the absolute numbers were quite low)
and indicators of the illicit heroin market, rising numbers of seizures and a fall in
price. Hepatitis B data were not available before 1979, so these could not be used
as an indicator of incidence, though they did not appear to be the most useful of the
indicators examined. However, in a similar situation in Dublin, this was the first 
indicator to show a change (O’Hare, 1992). Hospital admission data were not a use-
ful early indicator.  
New treatment notifications showed a longer delay before the trend became clear.
This was consistent with research data from treatment centres suggesting a typical
time lag of three or four years between first heroin use and first treatment demand.
The slower rise in deaths linked to heroin was consistent with research evidence
from treatment centres, and especially from ethnographic research amongst untreat-
ed heroin users, indicating that a significant part of the increase in heroin use was
associated with sniffing or smoking heroin, rather than injection. Otherwise deaths
involving heroin would almost certainly have increased more rapidly. As noted
above, the rise and fall of the total number of opiate-related deaths were affected by
the increased use and subsequent restriction of dipipanone.
Although not an indicator in the statistical sense, the other information source that
picked up the evolving trend, was the community-based fieldwork being carried out
amongst drug users, and especially heroin users. The emergence of heroin sniffing
and subsequently heroin smoking, the adoption of this practice amongst groups that
had not traditionally been involved in heroin use, the fall in price and the shift in
patterns of availability were all observed in the course of these studies.
Subsequent evidence (Hartnoll, Perera and Gorman, 1992) suggested that incidence
of heroin use started to level off around 1983 or 1984 though treatment and enforce-
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ment indicators continued to rise for another year or two, the former because of the
time lag between initiation and treatment, the latter because of increased police
attention on heroin. The number of seizures stabilised in 1985 and the price in 1984.
Subsequently the seizures fell and prices drifted upwards.
The above, simplified example is given to emphasise the importance of using indi-
cators in combination with prevalence estimates and other available sources of
information. Fitting information together in this fashion is rather like doing a large
and complicated jigsaw puzzle - the result is a picture that makes sense, the indi-
vidual pieces make very little sense at all. Another example of a multiple indicator
approach is the work of the expert epidemiology group of the Pompidou Group in
the Council of Europe (Hartnoll et al, 1989; Hartnoll et al, 1994).
Conclusions
This chapter has emphasised a point raised throughout this monograph, that the
mechanical application of statistical techniques is insufficient for achieving mean-
ingful and valid prevalence estimates. It has further stressed that it is vital to exam-
ine prevalence estimates, not only in terms of the methodological requirements of
each method, but to understand where the data come from and what they signify,
and to cross-check any interpretation of those data against information from other
sources and methods.
The final point relates to the usefulness of a prevalence estimate within a policy con-
text, an important issue that is covered in the first section of this monograph. In the
description of the research on prevalence and indicators described here, it was 
noted that treatment and law enforcement policies and resources did not change sig-
nificantly until much of the increase in heroin use and dependence had already
occurred.  This information was used to assist in the interpretation of the indicators
based on those sources. However the same information can also be used to com-
ment on the responsiveness of services and policies to changing patterns of drug use.
Viewed from this perspective, it becomes apparent that changes in treatment and
law enforcement responses occurred too late to have any impact on the develop-
ment of the ‘epidemic’, although they did develop in time to deal with the aftermath. 
When the research described in this chapter began in 1980, the general perception
amongst the different agencies that we contacted was that the big changes in ‘drugs’
had occurred in the late 1960s and early 1970s, and that since then the situation had
stabilised. A similar view could be observed in much of the media and in the (lack
of) political interest. There was some awareness of changing patterns of drug use by
more perceptive individual observers within the health and social care sector and
among specialised police drug squads, but this did not translate into action. 
Subsequently, it was widely accepted that there had been a substantial increase in
heroin use and dependence over that period, and media and political interest esca-
lated in the mid 1980s, but at first the reaction to the estimates and analysis of trends
was that they must be too high. 
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Since the research had been concerned with feasibility and pilot studies at a local
level, it was not possible to make strong generalisations to the national level, even
though we were confident of the conclusions for Inner London based on the cumula-
tive evidence from different sources and methods.  However, once political interest did
‘take off’ (stimulated, it must be added, not by research but by sensational and almost
certainly baseless stories about, for example, drug dealers adding heroin to the milk
provided for primary school children) these same estimates were quoted in justifica-
tion for increased funding, and criticised in other quarters for being too low. 
Many of the difficulties in the relationship between research and policy have been
covered in the first part of this monograph and so only one aspect is raised here. The
sort of situation described in the preceding paragraphs generates a dilemma for both
researchers and policy makers. 
Policy makers say they need information for policy making and planning but the
reactive nature of much policy making on social problems, combined with the time
lag between changes on the ground and the reflection of those changes in the indi-
cators, often means that research findings arrive even later. It thus becomes neces-
sary to think of the future of prevalence estimation not simply in terms of improving
the quality of individual cross-sectional estimates of prevalence in a given year, but
in terms of developing them in the context of dynamic modelling techniques that
take account of different indicators and that offer the possibility, despite the limita-
tions of such models, of projecting trends on a more scientific basis. 
To do this requires not only an extension in scientific methodology, but also a will-
ingness to adopt a broad and holistic approach to integrating a diversity of sources,
methods and sorts of information into future work on prevalence estimation. 
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by Richard Hartnoll
One of the main conclusions of the Scientific Seminar on ‘Addiction Prevalence
Estimation: Methods and Research Strategies’ was that the question ’How many
addicts are there?’ has neither a simple solution nor a single answer. The variety of
approaches described in this monograph reflects the scientific struggle to quantify
the complexity of the phenomena that lie behind this apparently simple question.
However, despite the difficulties of defining what it is that we wish to measure, and
the problems of finding ways to do so, the quality of the contributions contained in
this volume also suggest that the art of scientific prevalence estimation in Europe has
a healthy future. 
I suggested in my introduction that neither the Seminar nor this monograph repre-
sent a final state of knowledge but rather a starting point for the future. In this spirit,
the research agenda for this future can be summarised as follows.
One of the first priorities is to clarify case definitions. The word ‘addiction’, that was
used as a short hand term in the Scientific Seminar, has been changed in this mono-
graph to ‘problem drug use’. This is no accident, but this broader concept raises its
own difficulties. It becomes even more necessary to operationalise and specify, as
far as the sources on which the various estimates are based allow, who is counted
and to what the final estimates refer. In many situations it may not be possible to spe-
cify this precisely in advance, since researchers often have limited control over the
type of data that has been recorded in the registers or other sources on which they
rely. However, it is essential to try to assess and, if possible, stratify what it is that the
estimates they produce can reasonably be assumed to represent, for example in
terms of the main drugs involved, the frequency of use, the routes of administration,
whether or not people in treatment are included, and so on.
It is equally important to clarify the measures that are used. These include: the time
frame of the study; whether estimates refer to point or period prevalence; how well
the area of study is defined; what the reference population is and how issues con-
cerning non-residents are dealt with; whether the population is assumed to be open
or closed; whether longer time periods are studied; how incidence and cessation of
drug use or other movements in and out of the population are handled; whether 
rates are reported rather than numbers and, finally, whether they are broken down
by age, gender and other relevant demographic variables (e.g. urban/rural).
Data analysis, and especially analysis of sources of error, needs to be improved. This
can only be achieved through improved methodological rigour, from relatively basic
issues - such as presenting estimates in terms of confidence intervals rather than a
number or, if this is not possible, in terms of likely ranges - to more sophisticated
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analyses of possible biases in the estimates. Furthermore, this is not just a statistical
issue. Measurement errors may be very important. 
There is no point in developing more sophisticated analysis methods if the data on
which they depend is unreliable or of unknown quality. Thus, it is essential to impro-
ve the quality of basic data collection procedures and of the databases on which all
estimates rely.
It is apparent that there is a particular need to improve national estimates, not only
because of the political demand for such estimates, but also because many of the
methods used are more easily applied at local level. However, since it is known that
prevalence is not evenly distributed across a country, it is also important to aim for
regional and socio-demographic breakdown.
A vital need is to move beyond estimates based on a single method and to develop
strategies to integrate different methods into the estimation process. Different esti-
mates can then be compared and cross-validated. It is also important to include
approaches that go beyond static estimates and analyse trends over time and the
relationship of prevalence to other indicators. These should not only deal with 
trends in the overall prevalence but should also aim to differentiate patterns in dif-
ferent areas or different groups within the population.
Alongside improvement in the methodological quality, greater attention needs to be
given to the interpretation of the estimates: how they should be viewed in the wider
context of society and of the nature and extent of drug taking; what they mean in
terms of problems and needs; what the implications might be for services. To answer
these questions, it is necessary to move beyond prevalence and complement the 
estimates with information on other aspects of the situation, not only statistical stu-
dies, but also qualitative studies. This brings us back to one of the key purposes for
trying to answer the question of ‘How many addicts?’ in the first place. It is a major
challenge for researchers to aim to analyse the relationship and relevance of preva-
lence estimates to policy.
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